#BEGIN_DRUGCARD DB08231

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
28875

# Chemical_Formula:
C14H28O2

# Chemical_IUPAC_Name:
tetradecanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:29:49 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
MYRISTIC ACID

# HET_ID:
MYR

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C14H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2-13H2,1H3,(H,15,16)

# InChI_Key:
InChIKey=TUNFSRHWOTWDNC-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
8237

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
228.3709

# Molecular_Weight_Mono:
228.20893014

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
6.1

# Predicted_LogS:
-5.1

# Predicted_Water_Solubility:
1.72e-03 g/l

# Primary_Accession_No:
DB08231

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
11005

# PubChem_Substance_ID:
99444702

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCCCCCCCCCCCCC(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:26:36 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_10_Cellular_Location:
RNA-directed RNA polymerase 3D-POL:Host cytoplasmic vesicle membrane

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_10_Essentiality:
Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
AF029859

# Drug_Target_10_GenBank_ID_Protein:
7408184

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
Not Available

# Drug_Target_10_Gene_Sequence:
>6555 bp
ATGGGAGCACAGGTATCAACACAGAAGACCGGGGCGCACGAGACTAGCTTGAGCGCTACT
GGCAACTCCATAATACACTACACGAATATTAATTATTACAAAGATGCAGCCTCTAACTCT
GCCAATAGACAAGATTTCACCCAAGACCCTGGTAAGTTTACTGAACCAATGAAAGATGTC
ATGATAAAAACCCTGCCAGCGCTGAATTCTCCAACGGTTGAAGAGTGCGGGTACAGTGAC
AGGGTCAGGTCAATCACACTTGGGAACTCCACTATTACAACTCAAGAGTGTGCCAATGTG
GTGGTGGGGTACGGTGAATGGCCTGAGTATCTGAGTGATAACGAGGCAACTGCTGAGGAC
CAACCAACGCAGCCGGACGTGGCCACTTGCCGTTTTTACACCCTAGACTCAGTCCAATGG
GAGAATGGGTCACCAGGTTGGTGGTGGAAGTTTCCCGACGCTCTAAGGGATATGGGATTA
TTTGGCCAAAATATGTACTACCATTACTTAGGCAGAGCCGGGTATACCATCCACGTACAA
TGCAATGCTTCCAAGTTTCATCAAGGCTGTATCCTGGTAGTGTGTGTCCCTGAGGCGGAG
ATGGGAAGTGCCCAAACCTCAGGGGTGGTCAACTACGAACACATTAGTAAGGGTGAGATC
GCATCAAGGTTCACTACCACGACAACAGCAGAAGACCATGGCGTGCAGGCCGCGGTATGG
AATGCTGGTATGGGCGTTGGAGTTGGGAACTTGACGATCTTCCCGCACCAATGGATCAAC
CTTCGCACCAACAACAGCGCCACAATTGTTATGCCATACGTAAATAGTGTACCAATGGAC
AATATGTATAGACATCACAACTTTACACTAATGATAATACCCTTTGTGCCTCTGGATTTC
AGCGCGGGTGCATCCACATACGTGCCCATAACGGTGACAGTGGCCCCCATGTGTGCCGAG
TACAATGGACTACGACTAGCTGGACACCAAGGACTACCGACCATGAACACCCCTGGCAGC
AACCAATTTCTTACATCGGACGATTTCCAATCCCCGTCAGCGATGCCTCAATTTGATGTA
ACTCCAGAAATGCACATCCCTGGTGAGGTGCGCAACCTCATGGAAATTGCCGAAGTTGAT
TCTGTAATGCCAATTAACAATGATAGCGCCGCAAAAGTTTCATCCATGGAGGCTTATAGA
GTCGAATTGAGCACCAACACTAATGCCGGGACTCAAGTGTTTGGCTTTCAACTGAACCCC
GGAGCGGAATCAGTAATGAACCGCACATTAATGGGTGAAATCCTAAATTACTACGCACAC
TGGTCAGGAAGCATAAAGATAACATTCGTGTTCTGTGGTTCTGCCATGACCACTGGCAAG
TTTCTGCTGTCTTACGCCCCACCAGGTGCAGGTGCGCCAAAAACTCGCAAGGATGCCATG
TTAGGCACTCATGTGGTGTGGGATGTTGGGCTCCAATCCAGCTGCGTGTTATGCATCCCC
TGGATTAGTCAAACCCATTACAGATTTGTGGAAAAGGATCCATACACCAATGCCGGGTTT
GTGACATGTTGGTATCAGACCAGTGTAGTGTCCCCAGCGAGCAACCAGCCAAAGTGTTAT
ATGATGTGCATGGTTTCTGCGTGTAATGACTTCTCAGTTCGCATGTTGAGAGATACCAAG
TTCATTGAGCAAACATCTTTTTACCAAGGTGATGTGCAGAATGCTGTCGAAGGGGCTATG
GTCAGGGTGGCAGATACAGTGCAAACTTCAGCCACAAACTCAGAGAGGGTGCCTAACTTG
ACAGCAGTAGAAACTGGTCACACTTCGCAGGCAGTACCTGGTGATACCATGCAGACTAGA
CATGTGATCAACAATCACGTGAGGTCAGAATCTACAATTGAGAACTTCCTTGCCAGATCA
GCGTGTGTTTTCTACCTAGAGTACAAGACAGGGACCAAAGAGGATTCCAATAGCTTCAAC
AATTGGGTGATTACAACCAGGCGAGTGGCTCAACTACGTAGAAAACTGGAAATGTTTACT
TACCTACGGTTTGACATGGAAATCACCGTGGTCATTACAAGCTCGCAAGATCAGTCTACA
TCACAAAACCAGAATGCACCAGTGCTAACACACCAGATAATGTATGTACCACCAGGGGGA
CCCATACCCGTAAGCGTGGATGATTACAGCTGGCAAACATCCACCAACCCCAGTATCTTT
TGGACCGAAGGGAACGCTCCGGCACGCATGTCAATTCCATTTATTAGCATAGGCAATGCG
TATAGTAATTTCTACGATGGGTGGTCTCACTTCTCCCAGGCTGGCGTGTATGGCTTCACT
ACTCTGAACAACATGGGTCAATTGTTCTTCCGGCACGTAAACAAGCCCAACCCAGCCGCT
ATTACAAGTGTGGCGCGCATTTACTTCAAACCGAAACATGTACGCGCTTGGGTGCCTAGA
CCACCGCGCTTGTGTCCATACATCAATAGCACGAATGTCAACTTTGAACCCAAGCCAGTG
ACTGAAGTACGTACCAACATAATAACAACGGGTGCCTTTGGGCAGCAATCTGGCGCAGTG
TACGTGGGCAACTACAGAGTGGTCAATAGGCACTTGGCGACTCACATTGATTGGCAAAAC
TGTGTATGGGAGGACTATAACAGGGATCTACTGGTCAGCACAACTACAGCTCATGGGTGC
GACACCATAGCTAGGTGCCAGTGCACGACAGGGGTGTACTTCTGCCTGAGCAGAAACAAA
CACTACCCAGTGTCATTTGAAGGTCCAGGATTGGTTGAGGTTCAAGAGAGTGAGTATTAC
CCAAAAAGGTACCAATCCCACGTGCTTCTTGCAGCCGGATTTTCTGAACCTGGAGATTGT
GGTGGTATCTTGAGGTGTGAGCATGGTGTTATTGGTATAGTGACCATGGGAGGTGAAGGT
GTCGTTGGTTTCGCCGATGTGCGAGACCTTCTATGGCTAGAGGATGACGCCATGGAGCAG
GGAGTCAAGGACTACGTGGAACAGCTCGGCAACGCCTTTGGTTCAGGTTTCACCAATCAG
ATTTGTGAGCAGGTCAATCTCCTGAAAGAGTCCTTGGTAGGTCAAGACTCCATCTTGGAA
AAGTCTTTAAAAGCACTAGTAAAAATCATATCAGCATTAGTGATCGTGGTAAGGAACCAC
GACGACTTGATCACAGTGACTGCTACACTAGCCCTCATTGGCTGCACCTCTTCACCATGG
CGATGGCTCAAGCAGAAGGTATCACAATATTATGGAATACCCATGGCCGAGCGTCAGAAC
AATGGATGGCTCAAGAAATTCACTGAGATGACTAACGCCTGCAAAGGCATGGAGTGGATT
GCCATTAAAATTCAGAAATTTATTGAATGGCTGAAAGTTAAGATTCTACCTGAAGTAAAA
GAAAAACATGAATTTCTCAATAGATTAAAACAGCTGCCACTTCTTGAAAGTCAGATTGCT
ACCATAGAACAGAGCGCACCATCACAAGGTGACCAAGAACAGCTCTTCTCCAATGTGCAG
TATTTTGCCCACTATTGCAGAAAGTACGCACCTCTGTATGCCGCCGAAGCAAAAAGAGTG
TTCTCGTTGGAGAAAAAGATGAGCAACTACATACAGTTCAAGTCCAAATGCCGTATTGAG
CCTGTATGTTTACTTCTCCATGGCAGCCCAGGAGCGGGGAAATCCGTGGCTACAAACCTA
ATTGGTAGATCCCTCGCGGAGAAACTTAACAGCTCTGTGTACTCGTTACCACCAGACCCA
GATCATTTTGATGGATACAAACAACAAGCCGTAGTGATCATGGATGACCTGTGCCAGAAT
CCAGATGGGAAGGATGTGTCACTATTCTGTCAAATGGTATCCAGCGTGGACTTCGTACCA
CCCATGGCAGCTCTGGAGGAGAAAGGGATTCTTTTCACGTCCCCGTTTGTGCTAGCATCA
ACCAATGCGGGGTCTATCAATGCACCCACTGTGTCTGACAGCAGGGCACTTGCCAGAAGG
TTCCACTTTGATATGAACATCGAGGTGATCTCCATGTATAGCCAGAATGGGAAGATTAAC
ATGCCCATGTCTGTCAAAACATGTGATGAGGATTGCTGCCCGGTCAATTTCAAGAAATGC
TGCCCGCTGGTGTGTGGTAAGGCCATTCAATTTATTGACAGAAAGACCCAAGTTAGGTAT
TCACTGGACATGTTGGTCACCGAGATGTTCAGGGAGTACAACCACAGACACAGCGTGGGT
GCCACCCTCGAGGCTTTGTTCCAAGGGCCACCGGTCTACAGGGAGATTAAGATCAGTGTC
GCTCCAGAAACACCCCCTCCACCAGCAATCGCTGACCTGCTAAAATCAGTAGACAGTGAG
GCAGTAAGGGAGTACTGCAAGGAAAAAGGCTGGCTTGTGCCGGAAATTAGCTCCACCCTA
CAGATTGAGAAGCACGTCAGTAGAGCATTTATCTGCCTACAGGCTCTGACTACATTTGTC
TCAGTAGCTGGCATAATCTACATTATCTACAAATTGTTTGCCGGTTTTCAGGGCGCGTAT
ACGGGGATGCCAAATCAGAAACCCAAGGTGCCCACTCTGAGACAGGCTAAGGTGCAGGGC
CCGGCATTCGAGTTCGCCGTGGCGATGATGAAGAGAAACGCCAGCACAGTGAAAACAGAA
TATGGTGAGTTCACCATGCTCGGCATCTATGACAGATGGGCAGTGTTACCACGCCACGCC
AAGCCCGGACCGACCATCTTAATGAATGATCAGGAGGTCGGTGTGCTAGATGCCAAAGAA
TTGGTTGACAAAGATGGGACAAATCTGGAGTTGACTCTCCTAAAGCTCAATCGCAATGAG
AAGTTTAGGGATATCAGAGGGTTTCTGGCAAGAGAAGAAGCTGAGGTGAATGAGGCTGTT
TTGGCAATAAACACAAGCAAGTTCCCCAACATGTACATACCCGTAGGTCAAGTCACCGAC
TACGGTTTTCTGAACTTGGGAGGAACGCCCACAAAGAGGATGCTCATGTACAATTTCCCA
ACTAGAGCAGGCCAATGTGGCGGTGTCCTCATGTCAACAGGGAAGGTTCTAGGAATACAT
GTAGGCGGAAATGGACACCAAGGATTCTCTGCTGCCCTCCTTAGACATTACTTCAATGAG
GAACAAGGTGAGATAGAATTCATTGAGAGCTCAAAGGACGCAGGCTTCCCTGTGATCAAC
ACCCCCAGCAAAACCAAGCTGGAACCAAGCGTGTTTCACCAGGTGTTTGAGGGCAACAAA
GAGCCGGCAGTGCTTAGAAATGGGGATCCACGACTCAAGGTCAACTTTGAGGAGGCAATC
TTCTCCAAGTACATTGGCAATGTTAACACCCACGTGGACGAATACATGCAAGAGGCCGTG
GACCATTATGCAGGGCAGCTAGCTACACTGGACATCAGCACAGAGCCCATGAAACTGGAG
GATGCCGTGTATGGTACAGAGGGGCTGGAAGCACTAGACCTAACCACCAGTGCAGGCTAT
CCGTACGTGGCCCTAGGTATCAAGAAAAGAGACATTCTCTCTAAGAAGACCAAAGACCTT
ACCAAGTTGAAGGAATGCATGGACAAGTATGGCCTAAACTTACCAATGGTAACTTACGTC
AAAGATGAATTAAGATCTGCCGAGAAGGTAGCCAAGGGAAAGTCCAGACTTATTGAGGCC
TCCAGTCTCAATGACTCAGTAGCAATGAGGCAAACATTTGGAAACCTGTACAAAACCTTT
CATCTCAATCCGGGCATTGTCACGGGCAGTGCTGTTGGGTGTGACCCAGATGTATTTTGG
AGTAAGATCCCTGTCATGCTTGATGGACATCTCATAGCTTTTGACTATTCAGGTTATGAC
GCCAGTCTCAGCCCGGTGTGGTTTGCATGTCTGAAACTCCTCCTAGAGAAACTAGGGTAT
ACGAATAAGGAAACAAACTACATAGATTACCTCTGCAACTCTCACCACTTATATAGGGAC
AAGCACTACTTTGTGAGAGGCGGTATGCCATCAGGATGTTCGGGCACTAGCATATTTAAT
TCCATGATTAACAACATTATAATCAGGACTCTCATGCTGAAAGTTTATAAAGGCATTGAT
TTGGACCAATTCAGAATGATCGCTTATGGGGATGATGTGATTGCCTCCTACCCGTGGCCC
ATCGATGCGTCACTGTTAGCTGAAGCAGGAAAAGATTATGGATTGATCATGACCCCAGCA
GACAAAGGTGAGTGCTTTAATGAGGTAACCTGGACAAATGTGACCTTTTTGAAAAGGTAC
TTCAGAGCAGATGAACAGTACCCATTCCTGGTCCATCCTGTTATGCCAATGAAGGACATA
CATGAGTCCATTAGATGGACTAAAGACCCCAAAAACACACAGGATCACGTGCGCTCGCTG
TGCCTATTGGCTTGGCACAACGGGGAGCACGAATATGAGGAGTTTATTCGCAAGATCAGA
AGCGTGCCCGTCGGGCGCTGCTTGACCCTTCCTGCATTTTCGACACTGCGTAGGAAGTGG
TTGGACTCCTTCTAA

# Drug_Target_10_General_Function:
Involved in ATP binding

# Drug_Target_10_General_References:
10089503	Filman DJ, Wien MW, Cunningham JA, Bergelson JM, Hogle JM: Structure determination of echovirus 1. Acta Crystallogr D Biol Crystallogr. 1998 Nov 1;54(Pt 6 Pt 2):1261-72.
8411387	Bergelson JM, St John N, Kawaguchi S, Chan M, Stubdal H, Modlin J, Finberg RW: Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of human VLA-2. J Virol. 1993 Nov;67(11):6847-52.
8627260	Huttunen P, Santti J, Pulli T, Hyypia T: The major echovirus group is genetically coherent and related to coxsackie B viruses. J Gen Virol. 1996 Apr;77 ( Pt 4):715-25.
9971773	Oberste MS, Maher K, Kilpatrick DR, Pallansch MA: Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol. 1999 Mar;73(3):1941-8.

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
6738

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
244002.7

# Drug_Target_10_Name:
Genome polyprotein

# Drug_Target_10_Number_of_Residues:
2184

# Drug_Target_10_PDB_ID:
Not Available

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF00073	Rhv
PF00548	Peptidase_C3
PF00680	RdRP_1
PF00910	RNA_helicase
PF00947	Pico_P2A
PF01552	Pico_P2B
PF02226	Pico_P1A
PF08727	P3A

# Drug_Target_10_Protein_Sequence:
>Genome polyprotein
MGAQVSTQKTGAHETSLSATGNSIIHYTNINYYKDAASNSANRQDFTQDPGKFTEPMKDV
MIKTLPALNSPTVEECGYSDRVRSITLGNSTITTQECANVVVGYGEWPEYLSDNEATAED
QPTQPDVATCRFYTLDSVQWENGSPGWWWKFPDALRDMGLFGQNMYYHYLGRAGYTIHVQ
CNASKFHQGCILVVCVPEAEMGSAQTSGVVNYEHISKGEIASRFTTTTTAEDHGVQAAVW
NAGMGVGVGNLTIFPHQWINLRTNNSATIVMPYVNSVPMDNMYRHHNFTLMIIPFVPLDF
SAGASTYVPITVTVAPMCAEYNGLRLAGHQGLPTMNTPGSNQFLTSDDFQSPSAMPQFDV
TPEMHIPGEVRNLMEIAEVDSVMPINNDSAAKVSSMEAYRVELSTNTNAGTQVFGFQLNP
GAESVMNRTLMGEILNYYAHWSGSIKITFVFCGSAMTTGKFLLSYAPPGAGAPKTRKDAM
LGTHVVWDVGLQSSCVLCIPWISQTHYRFVEKDPYTNAGFVTCWYQTSVVSPASNQPKCY
MMCMVSACNDFSVRMLRDTKFIEQTSFYQGDVQNAVEGAMVRVADTVQTSATNSERVPNL
TAVETGHTSQAVPGDTMQTRHVINNHVRSESTIENFLARSACVFYLEYKTGTKEDSNSFN
NWVITTRRVAQLRRKLEMFTYLRFDMEITVVITSSQDQSTSQNQNAPVLTHQIMYVPPGG
PIPVSVDDYSWQTSTNPSIFWTEGNAPARMSIPFISIGNAYSNFYDGWSHFSQAGVYGFT
TLNNMGQLFFRHVNKPNPAAITSVARIYFKPKHVRAWVPRPPRLCPYINSTNVNFEPKPV
TEVRTNIITTGAFGQQSGAVYVGNYRVVNRHLATHIDWQNCVWEDYNRDLLVSTTTAHGC
DTIARCQCTTGVYFCLSRNKHYPVSFEGPGLVEVQESEYYPKRYQSHVLLAAGFSEPGDC
GGILRCEHGVIGIVTMGGEGVVGFADVRDLLWLEDDAMEQGVKDYVEQLGNAFGSGFTNQ
ICEQVNLLKESLVGQDSILEKSLKALVKIISALVIVVRNHDDLITVTATLALIGCTSSPW
RWLKQKVSQYYGIPMAERQNNGWLKKFTEMTNACKGMEWIAIKIQKFIEWLKVKILPEVK
EKHEFLNRLKQLPLLESQIATIEQSAPSQGDQEQLFSNVQYFAHYCRKYAPLYAAEAKRV
FSLEKKMSNYIQFKSKCRIEPVCLLLHGSPGAGKSVATNLIGRSLAEKLNSSVYSLPPDP
DHFDGYKQQAVVIMDDLCQNPDGKDVSLFCQMVSSVDFVPPMAALEEKGILFTSPFVLAS
TNAGSINAPTVSDSRALARRFHFDMNIEVISMYSQNGKINMPMSVKTCDEDCCPVNFKKC
CPLVCGKAIQFIDRKTQVRYSLDMLVTEMFREYNHRHSVGATLEALFQGPPVYREIKISV
APETPPPPAIADLLKSVDSEAVREYCKEKGWLVPEISSTLQIEKHVSRAFICLQALTTFV
SVAGIIYIIYKLFAGFQGAYTGMPNQKPKVPTLRQAKVQGPAFEFAVAMMKRNASTVKTE
YGEFTMLGIYDRWAVLPRHAKPGPTILMNDQEVGVLDAKELVDKDGTNLELTLLKLNRNE
KFRDIRGFLAREEAEVNEAVLAINTSKFPNMYIPVGQVTDYGFLNLGGTPTKRMLMYNFP
TRAGQCGGVLMSTGKVLGIHVGGNGHQGFSAALLRHYFNEEQGEIEFIESSKDAGFPVIN
TPSKTKLEPSVFHQVFEGNKEPAVLRNGDPRLKVNFEEAIFSKYIGNVNTHVDEYMQEAV
DHYAGQLATLDISTEPMKLEDAVYGTEGLEALDLTTSAGYPYVALGIKKRDILSKKTKDL
TKLKECMDKYGLNLPMVTYVKDELRSAEKVAKGKSRLIEASSLNDSVAMRQTFGNLYKTF
HLNPGIVTGSAVGCDPDVFWSKIPVMLDGHLIAFDYSGYDASLSPVWFACLKLLLEKLGY
TNKETNYIDYLCNSHHLYRDKHYFVRGGMPSGCSGTSIFNSMINNIIIRTLMLKVYKGID
LDQFRMIAYGDDVIASYPWPIDASLLAEAGKDYGLIMTPADKGECFNEVTWTNVTFLKRY
FRADEQYPFLVHPVMPMKDIHESIRWTKDPKNTQDHVRSLCLLAWHNGEHEYEEFIRKIR
SVPVGRCLTLPAFSTLRRKWLDSF

# Drug_Target_10_Reaction:
Not Available

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
RNA-directed RNA polymerase 3D-POL replicates genomic and antigenomic RNA by recognizing replications specific signals (By similarity)

# Drug_Target_10_SwissProt_ID:
O91734

# Drug_Target_10_SwissProt_Name:
POLG_EC01F

# Drug_Target_10_Synonyms:
P1A
P1B
P1C
P1D
P2A
P2B
P2C
P3A
P3B
P3C
P3D-POL
Picornain 2A
Picornain 3C
Protease 3C
Protein 2A
Protein 2B
Protein 2C
Protein 3A
Protein 3B
Protein VP0
Protein VP1
Protein VP2
Protein VP3
Protein VP4
RNA-directed RNA polymerase 3D-POL
VP4-VP2
VPg
Virion protein 1
Virion protein 2
Virion protein 3
Virion protein 4

# Drug_Target_10_Theoretical_pI:
6.72

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_11_Cellular_Location:
RNA-directed RNA polymerase 3D-POL:Host cytoplasmic vesicle membrane

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_11_Essentiality:
Essential

# Drug_Target_11_GenAtlas_ID:
Not Available

# Drug_Target_11_GenBank_ID_Gene:
X80059

# Drug_Target_11_GenBank_ID_Protein:
510834

# Drug_Target_11_GeneCard_ID:
Not Available

# Drug_Target_11_Gene_Name:
Not Available

# Drug_Target_11_Gene_Sequence:
>6588 bp
ATGGGAGCGCAAGTATCAACACAAAAGACCGGTGCGCATGAAACCGGCTTGAACGCCAGT
GGTAGTTCTATAATCCACTACACCAACATAAACTACTATAAAGATGCAGCATCCAACTCG
GCAAATAGGCAAGAATTTTCACAAGACCCTGGTAAGTTCACCGAACCAGTGAAGGATATC
ATGGTGAAGTCACTACCTGCACTTAACTCGCCGTCTGCTGAAGAGTGTGGGTACAGTGAC
AGAGTGCGATCCATAACACTAGGTAACTCTACCATCACAACACAAGAAAGTGCAAATGTA
GTAGTGGGGTATGGTCGATGGCCTGAGTACCTGAAAGACAATGAGGCCACTGCTGAAGAT
CAACCAACCCAGCCTGATGTAGCAACATGTAGGTTTTACACCCTGGAATCGGTCACGTGG
GAAAGAGATTCACCCGGGTGGTGGTGGAAATTCCCGGACGCCCTAAAAGATATGGGGCTC
TTCGGCCAAAACATGTACTACCACTATCTAGGAAGAGCCGGTTACACATTGCATGTACAA
TGTAATGCATCTAAATTCCATCAGGGATGCTTGCTAGTGGTCTGTGTACCGGAAGCAGAG
ATGGGATGCAGCCAAGTGGATGGTACTGTAAATGAGCATGGATTGAGTGAGGGGGAGACC
GCTAAGAAATTCTCTTCCACCAGCACAAATGGGACCAACACGGTACAGACGATTGTGACA
AATGCCGGTATGGGAGTGGGAGTGGGCAATCTCACTATATACCCACATCAGTGGATAAAT
TTGCGCACCAATAACTGCGCCACCATCGTCATGCCATACATAAACAACGTACCGATGGAC
AACATGTTCAGACACCACAATTTCACACTAATGATTATTCCCTTTGTACCATTAGACTAT
TCTTCAGATTCATCCACGTACGTGCCCATAACAGTGACAGTCGCTCCAATGTGTGCTGAG
TATAATGGTTTGAGGCTCTCAACCTCATTGCAAGGATTACCTGTCATGAATACACCGGGT
AGCAACCAGTTTCTGACATCGGACGACTTCCAGTCACCATCTGCCATGCCACAATTTGAT
GTCACCCCAGAGTTAAATATACCAGGGGAGGTACAAAACCTCATGGAAATTGCTGAAGTC
GACTCGGTGGTGCCAGTCAACAACGTGGAAGGGAAACTCGACACAATGGAGGTCTACCGG
ATTCCAGTGCAGAGTGGTAATCACCAAAGTGACCAAGTCTTCGGTTTTCAAGTGCAACCT
GGGCTAGATAGCGTTTTCAAACACACGCTACTGGGGGAGATTTTGAACTACTTTGCACAC
TGGTCTGGTAGTATAAAACTAACATTTGTTTTCTGTGGTTCCGCTATGGCTACGGGTAAA
TTCCTACTAGCCTACGCCCCGCCCGGAGCGAACGCTCCTAAGAATAGGAAAGATGCAATG
CTGGGCACACACATTATCTGGGATGTTGGACTGCAGTCATCGTGTGTCTTATGTGTGCCT
TGGATTAGTCAAACTCACTATAGGTTGGTGCAGCAGGACGAGTACACAAGCGCTGGCAAT
GTCACATGCTGGTATCAGACTGGAATAGTCGTCCCGGCGGGCACTCCGACATCGTGCTCC
ATCATGTGTTTTGTATCGGCATGCAATGATTTCTCTGTGAGATTACTAAAGGACACGCCA
TTTATAGAACAAACTGCATTACTGCAAGGTGATGTGGTAGAAGCTGTAGAGAACGCCGTT
GCACGTGTGGCAGATACAATTGGTAGTGGGCCGTCAAATTCGCAAGCAGTGCCTGCTTTA
ACAGCAGTTGAGACAGGGCACACATCTCAGGTGACACCCAGTGATACCATGCAAACCAGG
CATGTCAAGAACTACCATTCCAGATCTGAGTCCAGCATTGAAAACTTCCTCAGCAGATCT
GCCTGCGTTTATATGGGAGGATACCACACAACCAACACTGACCAGACAAAATTATTTGCC
TCATGGACTATTAGTGCACGACGCATGGTTCAAATGAGACGCAAGCTAGAGATCTTCACT
TACGTCCGTTTTGATGTGGAGGTGACTTTTGTGATTACCAGCAAGCAGGACCAGGGCTCC
CGATTGGGCCAAGACATGCCACCCCTGACTCACCAGATCATGTATATCCCACCAGGGGGG
CCCATTCCAAAGTCTGTCACTGACTATGCATGGCAAACCTCCACCAACCCCAGCATTTTC
TGGACTGAGGGGAACGCGCCACCCAGAATGTCTATCCCATTCATTAGCATTGGTAACGCC
TACAGTAATTTTTACGACGGGTGGTCTCACTTCTCGCAAAACGGGGTGTATGGCTACAAC
ACACTCAACCACATGGGTCAAATTTATGTTAGACACGTGAATGGATCATCACCACTCCCT
ATGACTAGCACTGTTAGAATGTACTTCAAGCCGAAGCATGTTAAAGCATGGGTCCCGCGG
CCTCCTAGGCTATGCCAATACAAAAATGCATCCACGGTGAACTTTACACCCACAAACGTC
ACCGACAAGCGAACCAGCATCAACTACATTCCTGAGACGGTCAAACCAGACCTATCAAAC
TACGGAGCTTTTGGATACCAATCAGGGGCCGTGTACGTCGTAAACTACAGGGTGGTGAAC
CGGCATCTGGCAACCCATACCGACTGGCAAAACTGTGTATGGGAGGACTACAACAGAGAC
CTCCTTATAAGCACCACCACAGCCCACGGATGCGATGTTATAGCCAGGTGTCGCTGTTCA
ACGGGGGTCTACTACTGTCAGTCTAAGGGTAAGCACTACCCAGTCAATTTTGAGGGACCG
GGTCTTGTGGAAGTTCAGGAGAGTGAGTACTATCCCAAGAGATATCAATCCCATGTCCTT
CTCGCGGCAGGATTTTCCGAGCCTGGCGATTGTGGTGGGATTCTGAGATGCGAGCACGGT
GTCATCGGAATTGTGACCATGGGGGGTGAAGGTGTCGTTGGCTTTGCCGACGTGCGTGAC
CTCTTGTGGTTGGAGGACGATGCGATGGAGCAGGGAGTGAAGGACTATGTAGAGCAACTT
GGAAATGCCTTTGGTTCGGGCTTCACCAACCAAATTTGTGAACAAGTCAACCTCCTAAAA
GAGTCACTAGTGGGTCAAGACTCCATCCTAGAGAAGTCTCTGAAAGCTTTGGTGAAAATA
ATATCAGCCTTAGTAATTGTGGTGAGAAATCACGATGACTTAATCACAGTAACTGCCACA
CTGGCCCTCATCGGCTGCACCTCATCCCCGTGGCGGTGGCTTAAACAGAAGGTATCGCAA
TACTATGGGATACCCATGGCTGAACGTCAAAACAACGGGTGGCTCAAGAAGTTCACTGAA
ATGACCAATTCTTGTAAGGGTATGGAATGGATATCCATAAAAATCCAGAAATTCATAGAA
TGGCTTAAGGTCAAAATATTACCAGAGGTCAGAGAAAAACATGAATTCCTGAACAGACTC
AAGCAGCTCCCTCTGTTGGAAAGCCAGATCGCCACAATCGAGCAAAGTGCGCCGTCCCAG
AGTGACCAAGAGCAATTGTTTTCCAATGTCCAGTACTTTGCTCACTATTGCAGGAAGTAT
GCTCCCCTCTACGCATCAGAAGCAAAGAGAGTATTCTCCCTTGAGAAGAAGATGAGCAAT
TACATACAGTTCAAGTCCAAATGCCGTATTGAACCTGTATGTCTACTTCTACACGGGAGC
CCTGGCGCCGGTAAGTCGGTAGCAACAAATCTAATCGGAAGATCACTCGCTGAGAAACTT
AACAGCTCAGTGTACACACTACCACCAGACCCAGATCACTTTGACGGATATAAACAGCAG
GCCGTGGTGATCGTGGACGACTTGTGCCAGAATCCTGATGGAAAAGATGTCTCTTTGTTC
TGCCAAATGGTCTCTAGTGTAGACTTTGTGCCACCTATGGCTGCCTTGGAAGAGAAAGGC
ATTCTGTTCACTTCTCTATTCGTCCTGGCGTCAACTAACGCAGGGTCTATCAACGCCCCA
ACCGTGTCAGATAGTAGGGCCCTGGCGCGAAGGTTCCACTTCGACATGAACATTGAAGTT
ATCTCCATGTACAGCCAAAATGGCAAAATAAATATGCCGATGTCAGAGAAAACGTGTGAT
GAAGAGTGTTGTCCAGTCAACTTTAAGAGATGCTGCCCCCTAGTGTGTGGGAAAGCAATT
CAGTTTATAGATAGAAGAACTCAAGTCAGATACTCCCTTGACATGCTGGTAACTGAGATG
TTCAGGGAATACAATCACAGGCACAGTGTTGGGGCAACCCTTGAAGCGCTATTCCAGGGT
CCACCGATATACAGAGAGATTAAGATCAGCGTGGCACCAGAGACACCACCACCACCAGCC
ATTGCAGACTTGCTCAAGTCAGTGGACAGTGAAGCCGTGAGAGAGTACTGTAAAGAAAAG
GGGTGGCTGGTTCCAGAGGTTAACTCTACCCTACAGATTGAGAAGCACGTTAGTCGGGCC
TTCATCTGTTTGCAAGCATTGACCACTTTTGTCTCAGTGGCTGGAATTATTTACATAATC
TACAAGCTCTTTGCAGGCTTCCAAGGAGCATACACAGGGATGCCCAATCAGAAACCCAAA
GTGCCCACACTCAGGCAGGCAAAAGTGCAAGGACCTGCGTTCGAATTTGCCGTAGCCATG
ATGAAGAGGAATTCAAGCACAGTGAAGACCGAATACCGAGAATTCACTATGTTGGGCATT
TATGACAGGTGGGCCGTACTGCCACGCCATGCTAAACCTGGACCAACCATTCTGATGAAC
AATCAAGAGGTCGGTGTGCTTGACGCCAAGGAACTAGTGGATAAGGATGGCACCAATCTG
GAGTTGACACTACTCAAGTTAAACCGGAATGAGAAGTTCAGAGACATCAGAGGCTTCTTG
GCCAAAGAGGAGGTGGAAGCTAACCAGGCTGTACTGGCGATTAACACCAGCAAGTTCCCC
AACATGTACATCCCAGTGGGTCAAGTCACAGATTACGGTTTCTTAAACTTAGGCGGTACA
CCCACCAAGAGAATGCTCATGTCCAACTTCCCCACACGAGCGGGCCAGTGCGGCGGGGTT
CTCATGTCCACCGGTAAGGTCTTGGGGATCCACGTTGGTGGAAATGGTCATCAGGGCTTC
TCAGCTGCACTCCTCAAGCACTATTTCAATGATGAGCAAGGGGAAATTGAGTTTATTGAG
AGTTCAAAGGATGCGGGGTTCCCAATCATTAATACGCCTAGTAAGACTAAGTTGGAACCG
AGCGTCTTCCATCAAGTATTCGAAGGGGACAAAGAACCAGCTGTCCTCAGGAACGGTGAT
CCACGCCTCAAGGCCAACTTTGAGGAAGCCATATTCTCAAAATACATTGGAAATGTCAAC
ACACACGTGGATGAATACATGCTAGAGGCTGTCGATCATTATGCTGGTCAGCTGGCCACA
CTGGATATCAGCACCGAACCTATGAGATTGGAGGATGCTGTGTATGGCACCGAGGGCCTC
GAAGCCCTTGACCTAACAACGAGTGCAGGCTACCCTTATGTTGCACTAGGCATCAAGAAG
AGAGACATCCTTTCAAGGAGGACCAGGGATCTAACCAAGTTGAAGGAATGTATGGATAAA
TACGGTTTGAACTTACCGATGGTGACTTATGTGAAAGATGAACTTAGGTCTGCAGACAAA
GTAGCAAAAGGGAAGTCTAGGTTGATTGAAGCATCCAGTTTGAATGACTCTGTAGCAATG
AGACAAACATTTGGCAACCTGTACAGAACCTTCCATCTAAACCCAGGGATCGTGACTGGT
AGCGCTGTCGGGTGCGACCCGGACCTCTTTTGGAGTAAAATTCCAGTGATGTTGGATGGT
CACCTCATAGCCTTTGACTACTCTGGATATGATGCTAGCTTGAGCCCCGTGTGGTTTGCC
TGCCTAAAACTATTACTTGAGAAATTAGGCTACACACACAAGGAAACAAATTACATTGAC
TACCTGTGTAATTCCCACCACCTGTACAGAGACAAACACTACTTTGAGCGGGGTGGTATG
CCCTCAGGATATTCCGGCACCAGCATGTTTAACTCAATGATAAACAACATCATCATCAGG
ACTCTCATGCTAAAAGTGTATAAGGGAATTGATTTGGACCAGTTTAGGATGATTGCATAC
GGTGACGACGTGATTGCGTCATATCCGTGGCCCATCGATGCATCTTTACTTGCCGAAACC
GGCAAAGGTTATGGGTTGATTATGACACCAGCAGATAAAGGGGAGTGCTTCAACGAAGTC
ACCTGGACCAACGTCACATTCCTGAAGAGGTATTTTAGAGCAGATGAGCAGTATCCCTTC
CTGGTACACCCAGTCATGCCCATGAAAGACATCCACGAGTCCATTAGGTGGACCAAAGAC
CCAAAGAACACCCAAGACCACGTGCGCTCGCTGTGTTTATTGGCCTGGCATAATGGGGAG
CACGAGTATGAGGAGTTCATCCGCAAGATCAGGAGCGTCCCGGTCGGACGTTGCTTGACT
CTGCCCGCATTTTCAACCTTGCGTAGGAAGTGGTTGGACTCTTTTTAA

# Drug_Target_11_General_Function:
Involved in ATP binding

# Drug_Target_11_General_References:
12097583	Stuart AD, McKee TA, Williams PA, Harley C, Shen S, Stuart DI, Brown TD, Lea SM: Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection. J Virol. 2002 Aug;76(15):7694-704.
2170575	Auvinen P, Hyypia T: Echoviruses include genetically distinct serotypes. J Gen Virol. 1990 Sep;71 ( Pt 9):2133-9.
7517044	Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW: Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6245-8.
7762294	Dahllund L, Nissinen L, Pulli T, Hyttinen VP, Stanway G, Hyypia T: The genome of echovirus 11. Virus Res. 1995 Feb;35(2):215-22.

# Drug_Target_11_HGNC_ID:
Not Available

# Drug_Target_11_HPRD_ID:
Not Available

# Drug_Target_11_ID:
6739

# Drug_Target_11_Locus:
Not Available

# Drug_Target_11_Molecular_Weight:
245405.1

# Drug_Target_11_Name:
Genome polyprotein

# Drug_Target_11_Number_of_Residues:
2195

# Drug_Target_11_PDB_ID:
Not Available

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
PF00073	Rhv
PF00548	Peptidase_C3
PF00680	RdRP_1
PF00910	RNA_helicase
PF00947	Pico_P2A
PF01552	Pico_P2B
PF02226	Pico_P1A
PF08727	P3A

# Drug_Target_11_Protein_Sequence:
>Genome polyprotein
MGAQVSTQKTGAHETGLNASGSSIIHYTNINYYKDAASNSANRQEFSQDPGKFTEPVKDI
MVKSLPALNSPSAEECGYSDRVRSITLGNSTITTQESANVVVGYGRWPEYLKDNEATAED
QPTQPDVATCRFYTLESVTWERDSPGWWWKFPDALKDMGLFGQNMYYHYLGRAGYTLHVQ
CNASKFHQGCLLVVCVPEAEMGCSQVDGTVNEHGLSEGETAKKFSSTSTNGTNTVQTIVT
NAGMGVGVGNLTIYPHQWINLRTNNCATIVMPYINNVPMDNMFRHHNFTLMIIPFVPLDY
SSDSSTYVPITVTVAPMCAEYNGLRLSTSLQGLPVMNTPGSNQFLTSDDFQSPSAMPQFD
VTPELNIPGEVQNLMEIAEVDSVVPVNNVEGKLDTMEVYRIPVQSGNHQSDQVFGFQVQP
GLDSVFKHTLLGEILNYFAHWSGSIKLTFVFCGSAMATGKFLLAYAPPGANAPKNRKDAM
LGTHIIWDVGLQSSCVLCVPWISQTHYRLVQQDEYTSAGNVTCWYQTGIVVPAGTPTSCS
IMCFVSACNDFSVRLLKDTPFIEQTALLQGDVVEAVENAVARVADTIGSGPSNSQAVPAL
TAVETGHTSQVTPSDTMQTRHVKNYHSRSESSIENFLSRSACVYMGGYHTTNTDQTKLFA
SWTISARRMVQMRRKLEIFTYVRFDVEVTFVITSKQDQGSRLGQDMPPLTHQIMYIPPGG
PIPKSVTDYAWQTSTNPSIFWTEGNAPPRMSIPFISIGNAYSNFYDGWSHFSQNGVYGYN
TLNHMGQIYVRHVNGSSPLPMTSTVRMYFKPKHVKAWVPRPPRLCQYKNASTVNFTPTNV
TDKRTSINYIPETVKPDLSNYGAFGYQSGAVYVVNYRVVNRHLATHTDWQNCVWEDYNRD
LLISTTTAHGCDVIARCRCSTGVYYCQSKGKHYPVNFEGPGLVEVQESEYYPKRYQSHVL
LAAGFSEPGDCGGILRCEHGVIGIVTMGGEGVVGFADVRDLLWLEDDAMEQGVKDYVEQL
GNAFGSGFTNQICEQVNLLKESLVGQDSILEKSLKALVKIISALVIVVRNHDDLITVTAT
LALIGCTSSPWRWLKQKVSQYYGIPMAERQNNGWLKKFTEMTNSCKGMEWISIKIQKFIE
WLKVKILPEVREKHEFLNRLKQLPLLESQIATIEQSAPSQSDQEQLFSNVQYFAHYCRKY
APLYASEAKRVFSLEKKMSNYIQFKSKCRIEPVCLLLHGSPGAGKSVATNLIGRSLAEKL
NSSVYTLPPDPDHFDGYKQQAVVIVDDLCQNPDGKDVSLFCQMVSSVDFVPPMAALEEKG
ILFTSLFVLASTNAGSINAPTVSDSRALARRFHFDMNIEVISMYSQNGKINMPMSEKTCD
EECCPVNFKRCCPLVCGKAIQFIDRRTQVRYSLDMLVTEMFREYNHRHSVGATLEALFQG
PPIYREIKISVAPETPPPPAIADLLKSVDSEAVREYCKEKGWLVPEVNSTLQIEKHVSRA
FICLQALTTFVSVAGIIYIIYKLFAGFQGAYTGMPNQKPKVPTLRQAKVQGPAFEFAVAM
MKRNSSTVKTEYREFTMLGIYDRWAVLPRHAKPGPTILMNNQEVGVLDAKELVDKDGTNL
ELTLLKLNRNEKFRDIRGFLAKEEVEANQAVLAINTSKFPNMYIPVGQVTDYGFLNLGGT
PTKRMLMSNFPTRAGQCGGVLMSTGKVLGIHVGGNGHQGFSAALLKHYFNDEQGEIEFIE
SSKDAGFPIINTPSKTKLEPSVFHQVFEGDKEPAVLRNGDPRLKANFEEAIFSKYIGNVN
THVDEYMLEAVDHYAGQLATLDISTEPMRLEDAVYGTEGLEALDLTTSAGYPYVALGIKK
RDILSRRTRDLTKLKECMDKYGLNLPMVTYVKDELRSADKVAKGKSRLIEASSLNDSVAM
RQTFGNLYRTFHLNPGIVTGSAVGCDPDLFWSKIPVMLDGHLIAFDYSGYDASLSPVWFA
CLKLLLEKLGYTHKETNYIDYLCNSHHLYRDKHYFERGGMPSGYSGTSMFNSMINNIIIR
TLMLKVYKGIDLDQFRMIAYGDDVIASYPWPIDASLLAETGKGYGLIMTPADKGECFNEV
TWTNVTFLKRYFRADEQYPFLVHPVMPMKDIHESIRWTKDPKNTQDHVRSLCLLAWHNGE
HEYEEFIRKIRSVPVGRCLTLPAFSTLRRKWLDSF

# Drug_Target_11_Reaction:
Not Available

# Drug_Target_11_Signals:
None

# Drug_Target_11_Specific_Function:
RNA-directed RNA polymerase 3D-POL replicates genomic and antigenomic RNA by recognizing replications specific signals (By similarity)

# Drug_Target_11_SwissProt_ID:
P29813

# Drug_Target_11_SwissProt_Name:
POLG_EC11G

# Drug_Target_11_Synonyms:
P1A
P1B
P1C
P1D
P2A
P2B
P2C
P3A
P3B
P3C
P3D-POL
Picornain 2A
Picornain 3C
Protease 3C
Protein 2A
Protein 2B
Protein 2C
Protein 3A
Protein 3B
Protein VP0
Protein VP1
Protein VP2
Protein VP3
Protein VP4
RNA-directed RNA polymerase 3D-POL
VP4-VP2
VPg
Virion protein 1
Virion protein 2
Virion protein 3
Virion protein 4

# Drug_Target_11_Theoretical_pI:
6.83

# Drug_Target_11_Transmembrane_Regions:
None

# Drug_Target_12_Cellular_Location:
Cytoplasm (Potential)

# Drug_Target_12_Chromosome_Location:
Not Available

# Drug_Target_12_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_12_Essentiality:
Essential

# Drug_Target_12_GenAtlas_ID:
Not Available

# Drug_Target_12_GenBank_ID_Gene:
X08087

# Drug_Target_12_GenBank_ID_Protein:
992991

# Drug_Target_12_GeneCard_ID:
fadR

# Drug_Target_12_Gene_Name:
fadR

# Drug_Target_12_Gene_Sequence:
>720 bp
ATGGTCATTAAGGCGCAAAGCCCGGCGGGTTTCGCGGAAGAGTACATTATTGAAAGTATC
TGGAATAACCGCTTCCCTCCCGGGACTATTTTGCCCGCAGAACGTGAACTTTCAGAATTA
ATTGGCGTAACGCGTACTACGTTACGTGAAGTGTTACAGCGTCTGGCACGAGATGGCTGG
TTGACCATTCAACATGGCAAGCCGACGAAGGTGAATAATTTCTGGGAAACTTCCGGTTTA
AATATCCTTGAAACACTGGCGCGACTGGATCACGAAAGTGTGCCGCAGCTTATTGATAAT
TTGCTGTCGGTGCGTACCAATATTTCCACTATTTTTATTCGCACCGCGTTTCGTCAGCAT
CCCGATAAAGCGCAGGAAGTGCTGGCTACCGCTAATGAAGTGGCCGATCACGCCGATGCC
TTTGCCGAGCTGGATTACAACATATTCCGCGGCCTGGCGTTTGCTTCCGGCAACCCGATT
TACGGTCTGATTCTTAACGGGATGAAAGGGCTGTATACGCGTATTGGTCGTCACTATTTC
GCCAATCCGGAAGCGCGCAGTCTGGCGCTGGGCTTCTACCACAAACTGTCGGCGTTGTGC
AGTGAAGGCGCGCACGATCAGGTGTACGAAACAGTGCGTCGCTATGGGCATGAGAGTGGC
GAGATTTGGCACCGGATGCAGAAAAATCTGCCGGGTGATTTAGCCATTCAGGGGCGATAA

# Drug_Target_12_General_Function:
Transcription

# Drug_Target_12_General_References:
11279025	Xu Y, Heath RJ, Li Z, Rock CO, White SW: The FadR.DNA complex. Transcriptional control of fatty acid metabolism in Escherichia coli. J Biol Chem. 2001 May 18;276(20):17373-9. Epub 2001 Feb 13.
11296236	van Aalten DM, DiRusso CC, Knudsen J: The structural basis of acyl coenzyme A-dependent regulation of the transcription factor FadR. EMBO J. 2001 Apr 17;20(8):2041-50.
1569108	DiRusso CC, Heimert TL, Metzger AK: Characterization of FadR, a global transcriptional regulator of fatty acid metabolism in Escherichia coli. Interaction with the fadB promoter is prevented by long chain fatty acyl coenzyme A. J Biol Chem. 1992 Apr 25;267(12):8685-91.
16738553	Hayashi K, Morooka N, Yamamoto Y, Fujita K, Isono K, Choi S, Ohtsubo E, Baba T, Wanner BL, Mori H, Horiuchi T: Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol Syst Biol. 2006;2:2006.0007. Epub 2006 Feb 21.
2843809	DiRusso CC: Nucleotide sequence of the fadR gene, a multifunctional regulator of fatty acid metabolism in Escherichia coli. Nucleic Acids Res. 1988 Aug 25;16(16):7995-8009.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-62.
9388199	Raman N, Black PN, DiRusso CC: Characterization of the fatty acid-responsive transcription factor FadR. Biochemical and genetic analyses of the native conformation and functional domains. J Biol Chem. 1997 Dec 5;272(49):30645-50.

# Drug_Target_12_HGNC_ID:
Not Available

# Drug_Target_12_HPRD_ID:
Not Available

# Drug_Target_12_ID:
6740

# Drug_Target_12_Locus:
Not Available

# Drug_Target_12_Molecular_Weight:
26968.3

# Drug_Target_12_Name:
Fatty acid metabolism regulator protein

# Drug_Target_12_Number_of_Residues:
239

# Drug_Target_12_PDB_ID:
1HW2

# Drug_Target_12_Pathway:
Not Available

# Drug_Target_12_Pfam_Domain_Function:
PF00392	GntR
PF07840	FadR_C

# Drug_Target_12_Protein_Sequence:
>Fatty acid metabolism regulator protein
MVIKAQSPAGFAEEYIIESIWNNRFPPGTILPAERELSELIGVTRTTLREVLQRLARDGW
LTIQHGKPTKVNNFWETSGLNILETLARLDHESVPQLIDNLLSVRTNISTIFIRTAFRQH
PDKAQEVLATANEVADHADAFAELDYNIFRGLAFASGNPIYGLILNGMKGLYTRIGRHYF
ANPEARSLALGFYHKLSALCSEGAHDQVYETVRRYGHESGEIWHRMQKNLPGDLAIQGR

# Drug_Target_12_Reaction:
Not Available

# Drug_Target_12_Signals:
None

# Drug_Target_12_Specific_Function:
Multifunctional regulator of fatty acid metabolism. Represses transcription of at least eight genes required for fatty acid transport and beta-oxidation including fadA, fadB, fadD, fadL and fadE. Activates transcription of at least three genes required for unsaturated fatty acid biosynthesis:fabA, fabB and iclR, the gene encoding the transcriptional regulator of the aceBAK operon encoding the glyoxylate shunt enzymes. Binding of fadR is specifically inhibited by long chain fatty acyl-CoA compounds

# Drug_Target_12_SwissProt_ID:
P0A8V6

# Drug_Target_12_SwissProt_Name:
FADR_ECOLI

# Drug_Target_12_Synonyms:
Not Available

# Drug_Target_12_Theoretical_pI:
7.03

# Drug_Target_12_Transmembrane_Regions:
None

# Drug_Target_13_Cellular_Location:
Isoform 2:Peroxisome matrix

# Drug_Target_13_Chromosome_Location:
6

# Drug_Target_13_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_13_Essentiality:
Non-Essential

# Drug_Target_13_GenAtlas_ID:
Not Available

# Drug_Target_13_GenBank_ID_Gene:
AF069301

# Drug_Target_13_GenBank_ID_Protein:
3193336

# Drug_Target_13_GeneCard_ID:
PECI

# Drug_Target_13_Gene_Name:
PECI

# Drug_Target_13_Gene_Sequence:
>1095 bp
ATGAATAGAACAGCAATGAGAGCCAGTCAGAAGGACTTTGAAAATTCAATGAATCAAGTG
AAACTCTTGAAAAAGGATCCAGGAAACGAAGTGAAGCTAAAACTCTACGCGCTATATAAG
CAGGCCACTGAAGGACCTTGTAACATGCCCAAACCAGGTGTATTTGACTTGATCAACAAG
GCCAAATGGGACGCATGGAATGCCCTTGGCAGCCTGCCCAAGGAAGCTGCCAGGCAGAAC
TATGTGGATTTGGTGTCCAGTTTGAGTCCTTCATTGGAATCCTCTAGTCAGGTGGAGCCT
GGAACAGACAGGAAATCAACTGGGTTTGAAACTCTGGTGGTGACCTCCGAAGATGGCATC
ACAAAGATCATGTTCAACCGGCCCAAAAAGAAAAATGCCATAAACACTGAGATGTATCAT
GAAATTATGCGTGCACTTAAAGCTGCCAGCAAGGATGACTCAATCATCACTGTTTTAACA
GGAAATGGTGACTGTTACAGTAGTGGGAATGATCTGACTAACTTCACTGATATTCCCCCT
GGTGGAGTAGAGGAGAAAGCTAAAAATAATGCCGTTTTACTGAGGGAATTTGTGGGCTGT
TTTATAGATTTTCCTAAGCCTCTGATTGCAGTGGTCAATGGTCCAGCTGTGGGCATCTCC
GTCACCCTCCTTGGGCTATTCGATGCCGTGTATGCATCTGACAGGGCAACATTTCATACA
CCATTTAGTCACCTAGGCCAAAGTCCGGAAGGATGCTCCTCTTACACTTTTCCGAAGATA
ATGAGCCCAGCCAAGGCAACAGAGATGCTTATTTTTGGAAAGAAGTTAACAGCGGGAGAG
GCATGTGCTCAAGGACTTGTTACTGAAGTTTTCCCTGATAGCACTTTTCAGAAAGAAGTC
TGGACCAGGCTGAAGGCATTTGCAAAGCTTCCCCCAAATGTCTTGAGAATTTCAAAAGAG
GTAATCAGGAAAAGAGAGAGAGAAAAACTACACGCTGTTAATGCTGAAGAATGCAATGTC
CTTCAGGGAAGATGGCTATCAGATGAATGCACAAATGCTGTGGTGAACTTCTTATCCAGA
AAATCAAAACTGTGA

# Drug_Target_13_General_Function:
Lipid transport and metabolism

# Drug_Target_13_General_References:
10354522	Suk K, Kim YH, Hwang DY, Ihm SH, Yoo HJ, Lee MS: Molecular cloning and expression of a novel human cDNA related to the diazepam binding inhibitor. Biochim Biophys Acta. 1999 May 31;1454(1):126-31.
10419495	Geisbrecht BV, Zhang D, Schulz H, Gould SJ: Characterization of PECI, a novel monofunctional Delta(3), Delta(2)-enoyl-CoA isomerase of mammalian peroxisomes. J Biol Chem. 1999 Jul 30;274(31):21797-803.
10508479	Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jager D, Jager E, Knuth A, Chen YT, Old LJ: Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer. 1999 Nov 12;83(4):456-64.
11230166	Wiemann S, Weil B, Wellenreuther R, Gassenhuber J, Glassl S, Ansorge W, Bocher M, Blocker H, Bauersachs S, Blum H, Lauber J, Dusterhoft A, Beyer A, Kohrer K, Strack N, Mewes HW, Ottenwalder B, Obermaier B, Tampe J, Heubner D, Wambutt R, Korn B, Klein M, Poustka A: Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs. Genome Res. 2001 Mar;11(3):422-35.
11256614	Simpson JC, Wellenreuther R, Poustka A, Pepperkok R, Wiemann S: Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. EMBO Rep. 2000 Sep;1(3):287-92.
12097419	Wang Y, Han KJ, Pang XW, Vaughan HA, Qu W, Dong XY, Peng JR, Zhao HT, Rui JA, Leng XS, Cebon J, Burgess AW, Chen WF: Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol. 2002 Jul 15;169(2):1102-9.
14574404	Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, Wilming L, Jones MC, Horton R, Hunt SE, Scott CE, Gilbert JG, Clamp ME, Bethel G, Milne S, Ainscough R, Almeida JP, Ambrose KD, Andrews TD, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beare DM, Beasley H, Beasley O, Bird CP, Blakey S, Bray-Allen S, Brook J, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Clark SY, Clark G, Clee CM, Clegg S, Cobley V, Collier RE, Collins JE, Colman LK, Corby NR, Coville GJ, Culley KM, Dhami P, Davies J, Dunn M, Earthrowl ME, Ellington AE, Evans KA, Faulkner L, Francis MD, Frankish A, Frankland J, French L, Garner P, Garnett J, Ghori MJ, Gilby LM, Gillson CJ, Glithero RJ, Grafham DV, Grant M, Gribble S, Griffiths C, Griffiths M, Hall R, Halls KS, Hammond S, Harley JL, Hart EA, Heath PD, Heathcott R, Holmes SJ, Howden PJ, Howe KL, Howell GR, Huckle E, Humphray SJ, Humphries MD, Hunt AR, Johnson CM, Joy AA, Kay M, Keenan SJ, Kimberley AM, King A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd CR, Lloyd DM, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, Maslen GL, Matthews L, McCann OT, McLaren SJ, McLay K, McMurray A, Moore MJ, Mullikin JC, Niblett D, Nickerson T, Novik KL, Oliver K, Overton-Larty EK, Parker A, Patel R, Pearce AV, Peck AI, Phillimore B, Phillips S, Plumb RW, Porter KM, Ramsey Y, Ranby SA, Rice CM, Ross MT, Searle SM, Sehra HK, Sheridan E, Skuce CD, Smith S, Smith M, Spraggon L, Squares SL, Steward CA, Sycamore N, Tamlyn-Hall G, Tester J, Theaker AJ, Thomas DW, Thorpe A, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, White SS, Whitehead SL, Whittaker H, Wild A, Willey DJ, Wilmer TE, Wood JM, Wray PW, Wyatt JC, Young L, Younger RM, Bentley DR, Coulson A, Durbin R, Hubbard T, Sulston JE, Dunham I, Rogers J, Beck S: The DNA sequence and analysis of human chromosome 6. Nature. 2003 Oct 23;425(6960):805-11.
14702039	Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21.
15217832	Feng X, Chuhjo T, Sugimori C, Kotani T, Lu X, Takami A, Takamatsu H, Yamazaki H, Nakao S: Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells. Blood. 2004 Oct 15;104(8):2425-31. Epub 2004 Jun 24.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.

# Drug_Target_13_HGNC_ID:
GNC:14601

# Drug_Target_13_HPRD_ID:
Not Available

# Drug_Target_13_ID:
6741

# Drug_Target_13_Locus:
6p24.3

# Drug_Target_13_Molecular_Weight:
43584.8

# Drug_Target_13_Name:
Peroxisomal 3,2-trans-enoyl-CoA isomerase

# Drug_Target_13_Number_of_Residues:
394

# Drug_Target_13_PDB_ID:
Not Available

# Drug_Target_13_Pathway:
Not Available

# Drug_Target_13_Pfam_Domain_Function:
PF00378	ECH
PF00887	ACBP

# Drug_Target_13_Protein_Sequence:
>Peroxisomal 3,2-trans-enoyl-CoA isomerase
MAMAYLAWRLARRSCPSSLQVTSFPVVQLHMNRTAMRASQKDFENSMNQVKLLKKDPGNE
VKLKLYALYKQATEGPCNMPKPGVFDLINKAKWDAWNALGSLPKEAARQNYVDLVSSLSP
SLESSSQVEPGTDRKSTGFETLVVTSEDGITKIMFNRPKKKNAINTEMYHEIMRALKAAS
KDDSIITVLTGNGDYYSSGNDLTNFTDIPPGGVEEKAKNNAVLLREFVGCFIDFPKPLIA
VVNGPAVGISVTLLGLFDAVYASDRATFHTPFSHLGQSPEGCSSYTFPKIMSPAKATEML
IFGKKLTAGEACAQGLVTEVFPDSTFQKEVWTRLKAFAKLPPNALRISKEVIRKREREKL
HAVNAEECNVLQGRWLSDECTNAVVNFLSRKSKL

# Drug_Target_13_Reaction:
Not Available

# Drug_Target_13_Signals:
None

# Drug_Target_13_Specific_Function:
Able to isomerize both 3-cis and 3-trans double bonds into the 2-trans form in a range of enoyl-CoA species. Has a preference for 3-trans substrates (By similarity)

# Drug_Target_13_SwissProt_ID:
O75521

# Drug_Target_13_SwissProt_Name:
PECI_HUMAN

# Drug_Target_13_Synonyms:
D3,D2-enoyl-CoA isomerase
DBI-related protein 1
DRS-1
Delta(3),delta(2)-enoyl-CoA isomerase
Diazepam-binding inhibitor-related protein 1
Dodecenoyl-CoA isomerase
Hepatocellular carcinoma-associated antigen 88
Renal carcinoma antigen NY-REN-1
pECI

# Drug_Target_13_Theoretical_pI:
9.42

# Drug_Target_13_Transmembrane_Regions:
None

# Drug_Target_14_Cellular_Location:
Not Available

# Drug_Target_14_Chromosome_Location:
1

# Drug_Target_14_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_14_Essentiality:
Non-Essential

# Drug_Target_14_GenAtlas_ID:
Not Available

# Drug_Target_14_GenBank_ID_Gene:
S43855

# Drug_Target_14_GenBank_ID_Protein:
255059

# Drug_Target_14_GeneCard_ID:
RCVRN

# Drug_Target_14_Gene_Name:
RCVRN

# Drug_Target_14_Gene_Sequence:
>603 bp
ATGGGGAACAGCAAAAGTGGGGCCCTGTCCAAGGAGATCCTGGAGGAGCTGCAGCTGAAC
ACCAAGTTCTCGGAGGAGGAGCTGTGCTCCTGGTACCAGTCCTTCCTGAAGGACTGTCCC
ACCGGCCGCATCACCCAGCAGCAGTTCCAGAGCATCTACGCCAAGTTCTTCCCCGACACC
GACCCCAAGGCCTACGCCCAGCATGTGTTCCGCAGCTTCGATTCCAACCTCGACGGCACC
CTGGACTTCAAGGAGTACGTCATCGCCCTGCACATGACCACCGCGGGCAAGACCAACCAG
AAGCTGGAGTGGGCCTTCTCCCTCTACGACGTGGACGGTAACGGGACCATCAGCAAGAAT
GAAGTGCTGGAGATCGTCATGGCTATTTTCAAAATGATCACTCCCGAGGACGTGAAGCTC
CTTCCAGACGATGAAAACACGCCGGAAAAGCGAGCCGAGAAGATCTGGAAGTACTTTGGA
AAGAATGATGATGATAAACTTACAGAGAAAGAATTCATTGAGGGGACACTGGCCAATAAG
GAAATTCTGCGACTGATCCAGTTTGAGCCTCAAAAAGTGAAGGAAAAGATGAAGAACGCC
TGA

# Drug_Target_14_General_Function:
Involved in calcium ion binding

# Drug_Target_14_General_References:
1387789	Murakami A, Yajima T, Inana G: Isolation of human retinal genes: recoverin cDNA and gene. Biochem Biophys Res Commun. 1992 Aug 31;187(1):234-44.
1388144	Thirkill CE, Tait RC, Tyler NK, Roth AM, Keltner JL: The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci. 1992 Sep;33(10):2768-72.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
1999465	Polans AS, Buczylko J, Crabb J, Palczewski K: A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J Cell Biol. 1991 Mar;112(5):981-9.
8500558	Wiechmann AF, Hammarback JA: Molecular cloning and nucleotide sequence of a cDNA encoding recoverin from human retina. Exp Eye Res. 1993 Apr;56(4):463-70.
8912538	Matsubara S, Yamaji Y, Sato M, Fujita J, Takahara J: Expression of a photoreceptor protein, recoverin, as a cancer-associated retinopathy autoantigen in human lung cancer cell lines. Br J Cancer. 1996 Nov;74(9):1419-22.

# Drug_Target_14_HGNC_ID:
GNC:9937

# Drug_Target_14_HPRD_ID:
Not Available

# Drug_Target_14_ID:
6742

# Drug_Target_14_Locus:
17p13.1

# Drug_Target_14_Molecular_Weight:
23130.1

# Drug_Target_14_Name:
Recoverin

# Drug_Target_14_Number_of_Residues:
200

# Drug_Target_14_PDB_ID:
1JSA

# Drug_Target_14_Pathway:
Not Available

# Drug_Target_14_Pfam_Domain_Function:
PF00036	efhand

# Drug_Target_14_Protein_Sequence:
>Recoverin
MGNSKSGALSKEILEELQLNTKFSEEELCSWYQSFLKDCPTGRITQQQFQSIYAKFFPDT
DPKAYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVDGNGTISKN
EVLEIVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGKNDDDKLTEKEFIEGTLANK
EILRLIQFEPQKVKEKMKNA

# Drug_Target_14_Reaction:
Not Available

# Drug_Target_14_Signals:
None

# Drug_Target_14_Specific_Function:
Seems to be implicated in the pathway from retinal rod guanylate cyclase to rhodopsin. May be involved in the inhibition of the phosphorylation of rhodopsin in a calcium-dependent manner. The calcium-bound recoverin prolongs the photoresponse

# Drug_Target_14_SwissProt_ID:
P35243

# Drug_Target_14_SwissProt_Name:
RECO_HUMAN

# Drug_Target_14_Synonyms:
Cancer-associated retinopathy protein
Protein CAR

# Drug_Target_14_Theoretical_pI:
4.79

# Drug_Target_14_Transmembrane_Regions:
None

# Drug_Target_15_Cellular_Location:
Not Available

# Drug_Target_15_Chromosome_Location:
Not Available

# Drug_Target_15_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_15_Essentiality:
Non-Essential

# Drug_Target_15_GenAtlas_ID:
CALM1

# Drug_Target_15_GenBank_ID_Gene:
J04046

# Drug_Target_15_GenBank_ID_Protein:
179888

# Drug_Target_15_GeneCard_ID:
CALM1

# Drug_Target_15_Gene_Name:
CALM1

# Drug_Target_15_Gene_Sequence:
>450 bp
ATGGCTGACCAGCTGACTGAGGAGCAGATTGCAGAGTTCAAGGAGGCCTTCTCCCTCTTT
GACAAGGATGGAGATGGCACTATCACCACCAAGGAGTTGGGGACAGTGATGAGATCCCTG
GGACAGAACCCCACTGAAGCAGAGCTGCAGGATATGATCAATGAGGTGGATGCAGATGGG
AACGGGACCATTGACTTCCCGGAGTTCCTGACCATGATGGCCAGAAAGATGAAGGACACA
GACAGTGAGGAGGAGATCCGAGAGGCGTTCCGTGTCTTTGACAAGGATGGGAATGGCTAC
ATCAGCGCCGCAGAGCTGCGTCACGTAATGACGAACCTGGGGGAGAAGCTGACCGATGAG
GAGGTGGATGAGATGATCAGGGAGGCTGACATCGATGGAGATGGCCAGGTCAATTATGAA
GAGTTTGTACAGATGATGACTGCAAAGTGA

# Drug_Target_15_General_Function:
Involved in calcium ion binding

# Drug_Target_15_General_References:
11807546	Drum CL, Yan SZ, Bard J, Shen YQ, Lu D, Soelaiman S, Grabarek Z, Bohm A, Tang WJ: Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature. 2002 Jan 24;415(6870):396-402.
12508121	Heilig R, Eckenberg R, Petit JL, Fonknechten N, Da Silva C, Cattolico L, Levy M, Barbe V, de Berardinis V, Ureta-Vidal A, Pelletier E, Vico V, Anthouard V, Rowen L, Madan A, Qin S, Sun H, Du H, Pepin K, Artiguenave F, Robert C, Cruaud C, Bruls T, Jaillon O, Friedlander L, Samson G, Brottier P, Cure S, Segurens B, Aniere F, Samain S, Crespeau H, Abbasi N, Aiach N, Boscus D, Dickhoff R, Dors M, Dubois I, Friedman C, Gouyvenoux M, James R, Madan A, Mairey-Estrada B, Mangenot S, Martins N, Menard M, Oztas S, Ratcliffe A, Shaffer T, Trask B, Vacherie B, Bellemere C, Belser C, Besnard-Gonnet M, Bartol-Mavel D, Boutard M, Briez-Silla S, Combette S, Dufosse-Laurent V, Ferron C, Lechaplais C, Louesse C, Muselet D, Magdelenat G, Pateau E, Petit E, Sirvain-Trukniewicz P, Trybou A, Vega-Czarny N, Bataille E, Bluet E, Bordelais I, Dubois M, Dumont C, Guerin T, Haffray S, Hammadi R, Muanga J, Pellouin V, Robert D, Wunderle E, Gauguet G, Roy A, Sainte-Marthe L, Verdier J, Verdier-Discala C, Hillier L, Fulton L, McPherson J, Matsuda F, Wilson R, Scarpelli C, Gyapay G, Wincker P, Saurin W, Quetier F, Waterston R, Hood L, Weissenbach J: The DNA sequence and analysis of human chromosome 14. Nature. 2003 Feb 6;421(6923):601-7. Epub 2003 Jan 1.
2223880	Koller M, Schnyder B, Strehler EE: Structural organization of the human CaMIII calmodulin gene. Biochim Biophys Acta. 1990 Oct 23;1087(2):180-9.
2445749	SenGupta B, Friedberg F, Detera-Wadleigh SD: Molecular analysis of human and rat calmodulin complementary DNA clones. Evidence for additional active genes in these species. J Biol Chem. 1987 Dec 5;262(34):16663-70.
3182832	Fischer R, Koller M, Flura M, Mathews S, Strehler-Page MA, Krebs J, Penniston JT, Carafoli E, Strehler EE: Multiple divergent mRNAs code for a single human calmodulin. J Biol Chem. 1988 Nov 15;263(32):17055-62.
6385987	Wawrzynczak EJ, Perham RN: Isolation and nucleotide sequence of a cDNA encoding human calmodulin. Biochem Int. 1984 Aug;9(2):177-85.
7093203	Sasagawa T, Ericsson LH, Walsh KA, Schreiber WE, Fischer EH, Titani K: Complete amino acid sequence of human brain calmodulin. Biochemistry. 1982 May 11;21(10):2565-9.
7925473	Rhyner JA, Ottiger M, Wicki R, Greenwood TM, Strehler EE: Structure of the human CALM1 calmodulin gene and identification of two CALM1-related pseudogenes CALM1P1 and CALM1P2. Eur J Biochem. 1994 Oct 1;225(1):71-82.
9681195	Toutenhoofd SL, Foletti D, Wicki R, Rhyner JA, Garcia F, Tolon R, Strehler EE: Characterization of the human CALM2 calmodulin gene and comparison of the transcriptional activity of CALM1, CALM2 and CALM3. Cell Calcium. 1998 May;23(5):323-38.

# Drug_Target_15_HGNC_ID:
HGNC:1442

# Drug_Target_15_HPRD_ID:
00243

# Drug_Target_15_ID:
465

# Drug_Target_15_Locus:
14q24-q31

# Drug_Target_15_Molecular_Weight:
16707

# Drug_Target_15_Name:
Calmodulin

# Drug_Target_15_Number_of_Residues:
148

# Drug_Target_15_PDB_ID:
1IQ5

# Drug_Target_15_Pathway:
Acebutolol Pathway	SMP00296
Alprenolol Pathway	SMP00297
Amlodipine Pathway	SMP00376
Atenolol Pathway	SMP00298
Benazepril Pathway	SMP00145
Betaxolol Pathway	SMP00299
Bisoprolol Pathway	SMP00300
Captopril Pathway	SMP00146
Carvedilol Pathway	SMP00367
Cilazapril Pathway	SMP00147
Diltiazem Pathway	SMP00359
Enalapril Pathway	SMP00148
Esmolol Pathway	SMP00301
Felodipine Pathway	SMP00377
Fosinopril Pathway	SMP00149
Isradipine Pathway	SMP00378
Labetalol Pathway	SMP00368
Lisinopril Pathway	SMP00150
Metoprolol Pathway	SMP00302
Moexipril Pathway	SMP00151
Nadolol Pathway	SMP00303
Nebivolol Pathway	SMP00366
Nifedipine Pathway	SMP00379
Nimodipine Pathway	SMP00380
Nisoldipine Pathway	SMP00381
Nitrendipine Pathway	SMP00382
Oxprenolol Pathway	SMP00304
Penbutolol Pathway	SMP00305
Perindopril Pathway	SMP00152
Pindolol Pathway	SMP00306
Propranolol Pathway	SMP00307
Quinapril Pathway	SMP00153
Ramipril Pathway	SMP00154
Rescinnamine Pathway	SMP00155
Spirapril Pathway	SMP00156
Trandolapril Pathway	SMP00157
Verapamil Pathway	SMP00375

# Drug_Target_15_Pfam_Domain_Function:
PF00036	efhand

# Drug_Target_15_Protein_Sequence:
>Calmodulin
ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN
GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEE
VDEMIREADIDGDGQVNYEEFVQMMTAK

# Drug_Target_15_Reaction:
Not Available

# Drug_Target_15_Signals:
None

# Drug_Target_15_Specific_Function:
Calmodulin mediates the control of a large number of enzymes and other proteins by Ca(2+). Among the enzymes to be stimulated by the calmodulin-Ca(2+) complex are a number of protein kinases and phosphatases

# Drug_Target_15_SwissProt_ID:
P62158

# Drug_Target_15_SwissProt_Name:
CALM_HUMAN

# Drug_Target_15_Synonyms:
CaM

# Drug_Target_15_Theoretical_pI:
3.84

# Drug_Target_15_Transmembrane_Regions:
None

# Drug_Target_16_Cellular_Location:
Not Available

# Drug_Target_16_Chromosome_Location:
Not Available

# Drug_Target_16_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_16_Essentiality:
Essential

# Drug_Target_16_GenAtlas_ID:
Not Available

# Drug_Target_16_GenBank_ID_Gene:
X08036

# Drug_Target_16_GenBank_ID_Protein:
45590

# Drug_Target_16_GeneCard_ID:
luxF

# Drug_Target_16_Gene_Name:
luxF

# Drug_Target_16_Gene_Sequence:
>1065 bp
ATGAAATTTGGCAATATTTGTTTCTCATACCAGCCACCAGGTGAATCTCATAAAGAAGTC
ATGGATCGCTTTGTTCGTCTTGGCGTTGCTTCAGAAGAATTAAACTTCGACACCTTCTGG
ACACTTGAGCACCACTTCACTGAATTCGGCCTAACAGGTAACTTATATGTTGCTTGTGCC
AATATTCTTGGTCGTACCAAAAAACTTAACGTCGGCACAATGGGTATCGTACTACCAACA
GCTCACCCTGCTCGCCAAATGGAAGATCTACTGCTACTGGATCAAATGTCAAAAGGACGT
TTTAACTTTGGTGTAGTACGTGGTCTATACCATAAAGATTTCCGGGTATTTGGTGTTACG
ATGGAAGATTCTCGTTCGATCACTGAAGATTTCCATAAAATGATCATGGACGGCTCTAAA
TCAGGCGTTTTACACACTGATGGTAAAAACATTGAATTCCCAGATGTAAATGTCTATCCA
GAGGCCTACCTAGACAAGATCCCTACTTGTATGACAGCGGAATCTGCGGCGACAACGACC
TGGCTAGCAGAACGTGGTTTGCCAATGGTACTGAGCTGGATCATCACCACCAGCGAGAAA
AAAGCACAGATGGAACTATACAATGAAATTGCAGCTGAGCATGGGCACGATATTCACAAT
ATCGACCACAGCATGACCTTCATCTGTTCCGTTAATGAAGATCCAGAAAAAGCAGAAAGT
GTCTGCCGTGACTTCCTATCAAACTGGTACGAGTCCTACACCAATGCGACCAATATCTTT
AAAGACAGTAACCAAACTCGTGGTTATGACTATCACAAAGGTCAATGGCGTGACTTTGTA
CTACAAGGCCATACCGATACCCGTCGTCGTCTTGATTACAGTAATAACCTAAACCCTGTT
GGTACACCTGAAAAATGTATTGAAATTATCCAGCGAGATATCGATGCAACAGGGATCAAC
AACATCACCCTTGGTTTTGAAGCAAACGGTTCTGAGCAAGAAATCATCGCATCGATGGAA
CGCTTCATGACACAAGTGGCGCCATACCTAAAAGATCCGAAATAA

# Drug_Target_16_General_Function:
Involved in monooxygenase activity

# Drug_Target_16_General_References:
2311938	Illarionov BA, Blinov VM, Donchenko AP, Protopopova MV, Karginov VA, Mertvetsov NP, Gitelson JI: Isolation of bioluminescent functions from Photobacterium leiognathi: analysis of luxA, luxB, luxG and neighboring genes. Gene. 1990 Jan 31;86(1):89-94.
3186447	Illarionov BA, Protopopova MV, Karginov VA, Mertvetsov NP, Gitelson JI: Nucleotide sequence of part of Photobacterium leiognathi lux region. Nucleic Acids Res. 1988 Oct 25;16(20):9855.
7776372	Moore SA, James MN: Structural refinement of the non-fluorescent flavoprotein from Photobacterium leiognathi at 1.60 A resolution. J Mol Biol. 1995 May 26;249(1):195-214.
8491169	Moore SA, James MN, O'Kane DJ, Lee J: Crystal structure of a flavoprotein related to the subunits of bacterial luciferase. EMBO J. 1993 May;12(5):1767-74.

# Drug_Target_16_HGNC_ID:
Not Available

# Drug_Target_16_HPRD_ID:
Not Available

# Drug_Target_16_ID:
6743

# Drug_Target_16_Locus:
Not Available

# Drug_Target_16_Molecular_Weight:
26238.5

# Drug_Target_16_Name:
Non-fluorescent flavoprotein

# Drug_Target_16_Number_of_Residues:
228

# Drug_Target_16_PDB_ID:
1NFP

# Drug_Target_16_Pathway:
Not Available

# Drug_Target_16_Pfam_Domain_Function:
PF00296	Bac_luciferase

# Drug_Target_16_Protein_Sequence:
>Non-fluorescent flavoprotein
MTKWNYGVFFLNFYHVGQQEPSLTMSNALETLRIIDEDTSIYDVVAFSEHHIDKSYNDET
KLAPFVSLGKQIHILATSPETVVKAAKYGMPLLFKWDDSQQKRIELLNHYQAAAAKFNVD
IAGVRHRLMLFVNVNDNPTQAKAELSIYLEDYLSYTQAETSIDEIINSNAAGNFDTCLHH
VAEMAQGLNNKVDFLFCFESMKDQENKKSLMINFDKRVINYRKEHNLN

# Drug_Target_16_Reaction:
Not Available

# Drug_Target_16_Signals:
None

# Drug_Target_16_Specific_Function:
Not Available

# Drug_Target_16_SwissProt_ID:
P09142

# Drug_Target_16_SwissProt_Name:
LUXF_PHOLE

# Drug_Target_16_Synonyms:
FP390
NFP

# Drug_Target_16_Theoretical_pI:
5.80

# Drug_Target_16_Transmembrane_Regions:
None

# Drug_Target_17_Cellular_Location:
RNA-directed RNA polymerase 3D-POL:Host cytoplasmic vesicle membrane

# Drug_Target_17_Chromosome_Location:
Not Available

# Drug_Target_17_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_17_Essentiality:
Essential

# Drug_Target_17_GenAtlas_ID:
Not Available

# Drug_Target_17_GenBank_ID_Gene:
X54521

# Drug_Target_17_GenBank_ID_Protein:
61168

# Drug_Target_17_GeneCard_ID:
Not Available

# Drug_Target_17_Gene_Name:
Not Available

# Drug_Target_17_Gene_Sequence:
>6558 bp
ATGGGAGCTCAAGTGTCAACACAAAAGACCGGTGCTCATGAGACCAGCTTGAGTGCAGCG
GGCAACTCAGTCATTCATTACACAAACATAAACTACTACAAGGATGCTGCTTCGAATTCA
GCAAATAGACAAGACTTCACACAGGACCCGGGGAAGTTCACCGAACCTGTGAAAGACATC
ATGGTCAAATCCATGCCTGCTCTCAATTCCCCATCAGCAGAGGAGTGTGGCTACAGTGAC
AGGGTAAGATCCATCACCTTAGGGAATTCGACCATAACAACTCAAGAATGTGCAAACGTG
GTAGTTGGATATGGGGTGTGGCCAACTTACTTGAAGGATGAAGAGGCAACAGCAGAGGAT
CAACCCACTCAACCAGATGTGGCCACGTGCAGGTTTTACACGCTCGAATCCGTGATGTGG
CAACAGAGTTCACCAGGCTGGTGGTGGAAGTTCCCTGACGCGTTGTCCAACATGGGGCTA
TTTGGGCAAAATATGCAGTACCACTACCTTGGGAGAGCCGGATACACGATACACGTGCAG
TGCAACGCGTCCAAATTTCACCAAGGGTGTCTGCTGGTGGTATGTGTGCCAGAAGCAGAG
ATGGGGTGTGCCACGTTGGCCAATAAGCCTGACCCAAAAAGCCTGAGTAAAGGGGAAATA
GCCAACATGTTTGAATCCCAAAACTCCACCGGGGAAACGGCCGTGCAAGCTAATGTGATC
AATGCTGGCATGGGTGTTGGTGTTGGTAATCTAACTATCTTCCCCCATCAGTGGATCAAC
TTGCGCACTAACAACAGCGCTACGATTGTCATGCCATATATAAACAGCGTGCCCATGGAC
AACATGTTCAGACACAACAATTTTACACTCATGGTCATCCCGTTCGCCCCACTGAGCTAC
AGCACAGGGGCTACCACGTACGTACCAATCACTGTAACAGTGGCGCCAATGTGCGCTGAA
TATAATGGGCTGCGTCTGGCCGGCAAGCAAGGTTTACCAACGCTGTCGACACCCGGGAGC
AACCAGTTTCTCACGTCCGATGACTTCCAGTCACCATCAGCCATGCCACAATTCGATGTC
ACTCCTGAGATGGATATTCCAGGACAAGTCAACAACTTGATGGAGATTGCAGAAGTAGAT
TCTGTAGTGCCTGTAAATAACACAGAAGGGAAAGTGATGTCAATTGAGGCATACCAGATA
CCTGTGCAATCGAATCCAACCAACGGTTCTCAGGTTTTTGGGTTCCCATTGACCCCAGGG
GCCAATAGTGTGTTAAACAGGACTTTGCTGGGAGAAATCTTAAACTACTATGCCCATTGG
TCAGGCAGCATCAAACTAACATTTATGTTTTGCGGGTCAGCGATGGCTACAGGAAAATTC
TTACTGGCGTACTCACCACCGGGAGCTGGGGCACCGACCACACGCAAGGAGGCGATGCTA
GGTACTCACGTGATCTGGGATGTGGGTCTACAATCGAGCTGCGTATTGTGTATACCATGG
ATTAGTCAAACGCACTACAGGTATGTAGTAATGGATGAATACACCGCTGGTGGATACATA
ACTTGCTGGTATCAAACAAATATTGTGGTGCCTGCAGATGCACAGAGTGACTGTAAGATC
TTGTGTTTTGTGTCGGCATGTAACGATTTTTCAGTTAGGATGCTCAAGGACACACCCTTT
ATAAAACAGGATAATTTCTTCCAAGGGCCCCCAGGAGAGGTGATGGGAAGAGCCATTGCC
CGCGTCGCTGATACCATTGGGAGCGGACCAGTTAACTCGGAATCCATTCCAGCCCTAACC
GCCGCAGAGACAGGGCACACGTCACAAGTTGTACCATCAGACACAATGCAAACTAGACAC
GTGAAGAATTACCATTCAAGATCAGAGTCGACAGTGGAGAACTTCCTGTGCAGATCTGCA
TGCGTCTTCTACACCACATACAAGAACCATGACTCCGATGGCGACAACTTCGCCTACTGG
GTGATCAACACACGGCAAGTTGCTCAACTGCGTCGGAAGCTCGAAATGTTCACGTACGCA
AGATTTGATCTGGAGTTGACCTTCGTGATCACTAGCACTCAGGAACAACCCACCGTTCGA
GGTCAAGATGCACCAGTGCTCACCCACCAAATAATGTATGTACCTCCAGGTGGTCCAGTA
CCCACAAAGGTAAACAGCTACAGCTGGCAAACGTCCACCAACCCGAGTGTGTTCTGGACG
GAAGGGAGCGCACCGCCTCGAATGTCGATACCATTCATTGGCATAGGCAACGCATACAGC
ATGTTCTATGACGGGTGGGCCAGGTTTGACAAGCAAGGGACATACGGCATCAGCACATTA
AACAACATGGGGACACTATATATGAGACATGTGAATGATGGGGGTCCCGGTCCCATTGTA
AGCACAGTACGAATTTACTTCAAGCCAAAGCACGTCAAAACGTGGGTCCCAAGACCGCCC
AGACTATGTCAATACCAAAAGGCTGGCAACGTGAATTTTGAACCCACTGGTGTGACTGAG
GGTAGGACAGATATAACAACCATGAAAACCACTGGCGCCTTCGGGCAGCAGTCTGGTGCC
GTGTACGTTGGCAACTATAGAGTGGTGAATAGACATCTCGCAACGCGCGCGGACTGGCAA
AACTGTGTGTGGGAAGACTACAACAGAGACCTTCTAGTGAGCACCACCACTGCACATGGC
TGCGACACCATTGCCAGGTGTGATTGCACAGCAGGAGTGTACTTCTGCGCCTCCAGAAAC
AAGCACTATCCAGTCACATTTGAGGGGCCCGGTCTTGTGGAGGTTCAAGAGAGTGAGTAT
TACCCGAAAAAGTACCAATCCCATGTACTGCTCGCAGCTGGATTTGCAGAGCCGGGTGAT
TGTGGAGGGATTCTCAGATGCCAACATGGGGTGATTGGCATAGTTACCGTGGGGGGGGAA
GGTGTTGTTGGTTTTGCCGATGTAAGAGACTTGTTGTGGCTGGAGGACGACGCCATGGAG
CAAGGAGTTAGGGATTATGTGGAACAACTCGGCAACTGCTTCGGCTCAGGATTCACCAAT
CAAATTTGCGAACAGGTTACCCTTCTAAAAGAGTCGTTAATTGGACAGGATTCTATCCTT
GAGAAGTCTCTCAAGGCCCTCGTCAAGATAGTATCAGCACTCGTGATCGTGGTGAGAAAT
CACGATGACCTCATTACGGTCACCGCCACACTGGCGTTAATAGGATGCACTACCTCACCA
TGGCGCTGGCTCAAGCAGAAAGTGTCTCAGTACTATGGCATCCCCATGGCTGAAAGGCAA
AATAGTGGCTGGTTAAAGAAGTTCACAGAGATGACCAATGCCTGTAAGGGCATGGAGTGG
ATAGCCATCAAGATCCAAAAATTCATAGAGTGGTTGAAGGTTAAGATCCTGCCAGAAGTC
AAGGAAAAGCATGAGTTCCTCAACAGGCTTAAACAACTACCACTCTTGGAAAGTCAAATA
GCAACTATTGAGCAGAGTGCACCATCTCAAAGTGACCAGGAGCAACTATTCTCTAATGTA
CAGTACTTTGCCCACTACTGTCGGAAGTATGCACCATTGTACGCCGCTGAAGCAAAGAGA
GTGTTCTCACTTGAAAAGAAGATGAGCAATTACATACAGTTCAAGTCCAAATGCCGTATT
GAACCTGTCTGTCTCTTGCTCCATGGCAGCCCAGGCGCTGGGAAGTCTGTGGCAACGAAC
TTGATTGGGCGCTCGCTCGCTGAGAAACTCAACAGCTCGGTGTACTCACTACCACCAGAT
CCAGACCATTTCGATGGTTACAAACAGCAAGCTGTTGTCATCATGGACGACTTGTGCCAG
AACCCGGACGGTAAAGATGTGTCCTTGTTTTGTCAGATGGTCTCCAGCGTTGACTTCGTG
CCTCCCATGGCGGCGCTTGAGGAAAAAGGCATTCTATTCACCTCGCCGTTCGTTCTCGCG
TCCACCAATGCAGGGTCAGTTAACGCCCCCACGGTCTCCGACAGTAGAGCACTCGTAAGA
AGGTTCCACTTTGACATGAACATTGAGGTTGTTTCCATGTATAGCCAGAACGGTAAGATC
AACATGCCTATGGCAGTTAAAACATGTGATGAGGAGTGTTGCCCGGTCAACTTCAAAAAG
TGCTGCCCACTAGTGTGTGGCAAAGCTATACAATTCATAGACAGGAGGACCCAAGTTAGG
TATTCATTGGACATGCTGGTTACCGAAATGTTTAGGGAGTACAATCACAGACACAGCGTG
GGGGCCACCCTCGAGGCATTGTTCCAAGGACCACCAGTTTATAGAGAGATCAAAATCAGT
GTTGCCCCAGAAACTCCCCCACCACCAGCAGTTGCCGACTTACTGAAATCAGTAGACAGT
GAGGCCGTGAGGGAGTACTGCAAGGAGAAAGGGTGGCTTATACCGGAGGTCGATTCCACC
CTACAGATAGAAAAACATGTGAACAGAGCGTTCATATGTTTGCAAGCTCTAACCACATTT
GTCTCGGTTGCAGGCATAATATACATCATCTACAAACTGTTTGCAGGTTTCCAAGGCGCA
TACACAGGGATGCCTAATCAGAAACCCAGGGTGCCCACCCTGAGACAAGCCAAAGTGCAG
GGTCCAGCGTTTGAGTTCGCCGTGGCGATGATGAAAAGAAACGCCAGTACAGTGAAAACT
GAGTACGGTGAATTCACCATGCTTGGGATTTACGACAGGTGGGCGGTGTTGCCACGCCAT
GCCAAACCTGGCCCCACCATCTTGATGAACGACCAGGTAGTCGGAGTGTTGGACGCCAAG
GAACTAGTTGATAAAGATGGGACCAACCTGGAATTGACTCTCTTGAAGCTCAACCGCAAC
GAGAAGTTTAGAGACATCAGGGGATTCTTAGCACGAGAGGAGGTCGAAGTGAACGAAGCT
GTCCTAGCAATAAACACAAGTAAATTCCCGAATATGTACATACCCGTGGGCCGGGTAACC
GACTATGGGTTCTTAAATCTGGGTGGAACCCCCACGAAGAGAATGCTCATGTACAATTTC
CCAACTAGGGCAGGCCAGTGTGGGGGTGTCCTTATGTCAACAGGGAAAGTCCTGGGAATA
CATGTAGGAGGGAATGGACACCAAGGGTTTTCAGCGGCACTCCTCAGACACTACTTCAAC
GAGGAGCAGGGTGAGATAGAATTCATTGAGAGCTCGAAGGACGCAGGATTTCCCGTGATC
AACACCCCCAGCAAGACAAAATTGGAACCAAGTGTGTTTCACCACGTGTTCGAGGGCAAC
AAGGAACCAGCGGTTCTCAGAAATGGGGACCCACGACTCAAGGCCAACTTTGAGGAGGCA
ATCTTCTCCAAGTACATTGGCAATGTTAACACACATGTAGACGAGTACATGATGGAGGCT
GTAGATCATTATGCAGGACAACTAGCCACACTGGACATCAGCACGGAGCCCATGAAGCTA
GAAGATGCCGTGTATGGCACTGAGGGGCTCGAAGCACTAGACCTGACCACCAGTGCAGGT
TACCCTTATGTGGCCCTGGGTATCAAGAAAAGAGACATCCTATCCAAGAAGACCAGAGAC
CTTACCAAGCTAAAGGAATGCATGGACAAATATGGTCTAAACCTGCCAATGGTAACCTAT
GTCAAGGACGAGTTGAGATCTGCCGACAAAGTGGCCAAGGGAAAGTCCAGGCTCATCGAG
GCTTCTAGCCTCAACGACTCAGTAGCAATGAGGCAGACATTTGGAAACCTATATAAGACT
TTCCACCTCAACCCGGGCATCGTTACGGGTAGCGCCGTTGGGTGTGACCCAGATGTCTTT
TGGAGCAAGATTCCCGTCATGCTCGATGGACATCTCATAGCGTTTGACTATTCAGGCTAT
GACGCCAGCCTCAGCCCAGTGTGGTTTACGTGCTTGAAACTCCTCCTGGAGAAGCTAGGG
TACACAAACAAGGAAACGAACTACATAGACTACCTCTGTAATTCCCACCACCTGTACAGG
GACAAACACTACTTTGTGAGGGGCGGCATGCCATCAGGATGCTCAGGCACTAGCATATTT
AATTCCATGATTAACAACATCATAATCAGAACCCTCATGCTGAAGGTTTATAAAGGCATT
GATTTGGACCAATTCAGAATGATTGCATATGGGGATGATGTGATAGCTTCATACCCGTGG
CCCATCGATGCCTCACTGCTAGCTGAAGCAGGGAAGGATTATGGCTTGATCATGACCCCA
GCAGATAAAGGCGAGTGTTTCAATGAGGTAACCTGGACAAACGTGACCTTCCTGAAAAGG
TACTTCAGGGCAGATGAACAGTACCCATTTTTGGTCCATCCTGTCATGCCAATGAAGGAT
ATACACGAATCCATTAGGTGGACTAAAGATCCTAAGAACACACAGGATCACGTGCGCTCG
CTGTGTCTATTGGCCTGGCACAACGGGGAGCACGAATATGAGGAGTTTATTCGTAAGATC
AGAAGCGTCCGCGTAGGGCGCTGCTTGTCCCTCCCTGCGTTTTCAACGCTGCGCAGGAAG
TGGTTGGACTCCTTTTAA

# Drug_Target_17_General_Function:
Involved in ATP binding

# Drug_Target_17_General_References:
10814575	Martino TA, Petric M, Weingartl H, Bergelson JM, Opavsky MA, Richardson CD, Modlin JF, Finberg RW, Kain KC, Willis N, Gauntt CJ, Liu PP: The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology. 2000 May 25;271(1):99-108.
12692248	Fry EE, Knowles NJ, Newman JW, Wilsden G, Rao Z, King AM, Stuart DI: Crystal structure of Swine vesicular disease virus and implications for host adaptation. J Virol. 2003 May;77(9):5475-86.
2168111	Seechurn P, Knowles NJ, McCauley JW: The complete nucleotide sequence of a pathogenic swine vesicular disease virus. Virus Res. 1990 Jul;16(3):255-74.

# Drug_Target_17_HGNC_ID:
Not Available

# Drug_Target_17_HPRD_ID:
Not Available

# Drug_Target_17_ID:
6744

# Drug_Target_17_Locus:
Not Available

# Drug_Target_17_Molecular_Weight:
243363.5

# Drug_Target_17_Name:
Genome polyprotein

# Drug_Target_17_Number_of_Residues:
2185

# Drug_Target_17_PDB_ID:
Not Available

# Drug_Target_17_Pathway:
Not Available

# Drug_Target_17_Pfam_Domain_Function:
PF00073	Rhv
PF00548	Peptidase_C3
PF00680	RdRP_1
PF00910	RNA_helicase
PF00947	Pico_P2A
PF01552	Pico_P2B
PF02226	Pico_P1A
PF08727	P3A

# Drug_Target_17_Protein_Sequence:
>Genome polyprotein
MGAQVSTQKTGAHETSLSAAGNSVIHYTNINYYKDAASNSANRQDFTQDPGKFTEPVKDI
MVKSMPALNSPSAEECGYSDRVRSITLGNSTITTQECANVVVGYGVWPTYLKDEEATAED
QPTQPDVATCRFYTLESVMWQQSSPGWWWKFPDALSNMGLFGQNMQYHYLGRAGYTIHVQ
CNASKFHQGCLLVVCVPEAEMGCATLANKPDPKSLSKGEIANMFESQNSTGETAVQANVI
NAGMGVGVGNLTIFPHQWINLRTNNSATIVMPYINSVPMDNMFRHNNFTLMVIPFAPLSY
STGATTYVPITVTVAPMCAEYNGLRLAGKQGLPTLSTPGSNQFLTSDDFQSPSAMPQFDV
TPEMDIPGQVNNLMEIAEVDSVVPVNNTEGKVMSIEAYQIPVQSNPTNGSQVFGFPLTPG
ANSVLNRTLLGEILNYYAHWSGSIKLTFMFCGSAMATGKFLLAYSPPGAGAPTTRKEAML
GTHVIWDVGLQSSCVLCIPWISQTHYRYVVMDEYTAGGYITCWYQTNIVVPADAQSDCKI
LCFVSACNDFSVRMLKDTPFIKQDNFFQGPPGEVMGRAIARVADTIGSGPVNSESIPALT
AAETGHTSQVVPSDTMQTRHVKNYHSRSESTVENFLCRSACVFYTTYKNHDSDGDNFAYW
VINTRQVAQLRRKLEMFTYARFDLELTFVITSTQEQPTVRGQDAPVLTHQIMYVPPGGPV
PTKVNSYSWQTSTNPSVFWTEGSAPPRMSIPFIGIGNAYSMFYDGWARFDKQGTYGISTL
NNMGTLYMRHVNDGGPGPIVSTVRIYFKPKHVKTWVPRPPRLCQYQKAGNVNFEPTGVTE
GRTDITTMKTTGAFGQQSGAVYVGNYRVVNRHLATRADWQNCVWEDYNRDLLVSTTTAHG
CDTIARCDCTAGVYFCASRNKHYPVTFEGPGLVEVQESEYYPKKYQSHVLLAAGFAEPGD
CGGILRCQHGVIGIVTVGGEGVVGFADVRDLLWLEDDAMEQGVRDYVEQLGNCFGSGFTN
QICEQVTLLKESLIGQDSILEKSLKALVKIVSALVIVVRNHDDLITVTATLALIGCTTSP
WRWLKQKVSQYYGIPMAERQNSGWLKKFTEMTNACKGMEWIAIKIQKFIEWLKVKILPEV
KEKHEFLNRLKQLPLLESQIATIEQSAPSQSDQEQLFSNVQYFAHYCRKYAPLYAAEAKR
VFSLEKKMSNYIQFKSKCRIEPVCLLLHGSPGAGKSVATNLIGRSLAEKLNSSVYSLPPD
PDHFDGYKQQAVVIMDDLCQNPDGKDVSLFCQMVSSVDFVPPMAALEEKGILFTSPFVLA
STNAGSVNAPTVSDSRALVRRFHFDMNIEVVSMYSQNGKINMPMAVKTCDEECCPVNFKK
CCPLVCGKAIQFIDRRTQVRYSLDMLVTEMFREYNHRHSVGATLEALFQGPPVYREIKIS
VAPETPPPPAVADLLKSVDSEAVREYCKEKGWLIPEVDSTLQIEKHVNRAFICLQALTTF
VSVAGIIYIIYKLFAGFQGAYTGMPNQKPRVPTLRQAKVQGPAFEFAVAMMKRNASTVKT
EYGEFTMLGIYDRWAVLPRHAKPGPTILMNDQVVGVLDAKELVDKDGTNLELTLLKLNRN
EKFRDIRGFLAREEVEVNEAVLAINTSKFPNMYIPVGRVTDYGFLNLGGTPTKRMLMYNF
PTRAGQCGGVLMSTGKVLGIHVGGNGHQGFSAALLRHYFNEEQGEIEFIESSKDAGFPVI
NTPSKTKLEPSVFHHVFEGNKEPAVLRNGDPRLKANFEEAIFSKYIGNVNTHVDEYMMEA
VDHYAGQLATLDISTEPMKLEDAVYGTEGLEALDLTTSAGYPYVALGIKKRDILSKKTRD
LTKLKECMDKYGLNLPMVTYVKDELRSADKVAKGKSRLIEASSLNDSVAMRQTFGNLYKT
FHLNPGIVTGSAVGCDPDVFWSKIPVMLDGHLIAFDYSGYDASLSPVWFTCLKLLLEKLG
YTNKETNYIDYLCNSHHLYRDKHYFVRGGMPSGCSGTSIFNSMINNIIIRTLMLKVYKGI
DLDQFRMIAYGDDVIASYPWPIDASLLAEAGKDYGLIMTPADKGECFNEVTWTNVTFLKR
YFRADEQYPFLVHPVMPMKDIHESIRWTKDPKNTQDHVRSLCLLAWHNGEHEYEEFIRKI
RSVRVGRCLSLPAFSTLRRKWLDSF

# Drug_Target_17_Reaction:
Not Available

# Drug_Target_17_Signals:
None

# Drug_Target_17_Specific_Function:
RNA-directed RNA polymerase 3D-POL replicates genomic and antigenomic RNA by recognizing replications specific signals (By similarity)

# Drug_Target_17_SwissProt_ID:
P13900

# Drug_Target_17_SwissProt_Name:
POLG_SVDVU

# Drug_Target_17_Synonyms:
P1A
P1B
P1C
P1D
P2A
P2B
P2C
P3A
P3B
P3C
P3D-POL
Picornain 2A
Picornain 3C
Protease 3C
Protein 2A
Protein 2B
Protein 2C
Protein 3A
Protein 3B
Protein VP0
Protein VP1
Protein VP2
Protein VP3
Protein VP4
RNA-directed RNA polymerase 3D-POL
VP4-VP2
VPg
Virion protein 1
Virion protein 2
Virion protein 3
Virion protein 4

# Drug_Target_17_Theoretical_pI:
6.90

# Drug_Target_17_Transmembrane_Regions:
None

# Drug_Target_18_Cellular_Location:
Cytoplasm

# Drug_Target_18_Chromosome_Location:
Not Available

# Drug_Target_18_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_18_Essentiality:
Non-Essential

# Drug_Target_18_GenAtlas_ID:
ABL1

# Drug_Target_18_GenBank_ID_Gene:
X16416

# Drug_Target_18_GenBank_ID_Protein:
28237

# Drug_Target_18_GeneCard_ID:
ABL1

# Drug_Target_18_Gene_Name:
ABL1

# Drug_Target_18_Gene_Sequence:
>3393 bp
ATGTTGGAGATCTGCCTGAAGCTGGTGGGCTGCAAATCCAAGAAGGGGCTGTCCTCGTCC
TCCAGCTGTTATCTGGAAGAAGCCCTTCAGCGGCCAGTAGCATCTGACTTTGAGCCTCAG
GGTCTGAGTGAAGCCGCTCGTTGGAACTCCAAGGAAAACCTTCTCGCTGGACCCAGTGAA
AATGACCCCAACCTTTTCGTTGCACTGTATGATTTTGTGGCCAGTGGAGATAACACTCTA
AGCATAACTAAAGGTGAAAAGCTCCGGGTCTTAGGCTATAATCACAATGGGGAATGGTGT
GAAGCCCAAACCAAAAATGGCCAAGGCTGGGTCCCAAGCAACTACATCACGCCAGTCAAC
AGTCTGGAGAAACACTCCTGGTACCATGGGCCTGTGTCCCGCAATGCCGCTGAGTATCTG
CTGAGCAGCGGGATCAATGGCAGCTTCTTGGTGCGTGAGAGTGAGAGCAGTCCTGGCCAG
AGGTCCATCTCGCTGAGATACGAAGGGAGGGTGTACCATTACAGGATCAACACTGCTTCT
GATGGCAAGCTCTACGTCTCCTCCGAGAGCCGCTTCAACACCCTGGCCGAGTTGGTTCAT
CATCATTCAACGGTGGCCGACGGGCTCATCACCACGCTCCATTATCCAGCCCCAAAGCGC
AACAAGCCCACTGTCTATGGTGTGTCCCCCAACTACGACAAGTGGGAGATGGAACGCACG
GACATCACCATGAAGCACAAGCTGGGCGGGGGCCAGTACGGGGAGGTGTACGAGGGCGTG
TGGAAGAAATACAGCCTGACGGTGGCCGTGAAGACCTTGAAGGAGGACACCATGGAGGTG
GAAGAGTTCTTGAAAGAAGCTGCAGTCATGAAAGAGATCAAACACCCTAACCTGGTGCAG
CTCCTTGGGGTCTGCACCCGGGAGCCCCCGTTCTATATCATCACTGAGTTCATGACCTAC
GGGAACCTCCTGGACTACCTGAGGGAGTGCAACCGGCAGGAGGTGAACGCCGTGGTGCTG
CTGTACATGGCCACTCAGATCTCGTCAGCCATGGAGTACCTGGAGAAGAAAAACTTCATC
CACAGAGATCTTGCTGCCCGAAACTGCCTGGTAGGGGAGAACCACTTGGTGAAGGTAGCT
GATTTTGGCCTGAGCAGGTTGATGACAGGGGACACCTACACAGCCCATGCTGGAGCCAAG
TTCCCCATCAAATGGACTGCACCCGAGAGCCTGGCCTACAACAAGTTCTCCATCAAGTCC
GACGTCTGGGCATTTGGAGTATTGCTTTGGGAAATTGCTACCTATGGCATGTCCCCTTAC
CCGGGAATTGACCTGTCCCAGGTGTATGAGCTGCTAGAGAAGGACTACCGCATGGAGCGC
CCAGAAGGCTGCCCAGAGAAGGTCTATGAACTCATGCGAGCATGTTGGCAGTGGAATCCC
TCTGACCGGCCCTCCTTTGCTGAAATCCACCAAGCCTTTGAAACAATGTTCCAGGAATCC
AGTATCTCAGACGAAGTGGAAAAGGAGCTGGGGAAACAAGGCGTCCGTGGGGCTGTGAGT
ACCTTGCTGCAGGCCCCAGAGCTGCCCACCAAGACGAGGACCTCCAGGAGAGCTGCAGAG
CACAGAGACACCACTGACGTGCCTGAGATGCCTCACTCCAAGGGCCAGGGAGAGAGCGAT
CCTCTGGACCATGAGCCTGCCGTGTCTCCATTGCTCCCTCGAAAAGAGCGAGGTCCCCCG
GAGGGCGGCCTGAATGAAGATGAGCGCCTTCTCCCCAAAGACAAAAAGACCAACTTGTTC
AGCGCCTTGATCAAGAAGAAGAAGAAGACAGCCCCAACCCCTCCCAAACGCAGCAGCTCC
TTCCGGGAGATGGACGGCCAGCCGGAGCGCAGAGGGGCCGGCGAGGAAGAGGGCCGAGAC
ATCAGCAACGGGGCACTGGCTTTCACCCCCTTGGACACAGCTGACCCAGCCAAGTCCCCA
AAGCCCAGCAATGGGGCTGGGGTCCCCAATGGAGCCCTCCGGGAGTCCGGGGGCTCAGGC
TTCCGGTCTCCCCACCTGTGGAAGAAGTCCAGCACGCTGACCAGCAGCCGCCTAGCCACC
GGCGAGGAGGAGGGCGGTGGCAGCTCCAGCAAGCGCTTCCTGCGCTCTTGCTCCGCCTCC
TGCGTTCCCCATGGGGCCAAGGACACGGAGTGGAGGTCAGTCACGCTGCCTCGGGACTTG
CAGTCCACGGGAAGACAGTTTGACTCGTCCACATTTGGAGGGCACAAAAGTGAGAAGCCG
GCTCTGCCTCGGAAGAGGGCAGGGGAGAACAGGTCTGACCAGGTGACCCGAGGCACAGTA
ACGCCTCCCCCCAGGCTGGTGAAAAAGAATGAGGAAGCTGCTGATGAGGTCTTCAAAGAC
ATCATGGAGTCCAGCCCGGGCTCCAGCCCGCCCAACCTGACTCCAAAACCCCTCCGGCGG
CAGGTCACCGTGGCCCCTGCCTCGGGCCTCCCCCACAAGGAAGAAGCTGAAAAGGGCAGT
GCCTTAGGGACCCCTGCTGCAGCTGAGCCAGTGACCCCCACCAGCAAAGCAGGCTCAGGT
GCACCAGGGGGCACCAGCAAGGGCCCCGCCGAGGAGTCCAGAGTGAGGAGGCACAAGCAC
TCCTCTGAGTCGCCAGGGAGGGACAAGGGGAAATTGTCCAGGCTCAAACCTGCCCCGCCG
CCCCCACCAGCAGCCTCTGCAGGGAAGGCTGGAGGAAAGCCCTCGCAGAGCCCGAGCCAG
GAGGCGGCCGGGGAGGCAGTCCTGGGCGCAAAGACAAAAGCCACGAGTCTGGTTGATGCT
GTGAACAGTGACGCTGCCAAGCCCAGCCAGCCGGGAGAGGGCCTCAAAAAGCCCGTGCTC
CCGGCCACTCCAAAGCCACAGTCCGCCAAGCCGTCGGGGACCCCCATCAGCCCAGCCCCC
GTTCCCTCCACGTTGCCATCAGCATCCTCGGCCCTGGCAGGGGACCAGCCGTCTTCCACT
GCCTTCATCCCTCTCATATCAACCCGAGTGTCTCTTCGGAAAACCCGCCAGCCTCCAGAG
CGGATCGCCAGCGGCGCCATCACCAAGGGCGTGGTCCTGGACAGCACCGAGGCGCTGTGC
CTCGCCATCTCTAGGAACTCCGAGCAGATGGCCAGCCACAGCGCAGTGCTGGAGGCCGGC
AAAAACCTCTACACGTTCTGCGTGAGCTATGTGGATTCCATCCAGCAAATGAGGAACAAG
TTTGCCTTCCGAGAGGCCATCAACAAACTGGAGAATAATCTCCGGGAGCTTCAGATCTGC
CCGGCGACAGCAGGCAGTGGTCCGGCGGCCACTCAGGACTTCAGCAAGCTCCTCAGTTCG
GTGAAGGAAATCAGTGACATAGTGCAGAGGTAG

# Drug_Target_18_General_Function:
Involved in protein kinase activity

# Drug_Target_18_General_References:
11374898	Lin WH, Huang CJ, Liu MW, Chang HM, Chen YJ, Tai TY, Chuang LM: Cloning, mapping, and characterization of the human sorbin and SH3 domain containing 1 (SORBS1) gene: a protein associated with c-Abl during insulin signaling in the hepatoma cell line Hep3B. Genomics. 2001 May 15;74(1):12-20.
12384576	Donaldson LW, Gish G, Pawson T, Kay LE, Forman-Kay JD: Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14053-8. Epub 2002 Oct 16.
12522270	Salomon AR, Ficarro SB, Brill LM, Brinker A, Phung QT, Ericson C, Sauer K, Brock A, Horn DM, Schultz PG, Peters EC: Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):443-8. Epub 2003 Jan 9.
1281542	Overduin M, Mayer B, Rios CB, Baltimore D, Cowburn D: Secondary structure of Src homology 2 domain of c-Abl by heteronuclear NMR spectroscopy in solution. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11673-7.
1505033	Overduin M, Rios CB, Mayer BJ, Baltimore D, Cowburn D: Three-dimensional solution structure of the src homology 2 domain of c-abl. Cell. 1992 Aug 21;70(4):697-704.
2687768	Fainstein E, Einat M, Gokkel E, Marcelle C, Croce CM, Gale RP, Canaani E: Nucleotide sequence analysis of human abl and bcr-abl cDNAs. Oncogene. 1989 Dec;4(12):1477-81.
2825022	Fainstein E, Marcelle C, Rosner A, Canaani E, Gale RP, Dreazen O, Smith SD, Croce CM: A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature. 1987 Nov 26-Dec 2;330(6146):386-8.
3021337	Shtivelman E, Lifshitz B, Gale RP, Roe BA, Canaani E: Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell. 1986 Oct 24;47(2):277-84.
6191223	Groffen J, Heisterkamp N, Reynolds FH Jr, Stephenson JR: Homology between phosphotyrosine acceptor site of human c-abl and viral oncogene products. Nature. 1983 Jul 14-20;304(5922):167-9.
7545908	Inokuchi K, Futaki M, Dan K, Nomura T: Sequence analysis of the mutation at codon 834 and the sequence variation of codon 837 of c-abl gene. Leukemia. 1994 Feb;8(2):343-4.
7665185	Chissoe SL, Bodenteich A, Wang YF, Wang YP, Burian D, Clifton SW, Crabtree J, Freeman A, Iyer K, Jian L, et al.: Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. Genomics. 1995 May 1;27(1):67-82.
7892170	Pisabarro MT, Ortiz AR, Serrano L, Wade RC: Homology modeling of the Abl-SH3 domain. Proteins. 1994 Nov;20(3):203-15.
8590002	Gosser YQ, Zheng J, Overduin M, Mayer BJ, Cowburn D: The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct. Structure. 1995 Oct 15;3(10):1075-86.
8805596	Nam HJ, Haser WG, Roberts TM, Frederick CA: Intramolecular interactions of the regulatory domains of the Bcr-Abl kinase reveal a novel control mechanism. Structure. 1996 Sep 15;4(9):1105-14.
9168116	Baskaran R, Wood LD, Whitaker LL, Canman CE, Morgan SE, Xu Y, Barlow C, Baltimore D, Wynshaw-Boris A, Kastan MB, Wang JY: Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature. 1997 May 29;387(6632):516-9.
9698566	Pisabarro MT, Serrano L, Wilmanns M: Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions. J Mol Biol. 1998 Aug 21;281(3):513-21.

# Drug_Target_18_HGNC_ID:
HGNC:76

# Drug_Target_18_HPRD_ID:
01809

# Drug_Target_18_ID:
17

# Drug_Target_18_Locus:
9q34.1

# Drug_Target_18_Molecular_Weight:
122873

# Drug_Target_18_Name:
Proto-oncogene tyrosine-protein kinase ABL1

# Drug_Target_18_Number_of_Residues:
1130

# Drug_Target_18_PDB_ID:
1OPL

# Drug_Target_18_Pathway:
Not Available

# Drug_Target_18_Pfam_Domain_Function:
PF00017	SH2
PF00018	SH3_1
PF07714	Pkinase_Tyr

# Drug_Target_18_Protein_Sequence:
>Proto-oncogene tyrosine-protein kinase ABL1
MLEICLKLVGCKSKKGLSSSSSCYLEEALQRPVASDFEPQGLSEAARWNSKENLLAGPSE
NDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVN
SLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTAS
DGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERT
DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ
LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI
HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS
DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP
SDRPSFAEIHQAFETMFQESSISDEVEKELGKQGVRGAVSTLLQAPELPTKTRTSRRAAE
HRDTTDVPEMPHSKGQGESDPLDHEPAVSPLLPRKERGPPEGGLNEDERLLPKDKKTNLF
SALIKKKKKTAPTPPKRSSSFREMDGQPERRGAGEEEGRDISNGALAFTPLDTADPAKSP
KPSNGAGVPNGALRESGGSGFRSPHLWKKSSTLTSSRLATGEEEGGGSSSKRFLRSCSAS
CVPHGAKDTEWRSVTLPRDLQSTGRQFDSSTFGGHKSEKPALPRKRAGENRSDQVTRGTV
TPPPRLVKKNEEAADEVFKDIMESSPGSSPPNLTPKPLRRQVTVAPASGLPHKEEAGKGS
ALGTPAAAEPVTPTSKAGSGAPGGTSKGPAEESRVRRHKHSSESPGRDKGKLSRLKPAPP
PPPAASAGKAGGKPSQSPSQEAAGEAVLGAKTKATSLVDAVNSDAAKPSQPGEGLKKPVL
PATPKPQSAKPSGTPISPAPVPSTLPSASSALAGDQPSSTAFIPLISTRVSLRKTRQPPE
RIASGAITKGVVLDSTEALCLAISRNSEQMASHSAVLEAGKNLYTFCVSYVDSIQQMRNK
FAFREAINKLENNLRELQICPATAGSGPAATQDFSKLLSSVKEISDIVQR

# Drug_Target_18_Reaction:
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate

# Drug_Target_18_Signals:
None

# Drug_Target_18_Specific_Function:
Not Available

# Drug_Target_18_SwissProt_ID:
P00519

# Drug_Target_18_SwissProt_Name:
ABL1_HUMAN

# Drug_Target_18_Synonyms:
Abelson murine leukemia viral oncogene homolog 1
EC 2.7.10.2
c- ABL
p150

# Drug_Target_18_Theoretical_pI:
8.94

# Drug_Target_18_Transmembrane_Regions:
None

# Drug_Target_19_Cellular_Location:
Cytoplasmic

# Drug_Target_19_Chromosome_Location:
Not Available

# Drug_Target_19_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_19_Essentiality:
Non-Essential

# Drug_Target_19_GenAtlas_ID:
Not Available

# Drug_Target_19_GenBank_ID_Gene:
AE000657

# Drug_Target_19_GenBank_ID_Protein:
2984065

# Drug_Target_19_GeneCard_ID:
Not Available

# Drug_Target_19_Gene_Name:
lpxC

# Drug_Target_19_Gene_Sequence:
>849 bp
ATGGGATTAGAAAAGACGGTTAAAGAGAAATTAAGCTTTGAGGGTGTCGGTATACACACA
GGTGAATACTCAAAATTAATCATACATCCCGAAAAAGAAGGAACAGGAATCAGGTTTTTC
AAGAACGGAGTTTACATACCCGCAAGACATGAGTTCGTCGTTCACACAAATCACTCCACG
GATTTAGGCTTTAAAGGGCAAAGAATAAAAACGGTTGAACACATACTTTCCGTTCTCCAC
CTACTTGAGATAACAAACGTGACAATAGAAGTAATAGGGAACGAAATCCCTATACTTGAC
GGAAGTGGCTGGGAATTCTACGAAGCCATTAGGAAAAATATTCTCAATCAGAACAGAGAA
ATAGATTACTTTGTTGTAGAAGAACCCATTATCGTGGAAGACGAGGGAAGATTGATAAAG
GCAGAACCTTCAGACACGCTTGAGGTCACCTACGAGGGAGAATTTAAAAATTTCCTGGGA
AGGCAGAAGTTTACCTTTGTTGAAGGGAACGAAGAAGAAATAGTCCTTGCGCGGACTTTT
TGCTTTGACTGGGAAATAGAACACATTAAAAAAGTCGGTCTTGGGAAGGGAGGAAGCCTG
AAAAACACCCTCGTTCTCGGAAAGGATAAAGTGTACAACCCTGAAGGGCTAAGATACGAA
AACGAACCTGTAAGACACAAAGTGTTTGACCTTATAGGAGACCTTTACCTCCTTGGAAGT
CCCGTAAAAGGTAAGTTTTACTCCTTCAGGGGAGGGCACTCGCTCAACGTAAAACTCGTA
AAAGAGCTTGCAAAGAAACAAAAACTTACTCGTGATTTACCTCACCTTCCTTCCGTCCAA
GCTCTCTGA

# Drug_Target_19_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_19_General_References:
9537320	Deckert G, Warren PV, Gaasterland T, Young WG, Lenox AL, Graham DE, Overbeek R, Snead MA, Keller M, Aujay M, Huber R, Feldman RA, Short JM, Olsen GJ, Swanson RV: The complete genome of the hyperthermophilic bacterium Aquifex aeolicus. Nature. 1998 Mar 26;392(6674):353-8.

# Drug_Target_19_HGNC_ID:
Not Available

# Drug_Target_19_HPRD_ID:
Not Available

# Drug_Target_19_ID:
2435

# Drug_Target_19_Locus:
Not Available

# Drug_Target_19_Molecular_Weight:
32145

# Drug_Target_19_Name:
UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase

# Drug_Target_19_Number_of_Residues:
282

# Drug_Target_19_PDB_ID:
1XXE

# Drug_Target_19_Pathway:
Not Available

# Drug_Target_19_Pfam_Domain_Function:
PF03331	LpxC

# Drug_Target_19_Protein_Sequence:
>UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase
MGLEKTVKEKLSFEGVGIHTGEYSKLIIHPEKEGTGIRFFKNGVYIPARHEFVVHTNHST
DLGFKGQRIKTVEHILSVLHLLEITNVTIEVIGNEIPILDGSGWEFYEAIRKNILNQNRE
IDYFVVEEPIIVEDEGRLIKAEPSDTLEVTYEGEFKNFLGRQKFTFVEGNEEEIVLARTF
CFDWEIEHIKKVGLGKGGSLKNTLVLGKDKVYNPEGLRYENEPVRHKVFDLIGDLYLLGS
PVKGKFYSFRGGHSLNVKLVKELAKKQKLTRDLPHLPSVQAL

# Drug_Target_19_Reaction:
Not Available

# Drug_Target_19_Signals:
None

# Drug_Target_19_Specific_Function:
Involved in the biosynthesis of lipid A, a phosphorylated glycolipid that anchors the lipopolysaccharide to the outer membrane of the cell

# Drug_Target_19_SwissProt_ID:
O67648

# Drug_Target_19_SwissProt_Name:
LPXC_AQUAE

# Drug_Target_19_Synonyms:
EC 3.5.1.-
UDP-3-O-acyl-GlcNAc deacetylase

# Drug_Target_19_Theoretical_pI:
6.75

# Drug_Target_19_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
V01149

# Drug_Target_1_GenBank_ID_Protein:
61253

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>6630 bp
ATGGGTGCTCAGGTTTCATCACAGAAAGTGGGCGCACATGAAAACTCAAATAGAGCGTAT
GGTGGTTCTACCATTAATTACACCACCATTAATTATTATAGAGATTCAGCTAGTAACGCG
GCTTCGAAACAGGACTTCTCTCAAGACCCTTCCAAGTTCACCGAGCCCATCAAGGATGTC
CTGATAAAAACAGCCCCAATGCTAAACTCGCCAAACATAGAGGCTTGCGGGTATAGCGAT
AGAGTACTGCAATTAACACTGGGAAACTCCACTATAACCACACAGGAGGCGGCTAATTCA
GTAGTCGCTTATGGGCGTTGGCCTGAATATCTGAGGGACAGCGAAGCCAATCCAGTGGAC
CAGCCGACAGAACCAGACGTCGCTGCATGCAGGTTTTATACGCTAGACACCGTGTCTTGG
ACGAAAGAGTCGCGAGGGTGGTGGTGGAAGTTGCCTGATGCACTGAGGGACATGGGACTC
TTTGGGCAAAATATGTACTACCACTACCTAGGTAGGTCCGGGTACACCGTGCATGTACAG
TGTAACGCCTCCAAATTCCACCAGGGGGCACTAGGGGTATTCGCCGTACCAGAGATGTGT
CTGGCCGGGGATAGCAACACCACTACCATGCACACCAGCTATCAAAATGCCAATCCTGGC
GAGAAAGGAGGCACTTTCACGGGTACGTTCACTCCTGACAACAACCAGACATCACCTGCC
CGCAGGTTCTGCCCGGTGGATTACCTCCTTGGAAATGGCACGTTGTTGGGGAATGCCTTT
GTGTTCCCGCACCAGATAATAAACCTACGGACCAACAACTGTGCTACACTGGTACTCCCT
TACGTGAACTCCCTCTCGATAGATAGTATGGTAAAGCACAATAATTGGGGAATTGCAATA
TTACCATTGGCCCCATTAAATTTTGCTAGTGAGTCCTCCCCAGAGATTCCAATCACCTTG
ACCATAGCCCCTATGTGCTGTGAGTTCAATGGATTAAGAAACATCACCCTGCCACGCTTA
CAGGGCCTGCCGGTCATGAACACCCCTGGTAGCAATCAATATCTTACTGCAGACAACTTC
CAGTCACCGTGTGCGCTGCCTGAATTTGATGTGACCCCACCTATTGACATACCCGGTGAA
GTAAAGAACATGATGGAATTGGCAGAAATCGACACCATGATTCCCTTTGACTTAAGTGCC
ACAAAAAAGAACACCATGGAAATGTATAGGGTTCGGTTAAGTGACAAACCACATACAGAC
GATCCCATACTCTGCCTGTCACTCTCTCCAGCTTCAGATCCTAGGTTGTCACATACTATG
CTTGGAGAAATCCTAAATTACTACACACACTGGGCAGGATCCCTGAAGTTCACGTTTCTG
TTCTGTGGATTCATGATGGCAACTGGCAAACTGTTGGTGTCATACGCGCCTCCTGGAGCC
GACCCACCAAAGAAGCGTAAGGAGGCGATGTTGGGAACACATGTGATCTGGGACATAGGA
CTGCAGTCCTCATGTACTATGGTAGTGCCATGGATTAGCAACACCACGTATCGGCAAACC
ATAGATGATAGTTTCACCGAAGGCGGATACATCAGCGTCTTCTACCAAACTAGAATAGTC
GTCCCTCTTTCGACACCCAGAGAGATGGACATCCTTGGTTTTGTGTCAGCGTGTAATGAC
TTCAGCGTGCGCTTGTTGCGAGATACCACACATATAGAGCAAAAAGCGCTAGCACAGGGG
TTAGGTCAGATGCTTGAAAGCATGATTGACAACACAGTCCGTGAAACGGTGGGGGCGGCA
ACATCTAGAGACGCTCTCCCAAACACTGAAGCCAGTGGACCAACACACTCCAAGGAAATT
CCGGCACTCACCGCAGTGGAAACTGGGGCCACAAATCCACTAGTCCCTTCTGATACAGTG
CAAACCAGACATGTTGTACAACATAGGTCAAGGTCAGAGTCTAGCATAGAGTCTTTCTTC
GCGCGGGGTGCATGCGTGACCATTATGACCGTGGATAACCCAGCTTCCACCACGAATAAG
GATAAGCTATTTGCAGTGTGGAAGATCACTTATAAAGATACTGTCCAGTTACGGAGGAAA
TTGGAGTTCTTCACCTATTCTAGATTTGATATGGAACTTACCTTTGTGGTTACTGCAAAT
TTCACTGAGACTAACAATGGGCATGCCTTAAATCAAGTGTACCAAATTATGTACGTACCA
CCAGGCGCTCCAGTGCCCGAGAAATGGGACGACTACACATGGCAAACCTCATCAAATCCA
TCAATCTTTTACACCTACGGAACAGCTCCAGCCCGGATCTCGGTACCGTATGTTGGTATT
TCGAACGCCTATTCACACTTTTACGACGGTTTTTCCAAAGTACCACTGAAGGACCAGTCG
GCAGCACTAGGTGACTCCCTTTATGGTGCAGCATCTCTAAATGACTTCGGTATTTTGGCT
GTTAGAGTAGTCAATGATCACAACCCGACCAAGGTCACCTCCAAAATCAGAGTGTATCTA
AAACCCAAACACATCAGAGTCTGGTGCCCGCGTCCACCGAGGGCAGTGGCGTACTACGGC
CCTGGAGTGGATTACAAGGATGGTACGCTTACACCCCTCTCCACCAAGGATCTGACCACA
TATGGATTCGGACACCAAAACAAAGCGGTGTACACTGCAGGTTACAAAATTTGCAACTAC
CACTTGGCCACTCAGGATGATTTGCAAAACGCAGTGAACGTCATGTGGAGTAGAGACCTC
TTAGTCACAGAATCAAGAGCCCAGGGCACCGATTCAATCGCAAGGTGCAATTGCAACGCA
GGGGTGTACTACTGCGAGTCTAGAAGGAAATACTACCCAGTATCCTTCGTTGGCCCAACG
TTCCAGTACATGGAGGCTAATAACTATTACCCAGCTAGGTACCAGTCCCATATGCTCATT
GGCCATGGATTCGCATCTCCAGGGGATTGTGGTGGCATACTCAGATGTCACCACGGGGTG
ATAGGGATCATTACTGCTGGTGGCGAAGGGTTGGTTGCATTTTCAGACATTAGAGACTTG
TATGCCTACGAAGAAGAAGCCATGGAACAAGGCATCACCAATTACATAGAGTCACTTGGG
GCCGCATTTGGAAGTGGATTTACTCAGCAGATTAGCGACAAAATAACAGAGTTGACCAAT
ATGGTGACCAGTACCATCACTGAAAAGCTACTTAAGAACTTGATCAAGATCATATCCTCA
CTAGTTATTATAACTAGGAACTATGAAGACACCACAACAGTGCTCGCTACCCTGGCCCTT
CTTGGGTGTGATGCTTCACCATGGCAGTGGCTTAGAAAGAAAGCATGCGATGTTCTGGAG
ATACCTTATGTCATCAAGCAAGGTGACAGTTGGTTGAAGAAGTTTACTGAAGCATGCAAC
GCAGCTAAGGGACTGGAGTGGGTGTCAAACAAAATCTCAAAATTCATTGATTGGCTCAAG
GAGAAAATTATCCCACAAGCTAGAGATAAGTTGGAATTTGTAACAAAACTTAGACAACTA
GAAATGCTGGAAAACCAAATCTCAACTATACACCAATCATGCCCTAGTCAGGAACACCAG
GAAATTCTATTCAATAATGTCAGATGGTTATCCATCCAGTCTAAGAGGTTTGCCCCTCTT
TACGCAGTGGAAGCCAAAAGAATACAGAAACTAGAGCATACTATTAACAACTACATACAG
TTCAAGAGCAAACACCGTATTGAACCAGTATGTTTGCTAGTACATGGCAGCCCCGGAACA
GGTAAATCTGTAGCAACCAACCTGATTGCTAGAGCCATAGCTGAAAGAGAAAACACGTCC
ACGTACTCGCTACCCCCGGATCCATCACACTTCGACGGATACAAACAACAGGGAGTGGTG
ATTATGGACGACCTGAATCAAAACCCAGATGGTGCGGACATGAAGCTGTTCTGTCAGATG
GTATCAACAGTGGAGTTTATACCACCCATGGCATCCCTGGAGGAGAAAGGAATCCTGTTT
ACTTCAAATTACGTTCTAGCATCCACAAACTCAAGCAGAATTTCCCCCCCCACTGTGGCA
CACAGTGATGCATTAGCCAGGCGCTTTGCGTTCGACATGGACATTCAGGTCATGAATGAG
TATTCTAGAGATGGGAAATTGAACATGGCCATGGCTACTGAAATGTGTAAGAACTGTCAC
CAACCAGCAAACTTTAAGAGATGCTGTCCTTTAGTGTGTGGTAAGGCAATTCAATTAATG
GACAAATCTTCCAGAGTTAGATACAGTATTGACCAGATCACTACAATGATTATCAATGAG
AGAAACAGAAGATCCAACATTGGCAATTGTATGGAGGCTTTGTTTCAAGGACCACTCCAG
TATAAAGACTTGAAAATTGACATCAAGACGAGTCCCCCTCCTGAATGTATCAATGACTTG
CTCCAAGCAGTTGACTCCCAGGAGGTGAGAGATTACTGTGAGAAGAAGGGTTGGATAGTC
AACATCACCAGCCAGGTTCAAACAGAAAGGAACATCAACAGGGCAATGACAATTCTACAA
GCGGTGACAACCTTCGCCGCAGTGGCTGGAGTTGTCTATGTCATGTATAAACTGTTTGCT
GGACACCAGGGAGCATACACTGGTTTACCAAACAAAAAACCCAACGTGCCCACCATTCGG
ACAGCAAAGGTACAAGGACCAGGGTTCGATTACGCAGTGGCTATGGCTAAAAGAAACATT
GTTACAGCAACTACTAGCAAGGGAGAGTTCACTATGTTAGGAGTCCACGACAACGTGGCT
ATTTTACCAACCCACGCTTCACCTGGTGAAAGCATTGTGATCGATGGCAAAGAAGTGGAG
ATCTTGGATGCCAAAGCGCTCGAAGATCAAGCAGGAACCAATCTTGAAATCACTATAATC
ACTCTAAAGAGAAATGAAAAGTTCAGAGACATTAGACCACATATACCTACTCAAATCACT
GAGACAAATGATGGAGTCTTGATCGTGAACACTAGCAAGTACCCCAATATGTATGTTCCT
GTCGGTGCTGTGACTGAACAGGGATATCTAAATCTCGGTGGGCGCCAAACTGCTCGTACT
CTAATGTACAACTTTCCAACCAGAGCAGGACAGTGTGGTGGAGTCATCACATGTACTGGG
AAAGTCATCGGGATGCATGTTGGTGGGAACGGTTCACACGGGTTTGCAGCGGCCCTGAAG
CGATCATACTTCACTCAGAGTCAAGGTGAAATCCAGTGGATGAGACCTTCGAAGGAAGTG
GGATATCCAATCATAAATGCCCCGTCCAAAACCAAGCTTGAACCCAGTGCTTTCCACTAT
GTGTTTGAAGGGGTGAAGGAACCAGCAGTCCTCACTAAAAACGATCCCAGGCTTAAGACA
GACTTTGAGGAGGCAATTTTCTCCAAGTACGTGGGTAACAAAATTACTGAAGTGGATGAG
TACATGAAAGAGGCAGTAGACCACTATGCTGGCCAGCTCATGTCACTAGACATCAACACA
GAACAAATGTGCTTGGAGGATGCCATGTATGGCACTGATGGTCTAGAAGCACTTGATTTG
TCCACCAGTGCTGGCTACCCTTATGTAGCAATGGGAAAGAAGAAGAGAGACATCTTGAAC
AAACAAACCAGAGACACTAAGGAAATGCAAAAACTGCTCGACACATATGGAATCAACCTC
CCACTGGTGACTTATGTAAAGGATGAACTTAGATCCAAAACAAAGGTTGAGCAGGGGAAA
TCCAGATTAATTGAAGCTTCTAGTTTGAATGACTCAGTGGCAATGAGAATGGCTTTTGGG
AACCTATATGCTGCTTTTCACAAAAACCCAGGAGTGATAACAGGTTCAGCAGTGGGGTGC
GATCCAGATTTGTTTTGGAGCAAAATTCCGGTATTGATGGAAGAGAAGCTGTTTGCTTTT
GACTACACAGGGTATGATGCATCTCTCAGCCCTGCTTGGTTCGAGGCACTAAAGATGGTG
CTTGAGAAAATCGGATTCGGAGACAGAGTTGACTACATCGACTACCTAAACCACTCACAC
CACCTGTACAAGAATAAAACATACTGTGTCAAGGGCGGTATGCCATCTGGCTGCTCAGGC
ACTTCAATTTTTAACTCAATGATTAACAACTTGATTATCAGGACACTCTTACTGAAAACC
TACAAGGGCATAGATTTAGACCACCTAAAAATGATTGCCTATGGTGATGATGTAATTGCT
TCCTACCCCCATGAAGTTGACGCTAGTCTCCTAGCCCAATCAGGAAAAGACTATGGACTA
ACTATGACTCCAGCTGACAAATCAGCTACATTTGAAACAGTCACATGGGAGAATGTAACA
TTCTTGAAGAGATTCTTCAGGGCAGACGAGAAATACCCATTTCTTATTCATCCAGTAATG
CCAATGAAGGAAATTCATGAATCAATTAGATGGACTAAAGATCCTAGGAACACTCAGGAT
CACGTTCGCTCTCTGTGCCTTTTAGCTTGGCACAATGGCGAAGAAGAATATAACAAATTC
CTAGCTAAAATCAGGAGTGTGCCAATTGGAAGAGCTTTATTGCTCCCAGAGTACTCAACA
TTGTACCGCCGTTGGCTTGACTCATTTTAG

# Drug_Target_1_General_Function:
Involved in nucleotide binding

# Drug_Target_1_General_References:
209034	Ambros V, Baltimore D: Protein is linked to the 5' end of poliovirus RNA by a phosphodiester linkage to tyrosine. J Biol Chem. 1978 Aug 10;253(15):5263-6.
2994218	Hogle JM, Chow M, Filman DJ: Three-dimensional structure of poliovirus at 2.9 A resolution. Science. 1985 Sep 27;229(4720):1358-65.
6250717	Kitamura N, Adler CJ, Rothberg PG, Martinko J, Nathenson SG, Wimmer E: The genome-linked protein of picornaviruses. VII. Genetic mapping of poliovirus VPg by protein and RNA sequence studies. Cell. 1980 Aug;21(1):295-302.
6264310	Kitamura N, Semler BL, Rothberg PG, Larsen GR, Adler CJ, Dorner AJ, Emini EA, Hanecak R, Lee JJ, van der Werf S, Anderson CW, Wimmer E: Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature. 1981 Jun 18;291(5816):547-53.
6272282	Racaniello VR, Baltimore D: Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4887-91.
6284987	Dorner AJ, Dorner LF, Larsen GR, Wimmer E, Anderson CW: Identification of the initiation site of poliovirus polyprotein synthesis. J Virol. 1982 Jun;42(3):1017-28.
7820548	Grant RA, Hiremath CN, Filman DJ, Syed R, Andries K, Hogle JM: Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr Biol. 1994 Sep 1;4(9):784-97.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2928

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
246543

# Drug_Target_1_Name:
Genome polyprotein

# Drug_Target_1_Number_of_Residues:
2209

# Drug_Target_1_PDB_ID:
1RDR

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00073	Rhv
PF00548	Peptidase_C3
PF00680	RdRP_1
PF00910	RNA_helicase
PF00947	Pico_P2A
PF01552	Pico_P2B
PF02226	Pico_P1A
PF08727	P3A

# Drug_Target_1_Protein_Sequence:
>Genome polyprotein [Contains: Capsid protein VP4
MGAQVSSQKVGAHENSNRAYGGSTINYTTINYYRDSASNAASKQDFSQDPSKFTEPIKDV
LIKTAPMLNSPNIEACGYSDRVLQLTLGNSTITTQEAANSVVAYGRWPEYLRDSEANPVD
QPTEPDVAACRFYTLDTVSWTKESRGWWWKLPDALRDMGLFGQNMYYHYLGRSGYTVHVQ
CNASKFHQGALGVFAVPEMCLAGDSNTTTMHTSYQNANPGEKGGTFTGTFTPDNNQTSPA
RRFCPVDYLLGNGTLLGNAFVFPHQIINLRTNNCATLVLPYVNSLSIDSMVKHNNWGIAI
LPLAPLNFASESSPEIPITLTIAPMCCEFNGLRNITLPRLQGLPVMNTPGSNQYLTADNF
QSPCALPEFDVTPPIDIPGEVKNMMELAEIDTMIPFDLSATKKNTMEMYRVRLSDKPHTD
DPILCLSLSPASDPRLSHTMLGEILNYYTHWAGSLKFTFLFCGFMMATGKLLVSYAPPGA
DPPKKRKEAMLGTHVIWDIGLQSSCTMVVPWISNTTYRQTIDDSFTEGGYISVFYQTRIV
VPLSTPREMDILGFVSACNDFSVRLLRDTTHIEQKALAQGLGQMLESMIDNTVRETVGAA
TSRDALPNTEASGPTHSKEIPALTAVETGATNPLVPSDTVQTRHVVQHRSRSESSIESFF
ARGACVTIMTVDNPASTTNKDKLFAVWKITYKDTVQLRRKLEFFTYSRFDMELTFVVTAN
FTETNNGHALNQVYQIMYVPPGAPVPEKWDDYTWQTSSNPSIFYTYGTAPARISVPYVGI
SNAYSHFYDGFSKVPLKDQSAALGDSLYGAASLNDFGILAVRVVNDHNPTKVTSKIRVYL
KPKHIRVWCPRPPRAVAYYGPGVDYKDGTLTPLSTKDLTTYGFGHQNKAVYTAGYKICNY
HLATQDDLQNAVNVMWSRDLLVTESRAQGTDSIARCNCNAGVYYCESRRKYYPVSFVGPT
FQYMEANNYYPARYQSHMLIGHGFASPGDCGGILRCHHGVIGIITAGGEGLVAFSDIRDL
YAYEEEAMEQGITNYIESLGAAFGSGFTQQISDKITELTNMVTSTITEKLLKNLIKIISS
LVIITRNYEDTTTVLATLALLGCDASPWQWLRKKACDVLEIPYVIKQGDSWLKKFTEACN
AAKGLEWVSNKISKFIDWLKEKIIPQARDKLEFVTKLRQLEMLENQISTIHQSCPSQEHQ
EILFNNVRWLSIQSKRFAPLYAVEAKRIQKLEHTINNYIQFKSKHRIEPVCLLVHGSPGT
GKSVATNLIARAIAERENTSTYSLPPDPSHFDGYKQQGVVIMDDLNQNPDGADMKLFCQM
VSTVEFIPPMASLEEKGILFTSNYVLASTNSSRISPPTVAHSDALARRFAFDMDIQVMNE
YSRDGKLNMAMATEMCKNCHQPANFKRCCPLVCGKAIQLMDKSSRVRYSIDQITTMIINE
RNRRSNIGNCMEALFQGPLQYKDLKIDIKTSPPPECINDLLQAVDSQEVRDYCEKKGWIV
NITSQVQTERNINRAMTILQAVTTFAAVAGVVYVMYKLFAGHQGAYTGLPNKKPNVPTIR
TAKVQGPGFDYAVAMAKRNIVTATTSKGEFTMLGVHDNVAILPTHASPGESIVIDGKEVE
ILDAKALEDQAGTNLEITIITLKRNEKFRDIRPHIPTQITETNDGVLIVNTSKYPNMYVP
VGAVTEQGYLNLGGRQTARTLMYNFPTRAGQCGGVITCTGKVIGMHVGGNGSHGFAAALK
RSYFTQSQGEIQWMRPSKEVGYPIINAPSKTKLEPSAFHYVFEGVKEPAVLTKNDPRLKT
DFEEAIFSKYVGNKITEVDEYMKEAVDHYAGQLMSLDINTEQMCLEDAMYGTDGLEALDL
STSAGYPYVAMGKKKRDILNKQTRDTKEMQKLLDTYGINLPLVTYVKDELRSKTKVEQGK
SRLIEASSLNDSVAMRMAFGNLYAAFHKNPGVITGSAVGCDPDLFWSKIPVLMEEKLFAF
DYTGYDASLSPAWFEALKMVLEKIGFGDRVDYIDYLNHSHHLYKNKTYCVKGGMPSGCSG
TSIFNSMINNLIIRTLLLKTYKGIDLDHLKMIAYGDDVIASYPHEVDASLLAQSGKDYGL
TMTPADKSATFETVTWENVTFLKRFFRADEKYPFLIHPVMPMKEIHESIRWTKDPRNTQD
HVRSLCLLAWHNGEEEYNKFLAKIRSVPIGRALLLPEYSTLYRRWLDSF

# Drug_Target_1_Reaction:
nucleoside triphosphate + RNAn = diphosphate + RNAn+1

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
RNA-directed RNA polymerase replicates genomic and antigenomic RNA by recognizing replications specific signals

# Drug_Target_1_SwissProt_ID:
P03300

# Drug_Target_1_SwissProt_Name:
POLG_POL1M

# Drug_Target_1_Synonyms:
Capsid protein VP1
Capsid protein VP2
Capsid protein VP3
Core protein P2A
Core protein P2B
Core protein P2C
Core protein P3A
EC 2.7.7.48
EC 3.4.22.28
EC 3.4.22.29
Genome polyprotein [Contains: Capsid protein VP4
Genome-linked protein VPg
P1A
P1B
P1C
P1D
P3B
P3C
P3D]
Picornain 2A
Picornain 3C
Protease 3C
RNA-directed RNA polymerase
Virion protein 1
Virion protein 2
Virion protein 3
Virion protein 4

# Drug_Target_1_Theoretical_pI:
7.13

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_20_Cellular_Location:
RNA-directed RNA polymerase 3D-POL:Host cytoplasmic vesicle membrane

# Drug_Target_20_Chromosome_Location:
Not Available

# Drug_Target_20_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_20_Essentiality:
Essential

# Drug_Target_20_GenAtlas_ID:
Not Available

# Drug_Target_20_GenBank_ID_Gene:
K01392

# Drug_Target_20_GenBank_ID_Protein:
332896

# Drug_Target_20_GeneCard_ID:
Not Available

# Drug_Target_20_Gene_Name:
Not Available

# Drug_Target_20_Gene_Sequence:
>6621 bp
GATTTCAGTGTCACAATGGGAGCTCAAGTATCATCCCAAAAAGTAGGCGCTCACGAGAAT
TCTAACCGAGCCTACGGTGGTTCTACGATCAACTACACCACAATTAATTATTATAAAGAT
TCCGCAAGTAATGCGGCGTCCAAGCAAGATTACTCACAGGATCCATCAAAATTCACCGAG
CCACTAAAGGACGTGCTCATAAAAACAGCTCCAGCACTCAATTCACCAAATGTGGAAGCG
TGTGGGTATAGTGATAGAGTGTTGCAACTCACTTTAGGCAATTCCACTATTACTACACAG
GAGGCAGCAAATTCAGTAGTGGCTTACGGACGTTGGCCTGAGTTTATTAGAGATGACGAA
GCAAACCCGGTGGACCAACCAACTGAACCAGATGTGGCTACATGCAGATTCTACACACTA
GACACTGTAATGTGGGGTAAGGAGTCGAAAGGCTGGTGGTGGAAGTTACCTGACGCACTG
AGAGACATGGGTCTGTTTGGACAAAACATGTATTACCACTACCTAGGAAGATCCGGGTAC
ACTGTGCACGTGCAGTGTAATGCATCCAAATTTCACCAAGGTGCACTCGGGGTGTTTGCG
ATTCCTGAGTATTGTCTGGCGGGTGACAGTGACAAGCAAAGGTACACTAGTTATGCAAAT
GCGAATCCAGGTGAAAGAGGGGGAAAATTTTACTCCCAATTCAACAAGGATAACGCAGTA
ACATCCCCAAAAAGAGAGTTCTGCCCAGTGGATTATCTCCTGGGATGTGGGGTGTTACTG
GGAAATGCCTTTGTATACCCACATCAAATCATTAATCTGAGGACCAACAACAGCGCAACT
ATTGTCCTACCATATGTGAATGCTTTGGCCATTGATTCAATGGTTAAACACAACAACTGG
GGCATTGCCATTCTGCCCTTATCACCGCTGGATTTTGCTCAAGATTCATCAGTTGAAATT
CCAATTACTGTGACAATTGCCCCAATGTGTAGCGAGTTCAACGGCCTTCGCAACGTGACT
GCACCTAAATTTCAAGGACTACCAGTGTTGAACACTCCTGGTAGTAACCAGTACCTGACG
TCAGACAACCACCAATCACCATGCGCAATCCCAGAATTTGATGTCACTCCGCCTATTGAT
ATCCCAGGTGAGGTTAAAAACATGATGGAGCTCGCCGAGATAGACACCATGATTCCTCTC
AATTTGGAGAGCACCAAGAGAAACACAATGGACATGTACAGAGTTACTCTGAGCGACAGT
GCCGATCTATCGCAACCAATTTTGTGCTTGTCACTATCCCCAGCATCTGATCCGCGCTTG
TCACACACCATGCTTGGGGAAGTACTGAACTATTATACTCATTGGGCCGGGTCCTTGAAA
TTTACCTTCCTGTTCTGTGGTTCAATGATGGCTACGGGGAAAATCCTAGTGGCCTATGCA
CCACCAGGTGCACAACCCCCCACCAGCCGTAAGGAGGCTATGTTGGGCACACATGTCATT
TGGGATCTTGGCCTGCAATCATCTTGTACTATGGTGGTGCCGTGGATTAGTAATGTGACA
TACAGACAGACTACACAAGATAGTTTCACTGAGGGCGGATATATCAGCATGTTCTACCAA
ACAAGAATTGTGGTGCCACTGTCCACCCCTAAGAGTATGAGCATGCTGGGGTTTGTGTCA
GCCTGTAATGATTTCAGTGTGCGATTGCTGCGAGACACCACTCACATTTCACAATCTGCG
CTTCCACAGGGTATTGAAGATTTGATTTCTGAAGTTGCACAGGGCGCCCTAACTTTGTCA
CTCCCGAAGCAACAGGATAGCTTACCTGATACTAAGGCCAGTGGCCCGGCGCATTCCAAG
GAGGTACCTGCACTCACTGCAGTCGAGACTGGAGCCACCAATCCTCTGGCACCATCCGAC
ACAGTTCAAACGCGCCACGTAGTCCAACGACGCAGCAGGTCAGAGTCCACAATAGAATCA
TTCTTCGCACGCGGGGCGTGCGTCGCTATTATTGAGGTGGACAATGAACAACCAACCACC
CGGGCACAGAAACTATTTGCCATGTGGCGCATTACATACAAAGATACAGTGCAGTTGCGC
CGTAAGTTGGAGTTTTTCACATACTCTCGTTTTGACATGGAATTCACCTTCGTGGTAACC
GCCAACTTCACCAACGCTAATAATGGGCATGCACTCAACCAGGTGTACCAGATAATGTAC
ATCCCCCCAGGGGCACCCACACCAAAGTCATGGGACGACTACACTTGGCAAACATCTTCC
AACCCGTCCATATTTTACACCTATGGGGCTGCCCCGGCGCGAATCTCAGTGCCATACGTG
GGGTTAGCCAATGCTTACTCGCACTTTTACGACGGCTTCGCCAAGGTGCCATTGAAGACA
GATGCCAATGACCAGATTGGTGATTCCTTGTACAGCGCCATGACAGTTGATGACTTTGGT
GTATTGGCAGTTCGTGTTGTCAATGATCACAACCCCACTAAAGTAACCTCCAAAGTCCGC
ATTTACATGAAACCCAAACACGTACGTGTCTGGTGCCCTAGACCGCCGCGCGCGGTACCT
TATTATGGACCAGGGGTGGACTATAAGAACAACTTGGACCCCTTATCTGAGAAAGGTTTG
ACCACATATGGCTTTGGGCATCAGAATAAAGCTGTGTACACTGCTGGTTACAAGATCTGC
AACTACCATCTCGCCACTAAGGAGGATTTACAAAATACTGTAAGCATCATGTGGAATAGA
GACCTCTTGGTTGTTGAATCAAAAGCTCAAGGTACCGACTCAATAGCAAGGTGCAATTGC
AATGCAGGGGTGTACTATTGTGAGTCCAGAAGGAAATACTACCCTGTGTCGTTTGTGGGA
CCCACCTTCCAATACATGGAGGCTAATGACTACTACCCAGCTAGATACCAATCCCACATG
TTAATCGGGCACGGCTTTGCCTCACCAGGTGACTGTGGTGGTATCCTTAGGTGTCAACAT
GGCGTCATCGGAATCGTGACAGCTGGTGGAGAGGGATTAGTCGCATTCTCTGACATAAGG
GACTTGTATGCTTACGAGGAAGAGGCCATGGAGCAGGGCATTTCAAACTATATTGAGTCA
CTCGGTGCTGCGTTCGGTAGTGGGTTCACTCAGCAAATAGGGGATAAGATATCAGAACTA
ACCAGCATGGTGACCAGCACGATTACAGAGAAGCTACTTAAAAACCTAATCAAAATTATT
TCATCTCTGGTGATTATCACTAGAAATTACGAAGATACCACCACAGTGCTCGCCACTCTA
GCTCTTCTTGGGTGTGATGTTTCACCGTGGCAATGGTTGAAGAAGAAAGCATGTGACACT
TTGGAGATTCCCTATGTTATTAGACAGGGTGATAGTTGGTTGAAAAAATTTACTGAGGCG
TGCAACGCAGCTAAGGGGTTGGAATGGGTGTCCAACAAAATCTCAAAATTTATTGACTGG
TTGAGAGAAAGAATCATCCCACAAGCCAGGGACAAGCTTGAGTTTGTAACCAAATTGAAA
CAGTTGGAAATGCTAGAGAATCAGATATCCACAATACACCAATCTTGTCCAAGTCAGGAA
CACCAGGAAATTTTGTTCAACAATGTACGCTGGTTGTCCATTCAATCCAAGAGATTCGCT
CCATTGTACGCACTTGAGGCCAAGAGAATACAAAAGTTGGAACACACCATTAATAATTAC
ATACAGTTCAAGAGCAAACACCGTATTGAGCCAGTATGTTTGTTAGTGCATGGGAGCCCA
GGTACAGGAAAATCAGTTGCGACTAACCTAATTGCTAGAGCCATAGCTGAGAAAGAGAAC
ACCTCCACCTACTCGCTACCACCGGACCCGTCTCACTTTGATGGATACAAACAACAAGGT
GTGGTTATCATGGACGACCTAAACCAAAACCCGGATGGGGCAGATATGAAGCTCTTTTGT
CAAATGGTGTCCACTGTGGAGTTTATCCCACCTATGGCCTCGCTGGAAGAGAAAGGCATT
CTGTTCACATCCAACTATGTTTTAGCCTCCACCAACTCCAGTCGCATCACACCACCTACA
GTAGCCCACAGTGACGCTCTGGCCAGGAGGTTCGCTTTCGATATGGATATTCAAGTGATG
GGCGAGTACTCCAGAGATGGTAAACTCAACATGGCAATGGCTACTGAGACGTGCAAGGAC
TGCCACCAACCAGCAAACTTCAAAAGATGCTGTCCTTTAGTGTGTGGTAAGGCAATTCAG
TTAATGGACAAATCTTCCAGAGTTAGGTACAGTGTTGACCAGATTACTACAATGATTATC
AACGAGAGAAACAGAAGATCTAACATTGGCAATTGCATGGAGGCTTTGTTCCAAGGACCA
CTCCAGTACAAAGACCTGAAAATTGACATCAAGACGAGGCCCCCCCCTGAATGCATCAAT
GATCTGCTTCAAGCAGTTGACTCCCAGGAAGTGAGGGATTATTGTGAAAAGAAAGGATGG
ATCGTCAACATCACTAGCCAAGTTCAAACAGAGAGAAACATTAACCGAGCAATGACCATT
TTGCAGGCAGTGACAACTTTCGCCGCAGTGGCTGGTGTCGTGTACGTCATGTACAAGTTA
TTCGCTGGACACCAGGGAGCATACACTGGTCTGCCAAACAAAAGACCCAATGTGCCCACC
ATTAGAGCAGCAAAAGTGCAAGGGCCTGGGTTTGACTATGCAGTGGCTATGGCTAAAAGA
AACATTGTTACAGCAACTACTAGCAAAGGGGAGTTCACAATGCTAGGAGTCCACGACAAC
GTGGCCATTTTACCAACTCATGCCTCACCTGGTGAGAGTATTGTAATTGATGGCAAAGAG
GTTGAAATCCTAGACGCTAAAGCCCTCGAAGATCAGGCAGGCACTAATCTGGAAATCACC
ATAATAACCCTCAAAAGAAATGAAAAGTTCAGAGATATCAGACAACACATACCCACTCAA
ATCACCGAGACGAATGATGGAGTTCTGATTGTGAACACTAGTAAGTACCCCAACATGTAT
GTTCCTGTCGGTGCTGTGACTGAGCAGGGATACCTAAATCTCGGTGGGCGCCAGACTGCT
CGTATTCTAATGTACAACTTTCCAACCAGAGCTGGTCAGTGTGGTGGAGTCATCACATGC
ACTGGGAAAGTCATCGGGATGCACGTTGGTGGGAATGGTTCACATGGGTTTGCAGCGGCC
CTGAAGCGGTCATACTTCACTCAGAGCCAAGGTGAAATCCAGTGGATGAGACCATCAAAG
GAGGCAGGGTATCCAATTATAAACGCCCCAACCAAGACCAAGCTCGAGCCCAGCGCTTTC
CACTATGTGTTTGAAGGAGTAAAGGAACCAGCAGTCCTCACAAAGAATGATCCCAGACTT
AAAACAGACTTTGAAGAAGCAATCTTCTCTAAGTATGTAGGGAACAAGATCACTGAGGTG
GATGAGTACATGAAAGAGGCAGTGGACCATTATGCTGGACAACTTATGTCGCTGGATATC
AGCACAGAGCAAATGTGTCTAGAAGACGCCATGTATGGTACTGATGGTCTGGAGGCGCTA
GATCTGTCTACCAGTGCCGGGTACCCCTACGTGGCAATGGGGAAGAAGAAGAGAGATATC
CTAAACAAGCAAACCAGAGACACCAAAGAAATGCAAAGACTTTTGGACGCTTACGGAATC
AACCTACCATTAGTGACATATGTCAAGGACGAGCTGAGGTCCAAAACAAAAGTGGAACAG
GGAAAATCCAGACTGATTGAAGCTTCCAGTCTAAATGACTCAGTGGCCATGAGAATGGCA
TTTGGAAACCTTTATGCAGCATTCCACAGGAATCCAGGGGTCGTCACTGGTAGTGCAGTT
GGATGCGATCCAGACCTATTCTGGAGCAAGATCCCAGTGTTGATGGAAGAAAAGCTATTT
GCCTTTGATTACACAGGATACGACGCATCACTTAGCCCAGCTTGGTTTGAGGCACTCAAG
ATGGTGTTAGAGAAAATTGGTTTTGGAGATAGAGTGGATTACATAGACTACCTTAACCAT
TCACACCACTTGTACAAAAACAAGATATATTGTGTTAAGGGCGGCATGCCATCTGGCTGC
TCCGGCACTTCAATTTTTAATTCAATGATTAACAATTTGATCATTAGGACGCTTTTACTG
AAAACCTACAAGGGCATAGATTTGGACCACTTAAAAATGATTGCCTATGGTGACGATGTA
ATAGCTTCCTATCCCCATGAGGTTGACGCTAGTCTCCTAGCCCAATCAGGAAAAGACTAT
GGACTAACCATGACTCCGGCAGATAAATCTGCCACTTTTGAGACAGTCACATGGGAGAAT
GTAACTTTCTTGAAAAGATTCTTCAGAGCAGATGAGAAATACCCCTTCCTCATACATCCA
GTAATGCCAATGAAGGAGATTCATGAATCAATCAGATGGACAAAAGATCCTCGGAATACG
CAGGACCATGTACGCTCCTTGTGTCTATTGGCTTGGCACAACGGGGAAGAAGAATACAAC
AAATTTTTAGCTAAAATTAGGAGTGTGCCAATCGGAAGAGCTTTGTTGCTCCCAGAGTAC
TCAACATTGTACCGCCGTTGG

# Drug_Target_20_General_Function:
Involved in ATP binding

# Drug_Target_20_General_References:
15299834	Hiremath CN, Grant RA, Filman DJ, Hogle JM: Binding of the antiviral drug WIN51711 to the sabin strain of type 3 poliovirus: structural comparison with drug binding in rhinovirus 14. Acta Crystallogr D Biol Crystallogr. 1995 Jul 1;51(Pt 4):473-89.
6310508	Stanway G, Cann AJ, Hauptmann R, Hughes P, Clarke LD, Mountford RC, Minor PD, Schild GC, Almond JW: The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res. 1983 Aug 25;11(16):5629-43.
6324200	Stanway G, Hughes PJ, Mountford RC, Reeve P, Minor PD, Schild GC, Almond JW: Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A. 1984 Mar;81(5):1539-43.
7820548	Grant RA, Hiremath CN, Filman DJ, Syed R, Andries K, Hogle JM: Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr Biol. 1994 Sep 1;4(9):784-97.

# Drug_Target_20_HGNC_ID:
Not Available

# Drug_Target_20_HPRD_ID:
Not Available

# Drug_Target_20_ID:
6652

# Drug_Target_20_Locus:
Not Available

# Drug_Target_20_Molecular_Weight:
246162.7

# Drug_Target_20_Name:
Genome polyprotein

# Drug_Target_20_Number_of_Residues:
2206

# Drug_Target_20_PDB_ID:
1RDR

# Drug_Target_20_Pathway:
Not Available

# Drug_Target_20_Pfam_Domain_Function:
PF00073	Rhv
PF00548	Peptidase_C3
PF00680	RdRP_1
PF00910	RNA_helicase
PF00947	Pico_P2A
PF01552	Pico_P2B
PF02226	Pico_P1A
PF08727	P3A

# Drug_Target_20_Protein_Sequence:
>Genome polyprotein
MGAQVSSQKVGAHENSNRAYGGSTINYTTINYYKDSASNAASKQDYSQDPSKFTEPLKDV
LIKTAPALNSPNVEACGYSDRVLQLTLGNSTITTQEAANSVVAYGRWPEFIRDDEANPVD
QPTEPDVATCRFYTLDTVMWGKESKGWWWKLPDALRDMGLFGQNMYYHYLGRSGYTVHVQ
CNASKFHQGALGVFAIPEYCLAGDSDKQRYTSYANANPGERGGKFYSQFNKDNAVTSPKR
EFCPVDYLLGCGVLLGNAFVYPHQIINLRTNNSATIVLPYVNALAIDSMVKHNNWGIAIL
PLSPLDFAQDSSVEIPITVTIAPMCSEFNGLRNVTAPKFQGLPVLNTPGSNQYLTSDNHQ
SPCAIPEFDVTPPIDIPGEVKNMMELAEIDTMIPLNLESTKRNTMDMYRVTLSDSADLSQ
PILCLSLSPASDPRLSHTMLGEVLNYYTHWAGSLKFTFLFCGSMMATGKILVAYAPPGAQ
PPTSRKEAMLGTHVIWDLGLQSSCTMVVPWISNVTYRQTTQDSFTEGGYISMFYQTRIVV
PLSTPKSMSMLGFVSACNDFSVRLLRDTTHISQSALPQGIEDLISEVAQGALTLSLPKQQ
DSLPDTKASGPAHSKEVPALTAVETGATNPLAPSDTVQTRHVVQRRSRSESTIESFFARG
ACVAIIEVDNEQPTTRAQKLFAMWRITYKDTVQLRRKLEFFTYSRFDMEFTFVVTANFTN
ANNGHALNQVYQIMYIPPGAPTPKSWDDYTWQTSSNPSIFYTYGAAPARISVPYVGLANA
YSHFYDGFAKVPLKTDANDQIGDSLYSAMTVDDFGVLAVRVVNDHNPTKVTSKVRIYMKP
KHVRVWCPRPPRAVPYYGPGVDYKNNLDPLSEKGLTTYGFGHQNKAVYTAGYKICNYHLA
TKEDLQNTVSIMWNRDLLVVESKAQGTDSIARCNCNAGVYYCESRRKYYPVSFVGPTFQY
MEANDYYPARYQSHMLIGHGFASPGDCGGILRCQHGVIGIVTAGGEGLVAFSDIRDLYAY
EEEAMEQGISNYIESLGAAFGSGFTQQIGDKISELTSMVTSTITEKLLKNLIKIISSLVI
ITRNYEDTTTVLATLALLGCDVSPWQWLKKKACDTLEIPYVIRQGDSWLKKFTEACNAAK
GLEWVSNKISKFIDWLRERIIPQARDKLEFVTKLKQLEMLENQISTIHQSCPSQEHQEIL
FNNVRWLSIQSKRFAPLYALEAKRIQKLEHTINNYIQFKSKHRIEPVCLLVHGSPGTGKS
VATNLIARAIAEKENTSTYSLPPDPSHFDGYKQQGVVIMDDLNQNPDGADMKLFCQMVST
VEFIPPMASLEEKGILFTSNYVLASTNSSRITPPTVAHSDALARRFAFDMDIQVMGEYSR
DGKLNMAMATETCKDCHQPANFKRCCPLVCGKAIQLMDKSSRVRYSVDQITTMIINERNR
RSNIGNCMEALFQGPLQYKDLKIDIKTRPPPECINDLLQAVDSQEVRDYCEKKGWIVNIT
SQVQTERNINRAMTILQAVTTFAAVAGVVYVMYKLFAGHQGAYTGLPNKRPNVPTIRAAK
VQGPGFDYAVAMAKRNIVTATTSKGEFTMLGVHDNVAILPTHASPGESIVIDGKEVEILD
AKALEDQAGTNLEITIITLKRNEKFRDIRQHIPTQITETNDGVLIVNTSKYPNMYVPVGA
VTEQGYLNLGGRQTARILMYNFPTRAGQCGGVITCTGKVIGMHVGGNGSHGFAAALKRSY
FTQSQGEIQWMRPSKEAGYPIINAPTKTKLEPSAFHYVFEGVKEPAVLTKNDPRLKTDFE
EAIFSKYVGNKITEVDEYMKEAVDHYAGQLMSLDISTEQMCLEDAMYGTDGLEALDLSTS
AGYPYVAMGKKKRDILNKQTRDTKEMQRLLDAYGINLPLVTYVKDELRSKTKVEQGKSRL
IEASSLNDSVAMRMAFGNLYAAFHRNPGVVTGSAVGCDPDLFWSKIPVLMEEKLFAFDYT
GYDASLSPAWFEALKMVLEKIGFGDRVDYIDYLNHSHHLYKNKIYCVKGGMPSGCSGTSI
FNSMINNLIIRTLLLKTYKGIDLDHLKMIAYGDDVIASYPHEVDASLLAQSGKDYGLTMT
PADKSATFETVTWENVTFLKRFFRADEKYPFLIHPVMPMKEIHESIRWTKDPRNTQDHVR
SLCLLAWHNGEEEYNKFLAKIRSVPIGRALLLPEYSTLYRRWLDSF

# Drug_Target_20_Reaction:
Not Available

# Drug_Target_20_Signals:
None

# Drug_Target_20_Specific_Function:
RNA-directed RNA polymerase 3D-POL replicates genomic and antigenomic RNA by recognizing replications specific signals (By similarity)

# Drug_Target_20_SwissProt_ID:
P03302

# Drug_Target_20_SwissProt_Name:
POLG_POL3L

# Drug_Target_20_Synonyms:
P1A
P1B
P1C
P1D
P2A
P2B
P2C
P3A
P3B
P3C
P3D-POL
Picornain 2A
Picornain 3C
Protease 3C
Protein 2A
Protein 2B
Protein 2C
Protein 3A
Protein 3B
Protein VP0
Protein VP1
Protein VP2
Protein VP3
Protein VP4
RNA-directed RNA polymerase 3D-POL
VP4-VP2
VPg
Virion protein 1
Virion protein 2
Virion protein 3
Virion protein 4

# Drug_Target_20_Theoretical_pI:
7.15

# Drug_Target_20_Transmembrane_Regions:
None

# Drug_Target_21_Cellular_Location:
Nucleus

# Drug_Target_21_Chromosome_Location:
2

# Drug_Target_21_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_21_Essentiality:
Non-Essential

# Drug_Target_21_GenAtlas_ID:
Not Available

# Drug_Target_21_GenBank_ID_Gene:
X87870

# Drug_Target_21_GenBank_ID_Protein:
1595752

# Drug_Target_21_GeneCard_ID:
HNF4A

# Drug_Target_21_Gene_Name:
HNF4A

# Drug_Target_21_Gene_Sequence:
>1368 bp
ATGGACATGGCCGACTACAGTGCTGCACTGGACCCAGCCTACACCACCCTGGAATTTGAG
AATGTGCAGGTGTTGACGATGGGCAATGACACGTCCCCATCAGAAGGCACCAACCTCAAC
GCGCCCAACAGCCTGGGTGTCAGCGCCCTGTGTGCCATCTGCGGGGACCGGGCCACGGGC
AAACACTACGGTGCCTCGAGCTGTGACGGCTGCAAGGGCTTCTTCCGGAGGAGCGTGCGG
AAGAACCACATGTACTCCTGCAGATTTAGCCGGCAGTGCGTGGTGGACAAGGACAAGAGG
AACCAGTGCCGCTACTGCAGGCTCAAGAAATGCTTCCGGGCTGGCATGAAGAAGGAAGCC
GTCCAGAATGAGCGGGACCGGATCAGCACTCGAAGGTCAAGCTATGAGGACAGCAGCCTG
CCCTCCATCAATGCGCTCCTGCAGGCGGAGGTCCTGTCCCGACAGATCACCTCCCCCGTC
TCCGGGATCAACGGCGACATTCGGGCGAAGAAGATTGCCAGCATCGCAGATGTGTGTGAG
TCCATGAAGGAGCAGCTGCTGGTTCTCGTTGAGTGGGCCAAGTACATCCCAGCTTTCTGC
GAGCTCCCCCTGGACGACCAGGTGGCCCTGCTCAGAGCCCATGCTGGCGAGCACCTGCTG
CTCGGAGCCACCAAGAGATCCATGGTGTTCAAGGACGTGCTGCTCCTAGGCAATGACTAC
ATTGTCCCTCGGCACTGCCCGGAGCTGGCGGAGATGAGCCGGGTGTCCATACGCATCCTT
GACGAGCTGGTGCTGCCCTTCCAGGAGCTGCAGATCGATGACAATGAGTATGCCTACCTC
AAAGCCATCATCTTCTTTGACCCAGATGCCAAGGGGCTGAGCGATCCAGGGAAGATCAAG
CGGCTGCGTTCCCAGGTGCAGGTGAGCTTGGAGGACTACATCAACGACCGCCAGTATGAC
TCGCGTGGCCGCTTTGGAGAGCTGCTGCTGCTGCTGCCCACCTTGCAGAGCATCACCTGG
CAGATGATCGAGCAGATCCAGTTCATCAAGCTCTTCGGCATGGCCAAGATTGACAACCTG
TTGCAGGAGATGCTGCTGGGAGGGTCCCCCAGCGATGCACCCCATGCCCACCACCCCCTG
CACCCTCACCTGATGCAGGAACATATGGGAACCAACGTCATCGTTGCCAACACAATGCCC
ACTCACCTCAGCAACGGACAGATGTCCACCCCTGAGACCCCACAGCCCTCACCGCCAGGT
GGCTCAGGGTCTGAGTCCTATAAGCTCCTGCCGGGAGCCGTCGCCACAATCGTCAAGCCC
CTCTCTGCCATCCCCCAGCCGACCATCACCAAGCAGGAAGTTATCTAG

# Drug_Target_21_General_Function:
Involved in fatty acid binding

# Drug_Target_21_General_References:
11780052	Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, Bailey J, Barlow KF, Bates KN, Beard LM, Beare DM, Beasley OP, Bird CP, Blakey SE, Bridgeman AM, Brown AJ, Buck D, Burrill W, Butler AP, Carder C, Carter NP, Chapman JC, Clamp M, Clark G, Clark LN, Clark SY, Clee CM, Clegg S, Cobley VE, Collier RE, Connor R, Corby NR, Coulson A, Coville GJ, Deadman R, Dhami P, Dunn M, Ellington AG, Frankland JA, Fraser A, French L, Garner P, Grafham DV, Griffiths C, Griffiths MN, Gwilliam R, Hall RE, Hammond S, Harley JL, Heath PD, Ho S, Holden JL, Howden PJ, Huckle E, Hunt AR, Hunt SE, Jekosch K, Johnson CM, Johnson D, Kay MP, Kimberley AM, King A, Knights A, Laird GK, Lawlor S, Lehvaslaiho MH, Leversha M, Lloyd C, Lloyd DM, Lovell JD, Marsh VL, Martin SL, McConnachie LJ, McLay K, McMurray AA, Milne S, Mistry D, Moore MJ, Mullikin JC, Nickerson T, Oliver K, Parker A, Patel R, Pearce TA, Peck AI, Phillimore BJ, Prathalingam SR, Plumb RW, Ramsay H, Rice CM, Ross MT, Scott CE, Sehra HK, Shownkeen R, Sims S, Skuce CD, Smith ML, Soderlund C, Steward CA, Sulston JE, Swann M, Sycamore N, Taylor R, Tee L, Thomas DW, Thorpe A, Tracey A, Tromans AC, Vaudin M, Wall M, Wallis JM, Whitehead SL, Whittaker P, Willey DL, Williams L, Williams SA, Wilming L, Wray PW, Hubbard T, Durbin RM, Bentley DR, Beck S, Rogers J: The DNA sequence and comparative analysis of human chromosome 20. Nature. 2001 Dec 20-27;414(6866):865-71.
14982928	Duda K, Chi YI, Shoelson SE: Structural basis for HNF-4alpha activation by ligand and coactivator binding. J Biol Chem. 2004 May 28;279(22):23311-6. Epub 2004 Feb 24.
7568236	Ktistaki E, Ktistakis NT, Papadogeorgaki E, Talianidis I: Recruitment of hepatocyte nuclear factor 4 into specific intranuclear compartments depends on tyrosine phosphorylation that affects its DNA-binding and transactivation potential. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9876-80.
7926813	Chartier FL, Bossu JP, Laudet V, Fruchart JC, Laine B: Cloning and sequencing of cDNAs encoding the human hepatocyte nuclear factor 4 indicate the presence of two isoforms in human liver. Gene. 1994 Sep 30;147(2):269-72.
8622695	Drewes T, Senkel S, Holewa B, Ryffel GU: Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes. Mol Cell Biol. 1996 Mar;16(3):925-31.
8945471	Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI: Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1) Nature. 1996 Dec 5;384(6608):458-60.
8964514	Kritis AA, Argyrokastritis A, Moschonas NK, Power S, Katrakili N, Zannis VI, Cereghini S, Talianidis I: Isolation and characterization of a third isoform of human hepatocyte nuclear factor 4. Gene. 1996 Sep 16;173(2):275-80.
9243109	Bulman MP, Dronsfield MJ, Frayling T, Appleton M, Bain SC, Ellard S, Hattersley AT: A missense mutation in the hepatocyte nuclear factor 4 alpha gene in a UK pedigree with maturity-onset diabetes of the young. Diabetologia. 1997 Jul;40(7):859-62.
9313765	Furuta H, Iwasaki N, Oda N, Hinokio Y, Horikawa Y, Yamagata K, Yano N, Sugahiro J, Ogata M, Ohgawara H, Omori Y, Iwamoto Y, Bell GI: Organization and partial sequence of the hepatocyte nuclear factor-4 alpha/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY. Diabetes. 1997 Oct;46(10):1652-7.

# Drug_Target_21_HGNC_ID:
GNC:5024

# Drug_Target_21_HPRD_ID:
Not Available

# Drug_Target_21_ID:
6522

# Drug_Target_21_Locus:
20q12-q13.1

# Drug_Target_21_Molecular_Weight:
52784.2

# Drug_Target_21_Name:
Hepatocyte nuclear factor 4-alpha

# Drug_Target_21_Number_of_Residues:
474

# Drug_Target_21_PDB_ID:
1M7W

# Drug_Target_21_Pathway:
Not Available

# Drug_Target_21_Pfam_Domain_Function:
PF00104	Hormone_recep
PF00105	zf-C4

# Drug_Target_21_Protein_Sequence:
>Hepatocyte nuclear factor 4-alpha
MRLSKTLVDMDMADYSAALDPAYTTLEFENVQVLTMGNDTSPSEGTNLNAPNSLGVSALC
AICGDRATGKHYGASSCDGCKGFFRRSVRKNHMYSCRFSRQCVVDKDKRNQCRYCRLKKC
FRAGMKKEAVQNERDRISTRRSSYEDSSLPSINALLQAEVLSRQITSPVSGINGDIRAKK
IASIADVCESMKEQLLVLVEWAKYIPAFCELPLDDQVALLRAHAGEHLLLGATKRSMVFK
DVLLLGNDYIVPRHCPELAEMSRVSIRILDELVLPFQELQIDDNEYAYLKAIIFFDPDAK
GLSDPGKIKRLRSQVQVSLEDYINDRQYDSRGRFGELLLLLPTLQSITWQMIEQIQFIKL
FGMAKIDNLLQEMLLGGSPSDAPHAHHPLHPHLMQEHMGTNVIVANTMPTHLSNGQMCEW
PRPRGQAATPETPQPSPPGGSGSEPYKLLPGAVATIVKPLSAIPQPTITKQEVI

# Drug_Target_21_Reaction:
Not Available

# Drug_Target_21_Signals:
None

# Drug_Target_21_Specific_Function:
Transcriptionally controlled transcription factor. Binds to DNA sites required for the transcription of alpha 1- antitrypsin, apolipoprotein CIII, transthyretin genes and HNF1- alpha. May be essential for development of the liver, kidney and intestine

# Drug_Target_21_SwissProt_ID:
P41235

# Drug_Target_21_SwissProt_Name:
HNF4A_HUMAN

# Drug_Target_21_Synonyms:
HNF-4-alpha
Nuclear receptor subfamily 2 group A member 1
Transcription factor 14
Transcription factor HNF-4

# Drug_Target_21_Theoretical_pI:
7.46

# Drug_Target_21_Transmembrane_Regions:
None

# Drug_Target_22_Cellular_Location:
Nucleus (By similarity)

# Drug_Target_22_Chromosome_Location:
2

# Drug_Target_22_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_22_Essentiality:
Non-Essential

# Drug_Target_22_GenAtlas_ID:
Not Available

# Drug_Target_22_GenBank_ID_Gene:
U59302

# Drug_Target_22_GenBank_ID_Protein:
1480646

# Drug_Target_22_GeneCard_ID:
NCOA1

# Drug_Target_22_Gene_Name:
NCOA1

# Drug_Target_22_Gene_Sequence:
>4323 bp
ATGAGTGGCCTCGGGGACAGTTCATCCGACCCTGCTAACCCAGACTCACATAAGAGGAAA
GGATCGCCATGTGACACACTGGCATCAAGCACGGAAAAGAGGCGCAGGGAGCAAGAAAAT
AAATATTTAGAAGAACTAGCTGAGTTACTGTCTGCCAACATTAGTGACATTGACAGCTTG
AGTGTAAAACCAGACAAATGCAAGATTTTGAAGAAAACAGTCGATCAGATACAGCTAATG
AAGAGAATGGAACAAGAGAAATCAACAACTGATGACGATGTACAGAAATCAGACATCTCA
TCAAGTAGTCAAGGAGTGATAGAAAAGGAATCCTTGGGACCCCTTCTTTTGGAGGCTTTG
GATGGATTTTTCTTTGTTGTGAACTGTGAAGGGAGAATTGTATTTGTGTCAGAGAATGTA
ACCAGCTACTTAGGTTACAATCAGGAGGAATTAATGAATACCAGCGTCTACAGCATACTG
CACGTGGGGGATCATGCAGAATTTGTGAAGAATCTGCTACCAAAATCACTAGTAAATGGA
GTTCCTTGGCCTCAAGAGGCAACACGACGAAATAGCCATACCTTTAACTGCAGGATGCTA
ATTCACCCTCCAGATGAGCCAGGGACCGAGAACCAAGAAGCTTGCCAGCGTTATGAAGTA
ATGCAGTGTTTCACTGTGTCACAGCCAAAATCAATTCAAGAGGATGGAGAAGATTTCCAG
TCATGTCTGATTTGTATTGCACGGCGATTACCTCGGCCTCCAGCTATTACGGGTGTAGAA
TCCTTTATGACCAAGCAAGATACTACAGGTAAAATCATCTCTATTGATACTAGTTCCCTG
AGAGCTGCTGGCAGAACTGGTTGGGAAGATTTAGTGAGGAAGTGCATTTATGCTTTTTTC
CAACCTCAGGGCAGAGAACCATCTTATGCCAGACAGCTGTTCCAAGAAGTGATGACTCGT
GGCACTGCCTCCAGCCCCTCCTATAGATTCATATTGAATGATGGGACAATGCTTAGCGCC
CACACCAAGTGTAAACTTTGCTACCCTCAAAGTCCAGACATGCAACCTTTCATCATGGGA
ATTCATATCATCGACAGGGAGCACAGTGGGCTTTCTCCTCAAGATGACACTAATTCTGGA
ATGTCAATTCCCCGAGTAAATCCCTCGGTCAATCCTAGTATCTCTCCAGCTCATGGTGTG
GCTCGTTCATCCACATTGCCACCATCCAACAGCAACATGGTATCCACCAGAATAAACCGC
CAGCAGAGCTCAGACCTTCATAGCAGCAGTCATAGTAATTCTAGCAACAGCCAAGGAAGT
TTCGGATGCTCACCCGGAAGTCAGATTGTAGCCAATGTTGCCTTAAACCAAGGACAGGCC
AGTTCACAGAGCAGTAATCCCTCTTTAAACCTCAATAATTCTCCTATGGAAGGTACAGGA
ATATCCCTAGCACAGTTCATGTCTCCAAGGAGACAGGTTACTTCTGGATTGGCAACAAGG
CCCAGGATGCCAAACAATTCCTTTCCTCCTAATATTTCGACATTAAGCTCTCCCGTTGGC
ATGACAAGTAGTGCCTGTAATAATAATAACCGATCTTATTCAAACATCCCAGTAACATCT
TTACAGGGTATGAATGAAGGACCCAATAACTCCGTTGGCTTCTCTGCCAGTTCTCCAGTC
CTCAGGCAGATGAGCTCACAGAATTCACCTAGCAGATTAAATATACAACCAGCAAAAGCT
GAGTCCAAAGATAACAAAGAGATTGCCTCAATTTTAAATGAAATGATTCAATCTGACAAC
AGCTCTAGTGATGGCAAACCTCTGGATTCAGGGCTTCTGCATAACAATGACAGACTTTCA
GATGGAGACAGTAAATACTCTCAAACCAGTCACAAACTAGTGCAGCTTTTGACAACAACT
GCCGAACAGCAGTTACGGCATGCTGATATAGACACAAGCTGCAAAGATGTCCTGTCTTGC
ACAGGCACTTCCAACTCTGCCTCTGCTAACTCTTCAGGAGGTTCTTGTCCCTCTTCTCAT
AGCTCATTGACAGAACGGCATAAAATTCTACACCGGCTCTTACAGGAGGGTAGCCCCTCA
GATATCACCACTTTGTCTGTCGAGCCTGATAAAAAGGACAGTGCATCTACTTCTGTGTCA
GTGACTGGACAGGTACAAGGAAACTCCAGTATAAAACTAGAACTGGATGCTTCAAAGAAA
AAAGAATCAAAAGACCATCAGCTCCTACGCTATCTTTTAGATAAAGATGAGAAAGATTTA
AGATCAACTCCAAACCTGAGCCTGGATGATGTAAAGGTGAAAGTGGAAAAGAAAGAACAG
ATGGATCCATGTAATACAAACCCAACCCCAATGACCAAACCCACTCCTGAGGAAATAAAA
CTGGAGGCCCAGAGCCAGTTTACAGCTGACCTTGACCAGTTTGATCAGTTACTGCCCACG
CTGGAGAAGGCAGCACAGTTGCCAGGCTTATGTGAGACAGACAGGATGGATGGTGCGGTC
ACCAGTGTAACCATCAAATCGGAGATCCTGCCAGCTTCACTTCAGTCCGCCACTGCCAGA
CCCACTTCCAGGCTAAATAGATTACCTGAGCTGGAATTGGAAGCAATTGATAACCAATTT
GGACAACCAGGAACAGGCGATCAGATTCCATGGACAAATAATACAGTGACAGCTATAAAT
CAGAGTAAATCAGAAGACCAGTGTATTAGCTCACAATTAGATGAGCTTCTCTGTCCACCC
ACAACAGTAGAAGGGAGAAATGATGAGAAGGCTCTTCTTGAACAGCTGGTATCCTTCCTT
AGTGGCAAAGATGAAACTGAGCTAGCTGAACTAGACAGAGCTCTGGGAATTGACAAACTT
GTTCAGGGGGGTGGATTAGATGTATTATCAGAGAGATTTCCACCACAACAAGCAACGCCA
CCTTTGATCATGGAAGAAAGACCCAACCTTTATTCCCAGCCTTACTCTTCTCCTTCTCCT
ACTGCCAATCTCCCTAGCCCTTTCCAAGGCATGGTCAGGCAAAAACCTTCACTGGGGACG
ATGCCTGTTCAAGTAACACCTCCCCGAGGTGCTTTTTCACCTGGCATGGGCATGCAGCCC
AGGCAAACTCTAAACAGACCTCCGGCTGCACCTAACCAGCTTCGACTTCAACTACAGCAG
CGATTACAGGGACAACAGCAGTTGATACACCAAAATCGGCAAGCTATCTTAAACCAGTTT
GCAGCAACTGCTCCTGTTGGCATCAATATGAGATCAGGCATGCAACAGCAAATTACACCT
CAGCCACCCCTGAATGCTCAAATGTTGGCACAACGTCAGCGGGAACTGTACAGTCAACAG
CACCGACAGAGGCAGCTAATACAGCAGCAAAGAGCCATGCTTATGAGGCAGCAAAGCTTT
GGGAACAACCTCCCTCCCTCATCTGGACTACCAGTTCAAATGGGGAACCCCCGTCTTCCT
CAGGGTGCTCCACAGCAATTCCCCTATCCACCAAACTATGGTACAAATCCAGGAACCCCA
CCTGCTTCTACCAGCCCGTTTTCACAACTAGCAGCAAATCCTGAAGCATCCTTGGCCAAC
CGCAACAGCATGGTGAGCAGAGGCATGACAGGAAACATAGGAGGACAGTTTGGCACTGGA
ATCAATCCTCAGATGCAGCAGAATGTCTTCCAGTATCCAGGAGCAGGAATGGTTCCCCAA
GGTGAGGCCAACTTTGCTCCATCTCTAAGCCCTGGGAGCTCCATGGTGCCGATGCCAATC
CCTCCTCCTCAGAGTTCTCTGCTCCAGCAAACTCCACCTGCCTCCGGGTATCAGTCACCA
GACATGAAGGCCTGGCAGCAAGGAGCGATAGGAAACAACAATGTGTTCAGTCAAGCTGTC
CAGAACCAGCCCACGCCTGCACAGCCAGGAGTATACAACAACATGAGCATCACCGTTTCC
ATGGCAGGTGGAAATACGAATGTTCAGAACATGAACCCAATGATGGCCCAGATGCAGATG
AGCTCTTTGCAGATGCCAGGAATGAACACTGTGTGCCCTGAGCAGATAAATGATCCCGCA
CTGAGACACACAGGCCTCTACTGCAACCAGCTCTCATCCACTGACCTTCTCAAAACAGAA
GCAGATGGAACCCAGGTGCAACAGGTTCAGGTGTTTGCTGACGTCCAGTGTACAGTGAAT
CTGGTAGGCGGGGACCCTTACCTGAACCAGCCTGGTCCACTGGGAACTCAAAAGCCCACG
TCAGGACCACAGACCCCCCAGGCCCAGCAGAAGAGCCTCCTTCAGCAGCTACTGACTGAA
TAA

# Drug_Target_22_General_Function:
Involved in androgen receptor binding

# Drug_Target_22_General_References:
11831720	Raineri I, Soler M, Senn HP: Analysis of human immunodeficiency virus type 1 promoter insertion in vivo. Virology. 1995 Apr 1;208(1):359-64.
15313887	Wachtel M, Dettling M, Koscielniak E, Stegmaier S, Treuner J, Simon-Klingenstein K, Buhlmann P, Niggli FK, Schafer BW: Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1. Cancer Res. 2004 Aug 15;64(16):5539-45.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
15815621	Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31.
7481822	Onate SA, Tsai SY, Tsai MJ, O'Malley BW: Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 1995 Nov 24;270(5240):1354-7.
8754792	Takeshita A, Yen PM, Misiti S, Cardona GR, Liu Y, Chin WW: Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator. Endocrinology. 1996 Aug;137(8):3594-7.
9427757	Kalkhoven E, Valentine JE, Heery DM, Parker MG: Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J. 1998 Jan 2;17(1):232-43.
9575154	Onate SA, Boonyaratanakornkit V, Spencer TE, Tsai SY, Tsai MJ, Edwards DP, O'Malley BW: The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J Biol Chem. 1998 May 15;273(20):12101-8.

# Drug_Target_22_HGNC_ID:
GNC:7668

# Drug_Target_22_HPRD_ID:
Not Available

# Drug_Target_22_ID:
6228

# Drug_Target_22_Locus:
2p23

# Drug_Target_22_Molecular_Weight:
156755.4

# Drug_Target_22_Name:
Nuclear receptor coactivator 1

# Drug_Target_22_Number_of_Residues:
1441

# Drug_Target_22_PDB_ID:
1OJ5

# Drug_Target_22_Pathway:
Not Available

# Drug_Target_22_Pfam_Domain_Function:
PF00010	HLH
PF00989	PAS
PF07469	DUF1518
PF08815	Nuc_rec_co-act
PF08832	SRC-1

# Drug_Target_22_Protein_Sequence:
>Nuclear receptor coactivator 1
MSGLGDSSSDPANPDSHKRKGSPCDTLASSTEKRRREQENKYLEELAELLSANISDIDSL
SVKPDKCKILKKTVDQIQLMKRMEQEKSTTDDDVQKSDISSSSQGVIEKESLGPLLLEAL
DGFFFVVNCEGRIVFVSENVTSYLGYNQEELMNTSVYSILHVGDHAEFVKNLLPKSLVNG
VPWPQEATRRNSHTFNCRMLIHPPDEPGTENQEACQRYEVMQCFTVSQPKSIQEDGEDFQ
SCLICIARRLPRPPAITGVESFMTKQDTTGKIISIDTSSLRAAGRTGWEDLVRKCIYAFF
QPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHTKCKLCYPQSPDMQPFIMG
IHIIDREHSGLSPQDDTNSGMSIPRVNPSVNPSISPAHGVARSSTLPPSNSNMVSTRINR
QQSSDLHSSSHSNSSNSQGSFGCSPGSQIVANVALNQGQASSQSSNPSLNLNNSPMEGTG
ISLAQFMSPRRQVTSGLATRPRMPNNSFPPNISTLSSPVGMTSSACNNNNRSYSNIPVTS
LQGMNEGPNNSVGFSASSPVLRQMSSQNSPSRLNIQPAKAESKDNKEIASILNEMIQSDN
SSSDGKPLDSGLLHNNDRLSDGDSKYSQTSHKLVQLLTTTAEQQLRHADIDTSCKDVLSC
TGTSNSASANSSGGSCPSSHSSLTERHKILHRLLQEGSPSDITTLSVEPDKKDSASTSVS
VTGQVQGNSSIKLELDASKKKESKDHQLLRYLLDKDEKDLRSTPNLSLDDVKVKVEKKEQ
MDPCNTNPTPMTKPTPEEIKLEAQSQFTADLDQFDQLLPTLEKAAQLPGLCETDRMDGAV
TSVTIKSEILPASLQSATARPTSRLNRLPELELEAIDNQFGQPGTGDQIPWTNNTVTAIN
QSKSEDQCISSQLDELLCPPTTVEGRNDEKALLEQLVSFLSGKDETELAELDRALGIDKL
VQGGGLDVLSERFPPQQATPPLIMEERPNLYSQPYSSPSPTANLPSPFQGMVRQKPSLGT
MPVQVTPPRGAFSPGMGMQPRQTLNRPPAAPNQLRLQLQQRLQGQQQLIHQNRQAILNQF
AATAPVGINMRSGMQQQITPQPPLNAQMLAQRQRELYSQQHRQRQLIQQQRAMLMRQQSF
GNNLPPSSGLPVQMGNPRLPQGAPQQFPYPPNYGTNPGTPPASTSPFSQLAANPEASLAN
RNSMVSRGMTGNIGGQFGTGINPQMQQNVFQYPGAGMVPQGEANFAPSLSPGSSMVPMPI
PPPQSSLLQQTPPASGYQSPDMKAWQQGAIGNNNVFSQAVQNQPTPAQPGVYNNMSITVS
MAGGNTNVQNMNPMMAQMQMSSLQMPGMNTVCPEQINDPALRHTGLYCNQLSSTDLLKTE
ADGTQQVQQVQVFADVQCTVNLVGGDPYLNQPGPLGTQKPTSGPQTPQAQQKSLLQQLLT
E

# Drug_Target_22_Reaction:
Not Available

# Drug_Target_22_Signals:
None

# Drug_Target_22_Specific_Function:
Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Involved in the coactivation of different nuclear receptors, such as for steroids (PGR, GR and ER), retinoids (RXRs), thyroid hormone (TRs) and prostanoids (PPARs). Also involved in coactivation mediated by STAT3, STAT5A, STAT5B and STAT6 transcription factors. Displays histone acetyltransferase activity toward H3 and H4; the relevance of such activity remains however unclear. Plays a central role in creating multisubunit coactivator complexes that act via remodeling of chromatin, and possibly acts by participating in both chromatin remodeling and recruitment of general transcription factors. Required with NCOA2 to control energy balance between white and brown adipose tissues. Required for mediating steroid hormone response. Isoform 2 has a higher thyroid hormone-dependent transactivation activity than isoform 1 and isoform 3

# Drug_Target_22_SwissProt_ID:
Q15788

# Drug_Target_22_SwissProt_Name:
NCOA1_HUMAN

# Drug_Target_22_Synonyms:
NCoA-1
Protein Hin-2
RIP160
Renal carcinoma antigen NY-REN-52
SRC-1
Steroid receptor coactivator 1

# Drug_Target_22_Theoretical_pI:
6.10

# Drug_Target_22_Transmembrane_Regions:
None

# Drug_Target_23_Cellular_Location:
Not Available

# Drug_Target_23_Chromosome_Location:
Not Available

# Drug_Target_23_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_23_Essentiality:
Non-Essential

# Drug_Target_23_GenAtlas_ID:
Not Available

# Drug_Target_23_GenBank_ID_Gene:
Not Available

# Drug_Target_23_GenBank_ID_Protein:
Not Available

# Drug_Target_23_GeneCard_ID:
Not Available

# Drug_Target_23_Gene_Name:
nef

# Drug_Target_23_Gene_Sequence:
Not Available

# Drug_Target_23_General_Function:
Not Available

# Drug_Target_23_General_References:
Not Available

# Drug_Target_23_HGNC_ID:
Not Available

# Drug_Target_23_HPRD_ID:
Not Available

# Drug_Target_23_ID:
6745

# Drug_Target_23_Locus:
Not Available

# Drug_Target_23_Molecular_Weight:
Not Available

# Drug_Target_23_Name:
Protein Nef

# Drug_Target_23_Number_of_Residues:
0

# Drug_Target_23_PDB_ID:
Not Available

# Drug_Target_23_Pathway:
Not Available

# Drug_Target_23_Pfam_Domain_Function:
Not Available

# Drug_Target_23_Protein_Sequence:
Not Available

# Drug_Target_23_Reaction:
Not Available

# Drug_Target_23_Signals:
Not Available

# Drug_Target_23_Specific_Function:
Not Available

# Drug_Target_23_SwissProt_ID:
P04324

# Drug_Target_23_SwissProt_Name:
NEF_HV112

# Drug_Target_23_Synonyms:
Not Available

# Drug_Target_23_Theoretical_pI:
Not Available

# Drug_Target_23_Transmembrane_Regions:
Not Available

# Drug_Target_24_Cellular_Location:
Cell outer membrane
multi-pass membrane protein

# Drug_Target_24_Chromosome_Location:
Not Available

# Drug_Target_24_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_24_Essentiality:
Non-Essential

# Drug_Target_24_GenAtlas_ID:
Not Available

# Drug_Target_24_GenBank_ID_Gene:
M12486

# Drug_Target_24_GenBank_ID_Protein:
2226438

# Drug_Target_24_GeneCard_ID:
Not Available

# Drug_Target_24_Gene_Name:
fhuA

# Drug_Target_24_Gene_Sequence:
>2244 bp
ATGGCGCGTTCCAAAACTGCTCAGCCAAAACACTCACTGCGTAAAATCGCAGTTGTAGTA
GCCACAGCGGTTAGCGGCATGTCTGTTTATGCACAGGCAGCGGTTGAACCGAAAGAAGAC
ACTATCACCGTTACCGCTGCACCTGCGCCGCAAGAAAGCGCATGGGGGCCTGCTGCAACT
ATTGCGGCGCGACAGTCTGCTACCGGCACTAAAACCGATACGCCGATTCAAAAAGTGCCA
CAGTCTATTTCTGTTGTGACCGCCGAAGAGATGGCGCTGCATCAGCCGAAGTCGGTAAAA
GAAGCGCTTAGCTACACGCCGGGTGTCTCTGTTGGTACGCGTGGCGCATCCAACACCTAT
GACCACCTGATCATTCGCGGCTTTGCGGCAGAAGGCCAAAGCCAGAATAACTATCTGAAT
GGCCTGAAGTTGCAGGGCAACTTCTATAACGATGCGGTCATTGACCCGTATATGCTGGAA
CGCGCTGAAATTATGCGTGGCCCGGTTTCCGTGCTTTACGGTAAAAGCAGTCCTGGCGGC
CTGTTGAATATGGTCAGCAAGCGTCCGACCACCGAACCGCTGAAAGAAGTTCAGTTTAAA
GCCGGTACTGACAGCCTGTTCCAGACTGGTTTTGACTTTAGCGATTCGTTGGATGATGAC
GGTGTTTACTCTTATCGCCTGACCGGTCTTGCGCGTTCTGCCAATGCCCAGCAGAAAGGG
TCAGAAGAGCAGCGTTATGCTATTGCACCGGCGTTCACCTGGCGTCCGGATGATAAAACC
AATTTTACCTTCCTTTCTTACTTCCAGAACGAGCCGGAAACCGGTTATTACGGCTGGTTG
CCGAAAGAGGGAACCGTTGAGCCGCTGCCGAACGGTAAGCGTCTGCCGACAGACTTTAAT
GAAGGGGCGAAGAACAACACCTATTCTCGTAATGAGAAGATGGTCGGCTACAGCTTCGAT
CACGAATTTAACGACACCTTTACTGTGCGTCAGAACCTGCGCTTTGCTGAAAACAAAACC
TCGCAAAACAGCGTTTATGGTTACGGCGTCTGCTCCGATCCGGCGAATGCTTACAGCAAA
CAGTGTGCGGCATTAGCGCCAGCGGATAAAGGCCATTATCTGGCACGTAAATACGTCGTT
GATGATGAGAAGCTGCAAAACTTCTCCGTTGATACCCAGTTGCAGAGCAAGTTTGCCACT
GGCGATATCGACCACACCCTGCTGACCGGTGTCGACTTTATGCGTATGCGTAATGACATC
AACGCCTGGTTTGGTTACGACGACTCTGTGCCACTGCTCAATCTGTACAATCCGGTGAAT
ACCGATTTCGACTTCAATGCCAAAGATCCGGCAAACTCCGGCCCTTACCGCATTCTGAAT
AAACAGAAACAAACGGGCGTTTATGTTCAGGATCAGGCGCAGTGGGATAAAGTGCTGGTC
ACCCTAGGCGGTCGTTATGACTGGGCAGATCAAGAATCTCTTAACCGCGTTGCCGGGACG
ACCGATAAACGTGATGACAAACAGTTTACCTGGCGTGGTGGTGTTAACTACCTGTTTGAT
AATGGTGTAACACCTTACTTCAGCTATAGCGAATCGTTTGAACCTTCTTCGCAAGTTGGG
AAGGATGGTAATATTTTCGCACCGTCTAAAGGTAAGCAGTATGAAGTCGGCGTGAAATAT
GTACCGGAAGATCGTCCGATTGTAGTTACTGGTGCCGTGTATAATCTCACTAAAACCAAC
AACCTGATGGCGGACCCTGAGGGTTCCTTCTTCTCGGTTGAAGGTGGCGAGATCCGCGCA
CGTGGCGTAGAAATCGAAGCGAAAGCGGCGCTGTCGGCGAGTGTTAACGTAGTCGGTTCT
TATACTTACACCGATGCGGAATACACCACCGATACTACCTATAAAGGCAATACGCCTGCA
CAGGTGCCAAAACACATGGCTTCGTTGTGGGCTGACTACACCTTCTTTGACGGTCCGCTT
TCAGGTCTGACGCTGGGCACCGGTGGTCGTTATACTGGCTCCAGTTATGGTGATCCGGCT
AACTCCTTTAAAGTGGGAAGTTATACGGTCGTGGATGCGTTAGTACGTTATGATCTGGCG
CGAGTCGGCATGGCTGGCTCCAACGTGGCGCTGCATGTTAACAACCTGTTCGATCGTGAA
TACGTCGCCAGCTGCTTTAACACTTATGGCTGCTTCTGGGGCGCAGAACGTCAGGTCGTT
GCAACCGCAACCTTCCGTTTCTAA

# Drug_Target_24_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_24_General_References:
10850805	Ferguson AD, Braun V, Fiedler HP, Coulton JW, Diederichs K, Welte W: Crystal structure of the antibiotic albomycin in complex with the outer membrane transporter FhuA. Protein Sci. 2000 May;9(5):956-63.
2823072	Burkhardt R, Braun V: Nucleotide sequence of the fhuC and fhuD genes involved in iron (III) hydroxamate transport: domains in FhuC homologous to ATP-binding proteins. Mol Gen Genet. 1987 Aug;209(1):49-55.
3079747	Coulton JW, Mason P, Cameron DR, Carmel G, Jean R, Rode HN: Protein fusions of beta-galactosidase to the ferrichrome-iron receptor of Escherichia coli K-12. J Bacteriol. 1986 Jan;165(1):181-92.
7515827	Braun V, Killmann H, Benz R: Energy-coupled transport through the outer membrane of Escherichia coli small deletions in the gating loop convert the FhuA transport protein into a diffusion channel. FEBS Lett. 1994 Jun 6;346(1):59-64.
8202364	Fujita N, Mori H, Yura T, Ishihama A: Systematic sequencing of the Escherichia coli genome: analysis of the 2.4-4.1 min (110,917-193,643 bp) region. Nucleic Acids Res. 1994 May 11;22(9):1637-9.
8617231	Bonhivers M, Ghazi A, Boulanger P, Letellier L: FhuA, a transporter of the Escherichia coli outer membrane, is converted into a channel upon binding of bacteriophage T5. EMBO J. 1996 Apr 15;15(8):1850-6.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9856937	Ferguson AD, Hofmann E, Coulton JW, Diederichs K, Welte W: Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science. 1998 Dec 18;282(5397):2215-20.
9865695	Locher KP, Rees B, Koebnik R, Mitschler A, Moulinier L, Rosenbusch JP, Moras D: Transmembrane signaling across the ligand-gated FhuA receptor: crystal structures of free and ferrichrome-bound states reveal allosteric changes. Cell. 1998 Dec 11;95(6):771-8.

# Drug_Target_24_HGNC_ID:
Not Available

# Drug_Target_24_HPRD_ID:
Not Available

# Drug_Target_24_ID:
2427

# Drug_Target_24_Locus:
Not Available

# Drug_Target_24_Molecular_Weight:
82183

# Drug_Target_24_Name:
Ferrichrome-iron receptor

# Drug_Target_24_Number_of_Residues:
747

# Drug_Target_24_PDB_ID:
1BY3

# Drug_Target_24_Pathway:
Not Available

# Drug_Target_24_Pfam_Domain_Function:
PF00593	TonB_dep_Rec
PF07715	Plug

# Drug_Target_24_Protein_Sequence:
>Ferrichrome-iron receptor precursor
MARSKTAQPKHSLRKIAVVVATAVSGMSVYAQAAVEPKEDTITVTAAPAPQESAWGPAAT
IAARQSATGTKTDTPIQKVPQSISVVTAEEMALHQPKSVKEALSYTPGVSVGTRGASNTY
DHLIIRGFAAEGQSQNNYLNGLKLQGNFYNDAVIDPYMLERAEIMRGPVSVLYGKSSPGG
LLNMVSKRPTTEPLKEVQFKAGTDSLFQTGFDFSDSLDDDGVYSYRLTGLARSANAQQKG
SEEQRYAIAPAFTWRPDDKTNFTFLSYFQNEPETGYYGWLPKEGTVEPLPNGKRLPTDFN
EGAKNNTYSRNEKMVGYSFDHEFNDTFTVRQNLRFAENKTSQNSVYGYGVCSDPANAYSK
QCAALAPADKGHYLARKYVVDDEKLQNFSVDTQLQSKFATGDIDHTLLTGVDFMRMRNDI
NAWFGYDDSVPLLNLYNPVNTDFDFNAKDPANSGPYRILNKQKQTGVYVQDQAQWDKVLV
TLGGRYDWADQESLNRVAGTTDKRDDKQFTWRGGVNYLFDNGVTPYFSYSESFEPSSQVG
KDGNIFAPSKGKQYEVGVKYVPEDRPIVVTGAVYNLTKTNNLMADPEGSFFSVEGGEIRA
RGVEIEAKAALSASVNVVGSYTYTDAEYTTDTTYKGNTPAQVPKHMASLWADYTFFDGPL
SGLTLGTGGRYTGSSYGDPANSFKVGSYTVVDALVRYDLARVGMAGSNVALHVNNLFDRE
YVASCFNTYGCFWGAERQVVATATFRF

# Drug_Target_24_Reaction:
Not Available

# Drug_Target_24_Signals:
1-33

# Drug_Target_24_Specific_Function:
This receptor binds the ferrichrome-iron ligand. It interacts with the tonB protein, which is responsible for energy coupling of the ferrichrome-promoted iron transport system. Acts as a receptor for bacteriophage T5 as well as T1, phi80 and colicin M. Binding of T5 triggers the opening of a high conductance ion channel. Can also transport the antibiotic albomycin

# Drug_Target_24_SwissProt_ID:
P06971

# Drug_Target_24_SwissProt_Name:
FHUA_ECOLI

# Drug_Target_24_Synonyms:
Ferric hydroxamate receptor
Ferric hydroxamate uptake
Ferrichrome-iron receptor precursor

# Drug_Target_24_Theoretical_pI:
5.35

# Drug_Target_24_Transmembrane_Regions:
193-201
207-215
223-231
246-255
260-268
313-321
327-335
388-396
405-413
465-473
478-486
509-517
523-531
552-560
566-574
602-610
614-622
646-654
662-670
690-698
706-714
738-746

# Drug_Target_25_Cellular_Location:
Cytoplasm

# Drug_Target_25_Chromosome_Location:
Not Available

# Drug_Target_25_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_25_Essentiality:
Non-Essential

# Drug_Target_25_GenAtlas_ID:
FKBP1A

# Drug_Target_25_GenBank_ID_Gene:
M34539

# Drug_Target_25_GenBank_ID_Protein:
182628

# Drug_Target_25_GeneCard_ID:
FKBP1A

# Drug_Target_25_Gene_Name:
FKBP1A

# Drug_Target_25_Gene_Sequence:
>327 bp
ATGGGAGTGCAGGTGGAAACCATCTCCCCAGGAGACGGGCGCACCTTCCCCAAGCGCGGC
CAGACCTGCGTGGTGCACTACACCGGGATGCTTGAAGATGGAAAGAAATTTGATTCCTCC
CGGGACAGAAACAAGCCCTTTAAGTTTATGCTAGGCAAGCAGGAGGTGATCCGAGGCTGG
GAAGAAGGGGTTGCCCAGATGAGTGTGGGTCAGAGAGCCAAACTGACTATATCTCCAGAT
TATGCCTATGGTGCCACTGGGCACCCAGGCATCATCCCACCACATGCCACTCTCGTCTTC
GATGTGGAGCTTCTAAAACTGGAATGA

# Drug_Target_25_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_25_General_References:
10656803	Burkhard P, Taylor P, Walkinshaw MD: X-ray structures of small ligand-FKBP complexes provide an estimate for hydrophobic interaction energies. J Mol Biol. 2000 Jan 28;295(4):953-62.
11780052	Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, Bailey J, Barlow KF, Bates KN, Beard LM, Beare DM, Beasley OP, Bird CP, Blakey SE, Bridgeman AM, Brown AJ, Buck D, Burrill W, Butler AP, Carder C, Carter NP, Chapman JC, Clamp M, Clark G, Clark LN, Clark SY, Clee CM, Clegg S, Cobley VE, Collier RE, Connor R, Corby NR, Coulson A, Coville GJ, Deadman R, Dhami P, Dunn M, Ellington AG, Frankland JA, Fraser A, French L, Garner P, Grafham DV, Griffiths C, Griffiths MN, Gwilliam R, Hall RE, Hammond S, Harley JL, Heath PD, Ho S, Holden JL, Howden PJ, Huckle E, Hunt AR, Hunt SE, Jekosch K, Johnson CM, Johnson D, Kay MP, Kimberley AM, King A, Knights A, Laird GK, Lawlor S, Lehvaslaiho MH, Leversha M, Lloyd C, Lloyd DM, Lovell JD, Marsh VL, Martin SL, McConnachie LJ, McLay K, McMurray AA, Milne S, Mistry D, Moore MJ, Mullikin JC, Nickerson T, Oliver K, Parker A, Patel R, Pearce TA, Peck AI, Phillimore BJ, Prathalingam SR, Plumb RW, Ramsay H, Rice CM, Ross MT, Scott CE, Sehra HK, Shownkeen R, Sims S, Skuce CD, Smith ML, Soderlund C, Steward CA, Sulston JE, Swann M, Sycamore N, Taylor R, Tee L, Thomas DW, Thorpe A, Tracey A, Tromans AC, Vaudin M, Wall M, Wallis JM, Whitehead SL, Whittaker P, Willey DL, Williams L, Williams SA, Wilming L, Wray PW, Hubbard T, Durbin RM, Bentley DR, Beck S, Rogers J: The DNA sequence and comparative analysis of human chromosome 20. Nature. 2001 Dec 20-27;414(6866):865-71.
12665801	Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31.
1375171	Lepre CA, Thomson JA, Moore JM: Solution structure of FK506 bound to FKBP-12. FEBS Lett. 1992 May 4;302(1):89-96.
1695378	Maki N, Sekiguchi F, Nishimaki J, Miwa K, Hayano T, Takahashi N, Suzuki M: Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5440-3.
1696686	Standaert RF, Galat A, Verdine GL, Schreiber SL: Molecular cloning and overexpression of the human FK506-binding protein FKBP. Nature. 1990 Aug 16;346(6285):671-4.
1701173	Siekierka JJ, Wiederrecht G, Greulich H, Boulton D, Hung SH, Cryan J, Hodges PJ, Sigal NH: The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous and highly conserved peptidyl-prolyl cis-trans isomerase. J Biol Chem. 1990 Dec 5;265(34):21011-5.
1709301	Michnick SW, Rosen MK, Wandless TJ, Karplus M, Schreiber SL: Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin. Science. 1991 May 10;252(5007):836-9.
1709302	Van Duyne GD, Standaert RF, Karplus PA, Schreiber SL, Clardy J: Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. Science. 1991 May 10;252(5007):839-42.
1709363	Rosen MK, Michnick SW, Karplus M, Schreiber SL: Proton and nitrogen sequential assignments and secondary structure determination of the human FK506 and rapamycin binding protein. Biochemistry. 1991 May 14;30(19):4774-89.
1716149	DiLella AG, Craig RJ: Exon organization of the human FKBP-12 gene: correlation with structural and functional protein domains. Biochemistry. 1991 Sep 3;30(35):8512-7.
2477715	Harding MW, Galat A, Uehling DE, Schreiber SL: A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 1989 Oct 26;341(6244):758-60.
7529739	Peattie DA, Hsiao K, Benasutti M, Lippke JA: Three distinct messenger RNAs can encode the human immunosuppressant-binding protein FKBP12. Gene. 1994 Dec 15;150(2):251-7.
7678431	Van Duyne GD, Standaert RF, Karplus PA, Schreiber SL, Clardy J: Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J Mol Biol. 1993 Jan 5;229(1):105-24.
7682113	Xu RX, Nettesheim D, Olejniczak ET, Meadows R, Gemmecker G, Fesik SW: 1H, 13C, and 15N assignments and secondary structure of the FK506 binding protein when bound to ascomycin. Biopolymers. 1993 Apr;33(4):535-50.

# Drug_Target_25_HGNC_ID:
HGNC:3711

# Drug_Target_25_HPRD_ID:
01741

# Drug_Target_25_ID:
768

# Drug_Target_25_Locus:
20p13

# Drug_Target_25_Molecular_Weight:
11820

# Drug_Target_25_Name:
FK506-binding protein 1A

# Drug_Target_25_Number_of_Residues:
107

# Drug_Target_25_PDB_ID:
1J4I

# Drug_Target_25_Pathway:
Not Available

# Drug_Target_25_Pfam_Domain_Function:
PF00254	FKBP_C

# Drug_Target_25_Protein_Sequence:
>FK506-binding protein 1A
GVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWE
EGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE

# Drug_Target_25_Reaction:
peptidylproline (omega=180) = peptidylproline (omega=0)

# Drug_Target_25_Signals:
None

# Drug_Target_25_Specific_Function:
May play a role in modulation of ryanodine receptor isoform-1 (RYR-1), a component of the calcium release channel of skeletal muscle sarcoplasmic reticulum. There are four molecules of FKBP12 per skeletal muscle RYR. PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides

# Drug_Target_25_SwissProt_ID:
P62942

# Drug_Target_25_SwissProt_Name:
FKB1A_HUMAN

# Drug_Target_25_Synonyms:
12 kDa FKBP
EC 5.2.1.8
FKBP-12
Immunophilin FKBP12
PPIase
Peptidyl-prolyl cis-trans isomerase
Rotamase

# Drug_Target_25_Theoretical_pI:
8.48

# Drug_Target_25_Transmembrane_Regions:
None

# Drug_Target_26_Cellular_Location:
Not Available

# Drug_Target_26_Chromosome_Location:
Not Available

# Drug_Target_26_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_26_Essentiality:
Non-Essential

# Drug_Target_26_GenAtlas_ID:
PPP3R1

# Drug_Target_26_GenBank_ID_Gene:
M30773

# Drug_Target_26_GenBank_ID_Protein:
180705

# Drug_Target_26_GeneCard_ID:
PPP3R1

# Drug_Target_26_Gene_Name:
PPP3R1

# Drug_Target_26_Gene_Sequence:
>513 bp
ATGGGAAATGAGGCAAGTTATCCTTTGGAAATGTGCTCACACTTTGATGCGGATGAAATT
AAAAGGCTAGGAAAGAGATTTAAGAAGCTTGATTTGGACAATTCTGGTTCTTTGAGTGTG
GAAGAGTTCATGTCTCTGCCTGAGTTACAACAGAATCCTTTAGTACAGCGAGTAATAGAT
ATATTCGACACAGATGGGAATGGAGAAGTAGACTTTAAAGAATTCATTGAGGGCGTCTCT
CAGTTCAGTGTCAAAGGAGATAAGGAGCAGAAATTGAGGTTTGCTTTCCGTATCTATGAC
ATGGATAAAGATGGCTATATTTCCAATGGGGAACTCTTCCAGGTATTGAAGATGATGGTG
GGGAACAATCTGAAAGATACACAGTTACAGCAAATTGTAGACAAAACCATAATAAATGCA
GATAAGGATGGAGATGGAAGAATATCCTTTGAAGAATTCTGTGCTGTTGTAGGTGGCCTA
GATATCCACAAAAAGATGGTGGTAGATGTGTGA

# Drug_Target_26_General_Function:
Involved in calcium ion binding

# Drug_Target_26_General_References:
2558868	Guerini D, Krinks MH, Sikela JM, Hahn WE, Klee CB: Isolation and sequence of a cDNA clone for human calcineurin B, the Ca2+-binding subunit of the Ca2+/calmodulin-stimulated protein phosphatase. DNA. 1989 Nov;8(9):675-82.
8524402	Kissinger CR, Parge HE, Knighton DR, Lewis CT, Pelletier LA, Tempczyk A, Kalish VJ, Tucker KD, Showalter RE, Moomaw EW, et al.: Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature. 1995 Dec 7;378(6557):641-4.

# Drug_Target_26_HGNC_ID:
HGNC:9317

# Drug_Target_26_HPRD_ID:
03195

# Drug_Target_26_ID:
394

# Drug_Target_26_Locus:
2p15

# Drug_Target_26_Molecular_Weight:
19169

# Drug_Target_26_Name:
Calcineurin subunit B isoform 1

# Drug_Target_26_Number_of_Residues:
169

# Drug_Target_26_PDB_ID:
1MF8

# Drug_Target_26_Pathway:
Not Available

# Drug_Target_26_Pfam_Domain_Function:
PF00036	efhand

# Drug_Target_26_Protein_Sequence:
>Calcineurin subunit B isoform 1
GNEASYPLEMCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNPLVQRVIDI
FDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVG
NNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGLDIHKKMVVDV

# Drug_Target_26_Reaction:
Not Available

# Drug_Target_26_Signals:
None

# Drug_Target_26_Specific_Function:
Regulatory subunit of calcineurin, a calcium-dependent, calmodulin stimulated protein phosphatase. Confers calcium sensitivity

# Drug_Target_26_SwissProt_ID:
P63098

# Drug_Target_26_SwissProt_Name:
CANB1_HUMAN

# Drug_Target_26_Synonyms:
Protein phosphatase 2B regulatory subunit 1
Protein phosphatase 3 regulatory subunit B alpha isoform 1

# Drug_Target_26_Theoretical_pI:
4.40

# Drug_Target_26_Transmembrane_Regions:
None

# Drug_Target_27_Cellular_Location:
Nucleus (By similarity)

# Drug_Target_27_Chromosome_Location:
4

# Drug_Target_27_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_27_Essentiality:
Non-Essential

# Drug_Target_27_GenAtlas_ID:
Not Available

# Drug_Target_27_GenBank_ID_Gene:
L14778

# Drug_Target_27_GenBank_ID_Protein:
306477

# Drug_Target_27_GeneCard_ID:
PPP3CA

# Drug_Target_27_Gene_Name:
PPP3CA

# Drug_Target_27_Gene_Sequence:
>1566 bp
ATGTCCGAGCCCAAGGCAATTGATCCCAAGTTGTCGACGACCGACAGGGTGGTGAAAGCT
GTTCCATTTCCTCCAAGTCACCGGCTTACAGCAAAAGAAGTGTTTGATAATGATGGAAAA
CCTCGTGTGGATATCTTAAAGGCGCATCTTATGAAGGAGGGAAGGCTGGAAGAGAGTGTT
GCATTGAGAATAATAACAGAGGGTGCATCAATTCTTCGACAGGAAAAAAATTTGCTGGAT
ATTGATGCGCCAGTCACTGTTTGTGGGGACATTCATGGACAATTCTTTGATTTGATGAAG
CTCTTTGAAGTCGGGGGATCTCCTGCCAACACTCGCTACCTCTTCTTAGGGGACTATGTT
GACAGAGGGTACTTCAGTATTGAATGTGTGCTGTATTTGTGGGCCTTGAAAATTCTCTAC
CCCAAAACACTGTTTTTACTTCGTGGAAATCATGAATGTAGACATCTAACAGAGTATTTC
ACATTTAAACAAGAATGTAAAATAAAGTATTCAGAACGAGTATATGATGCCTGTATGGAT
GCCTTTGACTGCCTTCCCCTGGCTGCCCTGATGAACCAACAGTTCCTGTGTGTGCATGGT
GGTTTGTCTCCAGAGATTAACACTTTAGATGATATCAGAAAATTAGACCGATTCAAAGAA
CCACCTGCATATGGACCTATGTGTGATATCCTGTGGTCAGACCCCCTGGAAGATTTTGGA
AATGAGAAGACTCAGGAACATTTCACTCACAACACAGTCAGGGGGTGTTCATACTTCTAC
AGTTACCCGGCTGTATGTGAATTCTTACAGCACAATAACTTGTTATCTATACTCCGAGCC
CACGAAGCCCAAGATGCAGGGTACCGCATGTACAGGAAAAGCCAAACAACAGGCTTCCCT
TCTCTAATTACAATTTTTTCAGCACCAAATTACTTAGATGTATACAATAACAAAGCTGCA
GTATTGAAGTATGAGAACAATGTTATGAATATCAGGCAATTCAACTGTTCTCCTCATCCA
TACTGGCTTCCAAATTTCATGGATGTTTTTACTTGGTCCCTTCCATTTGTTGGGGAAAAA
GTGACTGAGATGCTGGTAAATGTCCTCAACATCTGCTCAGATGATGAACTAGGGTCAGAA
GAAGATGGATTTGATGGTGCAACAGCTGCAGCCCGGAAAGAGGTGATAAGGAACAAGATC
CGAGCAATAGGCAAAATGGCCAGAGTGTTCTCAGTGCTCAGAGAAGAGAGTGAGAGTGTG
CTGACGCTGAAAGGCTTGACCCCAACTGGCATGCTCCCCAGCGGAGTACTTTCTGGAGGG
AAGCAAACCCTGCAAAGCGCTACTGTTGAGGCTATTGAGGCTGATGAAGCTATCAAAGGA
TTTTCACCACAACATAAGATCACTAGCTTCGAGGAAGCCAAGGGCTTAGACCGAATTAAT
GAGAGGATGCCGCCTCGCAGAGATGCCATGCCCTCTGACGCCAACCTTAACTCCATCAAC
AAGGCTCTCACCTCAGAGACTAACGGCACGGACAGCAATGGCAGTAATAGCAGCAATATT
CAGTGA

# Drug_Target_27_General_Function:
Involved in calcium ion binding

# Drug_Target_27_General_References:
11114196	Frey N, Richardson JA, Olson EN: Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14632-7.
11842093	Frey N, Olson EN: Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins. J Biol Chem. 2002 Apr 19;277(16):13998-4004. Epub 2002 Feb 12.
15454081	Screaton RA, Conkright MD, Katoh Y, Best JL, Canettieri G, Jeffries S, Guzman E, Niessen S, Yates JR 3rd, Takemori H, Okamoto M, Montminy M: The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell. 2004 Oct 1;119(1):61-74.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
15671020	Wang Y, Shibasaki F, Mizuno K: Calcium signal-induced cofilin dephosphorylation is mediated by Slingshot via calcineurin. J Biol Chem. 2005 Apr 1;280(13):12683-9. Epub 2005 Jan 24.
17974005	Bechtel S, Rosenfelder H, Duda A, Schmidt CP, Ernst U, Wellenreuther R, Mehrle A, Schuster C, Bahr A, Blocker H, Heubner D, Hoerlein A, Michel G, Wedler H, Kohrer K, Ottenwalder B, Poustka A, Wiemann S, Schupp I: The full-ORF clone resource of the German cDNA Consortium. BMC Genomics. 2007 Oct 31;8:399.
8392375	Muramatsu T, Kincaid RL: Molecular cloning of a full-length cDNA encoding the catalytic subunit of human calmodulin-dependent protein phosphatase (calcineurin A alpha). Biochim Biophys Acta. 1993 Jul 28;1178(1):117-20.
8524402	Kissinger CR, Parge HE, Knighton DR, Lewis CT, Pelletier LA, Tempczyk A, Kalish VJ, Tucker KD, Showalter RE, Moomaw EW, et al.: Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature. 1995 Dec 7;378(6557):641-4.

# Drug_Target_27_HGNC_ID:
GNC:9314

# Drug_Target_27_HPRD_ID:
Not Available

# Drug_Target_27_ID:
6746

# Drug_Target_27_Locus:
4q21-q24

# Drug_Target_27_Molecular_Weight:
58687.3

# Drug_Target_27_Name:
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform

# Drug_Target_27_Number_of_Residues:
521

# Drug_Target_27_PDB_ID:
1AUI

# Drug_Target_27_Pathway:
Not Available

# Drug_Target_27_Pfam_Domain_Function:
PF00149	Metallophos

# Drug_Target_27_Protein_Sequence:
>Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform
MSEPKAIDPKLSTTDRVVKAVPFPPSHRLTAKEVFDNDGKPRVDILKAHLMKEGRLEESV
ALRIITEGASILRQEKNLLDIDAPVTVCGDIHGQFFDLMKLFEVGGSPANTRYLFLGDYV
DRGYFSIECVLYLWALKILYPKTLFLLRGNHECRHLTEYFTFKQECKIKYSERVYDACMD
AFDCLPLAALMNQQFLCVHGGLSPEINTLDDIRKLDRFKEPPAYGPMCDILWSDPLEDFG
NEKTQEHFTHNTVRGCSYFYSYPAVCEFLQHNNLLSILRAHEAQDAGYRMYRKSQTTGFP
SLITIFSAPNYLDVYNNKAAVLKYENNVMNIRQFNCSPHPYWLPNFMDVFTWSLPFVGEK
VTEMLVNVLNICSDDELGSEEDGFDGATAAARKEVIRNKIRAIGKMARVFSVLREESESV
LTLKGLTPTGMLPSGVLSGGKQTLQSATVEAIEADEAIKGFSPQHKITSFEEAKGLDRIN
ERMPPRRDAMPSDANLNSINKALTSETNGTDSNGSNSSNIQ

# Drug_Target_27_Reaction:
Not Available

# Drug_Target_27_Signals:
None

# Drug_Target_27_Specific_Function:
Calcium-dependent, calmodulin-stimulated protein phosphatase. This subunit may have a role in the calmodulin activation of calcineurin. Dephosphorylates HSPB1 and SSH1

# Drug_Target_27_SwissProt_ID:
Q08209

# Drug_Target_27_SwissProt_Name:
PP2BA_HUMAN

# Drug_Target_27_Synonyms:
CAM-PRP catalytic subunit
Calmodulin-dependent calcineurin A subunit alpha isoform

# Drug_Target_27_Theoretical_pI:
5.66

# Drug_Target_27_Transmembrane_Regions:
None

# Drug_Target_28_Cellular_Location:
Not Available

# Drug_Target_28_Chromosome_Location:
Not Available

# Drug_Target_28_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_28_Essentiality:
Essential

# Drug_Target_28_GenAtlas_ID:
Not Available

# Drug_Target_28_GenBank_ID_Gene:
AE000516

# Drug_Target_28_GenBank_ID_Protein:
13879042

# Drug_Target_28_GeneCard_ID:
Not Available

# Drug_Target_28_Gene_Name:
MT1417

# Drug_Target_28_Gene_Sequence:
>1524 bp
TTGACCGATGACCCCGGTTCAGGCTTCACCACAGTGTGGAACGCGGTCGTCTCCGAACTT
AACGGCGACCCTAAGGTTGACGACGGACCCAGCAGTGATGCTAATCTCAGCGCTCCGCTG
ACCCCTCAGCAAAGGGCTTGGCTCAATCTCGTCCAGCCATTGACCATCGTCGAGGGGTTT
GCTCTGTTATCCGTGCCGAGCAGCTTTGTCCAAAACGAAATCGAGCGCCATCTGCGGGCC
CCGATTACCGACGCTCTCAGCCGCCGACTCGGACATCAGATCCAACTCGGGGTCCGCATC
GCTCCGCCGGCGACCGACGAAGCCGACGACACTACCGTGCCGCCTTCCGAAAATCCTGCT
ACCACATCGCCAGACACCACAACCGACAACGACGAGATTGATGACAGCGCTGCGGCACGG
GGCGATAACCAGCACAGTTGGCCAAGTTACTTCACCGAGCGCCCGCACAATACCGATTCC
GCTACCGCTGGCGTAACCAGCCTTAACCGTCGCTACACCTTTGATACGTTCGTTATCGGC
GCCTCCAACCGGTTCGCGCACGCCGCCGCCTTGGCGATCGCAGAAGCACCCGCCCGCGCT
TACAACCCCCTGTTCATCTGGGGCGAGTCCGGTCTCGGCAAGACACACCTGCTACACGCG
GCAGGCAACTATGCCCAACGGTTGTTCCCGGGAATGCGGGTCAAATATGTCTCCACCGAG
GAATTCACCAACGACTTCATTAACTCGCTCCGCGATGACCGCAAGGTCGCATTCAAACGC
AGCTACCGCGACGTAGACGTGCTGTTGGTCGACGACATCCAATTCATTGAAGGCAAAGAG
GGTATTCAAGAGGAGTTCTTCCACACCTTCAACACCTTGCACAATGCCAACAAGCAAATC
GTCATCTCATCTGACCGCCCACCCAAGCAGCTCGCCACCCTCGAGGACCGGCTGAGAACC
CGCTTTGAGTGGGGGCTGATCACTGACGTACAACCACCCGAGCTGGAGACCCGCATCGCC
ATCTTGCGCAAGAAAGCACAGATGGAACGGCTCGCGGTCCCCGACGATGTCCTCGAACTC
ATCGCCAGCAGTATCGAACGCAATATCCGTGAACTCGAGGGCGCGCTGATCCGGGTCACC
GCGTTCGCCTCATTGAACAAAACACCAATCGACAAAGCGCTGGCCGAGATTGTGCTTCGC
GATCTGATCGCCGACGCCAACACCATGCAAATCAGCGCGGCGACGATCATGGCTGCCACC
GCCGAATACTTCGACACTACCGTCGAAGAGCTTCGCGGGCCCGGCAAGACCCGAGCACTG
GCCCAGTCACGACAGATTGCGATGTACCTGTGTCGTGAGCTCACCGATCTTTCGTTGCCC
AAAATCGGCCAAGCGTTCGGCCGTGATCACACAACCGTCATGTACGCCCAACGCAAGATC
CTGTCCGAGATGGCCGAGCGCCGTGAGGTCTTTGATCACGTCAAAGAACTCACCACTCGC
ATCCGTCAGCGCTCCAAGCGCTAG

# Drug_Target_28_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_28_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_28_HGNC_ID:
Not Available

# Drug_Target_28_HPRD_ID:
Not Available

# Drug_Target_28_ID:
6747

# Drug_Target_28_Locus:
Not Available

# Drug_Target_28_Molecular_Weight:
42032.1

# Drug_Target_28_Name:
Chalcone/stilbene synthase family protein

# Drug_Target_28_Number_of_Residues:
393

# Drug_Target_28_PDB_ID:
1TED

# Drug_Target_28_Pathway:
Not Available

# Drug_Target_28_Pfam_Domain_Function:
PF00195	Chal_sti_synt_N
PF02797	Chal_sti_synt_C

# Drug_Target_28_Protein_Sequence:
>Chalcone/stilbene synthase family protein
MNVSAESGAPRRAGQRHEVGLAQLPPAPPTTVAVIEGLATGTPRRVVNQSDAADRVAELF
LDPGQRERIPRVYQKSRITTRRMAVDPLDAKFDVFRREPATIRDRMHLFYEHAVPLAVDV
SKRALAGLPYRAAEIGLLVLATSTGFIAPGVDVAIVKELGLSPSISRVVVNFMGCAAAMN
ALGTATNYVRAHPAMKALVVCIELCSVNAVFADDINDVVIHSLFGDGCAALVIGASQVQE
KLEPGKVVVRSSFSQLLDNTEDGIVLGVNHNGITCELSENLPGYIFSGVAPVVTEMLWDN
GLQISDIDLWAIHPGGPKIIEQSVRSLGISAELAAQSWDVLARFGNMLSVSLIFVLETMV
QQAESAKAISTGVAFAFGPGVTVEGMLFDIIRR

# Drug_Target_28_Reaction:
Not Available

# Drug_Target_28_Signals:
None

# Drug_Target_28_Specific_Function:
Not Available

# Drug_Target_28_SwissProt_ID:
Q7D8I1

# Drug_Target_28_SwissProt_Name:
Q7D8I1_MYCTU

# Drug_Target_28_Synonyms:
SubName: Putative uncharacterized protein

# Drug_Target_28_Theoretical_pI:
5.67

# Drug_Target_28_Transmembrane_Regions:
None

# Drug_Target_29_Cellular_Location:
Nucleus. Cytoplasm (By similarity). Note=Following virus entry, the nuclear localization signal (NLS

# Drug_Target_29_Chromosome_Location:
Not Available

# Drug_Target_29_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_29_Essentiality:
Non-Essential

# Drug_Target_29_GenAtlas_ID:
Not Available

# Drug_Target_29_GenBank_ID_Gene:
M19921

# Drug_Target_29_GenBank_ID_Protein:
328418

# Drug_Target_29_GeneCard_ID:
Not Available

# Drug_Target_29_Gene_Name:
gag-pol

# Drug_Target_29_Gene_Sequence:
>3012 bp
TTTTTTAGGGAAGATCTGGCCTTCCCACAAGGGAAGGCCAGGGAATTTTCTTCAGAGCAG
ACCAGAGCCAACAGCCCCACCAGAAGAGAGCTTCAGGTTTGGGGAAGAGACAACAACTCC
CTCTCAGAAGCAGGAGCCGATAGACAAGGAACTGTATCCTTTAGCTTCCCTCAGATCACT
CTTTGGCAGCGACCCCTCGTCACAATAAAGATAGGGGGGCAATTAAAGGAAGCTCTATTA
GATACAGGAGCAGATGATACAGTATTAGAAGAAATGAATTTGCCAGGAAGATGGAAACCA
AAAATGATAGGGGGAATTGGAGGTTTTATCAAAGTAGGACAGTATGATCAGATACTCATA
GAAATCTGCGGACATAAAGCTATAGGTACAGTATTAGTAGGACCTACACCTGTCAACATA
ATTGGAAGAAATCTGTTGACTCAGATTGGCTGCACTTTAAATTTTCCCATTAGTCCTATT
GAGACTGTACCAGTAAAATTAAAGCCAGGAATGGATGGCCCAAAAGTTAAACAATGGCCA
TTGACAGAAGAAAAAATAAAAGCATTAGTAGAAATTTGTACAGAAATGGAAAAGGAAGGA
AAAATTTCAAAAATTGGGCCTGAAAATCCATACAATACTCCAGTATTTGCCATAAAGAAA
AAAGACAGTACTAAATGGAGAAAATTAGTAGATTTCAGAGAACTTAATAAGAGAACTCAA
GATTTCTGGGAAGTTCAATTAGGAATACCACATCCTGCAGGGTTAAAACAGAAAAAATCA
GTAACAGTACTGGATGTGGGCGATGCATATTTTTCAGTTCCCTTAGATAAAGACTTCAGG
AAGTATACTGCATTTACCATACCTAGTATAAACAATGAGACACCAGGGATTAGATATCAG
TACAATGTGCTTCCACAGGGATGGAAAGGATCACCAGCAATATTCCAGTGTAGCATGACA
AAAATCTTAGAGCCTTTTAGAAAACAAAATCCAGACATAGTCATCTATCAATACATGGAT
GATTTGTATGTAGGATCTGACTTAGAAATAGGGCAGCATAGAACAAAAATAGAGGAACTG
AGACAACATCTGTTGAGGTGGGGATTTACCACACCAGACAAAAAACATCAGAAAGAACCT
CCATTCCTTTGGATGGGTTATGAACTCCATCCTGATAAATGGACAGTACAGCCTATAGTG
CTGCCAGAAAAGGACAGCTGGACTGTCAATGACATACAGAAATTAGTGGGAAAATTGAAT
TGGGCAAGTCAGATTTATGCAGGGATTAAAGTAAGGCAATTATGTAAACTTCTTAGGGGA
ACCAAAGCACTAACAGAAGTAGTACCACTAACAGAAGAAGCAGAGCTAGAACTGGCAGAA
AACAGGGAGATTCTAAAAGAACCGGTACATGGAGTGTATTATGACCCATCAAAAGACTTA
ATAGCAGAAATACAGAAGCAGGGGCAAGGCCAATGGACATATCAAATTTATCAAGAGCCA
TTTAAAAATCTGAAAACAGGAAAATATGCAAGAATGAAGGGTGCCCACACTAATGATGTG
AAACAATTAACAGAGGCAGTACAAAAAATAGCCACAGAAAGCATAGTAATATGGGGAAAG
ACTCCTAAATTTAAATTACCCATACAAAAGGAAACATGGGAAGCATGGTGGACAGAGTAT
TGGCAAGCCACCTGGATTCCTGAGTGGGAGTTTGTCAATACCCCTCCCTTAGTGAAGTTA
TGGTACCAGTTAGAGAAAGAACCCATAATAGGAGCAGAAACTTTCTATGTAGATGGGGCA
GCCAATAGGGAAACTAAATTAGGAAAAGCAGGATATGTAACTGACAGAGGAAGACAAAAA
GTTGTCCCCCTAACGGACACAACAAATCAGAAGACTGAGTTACAAGCAATTCATCTAGCT
TTGCAGGATTCGGGATTAGAAGTAAACATAGTGACAGACTCACAATATGCATTGGGAATC
ATTCAAGCACAACCAGATAAGAGTGAATCAGAGTTAGTCAGTCAAATAATAGAGCAGTTA
ATAAAAAAGGAAAAAGTCTACCTGGCATGGGTACCAGCACACAAAGGAATTGGAGGAAAT
GAACAAGTAGATGGGTTGGTCAGTGCTGGAATCAGGAAAGTACTATTTTTAGATGGAATA
GATAAGGCCCAAGAAGAACATGAGAAATATCACAGTAATTGGAGAGCAATGGCTAGTGAT
TTTAACCTACCACCTGTAGTAGCAAAAGAAATAGTAGCCAGCTGTGATAAATGTCAGCTA
AAAGGGGAAGCCATGCATGGACAAGTAGACTGTAGCCCAGGAATATGGCAGCTAGATTGT
ACACATTTAGAAGGAAAAGTTATCTTGGTAGCAGTTCATGTAGCCAGTGGATATATAGAA
GCAGAAGTAATTCCAGCAGAGACAGGGCAAGAAACAGCATACTTCCTCTTAAAATTAGCA
GGAAGATGGCCAGTAAAAACAGTACATACAGACAATGGCAGCAATTTCACCAGTACTACA
GTTAAGGCCGCCTGTTGGTGGGCGGGGATCAAGCAGGAATTTGGCATTCCCTACAATCCC
CAAAGTCAAGGAGTAATAGAATCTATGAATAAAGAATTAAAGAAAATTATAGGACAGGTA
AGAGATCAGGCTGAACATCTTAAGACAGCAGTACAAATGGCAGTATTCATCCACAATTTT
AAAAGAAAAGGGGGGATTGGGGGGTACAGTGCAGGGGAAAGAATAGTAGACATAATAGCA
ACAGACATACAAACTAAAGAATTACAAAAACAAATTACAAAAATTCAAAATTTTCGGGTT
TATTACAGGGACAGCAGAGATCCAGTTTGGAAAGGACCAGCAAAGCTCCTCTGGAAAGGT
GAAGGGGCAGTAGTAATACAAGATAATAGTGACATAAAAGTAGTGCCAAGAAGAAAAGCA
AAGATCATCAGGGATTATGGAAAACAGATGGCAGGTGATGATTGTGTGGCAAGTAGACAG
GATGAGGATTAA

# Drug_Target_29_General_Function:
Involved in RNA binding

# Drug_Target_29_General_References:
2200122	Erickson J, Neidhart DJ, VanDrie J, Kempf DJ, Wang XC, Norbeck DW, Plattner JJ, Rittenhouse JW, Turon M, Wideburg N, et al.: Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease. Science. 1990 Aug 3;249(4968):527-33.
2201682	Fitzgerald PM, McKeever BM, VanMiddlesworth JF, Springer JP, Heimbach JC, Leu CT, Herber WK, Dixon RA, Darke PL: Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution. J Biol Chem. 1990 Aug 25;265(24):14209-19.
2548279	Wlodawer A, Miller M, Jaskolski M, Sathyanarayana BK, Baldwin E, Weber IT, Selk LM, Clawson L, Schneider J, Kent SB: Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science. 1989 Aug 11;245(4918):616-21.
7929352	Chen Z, Li Y, Chen E, Hall DL, Darke PL, Culberson C, Shafer JA, Kuo LC: Crystal structure at 1.9-A resolution of human immunodeficiency virus (HIV) II protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases. J Biol Chem. 1994 Oct 21;269(42):26344-8.
7966331	Massiah MA, Starich MR, Paschall C, Summers MF, Christensen AM, Sundquist WI: Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J Mol Biol. 1994 Nov 25;244(2):198-223.
8610175	Hill CP, Worthylake D, Bancroft DP, Christensen AM, Sundquist WI: Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3099-104.
8623533	Welker R, Kottler H, Kalbitzer HR, Krausslich HG: Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology. 1996 May 1;219(1):228-36.
8977101	Bujacz G, Alexandratos J, Qing ZL, Clement-Mella C, Wlodawer A: The catalytic domain of human immunodeficiency virus integrase: ordered active site in the F185H mutant. FEBS Lett. 1996 Dec 2;398(2-3):175-8.
8980234	Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, Sundquist WI, Hill CP: Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell. 1996 Dec 27;87(7):1285-94.
9228950	Cai M, Zheng R, Caffrey M, Craigie R, Clore GM, Gronenborn AM: Solution structure of the N-terminal zinc binding domain of HIV-1 integrase. Nat Struct Biol. 1997 Jul;4(7):567-77.
9346481	Gamble TR, Yoo S, Vajdos FF, von Schwedler UK, Worthylake DK, Wang H, McCutcheon JP, Sundquist WI, Hill CP: Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science. 1997 Oct 31;278(5339):849-53.
9689049	Goldgur Y, Dyda F, Hickman AB, Jenkins TM, Craigie R, Davies DR: Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9150-4.
9878383	Turner BG, Summers MF: Structural biology of HIV. J Mol Biol. 1999 Jan 8;285(1):1-32.

# Drug_Target_29_HGNC_ID:
Not Available

# Drug_Target_29_HPRD_ID:
Not Available

# Drug_Target_29_ID:
2237

# Drug_Target_29_Locus:
Not Available

# Drug_Target_29_Molecular_Weight:
161691

# Drug_Target_29_Name:
Gag-Pol polyprotein

# Drug_Target_29_Number_of_Residues:
1435

# Drug_Target_29_PDB_ID:
1VRU

# Drug_Target_29_Pathway:
Not Available

# Drug_Target_29_Pfam_Domain_Function:
PF00075	RnaseH
PF00077	RVP
PF00078	RVT_1
PF00098	zf-CCHC
PF00540	Gag_p17
PF00552	Integrase
PF00607	Gag_p24
PF00665	rve
PF02022	Integrase_Zn
PF06815	RVT_connect
PF06817	RVT_thumb

# Drug_Target_29_Protein_Sequence:
>Gag-Pol polyprotein
MGARASVLSGGELDKWEKIRLRPGGKKQYKLKHIVWASRELERFAVNPGLLETSEGCRQI
LGQLQPSLQTGSEELRSLYNTIAVLYCVHQRIDVKDTKEALDKIEEEQNKSKKKAQQAAA
DTGNNSQVSQNYPIVQNLQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGAT
PQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRLHPVHAGPIAPGQMREPRGSDIAGTT
STLQEQIGWMTHNPPIPVGEIYKRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVDRF
YKTLRAEQASQEVKNWMTETLLVQNANPDCKTILKALGPGATLEEMMTACQGVGGPGHKA
RVLAEAMSQVTNPATIMIQKGNFRNQRKTVKCFNCGKEGHIAKNCRAPRKKGCWKCGKEG
HQMKDCTERQANFLREDLAFPQGKAREFSSEQTRANSPTRRELQVWGRDNNSLSEAGADR
QGTVSFSFPQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGG
FIKVGQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVPVKLK
PGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRK
LVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIP
SINNETPGIRYQYNVLPQGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDL
EIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWT
VNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEP
VHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQ
KIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEP
IIGAETFYVDGAANRETKLGKAGYVTDRGRQKVVPLTDTTNQKTELQAIHLALQDSGLEV
NIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDGLVS
AGIRKVLFLDGIDKAQEEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQ
VDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTV
HTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVIESMNKELKKIIGQVRDQAEHLK
TAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRDP
VWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED

# Drug_Target_29_Reaction:
deoxynucleoside triphosphate + DNAn = diphosphate + DNAn+1

# Drug_Target_29_Signals:
None

# Drug_Target_29_Specific_Function:
Integrase performs the integration of the newly synthesized dsDNA copy of the viral genome into the host chromosome. The integrated DNA is called provirus

# Drug_Target_29_SwissProt_ID:
P12497

# Drug_Target_29_SwissProt_Name:
POL_HV1N5

# Drug_Target_29_Synonyms:
Pr160Gag-Pol

# Drug_Target_29_Theoretical_pI:
8.83

# Drug_Target_29_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
RNA-directed RNA polymerase 3D-POL:Host cytoplasmic vesicle membrane

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
L24917

# Drug_Target_2_GenBank_ID_Protein:
409464

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
Not Available

# Drug_Target_2_Gene_Sequence:
>6462 bp
ATGGGCGCTCAAGTATCTAGACAGAATGTTGGTACGCACTCAACACAAAATATGGTGTCA
AATGGATCCAGCCTCAATTATTTTAACATTAATTATTTCAAAGATGCAGCTTCCAGTGGT
GCTTCTCGATTGGACTTCTCTCAAGACCCCAGTAAATTCACAGACCCAGTTAAGGATGTG
TTGGAGAAAGGCATACCCACTCTGCAATCTCCAAGTGTAGAAGCTTGTGGATACTCTGAT
AGAATAATCCAAATTACAAGAGGCGACTCAACCATAACATCTCAAGATGTTGCTAATGCA
GTGGTTGGGTATGGGGTATGGCCACACTACCTAACTCCGCAGGATGCAACGGCTATAGAC
AAGCCAACACAACCAGATACATCATCAAATAGGTTTTACACACTGGATAGTAAAATGTGG
AACAGTACCTCCAAAGGTTGGTGGTGGAAACTACCAGATGCTCTTAAAGACATGGGTATT
TTTGGTGAAAATATGTTTTATCATTTCTTGGGTAGAAGTGGTTATACAGTGCACGTACAG
TGCAATGCAAGTAAATTCCACCAGGGTACACTACTAGTGGTTATGATACCAGAACACCAG
TTAGCTACAGTAAATAAAGGTAATGTTAATGCAGGTTACAAATACACACATCCTGGTGAA
GCTGGTAGAGAAGTGGGTACACAAGTTGAAAATGAGAAACAACCTAGTGATGATAATTGG
CTAAATTTTGATGGTACATTATTGGGCAATTTACTGATATTCCCACACCAGTTTATTAAC
TTAAGGAGCAATAACTCAGCAACTCTTATAGTACCATATGTTAATGCTGTTCCAATGGAT
TCTATGGTTAGACATAACAATTGGAGTTTGGTAATAATACCAGTTTGTCAACTACAAAGC
AACAATATATCCAACATTGTTCCCATCACTGTTTCCATTAGCCCAATGTGTGCTGAATTC
TCTGGAGCACGTGCCAAAACAGTTGTGCAAGGTCTACCAGTATATGTTACACCAGGATCA
GGACAATTCATGACAACAGATGATATGCAATCTCCATGTGCACTGCCTTGGTACCATCCA
ACAAAAGAGATCTTTATACCAGGAGAGGTTAAGAACTTGATTGAAATGTGTCAGGTGGAT
ACACTCATACCAATAAATAGCACACAGTCTAACATTGGCAATGTCAGCATGTACACAGTA
ACTCTATCACCACAAACAAAATTAGCTGAAGAAATTTTTGCAATTAAAGTAGATATTGCC
TCACATCCCTTAGCCACAACCCTCATTGGTGAGATAGCAAGTTACTTTACACACTGGACA
GGGAGCCTGCGATTCAGTTTCATGTTTTGCGGGACTGCAAACACTACCTTAAAAGTTTTG
CTAGCATATACACCCCCAGGGATTGGTAAGCCTAGAAGTAGAAAGGAAGCAATGTTAGGG
ACACACGTGGTGTGGGATGTAGGTTTACAATCTACAGTGTCATTGGTTGTACCATGGATC
AGTGCCAGTCAGTATAGATTCACTACACCAGACACATACTCCTCAGCAGGCTACATTACA
TGCTGGTATCAAACTAATTTTGTTGTTCCACCAAACACACCTAACACTGCTGAGATGTTG
TGTTTTGTATCTGGATGCAACCACTTTTGCCTTCGGATGGCAAGAGACACAGACCTGCAC
AAGCAAACAGGACCAATAACACAAAATCCAGTGGAAAGATATGTAGATGAAGTCTTAAAT
GAAGTGTTAGTAGTGCCCAATATTAATCAGAGCCACCCTACCACATCAAATGCAGCCCCA
GTTTTGGATGCTGCTGAAACAGGACATACCAATAAGATACAGCCAGAAGACACTATAGAA
ACCAGATATGTGCAATCTTCACAGACATTGGATGAAATGAGTGTGGAAAGCTTCCTAGGC
AGATCGGGGTGCATCCATGAATCAGTGTTGGATATTGTGGACAATTACAATGATCAAAGT
TTCACTAAATGGAACATAAACCTGCAAGAAATGGCACAAATTAGAAGAAAATTTGAAATG
TTTACTTATGCAAGATTTGACTCTGAAATTACTATGGTACCAAGTGTAGCAGCCAAAGAT
GGTCACATTGGTCATATAGTCATGCAATATATGTATGTACCACCAGGAGCACCTATACCA
ACAACTAGAGATGACTATGCTTGGCAATCTGGAACAAATGCATCTGTATTTTGGCAGCAT
GGGCAACCTTTCCCTCGCTTTTCACTTCCCTTTTTGAGTATTGCATCAGCATATTACATG
TTTTATGATGGTTATGATGGAGACACATATAAATCCAGATATGGAACTGTAGTCACCAAT
GACATGGGAACTTTGTGTTCGCGTATTGTGACCAGTGAGCAATTACACAAAGTCAAAGTG
GTAACAAGGATATATCACAAAGCCAAACACACCAAAGCTTGGTGCCCAAGACCACCCAGA
GCTGTTCAATACTCACATACACATACCACCAACTACAAATTGAGTTCAGAAGTACACAAT
GATGTGGCTATAAGACCTAGAACAAATCTAACAACTGTTGGGCCTAGTGACATGTATGTG
CATGTTGGTAATCTAATATACAGAAATCTACATTTATTTAACTCTGACATACATGATTCC
ATTTTAGTGTCTTATTCATCAGATTTAATCATATACCGAACAAGCACACAAGGTGATGGT
TATATTCCAACATGTAATTGCACTGAAGCTACATATTACTGCAAACACAAAAACAGGTAC
TACCCAATTAATGTCACACCTCATGACTGGTATGAGATACAAGAGAGTGAATATTATCCA
AAACATATCCAGTACAATTTACTAATAGGTGAAGGACCATGTGAACCAGGTGATTGTGGT
GGGAAATTATTATGCAAACATGGAGTGATAGGTATTATTACAGCAGGTGGTGAGGGCCAT
GTTGCATTCATAGATCTTAGACACTTTCACTGTGCTGAAGAACAAGGAATCACTGATTAC
ATACACATGCTCGGTGAAGCTTTTGGTAGTGGATTTGTAGATAGTGTTAAAGACCAGATT
AATTCAATAAATCCCATCAATAACATTAGCAGTAAGATGGTTAAATGGATGTTAAGAATT
ATATCAGCTATGGTTATAATTATTAGAAACTCTTCAGATCCGCAAACAATAATTGCCACT
TTAACACTGATTGGATGCAATGGTTCTCCTTGGAGATTTCTCAAAGAAAAGTTCTGTAAA
TGGACTCAATTAACTTATATACACAAAGAATCAGATTCATGGCTCAAAAAATTCACTGAG
ATGTGTAATGCAGCTAGGGGGCTAGAATGGATTGGAAACAAAATATCCAAATTTATCGAT
TGGATGAAATCAATGCTACCCCAGGCACAATTAAAAGTTAAGTATTTGAGTGAACTTAAG
AAACTCAACTTTCTGGAGAAACAGGTTGAAAATCTCAGAGCAGCTGATACTAACACTCAA
GAAAAAATCAAGTGTGAGATAGATACATTGCATGACTTATCCTGTAAGTTTTTACCTCTG
TATGCCAGTGAAGCAAAGAGAATTAAAGTGTTGTATCACAAGTGCACTAACATAATTAAA
CAGAAGAAGAGAAGTGAACCTGTAGCAGTTATGATACACGGGCCTCCTGGGACCGGAAAA
TCAATCACTACAAGCTTCCTGGCTAGAATGATTACTAATGAGAGTGACATATACTCACTT
CCACCAGACCCTAAATATTTTGATGGTTATGATAACCAGAGTGTAGTAATAATGGATGAC
ATCATGCAAAACCCTGGTGGTGAGGACATGACATTATTCTGTCAGATGGTATCTAGTGTG
ACTTTTATACCCCCAATGGCTGATCTACCAGATAAGGGAAAACCCTTTGATTCTAGATTT
GTATTGTGTAGTACTAATCACTCACTCTTGGCACCCCCAACTATATCGTCGCTCCCAGCA
ATGAATAGAAGATTCTATTTAGATTTAGATATTCTTGTGCATGATAACTACAAAGATAAT
CAGGGTAAGTTAGATGTTTCTAGAGCATTTCGGCTATGTGATGTTGATTCAAAGATTGGA
AATGCAAAATGTTGTCCATTTGTATGTGGCAAGGCAGTGACATTCAAGGACCGCAACACA
TGTAGAACTTATTCACTTTCCCAAATATACAACCAAATTCTTGAGGAAGACAAGAGAAGG
AGACAGGTGGTTGATGTCATGTCTGCAATTTTCCAAGGGCCTATATCCATGGATAAACCC
CCACCACCAGCTATAACAGACCTTTTACGCTCAGTAAGGACACCAGAAGTAATTAAGTAC
TGCCAAGACAATAAATGGATAGTTCCTGCGGACTGCCAAATTGAAAGGGATCTGAATATA
GCTAATAGCATAATCACAATCATAGCTAATATCATCAGTATAGCAGGGATTATATATATA
ATTTATAAGCTCTTTTGCTCTCTACAGGGCCCTTACTCGGGGGAGCCCAAACCTAAGACA
AAAGTTCCCGAGAGAAGAGTGGTAGCTCAAGGTCCAGAAGAAGAATTTGGAATGTCTATT
ATTAAAAATAATACCTGTGTTGTGACCACAACAAATGGAAAATTTACAGGATTAGGCATT
TATGACAGAATCTTAATATTACCAACACATGCTGACCCGGGCAGTGAAATTCAAGTAAAT
GGAATACACACCAAAGTGCTTGATTCTTATGACTTATTTAATAAGGAAGGTGTCAAGTTG
GAAATTACTGTGCTAAAGTTAGATAGAAATGAGAAGTTCAGGGATATACGTAAGTACATA
CCTGAATCAGAAGATGACTATCCTGAATGCAACCTAGCACTAGTGGCCAATCAAACAGAA
CCAACTATAATCAAAGTAGGGGATGTTGTGTCTTATGGTAATATATTACTTAGTGGCACA
CAGACAGCCAGAATGCTTAAATATAACTATCCTACAAAATCTGGGTATTGTGGTGGTGTG
TTATACAAGATTGGCCAGATCTTAGGTATACATGTGGGTGGCAATGGTAGAGATGGGTTT
TCATCTATGCTATTGAGATCATACTTCACTGAACAACAAGGCCAAATTCAAATCTCTAAA
CATGTTAAAGATGTTGGCTTACCCTCAATACATACGCCAACTAAAACTAAATTGCAGCCA
AGTGTCTTCTATGACATTTTTCCAGGCAGTAAGGAACCAGCAGTCCTCACAGAAAAAGAT
CCTAGATTGAAAGTGGACTTTGACTCAGCTCTTTTTTCAAAATACAAAGGTAACACAGAG
TGCAGTTTGAATGAACATATACAAGTTGCAGTAGCACACTACTCAGCTCAGCTAGCAACA
CTAGATATAGATCCACAACCAATTGCAATGGAAGATAGTGTTTTTGGAATGGATGGCTTG
GAAGCTTTGGATCTGAATACTAGTGCAGGTTATCCCTATGTAACACTAGGAATTAAAAAG
AAAGATCTTATTAATAACAAGACTAAAGATATTTCCAAACTTAAGCTAGCATTAGACAAA
TATGATGTTGATTTGCCCATGATTACTTTCTTAAAAGATGAACTTAGAAAGAAGGATAAG
ATAGCAGCAGGCAAAACCAGAGTTATAGAAGCTAGTAGTATAAATGATACCATTTTGTTT
AGAACAGTTTATGGAAACCTATTTTCTAAATTTCACTTGAACCCAGGAGTGGTAACAGGC
TGTGCAGTTGGATGTGATCCAGAAACCTTTTGGTCTAAAATTCCCTTGATGTTAGATGGA
GATTGCATCATGGCTTTTGATTATACAAATTATGATGGTAGCATTCATCCAATTTGGTTT
AAAGCTCTCGGGATGGTACTTGATAATTTATCCTTTAACCCTACTCTAATCAATAGACTT
TGTAACTCAAAACATATTTTCAAGTCCACATATTATGAAGTTGAAGGTGGTGTGCCCTCT
GGTTGTTCTGGAACTAGTATATTTAACTCAATGATTAATAATATAATCATTAGAACCTTA
GTTTTGGATGCATATAAACATATTGATTTAGATAAACTTAAAATAATTGCCTATGGTGAT
GATGTGATCTTTTCTTACAAGTATAAACTAGACATGGAAGCCATAGCCAAGGAAGGGCAG
AAATATGGACTTACTATAACACCTGCAGATAAATCTAGTGAATTCAAAGAACTTGATTAT
GGAAATGTAACTTTTCTTAAAAGAGGATTTAGACAAGATGATAAATACAAATTTTTGATA
CATCCTACTTTTCCAGTTGAAGAGATTTATGAGTCCATTAGATGGACAAAGAAACCATCT
CAAATGCAGGAGCATGTCTTATCCTTGTGTCACTTAATGTGGCACAATGGTCCTGAGATT
TATAAGGACTTTGAAACAAAGATACGCAGTGTCAGCGCTGGACGTGCACTGTATATCCCT
CCTTATGAACTCCTAAGACATGAATGGTATGAAAAATTCTAG

# Drug_Target_2_General_Function:
Involved in ATP binding

# Drug_Target_2_General_References:
7732663	Lee WM, Wang W, Rueckert RR: Complete sequence of the RNA genome of human rhinovirus 16, a clinically useful common cold virus belonging to the ICAM-1 receptor group. Virus Genes. 1995 Jan;9(2):177-81.
7915182	Oliveira MA, Zhao R, Lee WM, Kremer MJ, Minor I, Rueckert RR, Diana GD, Pevear DC, Dutko FJ, McKinlay MA, et al.: The structure of human rhinovirus 16. Structure. 1993 Sep 15;1(1):51-68.
9083115	Hadfield AT, Lee W, Zhao R, Oliveira MA, Minor I, Rueckert RR, Rossmann MG: The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle. Structure. 1997 Mar 15;5(3):427-41.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6520

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
242242.1

# Drug_Target_2_Name:
Genome polyprotein

# Drug_Target_2_Number_of_Residues:
2153

# Drug_Target_2_PDB_ID:
1XR7

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00073	Rhv
PF00548	Peptidase_C3
PF00680	RdRP_1
PF00910	RNA_helicase
PF00947	Pico_P2A
PF01552	Pico_P2B
PF02226	Pico_P1A
PF08727	P3A

# Drug_Target_2_Protein_Sequence:
>Genome polyprotein
MGAQVSRQNVGTHSTQNMVSNGSSLNYFNINYFKDAASSGASRLDFSQDPSKFTDPVKDV
LEKGIPTLQSPSVEACGYSDRIIQITRGDSTITSQDVANAVVGYGVWPHYLTPQDATAID
KPTQPDTSSNRFYTLDSKMWNSTSKGWWWKLPDALKDMGIFGENMFYHFLGRSGYTVHVQ
CNASKFHQGTLLVVMIPEHQLATVNKGNVNAGYKYTHPGEAGREVGTQVENEKQPSDDNW
LNFDGTLLGNLLIFPHQFINLRSNNSATLIVPYVNAVPMDSMVRHNNWSLVIIPVCQLQS
NNISNIVPITVSISPMCAEFSGARAKTVVQGLPVYVTPGSGQFMTTDDMQSPCALPWYHP
TKEIFIPGEVKNLIEMCQVDTLIPINSTQSNIGNVSMYTVTLSPQTKLAEEIFAIKVDIA
SHPLATTLIGEIASYFTHWTGSLRFSFMFCGTANTTLKVLLAYTPPGIGKPRSRKEAMLG
THVVWDVGLQSTVSLVVPWISASQYRFTTPDTYSSAGYITCWYQTNFVVPPNTPNTAEML
CFVSGCKDFCLRMARDTDLHKQTGPITQNPVERYVDEVLNEVLVVPNINQSHPTTSNAAP
VLDAAETGHTNKIQPEDTIETRYVQSSQTLDEMSVESFLGRSGCIHESVLDIVDNYNDQS
FTKWNINLQEMAQIRRKFEMFTYARFDSEITMVPSVAAKDGHIGHIVMQYMYVPPGAPIP
TTRDDYAWQSGTNASVFWQHGQPFPRFSLPFLSIASAYYMFYDGYDGDTYKSRYGTVVTN
DMGTLCSRIVTSEQLHKVKVVTRIYHKAKHTKAWCPRPPRAVQYSHTHTTNYKLSSEVHN
DVAIRPRTNLTTVGPSDMYVHVGNLIYRNLHLFNSDIHDSILVSYSSDLIIYRTSTQGDG
YIPTCNCTEATYYCKHKNRYYPINVTPHDWYEIQESEYYPKHIQYNLLIGEGPCEPGDCG
GKLLCKHGVIGIITAGGEGHVAFIDLRHFHCAEEQGITDYIHMLGEAFGSGFVDSVKDQI
NSINPINNISSKMVKWMLRIISAMVIIIRNSSDPQTIIATLTLIGCNGSPWRFLKEKFCK
WTQLTYIHKESDSWLKKFTEMCNAARGLEWIGNKISKFIDWMKSMLPQAQLKVKYLSELK
KLNFLEKQVENLRAADTNTQEKIKCEIDTLHDLSCKFLPLYASEAKRIKVLYHKCTNIIK
QKKRSEPVAVMIHGPPGTGKSITTSFLARMITNESDIYSLPPDPKYFDGYDNQSVVIMDD
IMQNPGGEDMTLFCQMVSSVTFIPPMADLPDKGKPFDSRFVLCSTNHSLLAPPTISSLPA
MNRRFYLDLDILVHDNYKDNQGKLDVSRAFRLCDVDSKIGNAKCCPFVCGKAVTFKDRNT
CRTYSLSQIYNQILEEDKRRRQVVDVMSAIFQGPISMDKPPPPAITDLLRSVRTPEVIKY
CQDNKWIVPADCQIERDLNIANSIITIIANIISIAGIIYIIYKLFCSLQGPYSGEPKPKT
KVPERRVVAQGPEEEFGMSIIKNNTCVVTTTNGKFTGLGIYDRILILPTHADPGSEIQVN
GIHTKVLDSYDLFNKEGVKLEITVLKLDRNEKFRDIRKYIPESEDDYPECNLALVANQTE
PTIIKVGDVVSYGNILLSGTQTARMLKYNYPTKSGYCGGVLYKIGQILGIHVGGNGRDGF
SSMLLRSYFTEQQGQIQISKHVKDVGLPSIHTPTKTKLQPSVFYDIFPGSKEPAVLTEKD
PRLKVDFDSALFSKYKGNTECSLNEHIQVAVAHYSAQLATLDIDPQPIAMEDSVFGMDGL
EALDLNTSAGYPYVTLGIKKKDLINNKTKDISKLKLALDKYDVDLPMITFLKDELRKKDK
IAAGKTRVIEASSINDTILFRTVYGNLFSKFHLNPGVVTGCAVGCDPETFWSKIPLMLDG
DCIMAFDYTNYDGSIHPIWFKALGMVLDNLSFNPTLINRLCNSKHIFKSTYYEVEGGVPS
GCSGTSIFNSMINNIIIRTLVLDAYKHIDLDKLKIIAYGDDVIFSYKYKLDMEAIAKEGQ
KYGLTITPADKSSEFKELDYGNVTFLKRGFRQDDKYKFLIHPTFPVEEIYESIRWTKKPS
QMQEHVLSLCHLMWHNGPEIYKDFETKIRSVSAGRALYIPPYELLRHEWYEKF

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
RNA-directed RNA polymerase 3D-POL replicates genomic and antigenomic RNA by recognizing replications specific signals (By similarity)

# Drug_Target_2_SwissProt_ID:
Q82122

# Drug_Target_2_SwissProt_Name:
POLG_HRV16

# Drug_Target_2_Synonyms:
P1A
P1B
P1C
P1D
P2A
P2B
P2C
P3A
P3B
P3C
P3D-POL
Picornain 2A
Picornain 3C
Protease 3C
Protein 2A
Protein 2B
Protein 2C
Protein 3A
Protein 3B
Protein VP0
Protein VP1
Protein VP2
Protein VP3
Protein VP4
RNA-directed RNA polymerase 3D-POL
VP4-VP2
VPg
Virion protein 1
Virion protein 2
Virion protein 3
Virion protein 4

# Drug_Target_2_Theoretical_pI:
7.10

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_30_Cellular_Location:
Not Available

# Drug_Target_30_Chromosome_Location:
Not Available

# Drug_Target_30_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_30_Essentiality:
Non-Essential

# Drug_Target_30_GenAtlas_ID:
Not Available

# Drug_Target_30_GenBank_ID_Gene:
AB126656

# Drug_Target_30_GenBank_ID_Protein:
Not Available

# Drug_Target_30_GeneCard_ID:
Not Available

# Drug_Target_30_Gene_Name:
Not Available

# Drug_Target_30_Gene_Sequence:
>1626 bp
ATGGAGGGGGAAAGGATGAACGCGTTCCCAAGCACCATGATGGACGAGGAGCTGAACCTC
TGGGACTTTTTGGAGCGGGCGGCGGCGCTTTTCGGTAGGAAGGAGGTGGTCTCCCGCCTC
CACACCGGGGAGGTCCACCGCACCACCTACGCCGAGGTCTACCAAAGGGCCAGGAGGCTC
ATGGGGGGGCTTAGGGCCCTCGGGGTGGGCGTGGGGGACCGGGTGGCCACCCTGGGCTTC
AACCACTTCCGCCACCTCGAGGCCTACTTCGCCGTCCCCGGCATGGGGGCGGTGCTCCAC
ACCGCCAACCCCCGCCTCTCCCCCAAGGAGATCGCCTACATCCTGAACCACGCCGAGGAC
AAGGTCCTCCTCTTTGACCCCAACCTCCTGCCCCTGGTGGAGGCCATACGGGGCGAGCTC
AAGACGGTGCAGCACTTCGTGGTCATGGACGAGAAGGCCCCGGAGGGCTACCTGGCCTAC
GAGGAGGCCCTGGGGGAGGAGGCGGACCCCGTGCGGGTGCCGGAGCGGGCCGCCTGCGGC
ATGGCCTACACCACGGGGACCACGGGCCTCCCCAAGGGGGTGGTCTACAGCCACCGGGCT
TTGGTCCTCCACTCCCTGGCGGCAAGCCTCGTTGACGGCACCGCCCTCTCGGAGAAGGAC
GTGGTCTTGCCGGTGGTCCCCATGTTCCACGTGAACGCCTGGTGCCTGCCCTACGCCGCC
ACCCTGGTGGGGGCCAAACAGGTCCTGCCCGGGCCCAGGCTGGACCCCGCCTCCCTGGTG
GAGCTCTTTGACGGGGAGGGGGTGACCTTCACCGCCGGGGTGCCCACGGTCTGGCTCGCC
CTGGCGGACTACCTGGAAAGCACGGGCCACCGCCTGAAGACCCTGAGGCGGCTCGTGGTG
GGGGGCTCGGCCGCGCCCAGGAGCCTCATCGCCCGCTTTGAGCGGATGGGCGTGGAGGTG
CGCCAGGGCTACGGCCTCACCGAGACCTCCCCGGTGGTGGTGCAGAACTTCGTAAAAAGC
CACCTGGAGTCCCTCTCCGAGGAGGAGAAGCTCACCCTCAAGGCCAAGACGGGCCTCCCC
ATCCCCCTGGTGCGCCTAAGGGTGGCGGACGAGGAGGGCCGCCCCGTGCCCAAGGACGGG
AAGGCCCTGGGGGAGGTCCAGCTCAAGGGCCCCTGGATCACCGGGGGCTACTACGGAAAC
GAGGAGGCCACGCGGAGCGCCCTCACCCCGGACGGCTTCTTCCGCACCGGGGACATCGCC
GTCTGGGACGAGGAGGGGTACGTTGAGATCAAGGACCGGCTCAAGGACCTGATCAAGTCG
GGCGGGGAGTGGATCTCCAGCGTGGACCTGGAGAACGCCCTCATGGGCCACCCCAAGGTG
AAGGAGGCGGCGGTGGTGGCCATCCCCCACCCCAAGTGGCAGGAGAGGCCCCTGGCGGTG
GTGGTGCCCAGGGGCGAGAAGCCCACCCCGGAGGAGCTGAACGAGCACCTCCTAAAGGCC
GGCTTCGCCAAGTGGCAGCTCCCCGACGCCTACGTCTTCGCGGAGGAGATCCCGAGGACA
TCCGCGGGCAAGTTCCTCAAGCGGGCCTTAAGGGAGCAGTACAAGAACTACTACGGAGGC
GCCTGA

# Drug_Target_30_General_Function:
Involved in catalytic activity

# Drug_Target_30_General_References:
Not Available

# Drug_Target_30_HGNC_ID:
Not Available

# Drug_Target_30_HPRD_ID:
Not Available

# Drug_Target_30_ID:
4373

# Drug_Target_30_Locus:
Not Available

# Drug_Target_30_Molecular_Weight:
59572

# Drug_Target_30_Name:
Medium-chain-fatty-acid--CoA ligase

# Drug_Target_30_Number_of_Residues:
541

# Drug_Target_30_PDB_ID:
1V26

# Drug_Target_30_Pathway:
Not Available

# Drug_Target_30_Pfam_Domain_Function:
PF00501	AMP-binding

# Drug_Target_30_Protein_Sequence:
>Medium-chain-fatty-acid--CoA ligase
MEGERMNAFPSTMMDEELNLWDFLERAAALFGRKEVVSRLHTGEVHRTTYAEVYQRARRL
MGGLRALGVGVGDRVATLGFNHFRHLEAYFAVPGMGAVLHTANPRLSPKEIAYILNHAED
KVLLFDPNLLPLVEAIRGELKTVQHFVVMDEKAPEGYLAYEEALGEEADPVRVPERAACG
MAYTTGTTGLPKGVVYSHRALVLHSLAASLVDGTALSEKDVVLPVVPMFHVNAWCLPYAA
TLVGAKQVLPGPRLDPASLVELFDGEGVTFTAGVPTVWLALADYLESTGHRLKTLRRLVV
GGSAAPRSLIARFERMGVEVRQGYGLTETSPVVVQNFVKSHLESLSEEEKLTLKAKTGLP
IPLVRLRVADEEGRPVPKDGKALGEVQLKGPWITGGYYGNEEATRSALTPDGFFRTGDIA
VWDEEGYVEIKDRLKDLIKSGGEWISSVDLENALMGHPKVKEAAVVAIPHPKWQERPLAV
VVPRGEKPTPEELNEHLLKAGFAKWQLPDAYVFAEEIPRTSAGKFLKRALREQYKNYYGG
A

# Drug_Target_30_Reaction:
Not Available

# Drug_Target_30_Signals:
None

# Drug_Target_30_Specific_Function:
Not Available

# Drug_Target_30_SwissProt_ID:
Q6L8F0

# Drug_Target_30_SwissProt_Name:
Q6L8F0_THETH

# Drug_Target_30_Synonyms:
Not Available

# Drug_Target_30_Theoretical_pI:
6.47

# Drug_Target_30_Transmembrane_Regions:
None

# Drug_Target_31_Cellular_Location:
Golgi apparatus

# Drug_Target_31_Chromosome_Location:
Not Available

# Drug_Target_31_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_31_Essentiality:
Non-Essential

# Drug_Target_31_GenAtlas_ID:
TRAPPC3

# Drug_Target_31_GenBank_ID_Gene:
AJ224335

# Drug_Target_31_GenBank_ID_Protein:
Not Available

# Drug_Target_31_GeneCard_ID:
Not Available

# Drug_Target_31_Gene_Name:
TRAPPC3

# Drug_Target_31_Gene_Sequence:
>543 bp
ATGTCGAGGCAGGCGAACCGTGGCACCGAGAGCAAGAAAATGAGCTCTGAGCTCTTCACC
CTGACCTATGGTGCCCTGGTCACCCAGCTATGTAAGGACTATGAAAATGATGAAGATGTG
AATAAACAGCTGGACAAAATGGGCTTTAACATTGGAGTCCGGCTGATTGAAGATTTCTTG
GCTCGGTCAAATGTTGGGAGGTGCCATGACTTTCGGGAAACTGCGGATGTCATTGCCAAG
GTGGCGTTCAAGATGTACTTGGGCATCACTCCAAGCATTACTAATTGGAGCCCAGCTGGT
GATGAATTCTCCCTCATTTTGGAAAATAACCCCTTGGTGGACTTTGTGGAACTTCCTGAT
AACCACTCATCCCTTATTTATTCCAATCTCTTGTGTGGGGTGTTGCGGGGAGCTTTGGAG
ATGGTCCAGATGGCTGTGGAGGCCAAGTTTGTCCAGGACACCCTGAAAGGAGACGGTGTG
ACAGAAATCCGGATGAGATTCATCAGGCGGATTGAGGACAATCTTCCAGCTGGAGAGGAA
TAA

# Drug_Target_31_General_Function:
Not Available

# Drug_Target_31_General_References:
11805826	Gavin AC, Bosche M, Krause R, Grandi P, Marzioch M, Bauer A, Schultz J, Rick JM, Michon AM, Cruciat CM, Remor M, Hofert C, Schelder M, Brajenovic M, Ruffner H, Merino A, Klein K, Hudak M, Dickson D, Rudi T, Gnau V, Bauch A, Bastuck S, Huhse B, Leutwein C, Heurtier MA, Copley RR, Edelmann A, Querfurth E, Rybin V, Drewes G, Raida M, Bouwmeester T, Bork P, Seraphin B, Kuster B, Neubauer G, Superti-Furga G: Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature. 2002 Jan 10;415(6868):141-7.
9564032	Sacher M, Jiang Y, Barrowman J, Scarpa A, Burston J, Zhang L, Schieltz D, Yates JR 3rd, Abeliovich H, Ferro-Novick S: TRAPP, a highly conserved novel complex on the cis-Golgi that mediates vesicle docking and fusion. EMBO J. 1998 May 1;17(9):2494-503.

# Drug_Target_31_HGNC_ID:
HGNC:19942

# Drug_Target_31_HPRD_ID:
Not Available

# Drug_Target_31_ID:
5432

# Drug_Target_31_Locus:
1p34.3

# Drug_Target_31_Molecular_Weight:
20274

# Drug_Target_31_Name:
Trafficking protein particle complex subunit 3

# Drug_Target_31_Number_of_Residues:
180

# Drug_Target_31_PDB_ID:
1SZ7

# Drug_Target_31_Pathway:
Not Available

# Drug_Target_31_Pfam_Domain_Function:
PF04051	TRAPP_Bet3

# Drug_Target_31_Protein_Sequence:
>Trafficking protein particle complex subunit 3
MSRQANRGTESKKMSSELFTLTYGALVTQLCKDYENDEDVNKQLDKMGFNIGVRLIEDFL
ARSNVGRCHDFRETADVIAKVAFKMYLGITPSITNWSPAGDEFSLILENNPLVDFVELPD
NHSSLIYSNLLCGVLRGALEMVQMAVEAKFVQDTLKGDGVTEIRMRFIRRIEDNLPAGEE

# Drug_Target_31_Reaction:
Not Available

# Drug_Target_31_Signals:
None

# Drug_Target_31_Specific_Function:
May play a role in vesicular transport from endoplasmic reticulum to Golgi

# Drug_Target_31_SwissProt_ID:
O43617

# Drug_Target_31_SwissProt_Name:
TPPC3_HUMAN

# Drug_Target_31_Synonyms:
BET3 homolog

# Drug_Target_31_Theoretical_pI:
4.58

# Drug_Target_31_Transmembrane_Regions:
None

# Drug_Target_32_Cellular_Location:
Secreted

# Drug_Target_32_Chromosome_Location:
Not Available

# Drug_Target_32_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_32_Essentiality:
Non-Essential

# Drug_Target_32_GenAtlas_ID:
INS

# Drug_Target_32_GenBank_ID_Gene:
AJ009655

# Drug_Target_32_GenBank_ID_Protein:
Not Available

# Drug_Target_32_GeneCard_ID:
Not Available

# Drug_Target_32_Gene_Name:
INS

# Drug_Target_32_Gene_Sequence:
Not Available

# Drug_Target_32_General_Function:
Not Available

# Drug_Target_32_General_References:
12952878	Stead JD, Hurles ME, Jeffreys AJ: Global haplotype diversity in the human insulin gene region. Genome Res. 2003 Sep;13(9):2101-11.
503234	Bell GI, Swain WF, Pictet R, Cordell B, Goodman HM, Rutter WJ: Nucleotide sequence of a cDNA clone encoding human preproinsulin. Nature. 1979 Nov 29;282(5738):525-7.
6243748	Bell GI, Pictet RL, Rutter WJ, Cordell B, Tischer E, Goodman HM: Sequence of the human insulin gene. Nature. 1980 Mar 6;284(5751):26-32.
6248962	Ullrich A, Dull TJ, Gray A, Brosius J, Sures I: Genetic variation in the human insulin gene. Science. 1980 Aug 1;209(4456):612-5.
6927840	Sures I, Goeddel DV, Gray A, Ullrich A: Nucleotide sequence of human preproinsulin complementary DNA. Science. 1980 Apr 4;208(4439):57-9.
8358440	Lucassen AM, Julier C, Beressi JP, Boitard C, Froguel P, Lathrop M, Bell JI: Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat Genet. 1993 Jul;4(3):305-10.

# Drug_Target_32_HGNC_ID:
HGNC:6081

# Drug_Target_32_HPRD_ID:
Not Available

# Drug_Target_32_ID:
5961

# Drug_Target_32_Locus:
Not Available

# Drug_Target_32_Molecular_Weight:
11981

# Drug_Target_32_Name:
Insulin

# Drug_Target_32_Number_of_Residues:
110

# Drug_Target_32_PDB_ID:
Not Available

# Drug_Target_32_Pathway:
Glibenclamide Pathway	SMP00460
Gliclazide Pathway	SMP00461
Nateglinide Pathway	SMP00453
Repaglinide Pathway	SMP00454

# Drug_Target_32_Pfam_Domain_Function:
PF00049	Insulin

# Drug_Target_32_Protein_Sequence:
>Insulin
MALWMRLLPLLALLALWGPDPAAAFVNQHLCGSHLVEALYLVCGERGFFYTPKTRREAED
LQVGQVELGGGPGAGSLQPLALEGSLQKRGIVEQCCTSICSLYQLENYCN

# Drug_Target_32_Reaction:
Not Available

# Drug_Target_32_Signals:
1-24

# Drug_Target_32_Specific_Function:
Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver

# Drug_Target_32_SwissProt_ID:
P01308

# Drug_Target_32_SwissProt_Name:
INS_HUMAN

# Drug_Target_32_Synonyms:
Insulin precursor

# Drug_Target_32_Theoretical_pI:
5.01

# Drug_Target_32_Transmembrane_Regions:
None

# Drug_Target_33_Cellular_Location:
RNA-directed RNA polymerase 3D-POL:Host cytoplasmic vesicle membrane

# Drug_Target_33_Chromosome_Location:
Not Available

# Drug_Target_33_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_33_Essentiality:
Essential

# Drug_Target_33_GenAtlas_ID:
Not Available

# Drug_Target_33_GenBank_ID_Gene:
D00538

# Drug_Target_33_GenBank_ID_Protein:
221148

# Drug_Target_33_GeneCard_ID:
Not Available

# Drug_Target_33_Gene_Name:
Not Available

# Drug_Target_33_Gene_Sequence:
>6621 bp
ATGGGGGCTCAAGTTTCAACCCAAAAGACCGGTGCACACGAGAATCAAAACGTGGCAGCC
AATGGATCCACCATTAATTATACTACCATCAACTACTACAAAGACAGCGCGAGTAACTCC
GCTACTAGACAAGACCTCTCCCAAGATCCATCAAAATTCACAGAACCGGTTAAGGACTTA
ATGTTGAAAACAGCACCAGCTTTAAACTCGCCCAACGTGGAAGCATGTGGGTACAGTGAC
CGTGTGAGGCAAATCACTTTAGGTAACTCGACCATTACCACACAGGAAGCAGCTAATGCT
ATTGTTGCTTATGGTGAGTGGCCCACTTACATAAATGACTCAGAAGCTAATCCGGTAGAT
GCACCCACTGAACCAGACGTTAGTAGCAACCGTTTTTACACCCTGGAATCGGTGTCTTGG
AAGACCACTTCAAGGGGATGGTGGTGGAAGCTACCAGATTGTCTAAAAGATATGGGAATG
TTTGGTCAGAATATGTACTATCACTACTTAGGACGCTCTGGTTACACCATTCATGTCCAG
TGCAACGCTTCTAAGTTTCACCAAGGGGCGTTAGGAGTTTTCCTGATACCAGAGTTTGTC
ATGGCTTGCAACACTGAGAGTAAAACATCATATGTTTCATACATCAACGCAAATCCTGGT
GAAAGGGGCGGTGAGTTCACGAACACCTACAACCCATCAAACACTGATGTCAGTGAGGGC
AGACAGTTCGCAGCACTGGATTATCTGCTGGGTTCTGGTGTCCTAGCAGGAAACGCTTTC
GTATACCCGCACCAGATCATCAATTTGCGCACCAACAACAGTGCAACAATTGTGGTACCA
TATGTGAACTCGCTCGTGATTGATTGTATGGCAAAACACAATAACTGGGGTATTGTCATA
TTACCACTGGCACCCTTGGCCTTTGCCGCAACATCGTCACCACAGGTGCCTATTACAGTG
ACCATCGCACCCATGTGTACAGAATTTAATGGGTTGAGAAATATTACCATCCCAGTACAT
CAAGGGTTGCCAACAATGAACACACCTGGTTCCAATCAATTCCTTACATCTGATGACTTC
CAGTCGCCCTGTGCCTTACCTAATTTTGATGTTACTCCACCGATACACATACCCGGGGAA
GTGAAGAATATGATGGAACTAGCTGAAATTGACACACTGATCCCAATGAACGCAGTGGAC
GGGAAGGTGAACACAATGGAAATGTATCAAATACCATTGAATGACAATTTGAGCAAGGCA
CCTATATTCTGTCTATCTTTATCACCTGCTTCTGACAAACGACTGAGTCACACCATGTTG
GGTGAAATTCTAAATTATTACACTCATTGGACGGGGTCCATCAGGTTCACCTTTCTATTT
TGTGGTAGTATGATGGCCACTGGTAAACTGCTCCTCAGCTATTCCCCACCAGGAGCTAAA
CCACCAACCAATCGCAAGGATGCAATGCTAGGTACACACATCATCTGGGACCTAGGGTTA
CAATCCAGTTGTTCCATGGTTGCACCGTGGATCTCTAACACAGTGTACAGGCGGTGTGCA
CGTGATGACTTCACTGAGGGCGGGTTTATAACTTGCTTTTATCAAACTAGAATTGTTGTG
CCTGCTTCAACCCCCACCAGTATGTTCATGTTAGGCTTTGTTAGTGCGTGTCCAGATTTC
AGTGTCAGACTGCTTAGGGACACTTCCCATATTAGTCAATCAAAACTAATAGCACGCACA
CAAGGCATTGAAGACCTCATTGACACAGCGATAAAGAATGCCTTAAGAGTGTCCCAACCA
CTTCGGCCCAGTCAACTGAAGCAACCCAATGGAGTAAATAGCCAGGAGGTGCCAGCTCTA
ACTGCTGTGGAAACAGGAGCATCTGGTCAAGCGATCCCCAGTGATGTGGTGGAAACTAGA
CACGTGATAAATTACAAAACCAGGTCTGAATCGTGTCTTGAGTCATTCTTTGGGAGAGCT
GCGTGTGTCACAATCCTATCTCTGACCAACTCTTCCAAGAGCGGGGAGGAGAAGAAGCAT
TTCAACATATGGAACATTACATACACCGACACTGTTCAGTTACGCAGAAAATTGGAGTTT
TTCACGTATTCCAGGTTTGACCTTGAAATGACTTTTGTGTTCACAGAGAATTACCCTAGT
ACAGCCAGTGGGGAAGTGCGTAACCAATGTGACCAGATCATGTACATTCCACCAGGGGCA
CCCCGTCCATCATCCTGGGATGACTATACATGGCAATCCTCCTCTAACCCTTCCATCTTT
TACATGTATGGAAATGCACCTCCACGGATGTCAATTCCTTACGTGGGGATTGCCAATGCC
TATTCACACTTCTATGATGGCTTTGCACGGGTGCCACTTGAGGGTGAGAATACCGATGCT
GGTGACACGTTTTACGGCTTAGTGTCCATAAATGATTTTGGAGTTTTAGCAGTTAGAGCG
GTAAACCGCAGTAACCCACACACTATACACACATCTGTGAGAGTGTACATGAAACCAAAA
CACATTCGGTGTTGGTGCCCCAGACCTCCTCGGGCTGTATTATACAGGGGAGAGGGAGTG
GACATGATATCCAGTGCAATTCAACCTCTGACTAAAGTAGACTCAATTACCACTTTTGGG
TTTGGCCACCAGAACAAGGCAGTGTACGTTGCCGGTTACAAGATTTGTAACTACCACCTA
GCAACCCCAAGTGATCACTTGAATGCAATTAGTGTGTTATGGGACAGGGATTTAATGGTG
GTGGAATCTAGAGCCCAGGGAACTGATACCATTGCCAGGTGTAGTTGCAGGTGTGGAGTT
TACTATTGTGAATCTAGAAGGAAGTACTACCTTGTCACTTTCACTGGCCCAACGTTTCGA
TTTATGGAAGCAAATGACTACTATCCAGCAAGATACCAGTCTCACATGCTGATAGGGTGC
GGATTTGCAGAACCCGGGGACTGTGGTGGGATATTAAGGTGCACTCATGGGGTGATTGGT
ATCATCACTGCAGGGGGTGAAGGGATAGTAGCCTTTGCTGACATTAGAGACCTTTGGGTG
TATGAAGAGGAAGCCATGGAACAGGGAATAACAAGTTACATCGAATCCCTCGGTACAGCT
TTTGGTGCAGGGTTCACCCACACAATCAGTGAGAAAGTGACTGAGTTGACAACAATGGTC
ACCAGTACTATCACAGAAAAATTACTGAAAAATTTAGTGAAAATAGTATCGGCTCTAGTG
ATTGTTGTGAGAAATTATGAGGACACTACCACGATCCTTGCAACACTAGCATTACTTGGG
TGTGATATATCTCCTTGGCAATGGTTGAAGAAGAAGGCATGTGACTTACTAGAGATTCCT
CATGTGATGCGCCAAGGTGATGGGTGGATGAAGAAATTCACAGAGGCTTGCAATGCAGCT
AAAGGGCTTAGATGGGTCAGCAATAAAATTTCCAAGTTTGTAGATTGGTTGAAGTGTAAA
ATTATCCCAGAAGCTAAGGACAAGGTGGAATTTCTCACCAAGTTGAAACAGCTAGACATG
CTGGAAAATCAAATTGCAACCATCCACCAATCTTGCCCCAGCCAAGAACAACAAGAGATC
CTTTTCAACAACGTAAGATGGCTAGCAGTCCAGTCCCGTCGGTTCGCGCCATTATATGCT
GTGGAGGCACGCCGGATTAGCAAAATGGAGAGCACAATAAACAATTATATACAGTTCAAG
AGCAAACACCGTATTGAGCCAGTATGTATGCTCGTTCATGGGTCACCAGGGACGGGTAAG
GGTATAGCTAGCTCATTGATAGGTAGAGCAATAGCAGAGAGGGAAACCACATCGGTCTAC
TCAGTGCCACTGGCCCCATCTCACTTTGATGGCTATAAACAACAAGGGTATGATATGGAC
GACCTAAACCAAAACCCCGATGGTATGGACATGAAACTGTTTTGCCAAATGGTATCAACA
GTGGAGTTCATTCCTCCAATGGCCTCACTAGAGGAGAAGGGTATTTTGTTTACATCTGAT
TATGTCCTGGCTTCTACCAACTCTCACTCAATAGCACCACCCACAGTAGCTCATAGTGAT
GCCTTAACCAGACGATTTGCATTTGATGTGGAGGTTTACACGATGTCTGAACATTCAGTC
AAAGGCAAACTAAACATGGCCACAGCCACTCAGTTGTGTAAGGATTGTCCAACACCTGCA
AATTTCAAAAAGTGTTGCCCTCTCGTCTGTGGAAAGGCCTTGCAATTAATGGACAGGTAC
ACCAGACAGAGGTTCACTGTGGATGAGATTACCACATTAATCATGAATGAGAAAAACAGA
AGGGCCAACATTGGCAATTGTATGGAAGCCTTGTTTCAAGGACCACTGAGGTACAAAGAT
CTGAAGATTGATGTGAAGACAGTTCCCCCCCCTGAGTGCATCAGTGATTTATTACAAGCA
GTGGATTCTCAAGAGGTTAGGGATTACTGTGAGAAGAAAGGCTGGATCGTTAACGTTACT
AGCCAGATACAATTAGAAAGGAACATCAATAGGGCCATGACTATACTCCAAGCTGTTACC
ACATTTGCAGCAGTCGCAGGAGTAGTGTATGTAATGTACAAACTCTTCGCTGGCCAGCAG
GGTGCATACACTGGCTTGCCAAACAAAAAGCCCAATGTCCCTACTATCAGAATTGCTAAA
GTCCAGGGGCCAGGATTTGACTATGCAGTGGCAATGGCAAAAAGAAACATAGTTACTGCA
ACCACCACTAAGGGTGAATTTACCATGTTAGGGGTGCATGATAATGTAGCAATATTGCCA
ACCCATGCCGCTCCAGGAGAAACTATCATTGTTGATGGGAAAGAAGTGGAGATCCTAGAT
GCCAGAGCCTTAGAAGATCAAGCGGGAACCAACCTTGAGATTACCATTATTACTCTAAAA
AGAAATGAGAAATTTAGAGACATCAGACCACATATTCCCACCCAAATTACTGAAACTAAC
GATGGAGTGTTGATCGTGAACACTAGTAAGTACCCCAACATGTATGTCCCAGTTGGTGCT
GTGACTGAACAGGGATATCTTAATCTCAGTGGACGCCAAACTGCTCGTACTTTAATGTAC
AACTTTCCAACACGAGCAGGCCAGTGCGGAGGAATCATCACTTGTACTGGCAAAGTCATT
GGGATGCACGTTGGCGGGAACGGTTCACATGGGTTTGCAGCAGCCCTTAAGCGATCATAC
TTCACCCAAAATCAGGGCGAAATTCAATGGATGAGGTCATCAAAAGAAGTGGGGTACCCC
ATTATAAATGCCCCATCCAAGACAAAGTTAGAACCCAGTGCTTTTCACTATGTTTTTGAA
GGTGTTAAGGAACCAGCTGTGCTCACTAAAAATGACCCCAGACTAAAAACAGATTTTGAA
GAAGCCATCTTTTCAAAATACGTGGGGAACAAAATTACTGAAGTGGACGAATACATGAAA
GAAGCAGTGGATCACTATGCAGGACAGTTAATGTCACTGGATATCAACACAGAACAGATG
TGCCTGGAGGATGCCATGTACGGTACTGATGGTCTTGAAGCTCTGGATCTTAGCACTAGT
GCTGGATACCCTTATGTTGCAATGGGGAAAAAGAAAAGAGACATTCTAGACAAACAGACC
AGGGATACTAAAGAGATGCAGAGACTTTTGGACACCTATGGAATCAACCTACCATTAGTC
ACATACGTGAAAGATGAACTCAGATCAAAGACTAAAGTGGAACAAGGAAAGTCAAGGTTG
ATTGAAGCTTCCAGTCTTAATGATTCAGTTGCAATGAGAATGGCCTTTGGCAATCTTTAC
GCAGCTTTCCACAAGAATCCAGGCGTGGTGACAGGATCAGCAGTTGGTTGTGACCCAGAT
TTGTTTTGGAGCAAGATACCAGTGCTAATGGAAGAAAAACTCTTCGCTTTTGACTACACA
GGGTATGATGCCTCACTCAGCCCTGCTTGGTTTGAAGCTCTTAAAATGGTGTTAGAAAAG
ATTGGATTCGGCAATAGAGTAGACTACATAGACTACCTGAACCACTCTCACCACCTTTAT
AAAAACAAAACTTATTGTGTCAAAGGTGGCATGCCATCCGGCTGCTCTGGCACATCAATT
TTCAACTCAATGATTAATAACCTGATCATTAGGACGCTTTTACTGAGAACCTACAAGGGC
ATAGACTTGGACCACCTAAAAATGATTGCCTATGGTGATGACGTGATAGCTTCCTACCCC
CATGAGGTTGACGCTAGTCTCCTAGCCCAATCAGGAAAAGACTATGGACTGACCATGACT
CCAGCAGATAAATCAGCAACCTTTGAAACAGTCACATGGGAGAATGTAACATTCCTGAAA
AGATTTTTCAGAGCAGATGAGAAGTATCCATTCCTGGTGCATCCAGTGATGCCAATGAAA
GAAATTCACGAATCAATCAGATGGACCAAGGACCCTAGAAACACACAGGATCACGTACGC
TCATTGTGCCTATTGGCTTGGCATAACGGCGAAGAAGAATATAATAAATTTTTAGCTAAA
ATCAGAAGTGTGCCAATCGGAAGAGCTTTATTGCTCCCAGAGTACTCCACATTGTACCGC
CGATGGCTCGATTCATTTTAG

# Drug_Target_33_General_Function:
Involved in ATP binding

# Drug_Target_33_General_References:
2584950	Hughes PJ, North C, Minor PD, Stanway G: The complete nucleotide sequence of coxsackievirus A21. J Gen Virol. 1989 Nov;70 ( Pt 11):2943-52.

# Drug_Target_33_HGNC_ID:
Not Available

# Drug_Target_33_HPRD_ID:
Not Available

# Drug_Target_33_ID:
6748

# Drug_Target_33_Locus:
Not Available

# Drug_Target_33_Molecular_Weight:
246049.2

# Drug_Target_33_Name:
Genome polyprotein

# Drug_Target_33_Number_of_Residues:
2206

# Drug_Target_33_PDB_ID:
1RDR

# Drug_Target_33_Pathway:
Not Available

# Drug_Target_33_Pfam_Domain_Function:
PF00073	Rhv
PF00548	Peptidase_C3
PF00680	RdRP_1
PF00910	RNA_helicase
PF00947	Pico_P2A
PF01552	Pico_P2B
PF02226	Pico_P1A
PF08727	P3A

# Drug_Target_33_Protein_Sequence:
>Genome polyprotein
MGAQVSTQKTGAHENQNVAANGSTINYTTINYYKDSASNSATRQDLSQDPSKFTEPVKDL
MLKTAPALNSPNVEACGYSDRVRQITLGNSTITTQEAANAIVAYGEWPTYINDSEANPVD
APTEPDVSSNRFYTLESVSWKTTSRGWWWKLPDCLKDMGMFGQNMYYHYLGRSGYTIHVQ
CNASKFHQGALGVFLIPEFVMACNTESKTSYVSYINANPGERGGEFTNTYNPSNTDVSEG
RQFAALDYLLGSGVLAGNAFVYPHQIINLRTNNSATIVVPYVNSLVIDCMAKHNNWGIVI
LPLAPLAFAATSSPQVPITVTIAPMCTEFNGLRNITIPVHQGLPTMNTPGSNQFLTSDDF
QSPCALPNFDVTPPIHIPGEVKNMMELAEIDTLIPMNAVDGKVNTMEMYQIPLNDNLSKA
PIFCLSLSPASDKRLSHTMLGEILNYYTHWTGSIRFTFLFCGSMMATGKLLLSYSPPGAK
PPTNRKDAMLGTHIIWDLGLQSSCSMVAPWISNTVYRRCARDDFTEGGFITCFYQTRIVV
PASTPTSMFMLGFVSACPDFSVRLLRDTSHISQSKLIARTQGIEDLIDTAIKNALRVSQP
LRPSQLKQPNGVNSQEVPALTAVETGASGQAIPSDVVETRHVINYKTRSESCLESFFGRA
ACVTILSLTNSSKSGEEKKHFNIWNITYTDTVQLRRKLEFFTYSRFDLEMTFVFTENYPS
TASGEVRNQCDQIMYIPPGAPRPSSWDDYTWQSSSNPSIFYMYGNAPPRMSIPYVGIANA
YSHFYDGFARVPLEGENTDAGDTFYGLVSINDFGVLAVRAVNRSNPHTIHTSVRVYMKPK
HIRCWCPRPPRAVLYRGEGVDMISSAIQPLTKVDSITTFGFGHQNKAVYVAGYKICNYHL
ATPSDHLNAISVLWDRDLMVVESRAQGTDTIARCSCRCGVYYCESRRKYYLVTFTGPTFR
FMEANDYYPARYQSHMLIGCGFAEPGDCGGILRCTHGVIGIITAGGEGIVAFADIRDLWV
YEEEAMEQGITSYIESLGTAFGAGFTHTISEKVTELTTMVTSTITEKLLKNLVKIVSALV
IVVRNYEDTTTILATLALLGCDISPWQWLKKKACDLLEIPHVMRQGDGWMKKFTEACNAA
KGLRWVSNKISKFVDWLKCKIIPEAKDKVEFLTKLKQLDMLENQIATIHQSCPSQEQQEI
LFNNVRWLAVQSRRFAPLYAVEARRISKMESTINNYIQFKSKHRIEPVCMLVHGSPGTGK
GIASSLIGRAIAERETTSVYSVPLAPSHFDGYKQQGYDMDDLNQNPDGMDMKLFCQMVST
VEFIPPMASLEEKGILFTSDYVLASTNSHSIAPPTVAHSDALTRRFAFDVEVYTMSEHSV
KGKLNMATATQLCKDCPTPANFKKCCPLVCGKALQLMDRYTRQRFTVDEITTLIMNEKNR
RANIGNCMEALFQGPLRYKDLKIDVKTVPPPECISDLLQAVDSQEVRDYCEKKGWIVNVT
SQIQLERNINRAMTILQAVTTFAAVAGVVYVMYKLFAGQQGAYTGLPNKKPNVPTIRIAK
VQGPGFDYAVAMAKRNIVTATTTKGEFTMLGVHDNVAILPTHAAPGETIIVDGKEVEILD
ARALEDQAGTNLEITIITLKRNEKFRDIRPHIPTQITETNDGVLIVNTSKYPNMYVPVGA
VTEQGYLNLSGRQTARTLMYNFPTRAGQCGGIITCTGKVIGMHVGGNGSHGFAAALKRSY
FTQNQGEIQWMRSSKEVGYPIINAPSKTKLEPSAFHYVFEGVKEPAVLTKNDPRLKTDFE
EAIFSKYVGNKITEVDEYMKEAVDHYAGQLMSLDINTEQMCLEDAMYGTDGLEALDLSTS
AGYPYVAMGKKKRDILDKQTRDTKEMQRLLDTYGINLPLVTYVKDELRSKTKVEQGKSRL
IEASSLNDSVAMRMAFGNLYAAFHKNPGVVTGSAVGCDPDLFWSKIPVLMEEKLFAFDYT
GYDASLSPAWFEALKMVLEKIGFGNRVDYIDYLNHSHHLYKNKTYCVKGGMPSGCSGTSI
FNSMINNLIIRTLLLRTYKGIDLDHLKMIAYGDDVIASYPHEVDASLLAQSGKDYGLTMT
PADKSATFETVTWENVTFLKRFFRADEKYPFLVHPVMPMKEIHESIRWTKDPRNTQDHVR
SLCLLAWHNGEEEYNKFLAKIRSVPIGRALLLPEYSTLYRRWLDSF

# Drug_Target_33_Reaction:
Not Available

# Drug_Target_33_Signals:
None

# Drug_Target_33_Specific_Function:
RNA-directed RNA polymerase 3D-POL replicates genomic and antigenomic RNA by recognizing replications specific signals (By similarity)

# Drug_Target_33_SwissProt_ID:
P22055

# Drug_Target_33_SwissProt_Name:
POLG_CXA21

# Drug_Target_33_Synonyms:
P1A
P1B
P1C
P1D
P2A
P2B
P2C
P3A
P3B
P3C
P3D-POL
Picornain 2A
Picornain 3C
Protease 3C
Protein 2A
Protein 2B
Protein 2C
Protein 3A
Protein 3B
Protein VP0
Protein VP1
Protein VP2
Protein VP3
Protein VP4
RNA-directed RNA polymerase 3D-POL
VP4-VP2
VPg
Virion protein 1
Virion protein 2
Virion protein 3
Virion protein 4

# Drug_Target_33_Theoretical_pI:
7.24

# Drug_Target_33_Transmembrane_Regions:
None

# Drug_Target_34_Cellular_Location:
Cytoplasmic

# Drug_Target_34_Chromosome_Location:
Not Available

# Drug_Target_34_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_34_Essentiality:
Non-Essential

# Drug_Target_34_GenAtlas_ID:
Not Available

# Drug_Target_34_GenBank_ID_Gene:
AF465515

# Drug_Target_34_GenBank_ID_Protein:
33317929

# Drug_Target_34_GeneCard_ID:
Not Available

# Drug_Target_34_Gene_Name:
Not Available

# Drug_Target_34_Gene_Sequence:
>6624 bp
ATGGGGGCTCAAGTTTCAACGCAAAAGACCGGTGCGCACGAGAATCAAAACGTGGCAGCC
AATGGATCCACCATTAATTACACTACTATCAACTATTACAAAGACAGTGCGAGTAATTCC
GCTACTAGACAAGACCTCTCCCAAGATCCATCAAAATTCACAGAACCGGTTAAGGACTTA
ATGTTGAAAACAGCACCAGCTCTAAACTCGCCTAACGTGGAAGCATGTGGGTACAGTGAC
CGTGTGAGGCAAATCACTTTAGGCAACTCGACTATTACTACACAAGAAGCAGCCAATGCT
ATTGTTGCTTACGGTGAATGGCCCACTTACATAAATGATTCAGAAGCTAATCCGGTAGAT
GCACCCACTGAGCCAGACGTTAGTAGCAACCGGTTTTACACCCTAGAATCGGTGTCTTGG
AAGACCACTTCAAGGGGATGGTGGTGGAAGTTACCAGATTGTTTGAAGGACATGGGAATG
TTTGGTCAGAATATGTACTATCACTACTTGGGGCGCTCTGGTTACACCATTCATGTCCAG
TGCAACGCTTCAAAATTTCACCAAGGGGCGTTAGGAGTTTTTCTGATACCAGAGTTTGTC
ATGGCTTGCAACACTGAGAGTAAAACGTCATACGTTTCATACATCAATGCAAATCCTGGT
GAGAGAGGCGGTGAGTTTACGAACACCTACAATCCGTCAAATACAGACGCCAGTGAGGGC
AGAAAGTTTGCAGCATTGGATTATTTGCTGGGTTCTGGTGTTCTAGCAGGAAACGCCTTT
GTGTACCCGCACCAGATCATCAACCTACGTACCAACAACAGTGCAACAATTGTGGTGCCA
TACGTAAACTCACTTGTGATTGATTGTATGGCAAAACACAATAACTGGGGCATTGTCATA
TTACCACTGGCACCCTTGGCCTTTGCCGCAACATCGTCACCACAGGTGCCTATTACAGTG
ACCATTGCACCCATGTGTACAGAATTCAATGGGTTGAGAAACATCACCGTCCCAGTACAT
CAAGGGTTGCCGACAATGAACACACCTGGTTCCAATCAATTCCTTACATCTGATGACTTC
CAGTCGCCCTGTGCCTTACCTAATTTTGATGTTACTCCACCAATACACATACCCGGGGAA
GTAAAGAATATGATGGAACTAGCTGAAATTGACACATTGATCCCAATGAACGCAGTGGAC
GGGAAGGTGAACACAATGGAGATGTATCAAATACCATTGAATGACAATTTGAGCAAGGCA
CCTATATTCTGTTTATCCCTATCACCTGCTTCTGATAAACGACTGAGCCGCACCATGTTG
GGTGAAATCCTAAATTATTACACCCATTGGACGGGGTCCATCAGGTTCACCTTTCTATTT
TGTGGTAGTATGATGGCCACTGGTAAACTGCTCCTCAGCTATTCCCCACCGGGAGCTAAA
CCACCAACCAATCGCAAGGATGCAATGCTAGGCACACACATCATCTGGGACCTAGGGTTA
CAATCCAGTTGTTCCATGGTTGCACCGTGGATCTCCAACACAGTGTACAGACGGTGTGCA
CGTGATGACTTCACTGAGGGCGGATTTATAACTTGCTTCTATCAAACTAGAATTGTGGTA
CCTGCTTCAACCCCTACCAGTATGTTCATGTTAGGCTTTGTTAGTGCGTGTCCAGACTTC
AGTGTCAGACTGCTTAGGGACACTCCCCATATTAGTCAATCGAAACTAATAGGACGTACA
CAAGGCATTGAAGACCTCATTGACACAGCGATAAAGAATGCCTTAAGAGTGTCCCAACCA
CCCTCGACCCAGTCAACTGAAGCAACTAGTGGAGTGAATAGCCAGGAGGTGCCAGCTCTA
ACTGCTGTGGAAACAGGAGCATCTGGTCAAGCAATCCCCAGTGATGTGGTGGAAACTAGG
CACGTGGTAAATTACAAAACCAGGTCTGAATCGTGTCTTGAGTCATTCTTTGGGAGAGCT
GCGTGTGTCACAATCCTATCCTTGACCAACTCCTCCAAGAGCGGAGAGGAGAAAAAGCAT
TTCAACATATGGAATATTACATACACCGACACTGTCCAGTTACGCAGAAAATTAGAGTTT
TTCACGTATTCCAGGTTTGATCTTGAAATGACTTTTGTATTCACAGAGAACTATCCTAGT
ACAGCCAGTGGAGAAGTGCGAAACCAGGTGTACCAGATCATGTATATTCCACCAGGGGCA
CCCCGCCCATCATCCTGGGATGACTACACATGGCAATCCTCTTCAAACCCTTCCATCTTC
TACATGTATGGAAATGCACCTCCACGGATGTCAATTCCTTACGTAGGGATTGCCAATGCC
TATTCACACTTCTACGATGGCTTTGCACGGGTGCCACTTGAGGGTGAGAACACCGATGCT
GGCGACACGTTTTACGGTTTAGTGTCCATAAATGATTTTGGAGTTTTAGCAGTTAGAGCA
GTAAACCGCAGTAATCCACATACAATACACACATCTGTGAGAGTGTACATGAAACCAAAA
CACATTCGGTGTTGGTGCCCCAGACCTCCTCGAGCTGTATTATACAGGGGAGAGGGAGTG
GACATGATATCCAGTGCAATTCTACCTCTGACCAAGGTAGACTCAATTACCACTTTTGGG
TTTGGTCATCAGAACAAAGCAGTGTACGTTGCCGGTTACAAGATTTGCAACTACCACCTA
GCAACCCCAAGTGATCACTTGAATGCAATTAGTATGTTATGGGACAGGGATTTAATGGTG
GTGGAATCTAGAGCCCAGGGAACTGATACCATCGCCAGATGTAGTTGCAGGTGTGGAGTT
TACTATTGTGAATCTAGGAGGAAGTACTACCCTGTCACTTTTACTGGCCCAACGTTTCGA
TTCATGGAAGCAAACGACTACTATCCAGCAAGATACCAGTCTCACATGCTGATAGGGTGC
GGATTTGCAGAACCCGGGGACTGCGGTGGGATACTGAGGTGCACTCATGGGGTAATTGGT
ATCATTACTGCAGGAGGTGAAGGGGTAGTAGCCTTTGCTGACATTAGAGACCTCTGGGTG
TATGAAGAGGAGGCCATGGAACAGGGAATAACAAGCTACATCGAATCTCTCGGCACAGCC
TTTGGCGCAGGGTTCACCCACACAATCAGTGAGAAAGTGACTGAATTGACAACAATGGTT
ACCAGCACTATCACAGAAAAACTACTGAAAAACTTGGTGAAAATAGTGTCGGCTCTAGTG
ATTGTTGTGAGAAATTATGAGGACACTACCACGATCCTTGCAACACTAGCACTACTCGGG
TGTGATATATCTCCTTGGCAATGGTTGAAGAAGAAGGCATGTGACTTACTAGAGATTCCT
TATGTGATGCGCCAAGGTGATGGGTGGATGAAGAAATTCACAGAGGCGTGCAATGCAGCT
AAAGGCTTAGAGTGGATTAGCAACAAAATTTCCAAGTTTATAGATTGGTTGAAGTGTAAA
ATTATCCCAGACGCTAAGGACAAGGTGGAATTTCTCACCAAGTTGAAACAGCTAGACATG
TTGGAAAATCAAATTGCAACCATCCACCAATCTTGCCCCAGCCAAGAACAACAAGAGATT
CTTTTCAACAATGTGAGATGGCTAGCAGTCCAGTCCCGTCGGTTTGCACCATTATACGCT
GTGGAGGCACGCCGAATTAACAAAATGGAGAGCACAATAAACAATTATATACAGTTCAAG
AGCAAACACCGTATTGAACCAGTATGTATGCTCATTCATGGGTCACCAGGGACGGGTAAA
TCTATAGCTACTTCATTAATAGGTAGAGCAATAGCAGAGAAGGAAAGCACATCAGTCTAT
TCAATGCCACCTGACCCATCTCACTTTGATGGCTATAAACAACAAGGGGTAGTGATTATG
GACGACCTAAACCAAAACCCCGATGGTATGGACATGAAACTGTTTTGCCAAATGGTATCA
ACAGTGGAGTTTATTCCTCCAATGGCCTCATTAGAGGAGAAGGGCATTTTGTTTACATCT
GATTATGTCCTGGCTTCTACCAACTCTCATTCAATTGTACCACCCACAGTGGCTCACAGT
GATGCCTTAACCAGACGATTTGCATTTGATGTGGAGGTTTACACGATGTCTGAACATTCA
GTCAAAGGCAAACTGAATATGGCCACGGCCACTCAATTGTGTAAGGATTGTCCAACACCT
GCAAATTTTAAAAAGTGTTGCCCTCTCGTTTGTGGAAAGGCCTTGCAATTAATGGACAGG
TACACCAGACAAAGGTTCACTGTAGATGAGATTACCACATTAATCATGAATGAGAAAAAC
AGAAGGGCCAATATCGGCAATTGCATGGAAGCCTTGTTTCAAGGACCATTAAGGTATAAA
GATTTGAAGATCGATGTGAAGACAGTTCCCCCCCCTGAGTGCATCAGTGATTTGTTACAA
GCAGTGGATTCTCAAGAGGTTAGGGATTACTGTGAGAAGAAAGGCTGGATCGTTAACGTT
ACTAGCCAGATTCAACTAGAAAGGAACATCAATAGGGCCATGACTATACTCCAAGCTGTT
ACCACATTCGCAGCAGTCGCAGGAGTAGTGTATGTAATGTACAAACTCTTCGCCGGTCAA
CAGGGTGCATACACTGGCTTGCCAAACAAAAAACCCAATGTCCCTACTATCAGAGTCGCT
AAAGTCCAGGGGCCAGGATTTGACTACGCAGTGGCAATGGCAAAAAGAAACATAGTTACT
GCAACCACCACCAAGGGTGAATTTACCATGCTAGGGGTGCATGATAATGTAGCAATATTG
CCAACCCATGCCGCTCCAGGAGAAACCATTATTATTGATGGGAAAGAAGTAGAGATCCTA
GATGCCAGAGCCTTAGAAGATCAAGCGGGAACCAATCTTGAGATCACCATTATTACTCTA
AAAAGAAATGAGAAGTTTAGAGACATCAGATCACATATTCCCACCCAAATTACTGAAACT
AACGATGGAGTGTTGATCGTGAACACTAGCAAGTACCCCAATATGTATGTCCCCGTTGGT
GCTGTGACCGAACAGGGATATCTTAATCTCAGTGGACGTCAAACTGCTCGCACTTTAATG
TACAACTTTCCAACAAGGGCAGGCCAGTGCGGAGGAATCATCACTTGTACTGGCAAAGTC
ATTGGGATGCATGTTGGCGGGAACGGTTCACATGGGTTTGCAGCAGCCCTCAAGCGATCA
TACTTCACTCAAAATCAGGGCGAAATCCAGTGGATGAGGTCATCAAAAGAAGTGGGGTAC
CCCATTATAAATGCCCCATCCAAGACAAAGTTAGAACCCAGTGCTTTCCACTATGTTTTT
GAAGGTGTTAAGGAACCAGCTGTACTCACTAAGAATGACCCCAGACTAAAAACAGATTTT
GAAGAAGCCATCTTTTCTAAATATGTGGGGAACAAAATTACTGAAGTGGACGAGTACATG
AAAGAAGCAGTGGATCACTATGCAGGACAGTTAATGTCACTGGATATCAACACAGAACAG
ATGTGCCTGGAGGATGCCATGTACGGCACCGATGGTCTTGAGGCCCTGGATCTTAGCACT
AGTGCTGGATATCCTTATGTTGCAATGGGGAAAAAGAAAAGAGACATTCTAGATAAACAG
ACCAGAGATACTAAGGAGATGCAGAGACTTTTAGATACCTATGGAATCAATCTACCATTA
GTCACGTACGTGAAAGATGAACTCAGGTCAAAGACTAAAGTGGAACAAGGAAAGTCAAGA
TTGATTGAAGCTTCCAGCCTTAATGATTCAGTTGCAATGAGAATGGCCTTTGGCAATCTT
TACGCAGCTTTCCACAAGAATCCAGGTGTGGTGACAGGATCAGCAGTTGGTTGTGACCCA
GATTTGTTTTGGAGTAAGATACCAGTGCTAATGGAAGAAAAACTCTTCGCTTTTGACTAC
ACAGGGTATGATGCCTCACTCAGCCCTGCTTGGTTTGAAGCTCTTAAAATGGTGTTAGAA
AAAATTGGATTTGGCAGTAGAGTAGACTATATAGACTACCTGAACCACTCTCACCACCTT
TACAAAAACAAGACTTATTGTGTCAAAGGCGGCATGCCATCCGGCTGCTCTGGCACCTCA
ATTTTCAACTCAATGATTAACAACCTGATCATTAGGACGCTTTTACTGAGAACCTACAAG
GGCATAGACTTGGACCATTTAAAAATGATTGCCTATGGTGATGACGTGATAGCTTCCTAC
CCCCATGAGGTTGACGCTAGTCTCCTAGCCCAATCAGGAAAAGACTATGGACTAACCATG
ACTCCAGCAGATAAATCAGTAACCTTTGAAACAGTCACATGGGAGAATGTAACATTTCTG
AAAAGATTTTTCAGAGCAGATGAGAAGTATCCATTCCTGGTGCATCCAGTGATGCCAATG
AAAGAAATTCACGAATCAATCAGATGGACCAAGGACCCTAGAAACACACAGGATCACGTA
CGCTCGTTGTGCCTATTAGCTTGGCACAACGGTGAAGAAGAATACAATAAATTTTTAGCT
AAAATCAGAAGTGTGCCAATCGGAAGAGCTTTATTGCTCCCAGAGTACTCTACATTGTAC
CGCCGATGGCTCGACTCATTTTAG

# Drug_Target_34_General_Function:
Involved in ATP binding

# Drug_Target_34_General_References:
14573809	Newcombe NG, Andersson P, Johansson ES, Au GG, Lindberg AM, Barry RD, Shafren DR: Cellular receptor interactions of C-cluster human group A coxsackieviruses. J Gen Virol. 2003 Nov;84(Pt 11):3041-50.

# Drug_Target_34_HGNC_ID:
Not Available

# Drug_Target_34_HPRD_ID:
Not Available

# Drug_Target_34_ID:
6749

# Drug_Target_34_Locus:
Not Available

# Drug_Target_34_Molecular_Weight:
246035.2

# Drug_Target_34_Name:
Polyprotein

# Drug_Target_34_Number_of_Residues:
2207

# Drug_Target_34_PDB_ID:
1RDR

# Drug_Target_34_Pathway:
Not Available

# Drug_Target_34_Pfam_Domain_Function:
PF00073	Rhv
PF00548	Peptidase_C3
PF00680	RdRP_1
PF00910	RNA_helicase
PF00947	Pico_P2A
PF01552	Pico_P2B
PF02226	Pico_P1A
PF08727	P3A

# Drug_Target_34_Protein_Sequence:
>Polyprotein
MGAQVSTQKTGAHENQNVAANGSTINYTTINYYKDSASNSATRQDLSQDPSKFTEPVKDL
MLKTAPALNSPNVEACGYSDRVRQITLGNSTITTQEAANAIVAYGEWPTYINDSEANPVD
APTEPDVSSNRFYTLESVSWKTTSRGWWWKLPDCLKDMGMFGQNMYYHYLGRSGYTIHVQ
CNASKFHQGALGVFLIPEFVMACNTESKTSYVSYINANPGERGGEFTNTYNPSNTDASEG
RKFAALDYLLGSGVLAGNAFVYPHQIINLRTNNSATIVVPYVNSLVIDCMAKHNNWGIVI
LPLAPLAFAATSSPQVPITVTIAPMCTEFNGLRNITVPVHQGLPTMNTPGSNQFLTSDDF
QSPCALPNFDVTPPIHIPGEVKNMMELAEIDTLIPMNAVDGKVNTMEMYQIPLNDNLSKA
PIFCLSLSPASDKRLSRTMLGEILNYYTHWTGSIRFTFLFCGSMMATGKLLLSYSPPGAK
PPTNRKDAMLGTHIIWDLGLQSSCSMVAPWISNTVYRRCARDDFTEGGFITCFYQTRIVV
PASTPTSMFMLGFVSACPDFSVRLLRDTPHISQSKLIGRTQGIEDLIDTAIKNALRVSQP
PSTQSTEATSGVNSQEVPALTAVETGASGQAIPSDVVETRHVVNYKTRSESCLESFFGRA
ACVTILSLTNSSKSGEEKKHFNIWNITYTDTVQLRRKLEFFTYSRFDLEMTFVFTENYPS
TASGEVRNQVYQIMYIPPGAPRPSSWDDYTWQSSSNPSIFYMYGNAPPRMSIPYVGIANA
YSHFYDGFARVPLEGENTDAGDTFYGLVSINDFGVLAVRAVNRSNPHTIHTSVRVYMKPK
HIRCWCPRPPRAVLYRGEGVDMISSAILPLTKVDSITTFGFGHQNKAVYVAGYKICNYHL
ATPSDHLNAISMLWDRDLMVVESRAQGTDTIARCSCRCGVYYCESRRKYYPVTFTGPTFR
FMEANDYYPARYQSHMLIGCGFAEPGDCGGILRCTHGVIGIITAGGEGVVAFADIRDLWV
YEEEAMEQGITSYIESLGTAFGAGFTHTISEKVTELTTMVTSTITEKLLKNLVKIVSALV
IVVRNYEDTTTILATLALLGCDISPWQWLKKKACDLLEIPYVMRQGDGWMKKFTEACNAA
KGLEWISNKISKFIDWLKCKIIPDAKDKVEFLTKLKQLDMLENQIATIHQSCPSQEQQEI
LFNNVRWLAVQSRRFAPLYAVEARRINKMESTINNYIQFKSKHRIEPVCMLIHGSPGTGK
SIATSLIGRAIAEKESTSVYSMPPDPSHFDGYKQQGVVIMDDLNQNPDGMDMKLFCQMVS
TVEFIPPMASLEEKGILFTSDYVLASTNSHSIVPPTVAHSDALTRRFAFDVEVYTMSEHS
VKGKLNMATATQLCKDCPTPANFKKCCPLVCGKALQLMDRYTRQRFTVDEITTLIMNEKN
RRANIGNCMEALFQGPLRYKDLKIDVKTVPPPECISDLLQAVDSQEVRDYCEKKGWIVNV
TSQIQLERNINRAMTILQAVTTFAAVAGVVYVMYKLFAGQQGAYTGLPNKKPNVPTIRVA
KVQGPGFDYAVAMAKRNIVTATTTKGEFTMLGVHDNVAILPTHAAPGETIIIDGKEVEIL
DARALEDQAGTNLEITIITLKRNEKFRDIRSHIPTQITETNDGVLIVNTSKYPNMYVPVG
AVTEQGYLNLSGRQTARTLMYNFPTRAGQCGGIITCTGKVIGMHVGGNGSHGFAAALKRS
YFTQNQGEIQWMRSSKEVGYPIINAPSKTKLEPSAFHYVFEGVKEPAVLTKNDPRLKTDF
EEAIFSKYVGNKITEVDEYMKEAVDHYAGQLMSLDINTEQMCLEDAMYGTDGLEALDLST
SAGYPYVAMGKKKRDILDKQTRDTKEMQRLLDTYGINLPLVTYVKDELRSKTKVEQGKSR
LIEASSLNDSVAMRMAFGNLYAAFHKNPGVVTGSAVGCDPDLFWSKIPVLMEEKLFAFDY
TGYDASLSPAWFEALKMVLEKIGFGSRVDYIDYLNHSHHLYKNKTYCVKGGMPSGCSGTS
IFNSMINNLIIRTLLLRTYKGIDLDHLKMIAYGDDVIASYPHEVDASLLAQSGKDYGLTM
TPADKSVTFETVTWENVTFLKRFFRADEKYPFLVHPVMPMKEIHESIRWTKDPRNTQDHV
RSLCLLAWHNGEEEYNKFLAKIRSVPIGRALLLPEYSTLYRRWLDSF

# Drug_Target_34_Reaction:
Not Available

# Drug_Target_34_Signals:
None

# Drug_Target_34_Specific_Function:
RNA-directed RNA polymerase 3D-POL replicates genomic and antigenomic RNA by recognizing replications specific signals (By similarity)

# Drug_Target_34_SwissProt_ID:
Q71LY2

# Drug_Target_34_SwissProt_Name:
Q71LY2_9ENTO

# Drug_Target_34_Synonyms:
Not Available

# Drug_Target_34_Theoretical_pI:
7.13

# Drug_Target_34_Transmembrane_Regions:
None

# Drug_Target_35_Cellular_Location:
Lysosome

# Drug_Target_35_Chromosome_Location:
Not Available

# Drug_Target_35_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_35_Essentiality:
Non-Essential

# Drug_Target_35_GenAtlas_ID:
GM2A

# Drug_Target_35_GenBank_ID_Gene:
M76477

# Drug_Target_35_GenBank_ID_Protein:
183357

# Drug_Target_35_GeneCard_ID:
GM2A

# Drug_Target_35_Gene_Name:
GM2A

# Drug_Target_35_Gene_Sequence:
>582 bp
ATGCAGTCCCTGATGCAGGCTCCCCTCCTGATCGCCCTGGGCTTGCTTCTCGCGGCCCCT
GCGCAAGCCCACCTGAAAAAGCCATCCCAGCTCAGTAGCTTTTCCTGGGATAACTGTGAT
GAAGGGAAGGACCCTGCGGTGATCAGAAGCCTGACTCTGGAGCCTGACCCCATCGTCGTT
CCTGGAAATGTGACCCTCAGTGTCGTGGGCAGCACCAGTGTCCCCCTGAGTTCTCCTCTG
AAGGTGGATTTAGTTTTGGAGAAGGAGGTGGCTGGCCTCTGGATCAAGATCCCATGCACA
GACTACATTGGCAGCTGTACCTTTGAACACTTCTGTGATGTGCTTGACATGTTAATTCCT
ACTGGGGAGCCCTGCCCAGAGCCCCTGCGTACCTATGGGCTTCCTTGCCACTGTCCCTTC
AAAGAAGGAACCTACTCACTGCCCAAGAGCGAATTCGTTGTGCCTGACCTGGAGCTGCCC
AGTTGGCTCACCACCGGGAACTACCGCATAGAGAGCGTCCTGAGCAGCAGTGGGAAGCGT
CTGGGCTGCATCAAGATCGCTGCCTCTCTAAAGGGCATATAA

# Drug_Target_35_General_Function:
Involved in sphingolipid activator protein activity

# Drug_Target_35_General_References:
10364519	Chen B, Rigat B, Curry C, Mahuran DJ: Structure of the GM2A gene: identification of an exon 2 nonsense mutation and a naturally occurring transcript with an in-frame deletion of exon 2. Am J Hum Genet. 1999 Jul;65(1):77-87.
11090283	Wright CS, Li SC, Rastinejad F: Crystal structure of human GM2-activator protein with a novel beta-cup topology. J Mol Biol. 2000 Dec 1;304(3):411-22.
1427911	Xie B, Kennedy JL, McInnes B, Auger D, Mahuran D: Identification of a processed pseudogene related to the functional gene encoding the GM2 activator protein: localization of the pseudogene to human chromosome 3 and the functional gene to human chromosome 5. Genomics. 1992 Nov;14(3):796-8.
1554364	Nagarajan S, Chen HC, Li SC, Li YT, Lockyer JM: Evidence for two cDNA clones encoding human GM2-activator protein. Biochem J. 1992 Mar 15;282 ( Pt 3):807-13.
1915857	Klima H, Tanaka A, Schnabel D, Nakano T, Schroder M, Suzuki K, Sandhoff K: Characterization of full-length cDNAs and the gene coding for the human GM2 activator protein. FEBS Lett. 1991 Sep 9;289(2):260-4.
1915858	Schroder M, Schnabel D, Suzuki K, Sandhoff K: A mutation in the gene of a glycolipid-binding protein (GM2 activator) that causes GM2-gangliosidosis variant AB. FEBS Lett. 1991 Sep 23;290(1-2):1-3.
2059210	Xie B, McInnes B, Neote K, Lamhonwah AM, Mahuran D: Isolation and expression of a full-length cDNA encoding the human GM2 activator protein. Biochem Biophys Res Commun. 1991 Jun 28;177(3):1217-23.
2209618	Furst W, Schubert J, Machleidt W, Meyer HE, Sandhoff K: The complete amino-acid sequences of human ganglioside GM2 activator protein and cerebroside sulfate activator protein. Eur J Biochem. 1990 Sep 24;192(3):709-14.
2753159	Schroder M, Klima H, Nakano T, Kwon H, Quintern LE, Gartner S, Suzuki K, Sandhoff K: Isolation of a cDNA encoding the human GM2 activator protein. FEBS Lett. 1989 Jul 17;251(1-2):197-200.
8244332	Schroder M, Schnabel D, Hurwitz R, Young E, Suzuki K, Sandhoff K: Molecular genetics of GM2-gangliosidosis AB variant: a novel mutation and expression in BHK cells. Hum Genet. 1993 Nov;92(5):437-40.
8900233	Schepers U, Glombitza G, Lemm T, Hoffmann A, Chabas A, Ozand P, Sandhoff K: Molecular analysis of a GM2-activator deficiency in two patients with GM2-gangliosidosis AB variant. Am J Hum Genet. 1996 Nov;59(5):1048-56.

# Drug_Target_35_HGNC_ID:
HGNC:4367

# Drug_Target_35_HPRD_ID:
02034

# Drug_Target_35_ID:
2616

# Drug_Target_35_Locus:
5q31.3-q33.1

# Drug_Target_35_Molecular_Weight:
20822

# Drug_Target_35_Name:
Ganglioside GM2 activator

# Drug_Target_35_Number_of_Residues:
193

# Drug_Target_35_PDB_ID:
1PU5

# Drug_Target_35_Pathway:
Not Available

# Drug_Target_35_Pfam_Domain_Function:
Not Available

# Drug_Target_35_Protein_Sequence:
>Ganglioside GM2 activator precursor
MQSLMQAPLLIALGLLLATPAQAHLKKPSQLSSFSWDNCDEGKDPAVIRSLTLEPDPIVV
PGNVTLSVVGSTSVPLSSPLKVDLVLEKEVAGLWIKIPCTDYIGSCTFEHFCDVLDMLIP
TGEPCPEPLRTYGLPCHCPFKEGTYSLPKSEFVVPDLELPSWLTTGNYRIESVLSSSGKR
LGCIKIAASLKGI

# Drug_Target_35_Reaction:
Not Available

# Drug_Target_35_Signals:
1-23

# Drug_Target_35_Specific_Function:
Binds gangliosides and stimulates ganglioside GM2 degradation. It stimulates only the breakdown of ganglioside GM2 and glycolipid GA2 by beta-hexosaminidase A. It extracts single GM2 molecules from membranes and presents them in soluble form to beta-hexosaminidase A for cleavage of N-acetyl-D-galactosamine and conversion to GM3

# Drug_Target_35_SwissProt_ID:
P17900

# Drug_Target_35_SwissProt_Name:
SAP3_HUMAN

# Drug_Target_35_Synonyms:
Cerebroside sulfate activator protein
GM2-AP
Ganglioside GM2 activator precursor
SAP-3
Shingolipid activator protein 3

# Drug_Target_35_Theoretical_pI:
4.96

# Drug_Target_35_Transmembrane_Regions:
None

# Drug_Target_36_Cellular_Location:
Golgi apparatus. Cell membrane

# Drug_Target_36_Chromosome_Location:
1

# Drug_Target_36_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_36_Essentiality:
Non-Essential

# Drug_Target_36_GenAtlas_ID:
Not Available

# Drug_Target_36_GenBank_ID_Gene:
M57763

# Drug_Target_36_GenBank_ID_Protein:
178989

# Drug_Target_36_GeneCard_ID:
ARF6

# Drug_Target_36_Gene_Name:
ARF6

# Drug_Target_36_Gene_Sequence:
>528 bp
ATGGGGAAGGTGCTATCCAAAATCTTCGGGAACAAGGAAATGCGGATCCTCATGTTGGGC
CTGGACGCGGCCGGCAAGACAACAATCCTGTACAAGTTGAAGCTGGGCCAGTCGGTGACC
ACCATTCCCACTGTGGGTTTCAACGTGGAGACGGTGACTTACAAAAATGTCAAGTTCAAC
GTATGGGATGTGGGCGGCCAGGACAAGATCCGGCCGCTCTGGCGGCATTACTACACTGGG
ACCCAAGGTCTCATCTTCGTAGTGGACTGCGCCGACCGCGACCGCATCGATGAGGCTCGC
CAGGAGCTGCACCGCATTATCAATGACCGGGAGATGAGGGACGCCATAATCCTCATCTTC
GCCAACAAGCAGGACCTGCCCGATGCCATGAAACCCCACGAGATCCAGGAGAAACTGGGC
CTGACCCGGATTCGGGACAGGAACTGGTATGTGCAGCCCTCCTGTGCCACCTCAGGGGAC
GGACTCTATGAGGGGCTCACATGGTTAACCTCTAACTACAAATCTTAA

# Drug_Target_36_General_Function:
Involved in GTP binding

# Drug_Target_36_General_References:
12847086	Krauss M, Kinuta M, Wenk MR, De Camilli P, Takei K, Haucke V: ARF6 stimulates clathrin/AP-2 recruitment to synaptic membranes by activating phosphatidylinositol phosphate kinase type Igamma. J Cell Biol. 2003 Jul 7;162(1):113-24.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
15642342	Garcia-Gonzalo FR, Bartrons R, Ventura F, Rosa JL: Requirement of phosphatidylinositol-4,5-bisphosphate for HERC1-mediated guanine nucleotide release from ARF proteins. FEBS Lett. 2005 Jan 17;579(2):343-8.
15793564	Dubois T, Paleotti O, Mironov AA, Fraisier V, Stradal TE, De Matteis MA, Franco M, Chavrier P: Golgi-localized GAP for Cdc42 functions downstream of ARF1 to control Arp2/3 complex and F-actin dynamics. Nat Cell Biol. 2005 Apr;7(4):353-64. Epub 2005 Mar 27.
17555535	Haynes LP, Sherwood MW, Dolman NJ, Burgoyne RD: Specificity, promiscuity and localization of ARF protein interactions with NCS-1 and phosphatidylinositol-4 kinase-III beta. Traffic. 2007 Aug;8(8):1080-92. Epub 2007 Jun 6.
1993656	Tsuchiya M, Price SR, Tsai SC, Moss J, Vaughan M: Molecular identification of ADP-ribosylation factor mRNAs and their expression in mammalian cells. J Biol Chem. 1991 Feb 15;266(5):2772-7.
7589240	D'Souza-Schorey C, Stahl PD: Myristoylation is required for the intracellular localization and endocytic function of ARF6. Exp Cell Res. 1995 Nov;221(1):153-9.
9653160	Mao M, Fu G, Wu JS, Zhang QH, Zhou J, Kan LX, Huang QH, He KL, Gu BW, Han ZG, Shen Y, Gu J, Yu YP, Xu SH, Wang YX, Chen SJ, Chen Z: Identification of genes expressed in human CD34(+) hematopoietic stem/progenitor cells by expressed sequence tags and efficient full-length cDNA cloning. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8175-80.

# Drug_Target_36_HGNC_ID:
GNC:659

# Drug_Target_36_HPRD_ID:
Not Available

# Drug_Target_36_ID:
6750

# Drug_Target_36_Locus:
14q21.3

# Drug_Target_36_Molecular_Weight:
20082.0

# Drug_Target_36_Name:
ADP-ribosylation factor 6

# Drug_Target_36_Number_of_Residues:
175

# Drug_Target_36_PDB_ID:
1E0S

# Drug_Target_36_Pathway:
Not Available

# Drug_Target_36_Pfam_Domain_Function:
PF00025	Arf

# Drug_Target_36_Protein_Sequence:
>ADP-ribosylation factor 6
MGKVLSKIFGNKEMRILMLGLDAAGKTTILYKLKLGQSVTTIPTVGFNVETVTYKNVKFN
VWDVGGQDKIRPLWRHYYTGTQGLIFVVDCADRDRIDEARQELHRIINDREMRDAIILIF
ANKQDLPDAMKPHEIQEKLGLTRIRDRNWYVQPSCATSGDGLYEGLTWLTSNYKS

# Drug_Target_36_Reaction:
Not Available

# Drug_Target_36_Signals:
None

# Drug_Target_36_Specific_Function:
GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP- ribosyltransferase. Involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus

# Drug_Target_36_SwissProt_ID:
P62330

# Drug_Target_36_SwissProt_Name:
ARF6_HUMAN

# Drug_Target_36_Synonyms:
Not Available

# Drug_Target_36_Theoretical_pI:
9.32

# Drug_Target_36_Transmembrane_Regions:
None

# Drug_Target_37_Cellular_Location:
Secreted, extracellular space

# Drug_Target_37_Chromosome_Location:
8

# Drug_Target_37_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_37_Essentiality:
Non-Essential

# Drug_Target_37_GenAtlas_ID:
Not Available

# Drug_Target_37_GenBank_ID_Gene:
AB018549

# Drug_Target_37_GenBank_ID_Protein:
5051740

# Drug_Target_37_GeneCard_ID:
LY96

# Drug_Target_37_Gene_Name:
LY96

# Drug_Target_37_Gene_Sequence:
>483 bp
ATGTTACCATTTCTGTTTTTTTCCACCCTGTTTTCTTCCATATTTACTGAAGCTCAGAAG
CAGTATTGGGTCTGCAACTCATCCGATGCAAGTATTTCATACACCTACTGTGATAAAATG
CAATACCCAATTTCAATTAATGTTAACCCCTGTATAGAATTGAAAGGATCCAAAGGATTA
TTGCACATTTTCTACATTCCAAGGAGAGATTTAAAGCAATTATATTTCAATCTCTATATA
ACTGTCAACACCATGAATCTTCCAAAGCGCAAAGAAGTTATTTGCCGAGGATCTGATGAC
GATTACTCTTTTTGCAGAGCTCTGAAGGGAGAGACTGTGAATACAACAATATCATTCTCC
TTCAAGGGAATAAAATTTTCTAAGGGAAAATACAAATGTGTTGTTGAAGCTATTTCTGGG
AGCCCAGAAGAAATGCTCTTTTGCTTGGAGTTTGTCATCCTACACCAACCTAATTCAAAT
TAG

# Drug_Target_37_General_Function:
Involved in coreceptor activity

# Drug_Target_37_General_References:
10359581	Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M: MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med. 1999 Jun 7;189(11):1777-82.
10891475	Kato K, Morrison AM, Nakano T, Tashiro K, Honjo T: ESOP-1, a secreted protein expressed in the hematopoietic, nervous, and reproductive systems of embryonic and adult mice. Blood. 2000 Jul 1;96(1):362-4.
11160242	Dziarski R, Wang Q, Miyake K, Kirschning CJ, Gupta D: MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components. J Immunol. 2001 Feb 1;166(3):1938-44.
11435474	Schromm AB, Lien E, Henneke P, Chow JC, Yoshimura A, Heine H, Latz E, Monks BG, Schwartz DA, Miyake K, Golenbock DT: Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J Exp Med. 2001 Jul 2;194(1):79-88.
11593030	Visintin A, Mazzoni A, Spitzer JA, Segal DM: Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12156-61. Epub 2001 Oct 2.
12642668	Mullen GE, Kennedy MN, Visintin A, Mazzoni A, Leifer CA, Davies DR, Segal DM: The role of disulfide bonds in the assembly and function of MD-2. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3919-24. Epub 2003 Mar 17.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
17569869	Ohto U, Fukase K, Miyake K, Satow Y: Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science. 2007 Jun 15;316(5831):1632-4.
17803912	Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC, Enkhbayar P, Matsushima N, Lee H, Yoo OJ, Lee JO: Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell. 2007 Sep 7;130(5):906-17.
18810425	Nakajima T, Ohtani H, Satta Y, Uno Y, Akari H, Ishida T, Kimura A: Natural selection in the TLR-related genes in the course of primate evolution. Immunogenetics. 2008 Dec;60(12):727-35. Epub 2008 Sep 23.

# Drug_Target_37_HGNC_ID:
GNC:17156

# Drug_Target_37_HPRD_ID:
Not Available

# Drug_Target_37_ID:
6527

# Drug_Target_37_Locus:
8q21.11

# Drug_Target_37_Molecular_Weight:
18446.2

# Drug_Target_37_Name:
Lymphocyte antigen 96

# Drug_Target_37_Number_of_Residues:
160

# Drug_Target_37_PDB_ID:
Not Available

# Drug_Target_37_Pathway:
Not Available

# Drug_Target_37_Pfam_Domain_Function:
PF02221	E1_DerP2_DerF2

# Drug_Target_37_Protein_Sequence:
>Lymphocyte antigen 96
MLPFLFFSTLFSSIFTEAQKQYWVCNSSDASISYTYCDKMQYPISINVNPCIELKGSKGL
LHIFYIPRRDLKQLYFNLYITVNTMNLPKRKEVICRGSDDDYSFCRALKGETVNTTISFS
FKGIKFSKGKYKCVVEAISGSPEEMLFCLEFVILHQPNSN

# Drug_Target_37_Reaction:
Not Available

# Drug_Target_37_Signals:
1-18

# Drug_Target_37_Specific_Function:
Cooperates with TLR4 in the innate immune response to bacterial lipopolysaccharide (LPS), and with TLR2 in the response to cell wall components from Gram-positive and Gram-negative bacteria. Enhances TLR4-dependent activation of NF-kappa-B. Cells expressing both MD2 and TLR4, but not TLR4 alone, respond to LPS

# Drug_Target_37_SwissProt_ID:
Q9Y6Y9

# Drug_Target_37_SwissProt_Name:
LY96_HUMAN

# Drug_Target_37_Synonyms:
ESOP-1
Protein MD-2

# Drug_Target_37_Theoretical_pI:
8.46

# Drug_Target_37_Transmembrane_Regions:
None

# Drug_Target_38_Cellular_Location:
Cell inner membrane

# Drug_Target_38_Chromosome_Location:
Not Available

# Drug_Target_38_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_38_Essentiality:
Essential

# Drug_Target_38_GenAtlas_ID:
Not Available

# Drug_Target_38_GenBank_ID_Gene:
K00431

# Drug_Target_38_GenBank_ID_Protein:
148023

# Drug_Target_38_GeneCard_ID:
tonB

# Drug_Target_38_Gene_Name:
tonB

# Drug_Target_38_Gene_Sequence:
>735 bp
GAGACCTGGTTTTTCTACTGAAATGATTATGACTTCAATGACCCTTGATTTACCTCGCCG
CTTCCCCTGGCCGACGTTACTTTCGGTCTGCATTCATGGTGCTGTTGTGGCGGGTCTGCT
CTATACCTCGGTACATCAGGTTATTGAACTACCTGCGCCTGCGCAGCCGATTTCTGTCAC
GATGGTTACGCCTGCTGATCTCGAACCGCCACAAGCCGTTCAGCCGCCACCGGAGCCGGT
GGTAGAGCCAGAACCGGAACCTGAGCCGATCCCCGAACCGCCAAAAGAAGCACCGGTGGT
CATTGAAAAGCCGAAGCCGAAACCTAAGCCAAAACCGAAGCCGGTGAAAAAGGTACAGGA
GCAGCCAAAACGCGATGTCAAACCCGTAGAGTCGCGTCCGGCATCACCGTTTGAAAATAC
GGCACCGGCACGCCTGACATCAAGTACAGCAACGGCTGCAACCAGCAAGCCGGTTACCAG
TGTGGCTTCAGGACCACGCGCATTAAGCCGTAATCAGCCGCAGTATCCGGCACGAGCACA
GGCATTGCGCATTGAAGGGCAGGTTAAAGTTAAATTTGACGTTACGCCGGATGGTCGCGT
GGATAACGTACAAATCCTCTCAGCCAAGCCTGCGAACATGTTTGAGCGTGAGGTGAAAAA
TGCGATGCGCAGATGGCGTTATGAGCCGGGTAAGCCAGGCAGTGGGATTGTGGTGAATAT
CCTGTTTAAAATTAA

# Drug_Target_38_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_38_General_References:
11328822	Chang C, Mooser A, Pluckthun A, Wlodawer A: Crystal structure of the dimeric C-terminal domain of TonB reveals a novel fold. J Biol Chem. 2001 Jul 20;276(29):27535-40. Epub 2001 Apr 27.
16738553	Hayashi K, Morooka N, Yamamoto Y, Fujita K, Isono K, Choi S, Ohtsubo E, Baba T, Wanner BL, Mori H, Horiuchi T: Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol Syst Biol. 2006;2:2006.0007. Epub 2006 Feb 21.
1885532	Roof SK, Allard JD, Bertrand KP, Postle K: Analysis of Escherichia coli TonB membrane topology by use of PhoA fusions. J Bacteriol. 1991 Sep;173(17):5554-7.
6310567	Postle K, Good RF: DNA sequence of the Escherichia coli tonB gene. Proc Natl Acad Sci U S A. 1983 Sep;80(17):5235-9.
8316087	Karlsson M, Hannavy K, Higgins CF: A sequence-specific function for the N-terminal signal-like sequence of the TonB protein. Mol Microbiol. 1993 Apr;8(2):379-88.
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-62.

# Drug_Target_38_HGNC_ID:
Not Available

# Drug_Target_38_HPRD_ID:
Not Available

# Drug_Target_38_ID:
6524

# Drug_Target_38_Locus:
Not Available

# Drug_Target_38_Molecular_Weight:
26094.1

# Drug_Target_38_Name:
Protein tonB

# Drug_Target_38_Number_of_Residues:
239

# Drug_Target_38_PDB_ID:
1XX3

# Drug_Target_38_Pathway:
Not Available

# Drug_Target_38_Pfam_Domain_Function:
PF03544	TonB

# Drug_Target_38_Protein_Sequence:
>Protein tonB
MTLDLPRRFPWPTLLSVCIHGAVVAGLLYTSVHQVIELPAPAQPISVTMVTPADLEPPQA
VQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESR
PASPFENTAPARLTSSTATAATSKPVTSVASGPRALSRNQPQYPARAQALRIEGQVKVKF
DVTPDGRVDNVQILSAKPANMFEREVKNAMRRWRYEPGKPGSGIVVNILFKINGTTEIQ

# Drug_Target_38_Reaction:
Not Available

# Drug_Target_38_Signals:
None

# Drug_Target_38_Specific_Function:
Interacts with outer membrane receptor proteins that carry out high-affinity binding and energy dependent uptake into the periplasmic space of specific substrates such as cobalamin, and various iron compounds (such as iron dicitrate, enterochelin, aerobactin, etc.). In the absence of tonB these receptors bind their substrates but do not carry out active transport. TonB also interacts with some colicins and is involved in the energy- dependent, irreversible steps of bacteriophages phi 80 and T1 infection. It could act to transduce energy from the cytoplasmic membrane to specific energy-requiring processes in the outer membrane, resulting in the release into the periplasm of ligands bound by these outer membrane proteins

# Drug_Target_38_SwissProt_ID:
P02929

# Drug_Target_38_SwissProt_Name:
TONB_ECOLI

# Drug_Target_38_Synonyms:
Not Available

# Drug_Target_38_Theoretical_pI:
10.28

# Drug_Target_38_Transmembrane_Regions:
1-32

# Drug_Target_39_Cellular_Location:
Matrix protein p17:Virion (By similarity)

# Drug_Target_39_Chromosome_Location:
Not Available

# Drug_Target_39_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_39_Essentiality:
Non-Essential

# Drug_Target_39_GenAtlas_ID:
Not Available

# Drug_Target_39_GenBank_ID_Gene:
U26942

# Drug_Target_39_GenBank_ID_Protein:
902799

# Drug_Target_39_GeneCard_ID:
gag

# Drug_Target_39_Gene_Name:
gag

# Drug_Target_39_Gene_Sequence:
>1503 bp
ATGGGTGCGAGAGCGTCGGTATTAAGCGGGGGAGAATTAGATAAATGGGAAAAAATTCGG
TTAAGGCCAGGGGGAAAGAAACAATATAAACTAAAACATATAGTATGGGCAAGCAGGGAG
CTAGAACGATTCGCAGTTAATCCTGGCCTTTTAGAGACATCAGAAGGCTGTAGACAAATA
CTGGGACAGCTACAACCATCCCTTCAGACAGGATCAGAAGAACTTAGATCATTATATAAT
ACAATAGCAGTCCTCTATTGTGTGCATCAAAGGATAGATGTAAAAGACACCAAGGAAGCC
TTAGATAAGATAGAGGAAGAGCAAAACAAAAGTAAGAAAAAGGCACAGCAAGCAGCAGCT
GACACAGGAAACAACAGCCAGGTCAGCCAAAATTACCCTATAGTGCAGAACCTCCAGGGG
CAAATGGTACATCAGGCCATATCACCTAGAACTTTAAATGCATGGGTAAAAGTAGTAGAA
GAGAAGGCTTTCAGCCCAGAAGTAATACCCATGTTTTCAGCATTATCAGAAGGAGCCACC
CCACAAGATTTAAATACCATGCTAAACACAGTGGGGGGACATCAAGCAGCCATGCAAATG
TTAAAAGAGACCATCAATGAGGAAGCTGCAGAATGGGATAGATTGCATCCAGTGCATGCA
GGGCCTATTGCACCAGGCCAGATGAGAGAACCAAGGGGAAGTGACATAGCAGGAACTACT
AGTACCCTTCAGGAACAAATAGGATGGATGACACATAATCCACCTATCCCAGTAGGAGAA
ATCTATAAAAGATGGATAATCCTGGGATTAAATAAAATAGTAAGAATGTATAGCCCTACC
AGCATTCTGGACATAAGACAAGGACCAAAGGAACCCTTTAGAGACTATGTAGACCGATTC
TATAAAACTCTAAGAGCCGAGCAAGCTTCACAAGAGGTAAAAAATTGGATGACAGAAACC
TTGTTGGTCCAAAATGCGAACCCAGATTGTAAGACTATTTTAAAAGCACTGGGACCAGGA
GCGACACTAGAAGAAATGATGACAGCATGTCAGGGAGTGGGGGGACCCGGCCATAAAGCA
AGAGTTTTGGCTGAAGCAATGAGCCAAGTAACAAATCCAGCTACCATAATGATACAGAAA
GGCAATTTTAGGAACCAAAGAAAGACTGTTAAGTGTTTCAATTGTGGCAAAGAAGGGCAC
ATAGCCAAAAATTGCAGGGCCCCTAGGAAAAAGGGCTGTTGGAAATGTGGAAAGGAAGGA
CACCAAATGAAAGATTGTACTGAGAGACAGGCTAATTTTTTAGGGAAGATCTGGCCTTCC
CACAAGGGAAGGCCAGGGAATTTTCTTCAGAGCAGACCAGAGCCAACAGCCCCACCAGAA
GAGAGCTTCAGGTTTGGGGAAGAGACAACAACTCCCTCTCAGAGGCAGGAGCCGATAGAC
AAGGAACTGTATCCTTTAGCTTCCCTCAGATCACTCTTTGGCAGCGACCCCTCGTCACAA
TAA

# Drug_Target_39_General_Function:
Involved in RNA binding

# Drug_Target_39_General_References:
12032547	Tang C, Ndassa Y, Summers MF: Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein. Nat Struct Biol. 2002 Jul;9(7):537-43.
12730686	Howard BR, Vajdos FF, Li S, Sundquist WI, Hill CP: Structural insights into the catalytic mechanism of cyclophilin A. Nat Struct Biol. 2003 Jun;10(6):475-81.
3016298	Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 1986 Aug;59(2):284-91.
7483282	Salminen MO, Koch C, Sanders-Buell E, Ehrenberg PK, Michael NL, Carr JK, Burke DS, McCutchan FE: Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology. 1995 Oct 20;213(1):80-6.

# Drug_Target_39_HGNC_ID:
Not Available

# Drug_Target_39_HPRD_ID:
Not Available

# Drug_Target_39_ID:
6751

# Drug_Target_39_Locus:
Not Available

# Drug_Target_39_Molecular_Weight:
55846.4

# Drug_Target_39_Name:
Gag polyprotein

# Drug_Target_39_Number_of_Residues:
500

# Drug_Target_39_PDB_ID:
1L6N

# Drug_Target_39_Pathway:
Not Available

# Drug_Target_39_Pfam_Domain_Function:
PF00098	zf-CCHC
PF00540	Gag_p17
PF00607	Gag_p24
PF08705	Gag_p6

# Drug_Target_39_Protein_Sequence:
>Gag polyprotein
MGARASVLSGGELDKWEKIRLRPGGKKQYKLKHIVWASRELERFAVNPGLLETSEGCRQI
LGQLQPSLQTGSEELRSLYNTIAVLYCVHQRIDVKDTKEALDKIEEEQNKSKKKAQQAAA
DTGNNSQVSQNYPIVQNLQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGAT
PQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRLHPVHAGPIAPGQMREPRGSDIAGTT
STLQEQIGWMTHNPPIPVGEIYKRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVDRF
YKTLRAEQASQEVKNWMTETLLVQNANPDCKTILKALGPGATLEEMMTACQGVGGPGHKA
RVLAEAMSQVTNPATIMIQKGNFRNQRKTVKCFNCGKEGHIAKNCRAPRKKGCWKCGKEG
HQMKDCTERQANFLGKIWPSHKGRPGNFLQSRPEPTAPPEESFRFGEETTTPSQRQEPID
KELYPLASLRSLFGSDPSSQ

# Drug_Target_39_Reaction:
Not Available

# Drug_Target_39_Signals:
None

# Drug_Target_39_Specific_Function:
Nucleocapsid protein p7 encapsulates and protects viral dimeric unspliced (genomic) RNA. Binds these RNAs through its zinc fingers (By similarity)

# Drug_Target_39_SwissProt_ID:
Q72497

# Drug_Target_39_SwissProt_Name:
Q72497_9HIV1

# Drug_Target_39_Synonyms:
Not Available

# Drug_Target_39_Theoretical_pI:
9.19

# Drug_Target_39_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Protein VP1:Virion. Host cytoplasm (Potential)

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
Not Available

# Drug_Target_3_GenBank_ID_Protein:
Not Available

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
Not Available

# Drug_Target_3_Gene_Sequence:
Not Available

# Drug_Target_3_General_Function:
Involved in structural molecule activity

# Drug_Target_3_General_References:
2555523	Kim SS, Smith TJ, Chapman MS, Rossmann MC, Pevear DC, Dutko FJ, Felock PJ, Diana GD, McKinlay MA: Crystal structure of human rhinovirus serotype 1A (HRV1A). J Mol Biol. 1989 Nov 5;210(1):91-111.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
6521

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
92471.9

# Drug_Target_3_Name:
Genome polyprotein

# Drug_Target_3_Number_of_Residues:
833

# Drug_Target_3_PDB_ID:
2HWD

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00073	Rhv
PF02226	Pico_P1A

# Drug_Target_3_Protein_Sequence:
>Genome polyprotein
MGAGVSRQNVGTHSTQNSVSNGSSLNYFNINYFKDAASSGASRLDSPSVEACGYSDRIMQ
ITRGDSTISSDDVANAVVGYGVWPHYLTPQDATAINKPTQPDTSSNRFYTLESKHWNGSS
KGWWWKLPDALKDMGIFGENMYYHFLGRSGYTVHVQCNASKFHQGTLLVAMIPEHQLASA
KHGSVTAGYKLTHPGEAGRDVSQERDASLRQPSDDSWLNFDGTLLGNLLIFPHQFINLRS
NNSATLIVPYVNAVPMDSMLRHNNWCLVIIPISPLRSETTSSNIVPITVSISPMCAEFSG
ARAKNIKQGLPVYITPGSGQFMTTDDMQSPCALPWYHPTKEISIPGEVKNLIEMCQVDTL
IPVNNVGNNVGNVSMYTVQLGNQTGMAQKVFSIKVDITSTPLATTLIGEIASYYTHWTGS
LRFSFMFCGTANTTLKLLLAYTPPGIDEPTTRKDAMLGTHVVWDVGLQSTISLVVPWVSA
SHFRLTADNKYSMAGYITCWYQTNLVVPPSTPQTADMLCFVSACKDFCLRMARDTDLHIQ
SGPIEQNPVENYIDEVLNEVLVVPNIKESHHTTSNSAPLLDAAETGHTSNVQPEDAIETR
YVITSQTRDEMSIESFLGRSGCVHISRIKVDYTDYNGQDINFTKWKITLQEMAQIRRKFE
LFTYVRFDSEITLVPCIAGRGDDIGHIVMQYMYVPPGAPIPSKRNDFSWQSGTNMSIFWQ
HGQPFPRFSIPFLSIASAYYMFYDGYDGDNTSSKYGSVVTNDMGTICSRIVTEKQKLSVV
ITTHIYHKAKHTKAWCPRPPRAVPYTHSHVTNYMPETGDVTTAIVRRNTITTA

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
VP0 precursor is a component of immature procapsids (By similarity)

# Drug_Target_3_SwissProt_ID:
P23008

# Drug_Target_3_SwissProt_Name:
POLG_HRV1A

# Drug_Target_3_Synonyms:
P1A
P1B
P1C
Protein VP0
Protein VP1
Protein VP2
Protein VP3
Protein VP4
VP4-VP2
Virion protein 1
Virion protein 2
Virion protein 3
Virion protein 4

# Drug_Target_3_Theoretical_pI:
6.85

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_40_Cellular_Location:
Nucleus. Cytoplasm (By similarity). Note=Following virus entry, the nuclear localization signal (NLS

# Drug_Target_40_Chromosome_Location:
Not Available

# Drug_Target_40_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_40_Essentiality:
Non-Essential

# Drug_Target_40_GenAtlas_ID:
Not Available

# Drug_Target_40_GenBank_ID_Gene:
X05291

# Drug_Target_40_GenBank_ID_Protein:
Not Available

# Drug_Target_40_GeneCard_ID:
Not Available

# Drug_Target_40_Gene_Name:
gag-pol

# Drug_Target_40_Gene_Sequence:
Not Available

# Drug_Target_40_General_Function:
Involved in RNA binding

# Drug_Target_40_General_References:
3031510	Guyader M, Emerman M, Sonigo P, Clavel F, Montagnier L, Alizon M: Genome organization and transactivation of the human immunodeficiency virus type 2. Nature. 1987 Apr 16-22;326(6114):662-9.
7613867	Priestle JP, Fassler A, Rosel J, Tintelnot-Blomley M, Strop P, Grutter MG: Comparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with CGP 53820, a novel pseudosymmetric inhibitor. Structure. 1995 Apr 15;3(4):381-9.
7743130	Tong L, Pav S, Mui S, Lamarre D, Yoakim C, Beaulieu P, Anderson PC: Crystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere. Structure. 1995 Jan 15;3(1):33-40.
7929352	Chen Z, Li Y, Chen E, Hall DL, Darke PL, Culberson C, Shafer JA, Kuo LC: Crystal structure at 1.9-A resolution of human immunodeficiency virus (HIV) II protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases. J Biol Chem. 1994 Oct 21;269(42):26344-8.
8378311	Tong L, Pav S, Pargellis C, Do F, Lamarre D, Anderson PC: Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8387-91.
9216835	Beaulieu PL, Wernic D, Abraham A, Anderson PC, Bogri T, Bousquet Y, Croteau G, Guse I, Lamarre D, Liard F, Paris W, Thibeault D, Pav S, Tong L: Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere. J Med Chem. 1997 Jul 4;40(14):2164-76.
9368756	Eijkelenboom AP, van den Ent FM, Vos A, Doreleijers JF, Hard K, Tullius TD, Plasterk RH, Kaptein R, Boelens R: The solution structure of the amino-terminal HHCC domain of HIV-2 integrase: a three-helix bundle stabilized by zinc. Curr Biol. 1997 Oct 1;7(10):739-46.
9878383	Turner BG, Summers MF: Structural biology of HIV. J Mol Biol. 1999 Jan 8;285(1):1-32.

# Drug_Target_40_HGNC_ID:
Not Available

# Drug_Target_40_HPRD_ID:
Not Available

# Drug_Target_40_ID:
3165

# Drug_Target_40_Locus:
Not Available

# Drug_Target_40_Molecular_Weight:
164647

# Drug_Target_40_Name:
Gag-Pol polyprotein

# Drug_Target_40_Number_of_Residues:
1464

# Drug_Target_40_PDB_ID:
1MU2

# Drug_Target_40_Pathway:
Not Available

# Drug_Target_40_Pfam_Domain_Function:
PF00075	RnaseH
PF00077	RVP
PF00078	RVT_1
PF00098	zf-CCHC
PF00540	Gag_p17
PF00552	Integrase
PF00607	Gag_p24
PF00665	rve
PF02022	Integrase_Zn
PF06815	RVT_connect
PF06817	RVT_thumb

# Drug_Target_40_Protein_Sequence:
>Gag-Pol polyprotein
MGARNSVLRGKKADELERIRLRPGGKKKYRLKHIVWAANKLDRFGLAESLLESKEGCQKI
LTVLDPMVPTGSENLKSLFNTVCVIWCIHAEEKVKDTEGAKQIVRRHLVAETGTAEKMPS
TSRPTAPSSEKGGNYPVQHVGGNYTHIPLSPRTLNAWVKLVEEKKFGAEVVPGFQALSEG
CTPYDINQMLNCVGDHQAAMQIIREIINEEAAEWDVQHPIPGPLPAGQLREPRGSDIAGT
TSTVEEQIQWMFRPQNPVPVGNIYRRWIQIGLQKCVRMYNPTNILDIKQGPKEPFQSYVD
RFYKSLRAEQTDPAVKNWMTQTLLVQNANPDCKLVLKGLGMNPTLEEMLTACQGVGGPGQ
KARLMAEALKEVIGPAPIPFAAAQQRKAFKCWNCGKEGHSARQCRAPRRQGCWKCGKPGH
IMTNCPDRQAGFLRTGPLGKEAPQLPRGPSSAGADTNSTPSGSSSGSTGEIYAAREKTER
AERETIQGSDRGLTAPRAGGDTIQGATNRGLAAPQFSLWKRPVVTAYIEGQPVEVLLDTG
ADDSIVAGIELGNNYSPKIVGGIGGFINTKEYKNVEIEVLNKKVRATIMTGDTPINIFGR
NILTALGMSLNLPVAKVEPIKIMLKPGKDGPKLRQWPLTKEKIEALKEICEKMEKEGQLE
EAPPTNPYNTPTFAIKKKDKNKWRMLIDFRELNKVTQDFTEIQLGIPHPAGLAKKRRITV
LDVGDAYFSIPLHEDFRPYTAFTLPSVNNAEPGKRYIYKVLPQGWKGSPAIFQHTMRQVL
EPFRKANKDVIIIQYMDDILIASDRTDLEHDRVVLQLKELLNGLGFSTPDEKFQKDPPYH
WMGYELWPTKWKLQKIQLPQKEIWTVNDIQKLVGVLNWAAQLYPGIKTKHLCRLIRGKMT
LTEEVQWTELAEAELEENRIILSQEQEGHYYQEEKELEATVQKDQENQWTYKIHQEEKIL
KVGKYAKVKNTHTNGIRLLAQVVQKIGKEALVIWGRIPKFHLPVEREIWEQWWDNYWQVT
WIPDWDFVSTPPLVRLAFNLVGDPIPGAETFYTDGSCNRQSKEGKAGYVTDRGKDKVKKL
EQTTNQQAELEAFAMALTDSGPKVNIIVDSQYVMGISASQPTESESKIVNQIIEEMIKKE
AIYVAWVPAHKGIGGNQEVDHLVSQGIRQVLFLEKIEPAQEEHEKYHSNVKELSHKFGIP
NLVARQIVNSCAQCQQKGEAIHGQVNAELGTWQMDCTHLEGKIIIVAVHVASGFIEAEVI
PQESGRQTALFLLKLASRWPITHLHTDNGANFTSQEVKMVAWWIGIEQSFGVPYNPQSQG
VVEAMNHHLKNQISRIREQANTIETIVLMAIHCMNFKRRGGIGDMTPSERLINMITTEQE
IQFLQAKNSKLKDFRVYFREGRDQLWKGPGELLWKGEGAVLVKVGTDIKIIPRRKAKIIR
DYGGRQEMDSGSHLEGAREDGEMA

# Drug_Target_40_Reaction:
deoxynucleoside triphosphate + DNAn = diphosphate + DNAn+1

# Drug_Target_40_Signals:
None

# Drug_Target_40_Specific_Function:
Integrase performs the integration of the newly synthesized dsDNA copy of the viral genome into the host chromosome. The integrated DNA is called provirus

# Drug_Target_40_SwissProt_ID:
P04584

# Drug_Target_40_SwissProt_Name:
POL_HV2RO

# Drug_Target_40_Synonyms:
Pr160Gag-Pol

# Drug_Target_40_Theoretical_pI:
8.67

# Drug_Target_40_Transmembrane_Regions:
None

# Drug_Target_41_Cellular_Location:
Golgi apparatus. Cytoplasm, perinuclear region

# Drug_Target_41_Chromosome_Location:
1

# Drug_Target_41_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_41_Essentiality:
Non-Essential

# Drug_Target_41_GenAtlas_ID:
Not Available

# Drug_Target_41_GenBank_ID_Gene:
M36340

# Drug_Target_41_GenBank_ID_Protein:
178983

# Drug_Target_41_GeneCard_ID:
ARF1

# Drug_Target_41_Gene_Name:
ARF1

# Drug_Target_41_Gene_Sequence:
>546 bp
ATGGGGAACATCTTCGCCAACCTCTTCAAGGGCCTTTTTGGCAAAAAAGAAATGCGCATC
CTCATGGTGGGCCTGGATGCTGCAGGGAAGACCACGATCCTCTACAAGCTTAAGCTGGGT
GAGATCGTGACCACCATTCCCACCATAGGCTTCAACGTGGAAACCGTGGAGTACAAGAAC
ATCAGCTTCACTGTGTGGGACGTGGGTGGCCAGGACAAGATCCGGCCCCTGTGGCGCCAC
TACTTCCAGAACACACAAGGCCTGATCTTCGTGGTGGACAGCAATGACAGAGAGCGTGTG
AACGAGGCCCGTGAGGAGCTCATGAGGATGCTGGCCGAGGACGAGCTCCGGGATGCTGTC
CTCCTGGTGTTCGCCAACAAGCAGGACCTCCCCAACGCCATGAATGCGGCCGAGATCACA
GACAAGCTGGGGCTGCACTCACTACGCCACAGGAACTGGTACATTCAGGCCACCTGCGCC
ACCAGCGGCGACGGGCTCTATGAAGGACTGGACTGGCTGTCCAATCAGCTCCGGAACCAG
AAGTGA

# Drug_Target_41_General_Function:
Involved in GTP binding

# Drug_Target_41_General_References:
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
1577740	Lee CM, Haun RS, Tsai SC, Moss J, Vaughan M: Characterization of the human gene encoding ADP-ribosylation factor 1, a guanine nucleotide-binding activator of cholera toxin. J Biol Chem. 1992 May 5;267(13):9028-34.
16710414	Gregory SG, Barlow KF, McLay KE, Kaul R, Swarbreck D, Dunham A, Scott CE, Howe KL, Woodfine K, Spencer CC, Jones MC, Gillson C, Searle S, Zhou Y, Kokocinski F, McDonald L, Evans R, Phillips K, Atkinson A, Cooper R, Jones C, Hall RE, Andrews TD, Lloyd C, Ainscough R, Almeida JP, Ambrose KD, Anderson F, Andrew RW, Ashwell RI, Aubin K, Babbage AK, Bagguley CL, Bailey J, Beasley H, Bethel G, Bird CP, Bray-Allen S, Brown JY, Brown AJ, Buckley D, Burton J, Bye J, Carder C, Chapman JC, Clark SY, Clarke G, Clee C, Cobley V, Collier RE, Corby N, Coville GJ, Davies J, Deadman R, Dunn M, Earthrowl M, Ellington AG, Errington H, Frankish A, Frankland J, French L, Garner P, Garnett J, Gay L, Ghori MR, Gibson R, Gilby LM, Gillett W, Glithero RJ, Grafham DV, Griffiths C, Griffiths-Jones S, Grocock R, Hammond S, Harrison ES, Hart E, Haugen E, Heath PD, Holmes S, Holt K, Howden PJ, Hunt AR, Hunt SE, Hunter G, Isherwood J, James R, Johnson C, Johnson D, Joy A, Kay M, Kershaw JK, Kibukawa M, Kimberley AM, King A, Knights AJ, Lad H, Laird G, Lawlor S, Leongamornlert DA, Lloyd DM, Loveland J, Lovell J, Lush MJ, Lyne R, Martin S, Mashreghi-Mohammadi M, Matthews L, Matthews NS, McLaren S, Milne S, Mistry S, Moore MJ, Nickerson T, O'Dell CN, Oliver K, Palmeiri A, Palmer SA, Parker A, Patel D, Pearce AV, Peck AI, Pelan S, Phelps K, Phillimore BJ, Plumb R, Rajan J, Raymond C, Rouse G, Saenphimmachak C, Sehra HK, Sheridan E, Shownkeen R, Sims S, Skuce CD, Smith M, Steward C, Subramanian S, Sycamore N, Tracey A, Tromans A, Van Helmond Z, Wall M, Wallis JM, White S, Whitehead SL, Wilkinson JE, Willey DL, Williams H, Wilming L, Wray PW, Wu Z, Coulson A, Vaudin M, Sulston JE, Durbin R, Hubbard T, Wooster R, Dunham I, Carter NP, McVean G, Ross MT, Harrow J, Olson MV, Beck S, Rogers J, Bentley DR, Banerjee R, Bryant SP, Burford DC, Burrill WD, Clegg SM, Dhami P, Dovey O, Faulkner LM, Gribble SM, Langford CF, Pandian RD, Porter KM, Prigmore E: The DNA sequence and biological annotation of human chromosome 1. Nature. 2006 May 18;441(7091):315-21.
1899243	Kahn RA, Kern FG, Clark J, Gelmann EP, Rulka C: Human ADP-ribosylation factors. A functionally conserved family of GTP-binding proteins. J Biol Chem. 1991 Feb 5;266(4):2606-14.
2474826	Bobak DA, Nightingale MS, Murtagh JJ, Price SR, Moss J, Vaughan M: Molecular cloning, characterization, and expression of human ADP-ribosylation factors: two guanine nucleotide-dependent activators of cholera toxin. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6101-5.
8861955	Rosa JL, Casaroli-Marano RP, Buckler AJ, Vilaro S, Barbacid M: p619, a giant protein related to the chromosome condensation regulator RCC1, stimulates guanine nucleotide exchange on ARF1 and Rab proteins. EMBO J. 1996 Aug 15;15(16):4262-73.
9110174	Yu W, Andersson B, Worley KC, Muzny DM, Ding Y, Liu W, Ricafrente JY, Wentland MA, Lennon G, Gibbs RA: Large-scale concatenation cDNA sequencing. Genome Res. 1997 Apr;7(4):353-8.

# Drug_Target_41_HGNC_ID:
GNC:652

# Drug_Target_41_HPRD_ID:
Not Available

# Drug_Target_41_ID:
6316

# Drug_Target_41_Locus:
1q42

# Drug_Target_41_Molecular_Weight:
20696.6

# Drug_Target_41_Name:
ADP-ribosylation factor 1

# Drug_Target_41_Number_of_Residues:
181

# Drug_Target_41_PDB_ID:
1R8Q

# Drug_Target_41_Pathway:
Not Available

# Drug_Target_41_Pfam_Domain_Function:
PF00025	Arf

# Drug_Target_41_Protein_Sequence:
>ADP-ribosylation factor 1
MGNIFANLFKGLFGKKEMRILMVGLDAAGKTTILYKLKLGEIVTTIPTIGFNVETVEYKN
ISFTVWDVGGQDKIRPLWRHYFQNTQGLIFVVDSNDRERVNEAREELMRMLAEDELRDAV
LLVFANKQDLPNAMNAAEITDKLGLHSLRHRNWYIQATCATSGDGLYEGLDWLSNQLRNQ
K

# Drug_Target_41_Reaction:
Not Available

# Drug_Target_41_Signals:
None

# Drug_Target_41_Specific_Function:
GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP- ribosyltransferase. Involved in protein trafficking among different compartments. Modulates vesicle budding and uncoating within the Golgi complex. Deactivation induces the redistribution of the entire Golgi complex to the endoplasmic reticulum, suggesting a crucial role in protein trafficking. In its GTP-bound form, its triggers the association with coat proteins with the Golgi membrane. The hydrolysis of ARF1-bound GTP, which is mediated by ARFGAPs proteins, is required for dissociation of coat proteins from Golgi membranes and vesicles

# Drug_Target_41_SwissProt_ID:
P84077

# Drug_Target_41_SwissProt_Name:
ARF1_HUMAN

# Drug_Target_41_Synonyms:
Not Available

# Drug_Target_41_Theoretical_pI:
6.80

# Drug_Target_41_Transmembrane_Regions:
None

# Drug_Target_42_Cellular_Location:
Membrane

# Drug_Target_42_Chromosome_Location:
6

# Drug_Target_42_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_42_Essentiality:
Non-Essential

# Drug_Target_42_GenAtlas_ID:
Not Available

# Drug_Target_42_GenBank_ID_Gene:
L36859

# Drug_Target_42_GenBank_ID_Protein:
623403

# Drug_Target_42_GeneCard_ID:
GUCA1A

# Drug_Target_42_Gene_Name:
GUCA1A

# Drug_Target_42_Gene_Sequence:
>606 bp
ATGGGCAACGTGATGGAGGGAAAGTCAGTGGAGGAGCTGAGCAGCACCGAGTGCCACCAG
TGGTACAAGAAGTTCATGACTGAGTGCCCCTCTGGCCAACTCACCCTCTATGAGTTCCGC
CAGTTCTTCGGCCTCAAGAACCTGAGCCCGTCGGCCAGCCAGTACGTGGAACAGATGTTT
GAGACTTTTGACTTCAACAAGGACGGCTACATTGATTTCATGGAGTACGTGGCAGGCCTC
AGCTTGGTCCTCAAGGGGAAGGTGGAACAGAAGCTCCGCTGGTACTTCAAGCTCTATGAT
GTAGATGGCAACGGCTGCATTGACCGCGATGAGCTGCTCACCATCATCCAGGCCATTCGC
GCCATTAACCCCTGCAGCGATACCACCATGACTGCAGAGGAGTTCACCGATACAGTGTTC
TCCAAGATTGACGTCAACGGGGATGGGGAACTCTCCCTGGAAGAGTTTATAGAGGGCGTC
CAGAAGGACCAGATGCTCCTGGACACACTGACACGAAGCCTGGACCTTACCCGCATCGTG
CGCAGGCTCCAGAATGGCGAGCAAGACGAGGAGGGGGCTGACGAGGCCGCTGAGGCAGCC
GGCTGA

# Drug_Target_42_General_Function:
Involved in calcium ion binding

# Drug_Target_42_General_References:
11108966	Sokal I, Li N, Verlinde CL, Haeseleer F, Baehr W, Palczewski K: Ca(2+)-binding proteins in the retina: from discovery to etiology of human disease(1). Biochim Biophys Acta. 2000 Dec 20;1498(2-3):233-51.
11146732	Downes SM, Holder GE, Fitzke FW, Payne AM, Warren MJ, Bhattacharya SS, Bird AC: Autosomal dominant cone and cone-rod dystrophy with mutations in the guanylate cyclase activator 1A gene-encoding guanylate cyclase activating protein-1. Arch Ophthalmol. 2001 Jan;119(1):96-105.
11484154	Wilkie SE, Li Y, Deery EC, Newbold RJ, Garibaldi D, Bateman JB, Zhang H, Lin W, Zack DJ, Bhattacharya SS, Warren MJ, Hunt DM, Zhang K: Identification and functional consequences of a new mutation (E155G) in the gene for GCAP1 that causes autosomal dominant cone dystrophy. Am J Hum Genet. 2001 Sep;69(3):471-80. Epub 2001 Jul 31.
14574404	Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, Wilming L, Jones MC, Horton R, Hunt SE, Scott CE, Gilbert JG, Clamp ME, Bethel G, Milne S, Ainscough R, Almeida JP, Ambrose KD, Andrews TD, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beare DM, Beasley H, Beasley O, Bird CP, Blakey S, Bray-Allen S, Brook J, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Clark SY, Clark G, Clee CM, Clegg S, Cobley V, Collier RE, Collins JE, Colman LK, Corby NR, Coville GJ, Culley KM, Dhami P, Davies J, Dunn M, Earthrowl ME, Ellington AE, Evans KA, Faulkner L, Francis MD, Frankish A, Frankland J, French L, Garner P, Garnett J, Ghori MJ, Gilby LM, Gillson CJ, Glithero RJ, Grafham DV, Grant M, Gribble S, Griffiths C, Griffiths M, Hall R, Halls KS, Hammond S, Harley JL, Hart EA, Heath PD, Heathcott R, Holmes SJ, Howden PJ, Howe KL, Howell GR, Huckle E, Humphray SJ, Humphries MD, Hunt AR, Johnson CM, Joy AA, Kay M, Keenan SJ, Kimberley AM, King A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd CR, Lloyd DM, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, Maslen GL, Matthews L, McCann OT, McLaren SJ, McLay K, McMurray A, Moore MJ, Mullikin JC, Niblett D, Nickerson T, Novik KL, Oliver K, Overton-Larty EK, Parker A, Patel R, Pearce AV, Peck AI, Phillimore B, Phillips S, Plumb RW, Porter KM, Ramsey Y, Ranby SA, Rice CM, Ross MT, Searle SM, Sehra HK, Sheridan E, Skuce CD, Smith S, Smith M, Spraggon L, Squares SL, Steward CA, Sycamore N, Tamlyn-Hall G, Tester J, Theaker AJ, Thomas DW, Thorpe A, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, White SS, Whitehead SL, Whittaker H, Wild A, Willey DJ, Wilmer TE, Wood JM, Wray PW, Wyatt JC, Young L, Younger RM, Bentley DR, Coulson A, Durbin R, Hubbard T, Sulston JE, Dunham I, Rogers J, Beck S: The DNA sequence and analysis of human chromosome 6. Nature. 2003 Oct 23;425(6960):805-11.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
7983048	Subbaraya I, Ruiz CC, Helekar BS, Zhao X, Gorczyca WA, Pettenati MJ, Rao PN, Palczewski K, Baehr W: Molecular characterization of human and mouse photoreceptor guanylate cyclase-activating protein (GCAP) and chromosomal localization of the human gene. J Biol Chem. 1994 Dec 9;269(49):31080-9.
9425234	Payne AM, Downes SM, Bessant DA, Taylor R, Holder GE, Warren MJ, Bird AC, Bhattacharya SS: A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21.1. Hum Mol Genet. 1998 Feb;7(2):273-7.

# Drug_Target_42_HGNC_ID:
GNC:4678

# Drug_Target_42_HPRD_ID:
Not Available

# Drug_Target_42_ID:
6752

# Drug_Target_42_Locus:
6p21.1

# Drug_Target_42_Molecular_Weight:
22919.5

# Drug_Target_42_Name:
Guanylyl cyclase-activating protein 1

# Drug_Target_42_Number_of_Residues:
201

# Drug_Target_42_PDB_ID:
Not Available

# Drug_Target_42_Pathway:
Not Available

# Drug_Target_42_Pfam_Domain_Function:
PF00036	efhand

# Drug_Target_42_Protein_Sequence:
>Guanylyl cyclase-activating protein 1
MGNVMEGKSVEELSSTECHQWYKKFMTECPSGQLTLYEFRQFFGLKNLSPSASQYVEQMF
ETFDFNKDGYIDFMEYVAALSLVLKGKVEQKLRWYFKLYDVDGNGCIDRDELLTIIQAIR
AINPCSDTTMTAEEFTDTVFSKIDVNGDGELSLEEFIEGVQKDQMLLDTLTRSLDLTRIV
RRLQNGEQDEEGADEAAEAAG

# Drug_Target_42_Reaction:
Not Available

# Drug_Target_42_Signals:
None

# Drug_Target_42_Specific_Function:
Stimulates guanylyl cyclase 1 (GC1) when free calcium ions concentration is low and inhibits GC1 when free calcium ions concentration is elevated. This Ca(2+)-sensitive regulation of GC is a key event in recovery of the dark state of rod photoreceptors following light exposure

# Drug_Target_42_SwissProt_ID:
P43080

# Drug_Target_42_SwissProt_Name:
GUC1A_HUMAN

# Drug_Target_42_Synonyms:
GCAP 1
Guanylate cyclase activator 1A

# Drug_Target_42_Theoretical_pI:
4.07

# Drug_Target_42_Transmembrane_Regions:
None

# Drug_Target_43_Cellular_Location:
Not Available

# Drug_Target_43_Chromosome_Location:
Not Available

# Drug_Target_43_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_43_Essentiality:
Non-Essential

# Drug_Target_43_GenAtlas_ID:
Not Available

# Drug_Target_43_GenBank_ID_Gene:
Not Available

# Drug_Target_43_GenBank_ID_Protein:
Not Available

# Drug_Target_43_GeneCard_ID:
Not Available

# Drug_Target_43_Gene_Name:
Rv0233

# Drug_Target_43_Gene_Sequence:
Not Available

# Drug_Target_43_General_Function:
Not Available

# Drug_Target_43_General_References:
Not Available

# Drug_Target_43_HGNC_ID:
Not Available

# Drug_Target_43_HPRD_ID:
Not Available

# Drug_Target_43_ID:
6754

# Drug_Target_43_Locus:
Not Available

# Drug_Target_43_Molecular_Weight:
Not Available

# Drug_Target_43_Name:
R2-like ligand binding oxidase

# Drug_Target_43_Number_of_Residues:
0

# Drug_Target_43_PDB_ID:
Not Available

# Drug_Target_43_Pathway:
Not Available

# Drug_Target_43_Pfam_Domain_Function:
Not Available

# Drug_Target_43_Protein_Sequence:
Not Available

# Drug_Target_43_Reaction:
Not Available

# Drug_Target_43_Signals:
Not Available

# Drug_Target_43_Specific_Function:
Not Available

# Drug_Target_43_SwissProt_ID:
P96416

# Drug_Target_43_SwissProt_Name:
RIR2H_MYCTU

# Drug_Target_43_Synonyms:
Not Available

# Drug_Target_43_Theoretical_pI:
Not Available

# Drug_Target_43_Transmembrane_Regions:
Not Available

# Drug_Target_44_Cellular_Location:
Isoform Gamma:Secreted

# Drug_Target_44_Chromosome_Location:
1

# Drug_Target_44_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_44_Essentiality:
Non-Essential

# Drug_Target_44_GenAtlas_ID:
Not Available

# Drug_Target_44_GenBank_ID_Gene:
M24407

# Drug_Target_44_GenBank_ID_Protein:
190205

# Drug_Target_44_GeneCard_ID:
PVR

# Drug_Target_44_Gene_Name:
PVR

# Drug_Target_44_Gene_Sequence:
Not Available

# Drug_Target_44_General_Function:
Involved in cell adhesion molecule binding

# Drug_Target_44_General_References:
11437656	Lange R, Peng X, Wimmer E, Lipp M, Bernhardt G: The poliovirus receptor CD155 mediates cell-to-matrix contacts by specifically binding to vitronectin. Virology. 2001 Jul 5;285(2):218-27.
11751937	Mueller S, Cao X, Welker R, Wimmer E: Interaction of the poliovirus receptor CD155 with the dynein light chain Tctex-1 and its implication for poliovirus pathogenesis. J Biol Chem. 2002 Mar 8;277(10):7897-904. Epub 2001 Dec 21.
1331527	Zibert A, Wimmer E: N glycosylation of the virus binding domain is not essential for function of the human poliovirus receptor. J Virol. 1992 Dec;66(12):7368-73.
14702039	Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21.
15057824	Grimwood J, Gordon LA, Olsen A, Terry A, Schmutz J, Lamerdin J, Hellsten U, Goodstein D, Couronne O, Tran-Gyamfi M, Aerts A, Altherr M, Ashworth L, Bajorek E, Black S, Branscomb E, Caenepeel S, Carrano A, Caoile C, Chan YM, Christensen M, Cleland CA, Copeland A, Dalin E, Dehal P, Denys M, Detter JC, Escobar J, Flowers D, Fotopulos D, Garcia C, Georgescu AM, Glavina T, Gomez M, Gonzales E, Groza M, Hammon N, Hawkins T, Haydu L, Ho I, Huang W, Israni S, Jett J, Kadner K, Kimball H, Kobayashi A, Larionov V, Leem SH, Lopez F, Lou Y, Lowry S, Malfatti S, Martinez D, McCready P, Medina C, Morgan J, Nelson K, Nolan M, Ovcharenko I, Pitluck S, Pollard M, Popkie AP, Predki P, Quan G, Ramirez L, Rash S, Retterer J, Rodriguez A, Rogers S, Salamov A, Salazar A, She X, Smith D, Slezak T, Solovyev V, Thayer N, Tice H, Tsai M, Ustaszewska A, Vo N, Wagner M, Wheeler J, Wu K, Xie G, Yang J, Dubchak I, Furey TS, DeJong P, Dickson M, Gordon D, Eichler EE, Pennacchio LA, Richardson P, Stubbs L, Rokhsar DS, Myers RM, Rubin EM, Lucas SM: The DNA sequence and biology of human chromosome 19. Nature. 2004 Apr 1;428(6982):529-35.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
1851992	Koike S, Ise I, Nomoto A: Functional domains of the poliovirus receptor. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4104-8.
2170108	Koike S, Horie H, Ise I, Okitsu A, Yoshida M, Iizuka N, Takeuchi K, Takegami T, Nomoto A: The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 1990 Oct;9(10):3217-24.
2538245	Mendelsohn CL, Wimmer E, Racaniello VR: Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell. 1989 Mar 10;56(5):855-65.

# Drug_Target_44_HGNC_ID:
GNC:9705

# Drug_Target_44_HPRD_ID:
Not Available

# Drug_Target_44_ID:
6755

# Drug_Target_44_Locus:
19q13.2

# Drug_Target_44_Molecular_Weight:
45302.3

# Drug_Target_44_Name:
Poliovirus receptor

# Drug_Target_44_Number_of_Residues:
417

# Drug_Target_44_PDB_ID:
1DGI

# Drug_Target_44_Pathway:
Not Available

# Drug_Target_44_Pfam_Domain_Function:
PF00047	ig
PF07686	V-set
PF08205	C2-set_2

# Drug_Target_44_Protein_Sequence:
>Poliovirus receptor
MARAMAAAWPLLLVALLVLSWPPPGTGDVVVQAPTQVPGFLGDSVTLPCYLQVPNMEVTH
VSQLTWARHGESGSMAVFHQTQGPSYSESKRLEFVAARLGAELRNASLRMFGLRVEDEGN
YTCLFVTFPQGSRSVDIWLRVLAKPQNTAEVQKVQLTGEPVPMARCVSTGGRPPAQITWH
SDLGGMPNTSQVPGFLSGTVTVTSLWILVPSSQVDGKNVTCKVEHESFEKPQLLTVNLTV
YYPPEVSISGYDNNWYLGQNEATLTCDARSNPEPTGYNWSTTMGPLPPFAVAQGAQLLIR
PVDKPINTTLICNVTNALGARQAELTVQVKEGPPSEHSGISRNAIIFLVLGILVFLILLG
IGIYFYWSKCSREVLWHCHLCPSSTEHASASANGHVSYSAVSRENSSSQDPQTEGTR

# Drug_Target_44_Reaction:
Not Available

# Drug_Target_44_Signals:
1-20

# Drug_Target_44_Specific_Function:
Mediates NK cell adhesion and triggers NK cell effector functions. Binds two different NK cell receptors:CD96 and CD226. These interactions accumulates at the cell-cell contact site, leading to the formation of a mature immunological synapse between NK cell and target cell. This may trigger adhesion and secretion of lytic granules and IFN-gamma and activate cytoxicity of activated NK cells. May also promote NK cell-target cell modular exchange, and PVR transfer to the NK cell. This transfer is more important in some tumor cells expressing a lot of PVR, and may trigger fratricide NK cell activation, providing tumors with a mechanism of immunoevasion. Plays a role in mediating tumor cell invasion and migration. Serves as a receptor for poliovirus attachment to target cells. May play a role in axonal transport of poliovirus, by targeting virion-PVR-containing endocytic vesicles to the microtubular network through interaction with DYNLT1. This interaction would drive the virus-containing vesicle to the axonal retrograde transport

# Drug_Target_44_SwissProt_ID:
P15151

# Drug_Target_44_SwissProt_Name:
PVR_HUMAN

# Drug_Target_44_Synonyms:
CD155 antigen
Necl-5
Nectin-like protein 5

# Drug_Target_44_Theoretical_pI:
6.50

# Drug_Target_44_Transmembrane_Regions:
344-367

# Drug_Target_45_Cellular_Location:
Membrane

# Drug_Target_45_Chromosome_Location:
Not Available

# Drug_Target_45_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_45_Essentiality:
Non-Essential

# Drug_Target_45_GenAtlas_ID:
TLR4

# Drug_Target_45_GenBank_ID_Gene:
U93091

# Drug_Target_45_GenBank_ID_Protein:
Not Available

# Drug_Target_45_GeneCard_ID:
Not Available

# Drug_Target_45_Gene_Name:
TLR4

# Drug_Target_45_Gene_Sequence:
>2520 bp
ATGATGTCTGCCTCGCGCCTGGCTGGGACTCTGATCCCAGCCATGGCCTTCCTCTCCTGC
GTGAGACCAGAAAGCTGGGAGCCCTGCGTGGAGGTGGTTCCTAATATTACTTATCAATGC
ATGGAGCTGAATTTCTACAAAATCCCCGACAACCTCCCCTTCTCAACCAAGAACCTGGAC
CTGAGCTTTAATCCCCTGAGGCATTTAGGCAGCTATAGCTTCTTCAGTTTCCCAGAACTG
CAGGTGCTGGATTTATCCAGGTGTGAAATCCAGACAATTGAAGATGGGGCATATCAGAGC
CTAAGCCACCTCTCTACCTTAATATTGACAGGAAACCCCATCCAGAGTTTAGCCCTGGGA
GCCTTTTCTGGACTATCAAGTTTACAGAAGCTGGTGGCTGTGGAGACAAATCTAGCATCT
CTAGAGAACTTCCCCATTGGACATCTCAAAACTTTGAAAGAACTTAATGTGGCTCACAAT
CTTATCCAATCTTTCAAATTACCTGAGTATTTTTCTAATCTGACCAATCTAGAGCACTTG
GACCTTTCCAGCAACAAGATTCAAAGTATTTATTGCACAGACTTGCGGGTTCTACATCAA
ATGCCCCTACTCAATCTCTCTTTAGACCTGTCCCTGAATCCTATGAACTTTATCCAACCA
GGTGCATTTAAAGAAATTAGGCTTCATAAGCTGACTTTAAGAAATAATTTTGATAGTTTA
AATGTAATGAAAACTTGTATTCAAGGTCTGGCTGGTTTAGAAGTCCATCGTTTGGTTCTG
GGAGAATTTAGAAATGAAGGAAACTTGGAAAAGTTTGACAAATCTGCTCTAGAGGGCCTG
TGCAATTTGACCATTGAAGAATTCCGATTAGCATACTTAGACTACTACCTCGATGATATT
ATTGACTTATTTAATTGTTTGACAAATGTTTCTTCATTTTCCCTGGTGAGTGTGACTATT
GAAAGGGTAAAAGACTTTTCTTATAATTTCGGATGGCAACATTTAGAATTAGTTAACTGT
AAATTTGGACAGTTTCCCACATTGAAACTCAAATCTCTCAAAAGGCTTACTTTCACTTCC
AACAAAGGTGGGAATGCTTTTTCAGAAGTTGATCTACCAAGCCTTGAGTTTCTAGATCTC
AGTAGAAATGGCTTGAGTTTCAAAGGTTGCTGTTCTCAAAGTGATTTTGGGACAACCAGC
CTAAAGTATTTAGATCTGAGCTTCAATGGTGTTATTACCATGAGTTCAAACTTCTTGGGC
TTAGAACAACTAGAACATCTGGATTTCCAGCATTCCAATTTGAAACAAATGAGTGAGTTT
TCAGTATTCCTATCACTCAGAAACCTCATTTACCTTGACATTTCTCATACTCACACCAGA
GTTGCTTTCAATGGCATCTTCAATGGCTTGTCCAGTCTCGAAGTCTTGAAAATGGCTGGC
AATTCTTTCCAGGAAAACTTCCTTCCAGATATCTTCACAGAGCTGAGAAACTTGACCTTC
CTGGACCTCTCTCAGTGTCAACTGGAGCAGTTGTCTCCAACAGCATTTAACTCACTCTCC
AGTCTTCAGGTACTAAATATGAGCCACAACAACTTCTTTTCATTGGATACGTTTCCTTAT
AAGTGTCTGAACTCCCTCCAGGTTCTTGATTACAGTCTCAATCACATAATGACTTCCAAA
AAACAGGAACTACAGCATTTTCCAAGTAGTCTAGCTTTCTTAAATCTTACTCAGAATGAC
TTTGCTTGTACTTGTGAACACCAGAGTTTCCTGCAATGGATCAAGGACCAGAGGCAGCTC
TTGGTGGAAGTTGAACGAATGGAATGTGCAACACCTTCAGATAAGCAGGGCATGCCTGTG
CTGAGTTTGAATATCACCTGTCAGATGAATAAGACCATCATTGGTGTGTCGGTCCTCAGT
GTGCTTGTAGTATCTGTTGTAGCAGTTCTGGTCTATAAGTTCTATTTTCACCTGATGCTT
CTTGCTGGCTGCATAAAGTATGGTAGAGGTGAAAACATCTATGATGCCTTTGTTATCTAC
TCAAGCCAGGATGAGGACTGGGTAAGGAATGAGCTAGTAAAGAATTTAGAAGAAGGGGTG
CCTCCATTTCAGCTCTGCCTTCACTACAGAGACTTTATTCCCGGTGTGGCCATTGCTGCC
AACATCATCCATGAAGGTTTCCATAAAAGCCGAAAGGTGATTGTTGTGGTGTCCCAGCAC
TTCATCCAGAGCCGCTGGTGTATCTTTGAATATGAGATTGCTCAGACCTGGCAGTTTCTG
AGCAGTCGTGCTGGTATCATCTTCATTGTCCTGCAGAAGGTGGAGAAGACCCTGCTCAGG
CAGCAGGTGGAGCTGTACCGCCTTCTCAGCAGGAACACTTACCTGGAGTGGGAGGACAGT
GTCCTGGGGCGGCACATCTTCTGGAGACGACTCAGAAAAGCCCTGCTGGATGGTAAATCA
TGGAATCCAGAAGGAACAGTGGGTACAGGATGCAATTGGCAGGAAGCAACATCTATCTGA

# Drug_Target_45_General_Function:
Involved in protein binding

# Drug_Target_45_General_References:
10835634	Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2000 Jun;25(2):187-91.
11081518	Xu Y, Tao X, Shen B, Horng T, Medzhitov R, Manley JL, Tong L: Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature. 2000 Nov 2;408(6808):111-5.
11104518	Smirnova I, Poltorak A, Chan EK, McBride C, Beutler B: Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol. 2000;1(1):RESEARCH002. Epub 2000 Apr 27.
11514453	Smirnova I, Hamblin MT, McBride C, Beutler B, Di Rienzo A: Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genetics. 2001 Aug;158(4):1657-64.
11706042	da Silva Correia J, Ulevitch RJ: MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J Biol Chem. 2002 Jan 18;277(3):1845-54. Epub 2001 Nov 12.
9237759	Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997 Jul 24;388(6640):394-7.
9435236	Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF: A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):588-93.

# Drug_Target_45_HGNC_ID:
HGNC:11850

# Drug_Target_45_HPRD_ID:
Not Available

# Drug_Target_45_ID:
4210

# Drug_Target_45_Locus:
9q32-q33

# Drug_Target_45_Molecular_Weight:
95681

# Drug_Target_45_Name:
Toll-like receptor 4

# Drug_Target_45_Number_of_Residues:
839

# Drug_Target_45_PDB_ID:
Not Available

# Drug_Target_45_Pathway:
Not Available

# Drug_Target_45_Pfam_Domain_Function:
PF00560	LRR_1
PF01463	LRRCT
PF01582	TIR

# Drug_Target_45_Protein_Sequence:
>Toll-like receptor 4
MMSASRLAGTLIPAMAFLSCVRPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLD
LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG
AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL
DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSL
NVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDI
IDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTS
NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG
LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG
NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY
KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQL
LVEVERMECATPSDKQGMPVLSLNITCQMNKTIIGVSVLSVLVVSVVAVLVYKFYFHLML
LAGCIKYGRGENIYDAFVIYSSQDEDWVRNELVKNLEEGVPPFQLCLHYRDFIPGVAIAA
NIIHEGFHKSRKVIVVVSQHFIQSRWCIFEYEIAQTWQFLSSRAGIIFIVLQKVEKTLLR
QQVELYRLLSRNTYLEWEDSVLGRHIFWRRLRKALLDGKSWNPEGTVGTGCNWQEATSI

# Drug_Target_45_Reaction:
Not Available

# Drug_Target_45_Signals:
1-23

# Drug_Target_45_Specific_Function:
Cooperates with LY96 and CD14 to mediate the innate immune response to bacterial lipopolysaccharide (LPS). Acts via MyD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response

# Drug_Target_45_SwissProt_ID:
O00206

# Drug_Target_45_SwissProt_Name:
TLR4_HUMAN

# Drug_Target_45_Synonyms:
CD284 antigen
Toll-like receptor 4 precursor
hToll

# Drug_Target_45_Theoretical_pI:
6.26

# Drug_Target_45_Transmembrane_Regions:
632-652

# Drug_Target_4_Cellular_Location:
RNA-directed RNA polymerase 3D-POL:Host cytoplasmic vesicle membrane

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_4_Essentiality:
Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
D00214

# Drug_Target_4_GenBank_ID_Protein:
2696867

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
Not Available

# Drug_Target_4_Gene_Sequence:
>6528 bp
ATGGGAGCCCAGTTGAGCAGAAATACTGCCGGGAGCCACACTACTGGAACCTACGCTACC
GGAGGCTCAACCATTAATTATAACAACATTAACTACTACAGCCACGCCGCTTCTGCAGCG
CAGAACAAACAAGACTTCACCCAGGACCCATCCAAGTTCACTCAGCCAATTGCGGATGTG
ATAAAGGAGACAGCGGTTCCACTTAAGTCACCAAGCGCAGAAGCGTGCGGTTACAGTGAT
CGCGTAGCCCAGTTGACACTTGGCAACAGCACTATCACTACCCAAGAGGCAGCAAATATA
TGCGTTGCTTATGGCTGCTGGCCTGCAAAGCTTAGCGACACTGATGCCACATCAGTGGAC
AAGCCCACTGAACCAGGTGTATCAGCGGAGCGCTTTTATACCCTCCGTTCCAAGCCGTGG
CAGGCAGATAGCAAGGGGTGGTATTGGAAGCTACCCGATGCACTCAACAATACAGGAATG
TTTGGACAGAACGCCCAGTTCCACTACATCTATAGAGGTGGGTGGGCAGTGCACGTCCAA
TGCAATGCAACCAAATTCCACCAGGGCACGCTCCTTGTGCTTGCAATCCCAGAACACCAA
ATCGCCACACAAGAGCAGCCCGCTTTTGACAGAACCATGCCAGGCAGCGAAGGCGGCACT
TTCCAAGAGCCCTTCTGGCTCGAGGATGGAACGTCTTTAGGAAACTCCCTGATCTATCCG
CACCAGTGGATCAACCTTAGGACAAACAATTCAGCAACCCTGATATTACCATACGTGAAT
GCCATTCCGATGGACTCGGCCATTAGGCATTCAAATTGGACACTAGCTATCATTCCAGTT
GCACCCTTGAAATATGCAGCCGAGACCACGCCGCTTGTCCCCATTACTGTGACTATCGCA
CCGATGGAGACGGAGTACAACGGGCTTAGACGCGCTATAGCTAGCAATCAAGGCCTTCCA
ACTAAGCCAGGGCCAGGTTCCTACCAGTTCATGACTACTGATGAGGATTGTTCCCCGTGC
ATTTTGCCTGATTTCCAGCCGACCCCTGAAATTTTCATCCCTGGTAAGGTCAATAACCTT
TTGGAAATTGCGCAAGTTGAGTCTATCCTTGAGGCCAACAACAGGGAAGGGGTAGAGGGT
GTTGAGCGGTATGTCATCCCAGTAAGTGTTCAGGACGCATTGGATGCCCAGATTTATGCC
CTAAGACTTGAGCTTGGCGGAAGTGGCCCTCTCTCCTCCAGCCTTCTAGGTACCTTAGCA
AAGCATTATACCCAATGGAGTGGGTCAGTGGAGATCACCTGCATGTTCACTGGCACCTTC
ATGACAACAGGAAAGGTCCTCTTGGCATACACACCTCCAGGTGGAGATATGCCTAGGAAT
AGAGAAGAAGCCATGCTTGGAACGCATGTTGTCTGGGACTTTGGTCTACAATCATCAATA
ACCTTGGTCATACCTTGGATCTCTGCATCACATTTTAGAGGAGTCAGTAATGACGATGTG
CTGAATTACCAATATTATGCAGCAGGTCATGTCACCATCTGGTACCAAACAAACATGGTA
ATCCCTCCGGGATTCCCTAACACGGCAGGCATAATCATGATGATTGCCGCACAGCCAAAC
TTCTCCTTCCGCATTCAAAAGGATAGGGAAGACATGACCCAAACTGCAATTCTGCAGAAT
GACCCAGGCAAGATGCTAAAGGATGCGATTGACAAACAAGTTGCAGGAGCCCTAGTTGCT
GGTACCACGACATCCACCCACTCAGTAGCCACGGACAGCACACCAGCCCTGCAGGCCGCT
GAGACTGGTGCCACGTCAACTGCCAGGGATGAGAGCATGATTGAGACCCGCACTATTGTG
CCGACTCACGGTATCCACGAGACAAGTGTGGAGAGTTTCTTTGGACGCTCCTCACTCGTG
GGTATGCCGCTGCTGGCCACTGGCACCAGTATCACCAACTGGCGCATTGACTTCAGGGAG
TTCGTCCAGTTGAGAGCCAAGATGTCCTGGTTTACTTACATGCGCTTTGACGTGGAGTTC
ACCATAATTGCAACAAGTTCTACTGGGCAGAATGTTACCACCGAGCAGCACACCACTTAC
CAGGTGATGTACGTCCCCCCTGGGGCACCCGTTCCCTCCAATCAAGACTCATTTCAGTGG
CAATCTGGGTGCAACCCCTCGGTATTCGCGGACACGGACGGACCACCTGCCCAATTCTCA
GTACCCTTCATGAGCTCAGCCAATGCGTATTCCACGGTTTATGATGGGTACGCACGATTC
ATGGACACTGACCCAGATAGATATGGCATCCTCCCGAGCAATTTCCTGGGATTCATGTAC
TTCAGGACACTCGAAGACGCAGCACACCAAGTAAGGTTCCGCATCTGTGCCAAAATAAAA
CACACCAGCTGCTGGATCCCACGTGCACCCAGACAAGCACCATACAAGAAGAGGTACAAC
CTGGTATTCAGTGGGGATTCCGACAGGATTTGTTCTAACAGAGCCAGCTTGACTAGCTAT
GGACCCTTTGGGCAGCAGCAGGGTGCTGCGTATGTGGGCTCCTACAAAATTTTAAACAGA
CACCTTGCCACATACGCTGATTGGGAAAATGAAGTCTGGCAATCTTACCAGCGTGATCTA
CTTGTTACTAGAGTTGATGCTCACGGGTGTGACACCATCGCTCGATGCAATTGCAGATCT
GGTATCTATTACTGCAAATCCACAGCCAAGCACTATCCTATTGTAGTCACGCCCCCATCT
ATCTACAAGATTGAGGCCAACGATTATTACCCAGAAAGAATGCAAACTCACATCCTTCTT
GGGATTGGCTTCGCTGAGCCCGGTGATTGCGGTGGTCTTCTTCGTTGTGAGCATGGTGTT
ATGGGCATTCTTACGGTTGGCGGTGGAGACCATGTCGGGTTTGCAGATGTTCGTGACCTC
CTTTGGATAGAGGATGACGCCATGGAACAGGGAATCACTGACTACGTCCAACAGTTAGGC
AATGCCTTTGGAGCTGGATTCACTGCTGAGATTGCAAATTACACCAACCAACTCAGGGAC
ATGTTAATGGGCTCAGATTCAGTAGTAGAGAAGATCATTAGGTCTCTTGTCCGACTGGTT
TCTGCGCTGGTTATAGTGGTGAGAAACCACCAGGATTTGATTACCGTGGGAGCAACCCTC
GCCCTTCTAGGTTGTGAAGGCTCTCCATGGAAATGGCTGAAGAGAAAGGTTTGCCAAATT
CTTGGAATCAACATGGCAGAAAGGCAGTCAGACAACTGGATGAAAAAGTTCACTGAGATG
TGCAACGCCTTCAGAGGCCTAGACTGGATCGCAGCAAAAATCTCCAAGTTTATTGATTGG
CTTAAACAAAAGATCCTACCAGAACTCAAAGAGAGAGCAGAGTTCGTCAAGAAGTTAAAA
CAGCTCCCACTCTTAGAGGCTCAGGTGAACACTCTGGAACACTCTTCCGCTAGTCAGGAG
AGGCAAGAACAATTGTTTGGGAATGTTCAGTACCTTGCCCATCATTGTAGAAAGAACGCC
CCGCTTTATGCCGCAGAAGCTAAGCGCGTCTACCATCTAGAGAAGCGCGTCCTCCGTGCC
ATGCAGTTCAAGACCAAGAACCGCATTGAACCTGTATGTGCACTGATTCATGGCTCACCT
GGTACCGGTCAGTCGTTGGCTACTATGATAGTAGGAAGAAAACTGGCTGAGTACGAAGGT
TCCGACGTCTACTCCCTACCGCCTGACCCGGATCATTTTGATGGCTACCAACAACAAGCC
GTCGTAGTGATGGATGATTTACTTCAAAACCCCGATGGGAAGGACATGACCTTGTTTTGC
CAAATGGTTTCGACGGCTCCTTTTACTGTGCCCATGGCTGCTTTGGAGGATAAGGGGAAG
CTCTTCACTTCCAAATTTGTGCTAGCTTCTACTAATGCAGGCCAAGTTACTCCGCCAACC
GTGGCTGATTATAAGGCGCTGCAGAGAAGGTTTTTCTTTGATTGTGACATTGAGGTCCAG
AAGGAATACAAAAGAGATGGGGTCACTCTGGATGTGGCCAAGGCTACTGAGACCTGTGAA
GACTGCTCCCCAGCCAATTTCAAGAAGTGCATGCCGTTGATTTGCGGAAAGGCCCTCCAG
CTAAAATCGCGCAAGGGCGATGGGATGAGATACAGCCTGGACACCCTGATTAGTGAGCTT
CGGCGTGAGAGCAACCGCCGTTACAATATTGGCAACGTCCTTGAGGCCCTGTTCCAAGGG
CCAGTGTGTTATAAGCCTCTTAGAATTGAAGTTCATGAGGAAGAACCAGCACCTTCCGCC
ATTAGCGATTTGCTGCAGGCAGTCGATAGTGAGGAGGTGAGGGAATATTGCAGGTCCAAG
GGTTGGATTGTTGAAGAGAGGGTCACTGAACTTAAGCTTGAGCGCAACGTGAACCGTGCG
CTGGCAGTCATTCAGAGTGTGTCTCTCATTGCTGCAGTGGCTGGGACCATTTACATAGTT
TATCGCCTCTTTTCTGGTATGCAGGGCCCTTACTCAGGTATCGGCACAAACTACGCCACA
AAGAAACCAGTGGTAAGACAGGTACAAACCCAAGGTCCTCTTTTTGATTTCGGCGTCTCC
CTACTTAAGAAGAACATTAGGACAGTCAAAACAGGTGCAGGCGAGTTTACCGCCCTGGGG
GTTTATGATACTGTGGTGGTCCTGCCCCGCCATGCCATGCCTGGCAAGACCATTGAAATG
AATGGGAAGGACATTGAAGTTTTGGACGCTTATGACCTCAACGACAAGACCGACACTTCT
CTAGAATTGACCATAGTGAAATTGAAAATGAATGAGAAGTTCAGGGACATTAGAGCAATG
GTTCCGGACCAAATTACAGATTACAATGAGGCAGTGGTGGTTGTGAATACCTCATACTAC
CCCCAGCTTTTTACCTGCGTGGGGCGTGTCAAGGACTACGGATTCCTGAACCTTGCTGGC
AGGCCAACACATAGAGTTTTGATGTATGAATTCCCCACCAAGGCAGGCCAATGCGGTGGT
GTGGTTATTAGCATGGGTAAGATAGTGGGTGTCCACGTAGGAGGTAACGGTGCCCAAGGT
TTTGCCGCCTCCCTTCTACGCAGGTACTTTACAGCAGAACAAGGACAAATTGAATATATC
GAGAAGAGTAAAGATGCCGGGTACCCCGTGATCAATGCACCCACCCAAACCAAATTAGAG
CCCAGTGTTTTCTTTGATGTTTTCCCCGGGGTGAAAGAACCAGCGGTACTCCACAAGAAG
GACAAGAGGCTTGAAACCAACTTTGAGGAAGCTCTATTTTCCAAGTACATAGGAAATGTA
CAAAGGGACATGCCTGAGGAATTACTCATTGCCATAGATCATTATTCTGAACAACTCAAA
ATGTTGAATATTGACCCGAGGCCCATTTCAATGGAGGATGCAATTTACGGTACAGAGGGG
CTTGAGGCACTTGATCTTGGAACTAGTGCGAGCTACCCGTACGTTGCAATGGGCATCAAG
AAAAGAGATATTTTGAATAAAGAGACCAGGGATGTCACTAAGATGCAAGAGTGCATAGAT
AAGTATGGTTTAAATCTACCCATGGTCACCTATGTCAAGGATGAACTCAGGGCGCCAGAT
AAGATCAGGAAAGGAAAAAGCCGTTTGATAGAGGCATCTAGCTTGAATGATTCAGTAGCC
ATGCGGTGCTACTTTGGGAACCTCTACAAGGTTTTCCACACCAACCCTGGAACCATCTCC
GGCTGTGCCGTTGGATGCGACCCTGAAACCTTCTGGAGCAAGATCCCAGTGATGATGGAT
GGTGAGCTTTTTGGCTTTGATTATACTGCATATGATGCTAGCCTGTCTCCCATGTGGTTC
CATGCCCTGGCAGAAGTCCTTAGACGGATTGGATTTGTTGAGTGCAAGCACTTTATTGAT
CAACTTTGCTGCAGCCACCACCTTTATATGGATAAGCACTATTATGTGGTTGGGGGCATG
CCTTCTGGCTGCTCTGGCACCTCCATCTTCAATTCTATGATTAACAACCTAATCATCCGC
ACTCTTGTGCTCACAGTTTATAAAAATATTGATTTGGATGATCTTAAGATAATAGCCTAC
GGGGATGACGTGCTCGCGTCGTACCCGTATGAGATTGATGCCAGCCTCTTGGCAGAAGCT
GGTAAAAGCTTTGGTCTAATCATGACTCCACCAGATAAATCTGCGGAGTTTGTCAAATTA
ACCTGGGATAACGTGACCTTTTTGAAGAGGAAGTTCGTGCGTGATGCACGGTACCCTTTC
CTTGTACATCCGGTCATGGACATGTCGAACATCCATGAGTCCATTCGGTGGACGAAAGAT
CCCAGGCATACTGAAGACCATGTCCGCTCACTTTGCCTATTGGCCTGGCATTGTGGCGAG
GAAGAATACAACGAATTTGTTACAAAGATCCGTTCCGTTCCTGTCGGGAGAGCCCTCCAT
CTACCTTCATTCAAGGCGCTCGAGAGGAAATGGTACGACTCTTTCTGA

# Drug_Target_4_General_Function:
Involved in ATP binding

# Drug_Target_4_General_References:
2828511	Earle JA, Skuce RA, Fleming CS, Hoey EM, Martin SJ: The complete nucleotide sequence of a bovine enterovirus. J Gen Virol. 1988 Feb;69 ( Pt 2):253-63.
7773791	Smyth M, Tate J, Hoey E, Lyons C, Martin S, Stuart D: Implications for viral uncoating from the structure of bovine enterovirus. Nat Struct Biol. 1995 Mar;2(3):224-31.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
6734

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
242501.7

# Drug_Target_4_Name:
Genome polyprotein

# Drug_Target_4_Number_of_Residues:
2175

# Drug_Target_4_PDB_ID:
Not Available

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00073	Rhv
PF00548	Peptidase_C3
PF00680	RdRP_1
PF00910	RNA_helicase
PF00947	Pico_P2A
PF01552	Pico_P2B
PF02226	Pico_P1A
PF08727	P3A

# Drug_Target_4_Protein_Sequence:
>Genome polyprotein
MGAQLSRNTAGSHTTGTYATGGSTINYNNINYYSHAASAAQNKQDFTQDPSKFTQPIADV
IKETAVPLKSPSAEACGYSDRVAQLTLGNSTITTQEAANICVAYGCWPAKLSDTDATSVD
KPTEPGVSADAFYTLRSKPWQADSKGWYWKLPDALNNTGMFGQNAQFHYIYRGGWAVHVQ
CNATKFHQGTLLVLAIPEHQIATQEQPAFDRTMPGSEGGTFQEPFWLEDGTSLGNSLIYP
HQWINLRTNNSATLILPYVNAIPMDSAIRHSNWTLAIIPVAPLKYAAETTPLVPITVTIA
PMETEYNGLRRAIASNQGLPTKPGPGSYQFMTTDEDCSPCILPDFQPTLEIFIPGKVNNL
LEIAQVESILEANNREGVEGVERYVIPVSVQDALDAQIYALRLELGGSGPLSSSLLGTLA
KHYTQWSGSVEITCMFTGTFMTTGKVLLAYTPPGGDMPRNREEAMLGTHVVWDFGLQSSI
TLVIPWISASHFRGVSNDDVLNYQYYAAGHVTIWYQTNMVIPPGFPNTAGIIMMIAAQPN
FSFRIQKDREDMTQTAILQNDPGKMLKDAIDKQVAGALVAGTTTSTHSVATDSTPALQAA
ETGATSTARDESMIETRTIVPTHGIHETSVESFFGRSSLVGMPLLATGTSITNWRIDFRE
FVQLRAKMSWFTYMRFDVEFTIIATSSTGQNVTTEQHTTYQVMYVPPGAPVPSNQDSFQW
QSGCNPSVFADTDGPPAQFSVPFMSSANAYSTVYDGYARFMDTDPDRYGILPSNFLGFMY
FRTLEDAAHQVRFRICAKIKHTSCWIPRAPRQAPYKKRYNLVFSGDSDRICSNRASLTSY
GPFGQQQGAAYVGSYKILNRHLATYADWENEVWQSYQRDLLVTRVDAHGCDTIARCNCRS
GIYYCKSTAKHYPIVVTPPSIYKIEANDYYPERMQTHILLGIGFAEPGDCGGLLRCEHGV
MGILTVGGGDHVGFADVRDLLWIEDDAMEQGITDYVQQLGNAFGAGFTAEIANYTNQLRD
MLMGSDSVVEKIIRSLVRLVSALVIVVRNHQDLITVGATLALLGCEGSPWKWLKRKVCQI
LGINMAERQSDNWMKKFTEMCNAFRGLDWIAAKISKFIDWLKQKILPELKERAEFVKKLK
QLPLLEAQVNTLEHSSASQERQEQLFGNVQYLAHHCRKNAPLYAAEAKRVYHLEKRVLGA
MQFKTKNRIEPVCALIHGSPGTGQSLATMIVGRKLAEYEGSDVYSLPPDPDHFDGYQQQA
VVVMDDLLQNPDGKDMTLFCQMVSTAPFTVPMAALEDKGKLFTSKFVLASTNAGQVTPPT
VADYKALQRRFFFDCDIEVQKEYKRDGVTLDVAKATETCEDCSPANFKKCMPLICGKALQ
LKSRKGDGMRYSLDTLISELRRESNRRYNIGNVLEALFQGPVCYKPLRIEVHEEEPAPSA
ISDLLQAVDSEEVREYCRSKGWIVEERVTELKLERNVNRALAVIQSVSLIAAVAGTIYIV
YRLFSGMQGPYSGIGTNYATKKPVVRQVQTQGPLFDFGVSLLKKNIRTVKTGAGEFTALG
VYDTVVVLPRHAMPGKTIEMNGKDIEVLDAYDLNDKTDTSLELTIVKLKMNEKFRDIRAM
VPDQITDYNEAVVVVNTSYYPQLFTCVGRVKDYGFLNLAGRPTHRVLMYEFPTKAGQCGG
VVISMGKIVGVHVGGNGAQGFAASLLRRYFTAEQGQIEYIEKSKDAGYPVINAPTQTKLE
PSVFFDVFPGVKEPAVLHKKDKRLETNFEEALFSKYIGNVQRDMPEELLIAIDHYSEQLK
MLNIDPRPISMEDAIYGTEGLEALDLGTSASYPYVAMGIKKRDILNKETRDVTKMQECID
KYGLNLPMVTYVKDELRAPDKIRKGKSRLIEASSLNDSVAMRCYFGNLYKVFHTNPGTIS
GCAVGCDPETFWSKIPVMMDGELFGFDYTAYDASLSPMWFHALAEVLRRIGFVECKHFID
QLCCSHHLYMDKHYYVVGGMPSGCSGTSIFNSMINNLIIRTLVLTVYKNIDLDDLKIIAY
GDDVLASYPYEIDASLLAEAGKSFGLIMTPPDKSAEFVKLTWDNVTFLKRKFVRDARYPF
LVHPVMDMSNIHESIRWTKDPRHTEDHVRSLCLLAWHCGEEEYNEFVTKIRSVPVGRALH
LPSFKALERKWYDSF

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
RNA-directed RNA polymerase 3D-POL replicates genomic and antigenomic RNA by recognizing replications specific signals (By similarity)

# Drug_Target_4_SwissProt_ID:
P12915

# Drug_Target_4_SwissProt_Name:
POLG_BOVEV

# Drug_Target_4_Synonyms:
P1A
P1B
P1C
P1D
P2A
P2B
P2C
P3A
P3B
P3C
P3D-POL
Picornain 2A
Picornain 3C
Protease 3C
Protein 2A
Protein 2B
Protein 2C
Protein 3A
Protein 3B
Protein VP0
Protein VP1
Protein VP2
Protein VP3
Protein VP4
RNA-directed RNA polymerase 3D-POL
VP4-VP2
VPg
Virion protein 1
Virion protein 2
Virion protein 3
Virion protein 4

# Drug_Target_4_Theoretical_pI:
6.49

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
8

# Drug_Target_5_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
S76965

# Drug_Target_5_GenBank_ID_Protein:
243494

# Drug_Target_5_GeneCard_ID:
PKIA

# Drug_Target_5_Gene_Name:
PKIA

# Drug_Target_5_Gene_Sequence:
>231 bp
ATGACTGATGTGGAAACTACATATGCAGATTTTATTGCTTCAGGAAGAACAGGTAGAAGA
AATGCAATACATGATATCCTGGTTTCCTCTGCAAGTGGCAACAGCAATGAATTAGCCTTG
AAATTAGCAGGTCTTGATATCAACAAGACAGAAGGTGAAGAAGATGCACAACGAAGTTCT
ACAGAACAAAGTGGGGAAGCCCAGGGAGAAGCAGCAAAATCTGAAAGCTAA

# Drug_Target_5_General_Function:
Involved in cAMP-dependent protein kinase inhibitor act

# Drug_Target_5_General_References:
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
1770951	Olsen SR, Uhler MD: Inhibition of protein kinase-A by overexpression of the cloned human protein kinase inhibitor. Mol Endocrinol. 1991 Sep;5(9):1246-56.

# Drug_Target_5_HGNC_ID:
GNC:9017

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
6264

# Drug_Target_5_Locus:
8q21.12

# Drug_Target_5_Molecular_Weight:
7988.4

# Drug_Target_5_Name:
cAMP-dependent protein kinase inhibitor alpha

# Drug_Target_5_Number_of_Residues:
76

# Drug_Target_5_PDB_ID:
1CMK

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF02827	PKI

# Drug_Target_5_Protein_Sequence:
>cAMP-dependent protein kinase inhibitor alpha
MTDVETTYADFIASGRTGRRNAIHDILVSSASGNSNELALKLAGLDINKTEGEEDAQRSS
TEQSGEAQGEAAKSES

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Extremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulatory chains

# Drug_Target_5_SwissProt_ID:
P61925

# Drug_Target_5_SwissProt_Name:
IPKA_HUMAN

# Drug_Target_5_Synonyms:
PKI-alpha
cAMP-dependent protein kinase inhibitor, muscle/brain isoform

# Drug_Target_5_Theoretical_pI:
4.18

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cytoplasm (By similarity). Nucleus (By similarity)

# Drug_Target_6_Chromosome_Location:
1

# Drug_Target_6_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
X07767

# Drug_Target_6_GenBank_ID_Protein:
35479

# Drug_Target_6_GeneCard_ID:
PRKACA

# Drug_Target_6_Gene_Name:
PRKACA

# Drug_Target_6_Gene_Sequence:
>1056 bp
ATGGGCAACGCCGCCGCCGCCAAGAAGGGCAGCGAGCAGGAGAGCGTGAAAGAATTCTTA
GCCAAAGCCAAAGAAGATTTTCTTAAAAAATGGGAAAGTCCCGCTCAGAACACAGCCCAC
TTGGATCAGTTTGAACGAATCAAGACCCTCGGCACGGGCTCCTTCGGGCGGGTGATGCTG
GTGAAACACAAGGAGACCGGGAACCACTATGCCATGAAGATCCTCGACAAACAGAAGGTG
GTGAAACTGAAACAGATCGAACACACCCTGAATGAAAAGCGCATCCTGCAAGCTGTCAAC
TTTCCGTTCCTCGTCAAACTCGAGTTCTCCTTCAAGGACAACTCAAACTTATACATGGTC
ATGGAGTACGTGCCCGGCGGGGAGATGTTCTCACACCTACGGCGGATCGGAAGGTTCAGT
GAGCCCCATGCCCGTTTCTACGCGGCCCAGATCGTCCTGACCTTTGAGTATCTGCACTCG
CTGGATCTCATCTACAGGGACCTGAAGCCGGAGAATCTGCTCATTGACCAGCAGGGCTAC
ATTCAGGTGACAGACTTCGGTTTCGCCAAGCGCGTGAAGGGCCGCACTTGGACCTTGTGC
GGCACCCCTGAGTACCTGGCCCCTGAGATTATCCTGAGCAAAGGCTACAACAAGGCCGTG
GACTGGTGGGCCCTGGGGGTTCTTATCTATGAAATGGCCGCTGGCTACCCGCCCTTCTTC
GCAGACCAGCCCATCCAGATCTATGAGAAGATCGTCTCTGGGAAGGTGCGCTTCCCTTCC
CACTTCAGCTCTGACTTGAAGGACCTGCTGCGGAACCTCCTGCAGGTAGATCTCACCAAG
CGCTTTGGGAACCTCAAGAATGGGGTCAACGATATCAAGAACCACAAGTGGTTTGCCACA
ACTGACTGGATTGCCATCTACCAGAGGAAGGTGGAAGCTCCCTTCATACCAAAGTTTAAA
GGCCCTGGGGATACGAGTAACTTTGACGACTATGAGGAAGAAGAAATCCGGGTCTCCATC
AATGAGAAGTGTGGCAAGGAGTTTTCTGAGTTTTAG

# Drug_Target_6_General_Function:
Involved in ATP binding

# Drug_Target_6_General_References:
10841548	Desseyn JL, Burton KA, McKnight GS: Expression of a nonmyristylated variant of the catalytic subunit of protein kinase A during male germ-cell development. Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6433-8.
10982398	Agustin JT, Wilkerson CG, Witman GB: The unique catalytic subunit of sperm cAMP-dependent protein kinase is the product of an alternative Calpha mRNA expressed specifically in spermatogenic cells. Mol Biol Cell. 2000 Sep;11(9):3031-44.
12509440	Ficarro S, Chertihin O, Westbrook VA, White F, Jayes F, Kalab P, Marto JA, Shabanowitz J, Herr JC, Hunt DF, Visconti PE: Phosphoproteome analysis of capacitated human sperm. Evidence of tyrosine phosphorylation of a kinase-anchoring protein 3 and valosin-containing protein/p97 during capacitation. J Biol Chem. 2003 Mar 28;278(13):11579-89. Epub 2002 Dec 30.
14702039	Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
17081983	Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006 Nov 3;127(3):635-48.
2843813	Maldonado F, Hanks SK: A cDNA clone encoding human cAMP-dependent protein kinase catalytic subunit C alpha. Nucleic Acids Res. 1988 Aug 25;16(16):8189-90.

# Drug_Target_6_HGNC_ID:
GNC:9380

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
6263

# Drug_Target_6_Locus:
19p13.1

# Drug_Target_6_Molecular_Weight:
40589.4

# Drug_Target_6_Name:
cAMP-dependent protein kinase catalytic subunit alpha

# Drug_Target_6_Number_of_Residues:
351

# Drug_Target_6_PDB_ID:
1CTP

# Drug_Target_6_Pathway:
Acebutolol Pathway	SMP00296
Alprenolol Pathway	SMP00297
Atenolol Pathway	SMP00298
Betaxolol Pathway	SMP00299
Bisoprolol Pathway	SMP00300
Carvedilol Pathway	SMP00367
Celecoxib Pathway	SMP00096
Citalopram Pathway	SMP00424
Desipramine Pathway	SMP00423
Escitalopram Pathway	SMP00425
Esmolol Pathway	SMP00301
Etodolac Pathway	SMP00084
Fluoxetine Pathway	SMP00426
Imipramine Pathway	SMP00422
Labetalol Pathway	SMP00368
Meloxicam Pathway	SMP00106
Metoprolol Pathway	SMP00302
Nadolol Pathway	SMP00303
Nebivolol Pathway	SMP00366
Oxprenolol Pathway	SMP00304
Penbutolol Pathway	SMP00305
Pindolol Pathway	SMP00306
Propranolol Pathway	SMP00307
Rofecoxib Pathway	SMP00087
Valdecoxib Pathway	SMP00116

# Drug_Target_6_Pfam_Domain_Function:
PF00069	Pkinase

# Drug_Target_6_Protein_Sequence:
>cAMP-dependent protein kinase catalytic subunit alpha
MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVML
VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV
MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY
IQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF
ADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT
TDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Phosphorylates a large number of substrates in the cytoplasm and the nucleus

# Drug_Target_6_SwissProt_ID:
P17612

# Drug_Target_6_SwissProt_Name:
KAPCA_HUMAN

# Drug_Target_6_Synonyms:
PKA C-alpha

# Drug_Target_6_Theoretical_pI:
9.22

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
RNA-directed RNA polymerase 3D-POL:Host cytoplasmic vesicle membrane

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_7_Essentiality:
Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
U57056

# Drug_Target_7_GenBank_ID_Protein:
1373228

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
Not Available

# Drug_Target_7_Gene_Sequence:
>6558 bp
ATGGGAGCTCAAGTATCAACGCAAAAGACTGGGGCACATGAGACCGGGCTGAATGCTAGC
GGCAATTCCATTATTCACTACACGAATATTAATTATTACAAAGACGCCGCATCCAACTCA
GCCAATCGGCAGGATTTCACTCAAGATCCGAGCAAGTTCACGGAACCAGTGAAAGATATC
ATGATTAAATCACTACCAGCTCTCAACTCCCCCACAGTAGAGGAGTGCGGATACAGTGAC
AGGGTGAGATCAATCACACTAGGTAACTCCACCATAACGACTCAGGAATGCGCTAACGTG
GTGGTAGGCTATGGAGTGTGGCCAGATTATCTGAAGGATAGCGAGGCTACAGCAGAGGAC
CAACCGACCCAACCAGACGTTGCCACATGTAGGTTCTATACCCTTGACTCTGTACAATGG
CAGAAAACCTCACCAGGATGGTGGTGGAAGCTGCCTGATGCTTTGTCGAACTTAGGACTG
TTTGGGCAGAACATGCAGTACCACTACTTGGGCCGAACTGGGTATACCATACATGTGCAG
TGCAATGCATCCAAGTTCCACCAAGGATGCTTGCTAGTAGTGTGTGTACCGGAAGCTGAG
ATGGGTTGCGCAACGCTAAACAACACCCCATCCAGTGCAGAATTGCTGGGGGGCGATAGC
GCCAAAGAGTTTGCGGACAAACCGGTTGCATCCGGGTCCAACAAGTTGGTACAGAGGGTG
GTGTATAATGCAGGCATGGGGGTGGGTGTTGGAAACCTTACCATTTTCCCTCACCAGTGG
ATCAATCTACGCACCAACAATAGTGCTACAATTGTGATGCCATACACCAACAGCGTACCT
ATGGATAACATGTTTAGGCATAACAACGTCACCCTAATGGTTATCCCATTTGTACCGCTA
GATTACTGCCCTGGGTCTACCACGTACGTCCCAATCACGATCACGATAGCCCCAATGTGT
GCCGAGTACAATGGACTACGTTTGGCCGGGCACCAGGGCTTACCAACCATGAACACTCCG
GGGAGCTGTCAATTTCTGACATCAGACGACTTCCAATCACCATCTGCCATGCCGCAATAC
GACGTCACGCCAGAGATGAGGATACCTGGTGAGGTGAAGAACTTGATGGAAATAGCTGAG
GTTGACTCAGTTGTCCCGGTCCAAAATGTTGGAGAGAAGGTCAACTCCATGGAAGCGTAC
CAGATACCTGTGAGATCCAATGAAGGATCTGGAACGCAAGTATTCGGCTTCCCACTGCAA
CCAGGGTATTCGAGTGTTTTCAGTCGGACGCTCCTAGGAGAGATCTTGAACTATTACACC
CATTGGTCGGGCAGCATAAAGCTCACGTTTATGTTCTGTGGTTCGGCCATGGCCACTGGA
AAATTCCTTTTGGCATACTCACCACCAGGCGCTGGGGCTCCCACAAAAAGGGTTGATGCT
ATGCTTGGCACTCATGTAGTTTGGGATGTGGGGCTACAATCAAGTTGCGTGCTGTGCATA
CCCTGGATAAGCCAAACACACTACCGGTATGTTGCTTCAGATGAGTATACCGCAGGGGGT
TTTATTACGTGCTGGTATCAAACAAACATAGTCGTCCCAGCAGATGCCCAAAGCTCCTGT
TACATCATGTGTTTCGTATCAGCATGCAATGATTTCTCTGTCAGGCTATTGAAGGACACT
CCTTTTATTTCGCAGCAAAACTTTTTCCAGGGCCCCGTGGAAGACGCGATAACAGCCGCC
ATAGGGAGAGTTGCGGACACCGTGGGTACAGGGCCAACCAACTCAGAGGCTATACCAGCA
CTCACTGCTGCTGAGACAGGTCACACGTCGCAAGTAGTGCCGAGTGACACCATGCAGACA
CGCCACGTTAAGAACTACCATTCAAGGTCTGAGTCGACCATAGAGAACTTCCTATGTAGG
TCAGCATGCGTGTACTTTACAGAGTATGAAAACTCAGGCGCCAAGCGGTATGCTGAATGG
GTAATAACACCACGACAAGCGGCACAACTTAGGAGAAAGCTAGAATTCTTTACCTACGTC
CGGTTTGACCTGGAGCTGACGTTTGTCATAACAAGTACTCAACAGCCCTCAACCACACAG
AACCAGGATGCACAGATCCTAACACACCAAATTATGTATGTACCACCAGGTGGGCCTGTG
CCAGACAAAGTCGATTCTTACGTGTGGCAAACATCTACGAATCCCAGTGTGTTTTGGACC
GAGGGAAACGCCCCGCCGCGTATGTCCGTACCGTTTTTGAGCATTGGCAACGCTTATTCA
AATTTCTATGATGGGTGGTCTGAATTTTCCAGGAACGGGGTTTACGGTATCAACACACTA
AACAACATGGGCACGCTATATGCAAGACATGTCAATGCTGGAAGCACGGGACCAATAAAA
AGCACCATTAGAATCTACTTCAAACCTAAGCATGTCAAAGCGTGGATACCTAGACCACCT
AGACTCTGCCAATACGAGAAGGCAAAGAACGTGAACTTCCAACCCAGCGGAGTTACCACT
ACTAGGCAAAGCATCACTACAATGACAAATACGGGCGCATTTGGACAACAATCAGGGGCA
GTATACGTAGGGAACTACAGGGTAGTAAATAGACATCTAGCTACCAGTGCTGACTGGCAA
AACTGTGTGTGGGAAAATTACAACAGAGACCTCTTAGTGAGCACGACCACAGCACATGGA
TGTGATATTATAGCCAGATGTCGGTGTACAACGGGAGTGTACTTTTGTGCGTCCAAAAAC
AAACACTACCCAATTTCATTTGAAGGACCAGGTATAGTAGAGGTCCAAGAGAGTGAGTAC
TACCCTAGGAGATACCAATCCCATGTGCTTTTAGCAGCTGGGTTTTCCGAACCAGGTGAC
TGTGGCGGTATCCTAAGGTGTGAGCATGGTGTCATTGGCATTGTGACCATGGGGGGTGAA
GGCGTGGTCGGCTTTGCAGACATCCGTGATCTCCTGTGGCTGGAAGATGATGCAATGGAA
CAGGGAGTGAAGGACTATGTGGAACAGCTTGGAAATGCATTCGGCTCTGGCTTCACTAAC
CAAATATGTGAGCAAGTCAACCTCCTGAAGGAATCACTAGTGGGTCAAGACTCCATCTTA
GAGAAGTCTCTAAAAGCCTTAGTTAAGATAATATCAGCCTTAGTAATTGTGGTGAGGAAC
CACGATGACCTAATCACGGTGACTGCCACACTAGCCCTCATTGGTTGTACCTCGTCCCCA
TGGCGGTGGCTTAAGCAGAAAGTGTCCCAATATTACGGAATACCCATGGCTGAACGCCAA
AACAACGGATGGCTAAAAAAGTTCACTGAGATGACAAACGCCTGCAAGGGCATGGAATGG
ATAGCCATTAAGATTCAGAAATTCATTGAGTGGCTCAAAGTTAAAATTTTACCTGAGGTC
AGGGAAAAACACGAATTCCTGAACAGACTCAAACAGCTCCCCCTGTTAGAGAGTCAAATT
GCCACAATCGAGCAAAGTGCACCGTCACAGAGTGACCAGGAGCAATTGTTTTCCAATGTC
CAATACTTTGCTCACTATTGCAGAAAGTATGCTCCCCTTTATGCATCAGAGGCAAAGAGA
GTGTTCTCCCTTGAGAAGAAGATGAGTAATTACATACAGTTCAAGTCCAAATGCCGTATT
GAGCCTGTATGTCTGCTCCTGCATGGGAGTCCCGGTGCAGGTAAGTCAGTTGCAACAAAT
CTGATCGGAAGATCACTCGCGGAAAAGTTAAACAGCTCAGTGTATTCACTACCCCCAGAC
CCAGATCACTTCGATGGCTATAAACAGCAGGCTGTAGTGATCATGGACGATCTATGTCAG
AAACCCGATGGGAAAGATGTCTCCTTGTTCTGTCAGATGGTTTCCAGTGTGGATTTTGTA
CCACCCATGGCCGCCCTGGAAGAGAAAGGCATCTTGTTCACCTCCCCGTTCGTTTTGGCA
TCAACCAATGCGGGATCTATTAACGCTCCAACTGTGTCAGACAGCAGGGCCTTAGCAAGG
AGATTCCACTTTGACATGAATATTGAAGTTATTTCTATGTACAGCCAAAATGGCAAGATA
AACATGCCAATGTCAGTGAAGACGTGTGATGAAGAGTGTTGCCCAGTCAACTTTAAGAAA
TGTTGCCCGTTAGTCTGTGGAAAGGCCATCCAATTCATAGACAGAAGAACTCAAGTCAGA
TACTCTCTAGATATGCTGGTAACTGAGATGTTTAGGGAATACAACCACAGGCACAGTGTC
GGGGCTACCCTTGAGGCACTGTTCCAGGGTCCACCAGTATACAGAGAGATTAAGATTAGC
GTGGCACCAGAAACACCACCACCACCACGTATCGCGGACTTGCTTAAATCAGTGGATAGC
GAAGCCGTGAGAGAGTATTGCAAAGAAAAGGGATGGTTGGTTCCTGAGGTCAACTCCACC
CTCCAAATTGAAAAACATGTCAGTCGGGCTTTCATCTGCTTGCAGGCAATAACTACGTTT
GTGTCAGTAGCTGGAATCATCTATATAATATACAAGCTCTTTGCAGGCTTTCAAGGTGCA
TATACAGGAATACCCAACCAGAAGCCCAAGGTACCTACCCTAAGGCAAGCAAAAGTGCAG
GGTCCTGCATTTGAATTTGCTGTTGCAATGATGAAGAGGAACTCAAGCACAGTGAAGACA
GAGTATGGTGAGTTCACCATGTTGGGCATTTATGATAGGTGGGCCGTTTTGCCACGTCAT
GCCAAACCCGGACCAACCATCCTGATGAATGACCAGGAGGTAGGCGTGCTGGACGCTAAA
GAGTTAGTGGATAAGGATGGTACAAACCTAGAACTGACACTGCTCAAGTTGAACAGGAAC
GAGAAGTTCAGAGACATCAGAGGCTTCTTAGCAAAGGAGGAGGTGGAAGTCAACGAGGCC
GTGCTAGCAATTAATACCAGTAAATTTCCCAACATGTACATTCCGGTGGGACAAGTCACG
GATTACGGTTTCCTAAACCTGGGTGGTACGCCCACTAAAAGAATGCTTATGTACAACTTC
CCCACGAGAGCAGGTCAATGTGGCGGAGTACTCATGTCCACCGGCAAAGTCCTGGGGATC
CATGTTGGTGGAAATGGTCATCAAGGTTTCTCAGCGGCACTTCTCAAGCACTATTTCAAT
GATGAACAAGGAGAGATCGAGTTTATTGAGAGCTCAAAGGAAGCAGGGTTCCCTATTATC
AACACACCTAGTAAGACTAAGCTGGAGCCGAGTGTCTTCCACCAGGTTTTTGAAGGTGAC
AAAGAGCCAGCGGTCCTCAGGAATGGTGATCCACGCCTCAAAGTCAACTTTGAGGAGGCC
ATATTTTCCAAGTACATCGGGAATGTTAACACACACGTGGATGAATACATGATGGAGGCT
GTTGACCATTATGCCGGACAATTGGCCACCCTAGACATTAGCACTGAACCAATGAAGTTG
GAGGATGCTGTATACGGTACTGAAGGCCTTGAGGCTCTTGATCTAACAACGAGTGCAGGT
TACCCTTATGTCGCCCTGGGCATCAAGAAGAGAGACATCCTCTCAAAGAAGACCAGGGAC
CTTACTAAGCTGAAAGAGTGCATGGATAAGTACGGTCTAAACCTACCAATGGTAACCTAT
GTGAAAGACGAACTCAGATCTGCAGAGAAGGTGGCAAAGGGAAAGTCCAGGCTCATTGAG
GCGTCCAGTTTGAATGACTCTGTGGCAATGAGACAGACATTCGGCAACTTGTACAAAACT
TTTCACCTAAACCCAGGGGTTGTGACTGGCAGTGCTGTCGGGTGTGACCCGGACCTCTTT
TGGAGTAAAATACCAGTGATGTTGGACGGTCATCTCATAGCTTTTGATTATTCTGGATAT
GATGCTAGCTTGAGTCCCGTATGGTTTGCTTGTTTAAAACTACTACTTGAAAAACTTGGT
TACTCGCACAAGGAGACCAATTACATTGATTACCTGTGCAACTCCCATCACCTGTACAGG
GACAAACATTATTTTGTGCGGGGTGGCATGCCATCTGGATGTTCTGGCACAAGCATCTTT
AACTCAATGATAAATAACATCATAATCAGGACACTCATGCTGAAGGTGTACAAAGGGATC
GACTTGGATCAATTCAGGATGATTGCTTATGGTGACGATGTGATTGCATCATACCCGTGG
CCCATAGATGCGTCTTTGCTTGCTGAAGCTGGCAAGGACTATGGATTAATCATGACACCA
GCAGACAAAGGGGAGTGCTTCAATGAAGTTACTTGGACTAACGTCACATTCCTAAAGAGG
TATTTTAGAGCAGATGAACAATACCCCTTTTTAGTGCACCCCGTTATGCCCATGAAAGAC
ATACACGAATCAATCAGATGGACCAAGGATCCAAAGAATACCCAAGACCATGTGCGCTCA
TTGTGCTTATTGGCCTGGCACAACGGGGAGCACGAATATGAGGAGTTTATCCGCAAAATC
AGGAGCGTCCCAGTTGGACGTTGTTTGACTCTACCTGCGTTCTCAACCATTCGTAGGAAG
TGGTTGGACTCTTTCTAA

# Drug_Target_7_General_Function:
Involved in ATP binding

# Drug_Target_7_General_References:
8591043	Muckelbauer JK, Kremer M, Minor I, Diana G, Dutko FJ, Groarke J, Pevear DC, Rossmann MG: The structure of coxsackievirus B3 at 3.5 A resolution. Structure. 1995 Jul 15;3(7):653-67.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
6735

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
243680.6

# Drug_Target_7_Name:
Genome polyprotein

# Drug_Target_7_Number_of_Residues:
2185

# Drug_Target_7_PDB_ID:
Not Available

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00073	Rhv
PF00548	Peptidase_C3
PF00680	RdRP_1
PF00910	RNA_helicase
PF00947	Pico_P2A
PF01552	Pico_P2B
PF02226	Pico_P1A
PF08727	P3A

# Drug_Target_7_Protein_Sequence:
>Genome polyprotein
MGAQVSTQKTGAHETGLNASGNSIIHYTNINYYKDAASNSANRQDFTQDPSKFTEPVKDI
MIKSLPALNSPTVEECGYSDRVRSITLGNSTITTQECANVVVGYGVWPDYLKDSEATAED
QPTQPDVATCRFYTLDSVQWQKTSPGWWWKLPDALSNLGLFGQNMQYHYLGRTGYTIHVQ
CNASKFHQGCLLVVCVPEAEMGCATLNNTPSSAELLGGDSAKEFADKPVASGSNKLVQRV
VYNAGMGVGVGNLTIFPHQWINLRTNNSATIVMPYTNSVPMDNMFRHNNVTLMVIPFVPL
DYCPGSTTYVPITITIAPMCAEYNGLRLAGHQGLPTMNTPGSCQFLTSDDFQSPSAMPQY
DVTPEMRIPGEVKNLMEIAEVDSVVPVQNVGEKVNSMEAYQIPVRSNEGSGTQVFGFPLQ
PGYSSVFSRTLLGEILNYYTHWSGSIKLTFMFCGSAMATGKFLLAYSPPGAGAPTKRVDA
MLGTHVVWDVGLQSSCVLCIPWISQTHYRYVASDEYTAGGFITCWYQTNIVVPADAQSSC
YIMCFVSACNDFSVRLLKDTPFISQQNFFQGPVEDAITAAIGRVADTVGTGPTNSEAIPA
LTAAETGHTSQVVPSDTMQTRHVKNYHSRSESTIENFLCRSACVYFTEYENSGAKRYAEW
VITPRQAAQLRRKLEFFTYVRFDLELTFVITSTQQPSTTQNQDAQILTHQIMYVPPGGPV
PDKVDSYVWQTSTNPSVFWTEGNAPPRMSVPFLSIGNAYSNFYDGWSEFSRNGVYGINTL
NNMGTLYARHVNAGSTGPIKSTIRIYFKPKHVKAWIPRPPRLCQYEKAKNVNFQPSGVTT
TRQSITTMTNTGAFGQQSGAVYVGNYRVVNRHLATSADWQNCVWENYNRDLLVSTTTAHG
CDIIARCRCTTGVYFCASKNKHYPISFEGPGIVEVQESEYYPRRYQSHVLLAAGFSEPGD
CGGILRCEHGVIGIVTMGGEGVVGFADIRDLLWLEDDAMEQGVKDYVEQLGNAFGSGFTN
QICEQVNLLKESLVGQDSILEKSLKALVKIISALVIVVRNHDDLITVTATLALIGCTSSP
WRWLKQKVSQYYGIPMAERQNNGWLKKFTEMTNACKGMEWIAIKIQKFIEWLKVKILPEV
REKHEFLNRLKQLPLLESQIATIEQSAPSQSDQEQLFSNVQYFAHYCRKYAPLYASEAKR
VFSLEKKMSNYIQFKSKCRIEPVCLLLHGSPGAGKSVATNLIGRSLAEKLNSSVYSLPPD
PDHFDGYKQQAVVIMDDLCQKPDGKDVSLFCQMVSSVDFVPPMAALEEKGILFTSPFVLA
STNAGSINAPTVSDSRALARRFHFDMNIEVISMYSQNGKINMPMSVKTCDEECCPVNFKK
CCPLVCGKAIQFIDRRTQVRYSLDMLVTEMFREYNHRHSVGATLEALFQGPPVYREIKIS
VAPETPPPPRIADLLKSVDSEAVREYCKEKGWLVPEVNSTLQIEKHVSRAFICLQAITTF
VSVAGIIYIIYKLFAGFQGAYTGIPNQKPKVPTLRQAKVQGPAFEFAVAMMKRNSSTVKT
EYGEFTMLGIYDRWAVLPRHAKPGPTILMNDQEVGVLDAKELVDKDGTNLELTLLKLNRN
EKFRDIRGFLAKEEVEVNEAVLAINTSKFPNMYIPVGQVTDYGFLNLGGTPTKRMLMYNF
PTRAGQCGGVLMSTGKVLGIHVGGNGHQGFSAALLKHYFNDEQGEIEFIESSKEAGFPII
NTPSKTKLEPSVFHQVFEGDKEPAVLRNGDPRLKVNFEEAIFSKYIGNVNTHVDEYMMEA
VDHYAGQLATLDISTEPMKLEDAVYGTEGLEALDLTTSAGYPYVALGIKKRDILSKKTRD
LTKLKECMDKYGLNLPMVTYVKDELRSAEKVAKGKSRLIEASSLNDSVAMRQTFGNLYKT
FHLNPGVVTGSAVGCDPDLFWSKIPVMLDGHLIAFDYSGYDASLSPVWFACLKLLLEKLG
YSHKETNYIDYLCNSHHLYRDKHYFVRGGMPSGCSGTSIFNSMINNIIIRTLMLKVYKGI
DLDQFRMIAYGDDVIASYPWPIDASLLAEAGKDYGLIMTPADKGECFNEVTWTNVTFLKR
YFRADEQYPFLVHPVMPMKDIHESIRWTKDPKNTQDHVRSLCLLAWHNGEHEYEEFIRKI
RSVPVGRCLTLPAFSTIRRKWLDSF

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
RNA-directed RNA polymerase 3D-POL replicates genomic and antigenomic RNA by recognizing replications specific signals (By similarity)

# Drug_Target_7_SwissProt_ID:
Q66282

# Drug_Target_7_SwissProt_Name:
POLG_CXB3W

# Drug_Target_7_Synonyms:
P1A
P1B
P1C
P1D
P2A
P2B
P2C
P3A
P3B
P3C
P3D-POL
Picornain 2A
Picornain 3C
Protease 3C
Protein 2A
Protein 2B
Protein 2C
Protein 3A
Protein 3B
Protein VP0
Protein VP1
Protein VP2
Protein VP3
Protein VP4
RNA-directed RNA polymerase 3D-POL
VP4-VP2
VPg
Virion protein 1
Virion protein 2
Virion protein 3
Virion protein 4

# Drug_Target_7_Theoretical_pI:
6.97

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
RNA-directed RNA polymerase 3D-POL:Host cytoplasmic vesicle membrane

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_8_Essentiality:
Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
D00627

# Drug_Target_8_GenBank_ID_Protein:
221215

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
Not Available

# Drug_Target_8_Gene_Sequence:
>6606 bp
ATGGGAGCTCAAGTGTCAACACAGAAAACTGGAGCTCATGAAACCAGTTTAAGTGCGGCA
GGTAATTCAATTATACATTATACGAACATCAACTACTATAAAGATGCTGCGTCTAATTCG
GCTAATCGGCAAGACTTTACACAAGACCCGAGTAAGTTTACAGAGCCTGTTAAAGATGTT
ATGATTAAGTCTTTACCTGCCCTCAACTCACCAACAGTAGAAGAGTGCGGGTACAGCGAT
CGGGTTAGGTCCATCACCCTTGGAAACTCCACGATAACCACGCAGGAGTGTGCTAACGTG
GTGGTGGGGTATGGTAGATGGCCCACTTACCTCAGGGACGACGAGGCGACTGCCGAGGAT
CAACCCACACAGCCTGACGTAGCAACATGCCGCTTTTATACTTTAGATTCAATCAAGTGG
GAAAAGGGATCGGTGGGGTGGTGGTGGAAGTTCCCAGAAGCGCTTAGTGATATGGGATTA
TTCGGTCAGAACATGCAATACCACTACCTGGGTCGTGCAGGGTACACTATTCACCTACAA
TGTAACGCTTCCAAGTTCCATCAAGGGTGTTTGCTAGTAGTGTGTGTGCCCGAGGCTGAG
ATGGGAGGAGCTGTGGTTGGACAAGCATTTTCCGCCACCGCGATGGCAAATGGTGATAAA
GCATATGAGTTCACTAGCGCAACCCAAAGTGATCAGACAAAAGTTCAAACTGCTATACAC
AATGCAGGGATGGGCGTAGGTGTAGGGAACCTCACTATCTACCCGCACCAGTGGATAAAT
TTGCGCACCAACAACAGTGCCACCATAGTGATGCCATATATTAATAGTGTGCCCATGGAC
AACATGTTCAGACATTATAATTTTACCCTGATGGTGATACCTTTTGTGAAACTGGACTAT
GCCGACACCGCATCCACGTACGTGCCAATTACAGTGACGGTGGCCCCAATGTGTGCGGAG
TATAACGGCTTACGTCTGGCACAAGCGCAAGGTTTGCCAACTATGAACACACCAGGAAGC
ACGCAATTCCTAACATCAGATGACTTTCAATCGCCGTGCGCTTTGCCACAATTTGATGTG
ACGCCTAGTATGAACATCCCAGGAGAAGTGAAGAACCTAATGGAAATAGCAGAAGTGGAC
TCGGTCGTGCCCGTGAACAATGTCCAAGACACCACTGACCAAATGGAGATGTTCAGGATA
CCAGTGACCATAAATGCCCCTCTACAACAACAGGTTTTTGGCCTCAGATTGCAACCAGGC
TTAGATAGTGTGTTTAAGCACACTCTGTTGGGAGAAATTCTAAACTACTATGCGCACTGG
TCAGGCAGCATGAAGCTGACATTTGTGTTTTGCGGGTCTGCAATGGCAACAGGGAAATTT
TTAATAGCATATTCACCACCTGGGGCCAACCCCCCGAAAACACGAAAGGATGCAATGCTG
GGAACACATATCATATGGGACATTGGTTTACAATCTAGCTGTGTGTTGTGTGTGCCATGG
ATCAGTCAAACACATTATAGGCTTGTACAGCAGGATGAGTACACCAGCGCTGGTTACGTG
ACGTGTTGGTATCAGACTGGTATGATTGTCCCACCAGGAACCCCAAATTCTAGCTCTATT
ATGTGCTTTGCATCAGCGTGCAACGACTTCTCAGTAAGAATGTTGAGGGACACACCATTC
ATATCCCAGGATAATAAGCTGCAAGGGGATGTGGAAGAAGCCATTGAGAGGGCACGTTGT
ACAGTTGCTGACACCATGCGTACGGGGCCTAGCAATTCCGCGAGCGTACCTGCACTCACT
GCAGTTGAGACAGGGCACACCTCGCAAGTTACTCCAAGTGACACTATGCAGACAAGACAT
GTGAAAAACTATCATTCGCGCTCTGAGTCGACTGTGGAGAATTTCCTCGGTCGGTCGGCA
TGCGTGTACATGGAAGAGTACAAGACCACTGATAAGCATGTTAACAAGAAATTCGTCGCC
TGGCCAATCAACACAAAACAAATGGTTCAGATGCGGAGGAAGCTGGAAATGTTCACTTAT
CTTAGGTTTGATATGGAGGTAACTTTTGTGATCACAAGTCGACAAGACCCCGGAACAACC
CTAGCTCAGGACATGCCCGTGTTGACGCGCCAAATCATGTATGTGCCACCTGGCGGTCCG
ATTCCAGCAAAAGTTGATGATTATGCCTGGCAGACGTCTACAAACCCCAGCATTTTCTGG
ACGGAAGGAAACGCACCAGCGCGCATGTCCATCCCATTTATCAGCATAGGAAATGCATAC
AGCAATTTTTATGACGGGTGGTCAAATTTTGATCAGAGGGGCTCATACGGGTACAATACC
CTGAATAACTTAGGTCACATATATGTGAGACACGTGAGTGGAAGTAGTCCTCACCCAATC
ACGAGCACTATTAGAGTGTATTTCAAGCCAAAACATACCAGAGCTTGGGTGCCGCGCCCT
CCAAGGCTATGCCAATACAAGAAGGCATTTAGCGTGGATTTCACGCCAACTCCCATTACA
GACACCAGGAAAGACATCAACACTGTAACCACCGTGGCGCAAAGTCGGCGTCGGGGTGAC
ATGTCCACCCTTAACACGCATGGTGCCTTCGGACAACAATCCGGGGCCGTCTATGTGGGC
AACTACAGAGTGATCAACAGACACCTGGCAACACACACGGATTGGCAAAATTGCGTGTGG
GAGGATTACAATAGAGACCTCCTTGTGAGCACGACTACAGCGCACGGGTGTGATGTCATA
GCTAGATGCCAGTGTACAACCGGGGTGTACTTTTGTGCATCCAAGAACAAGCACTACCCT
GTTTCATTCGAAGGGCCAGGTTTAGTGGAAGTCCAAGAGAGTGAATACTACCCTAAAAGA
TATCAATCCCATGTACTTCTGGCAGCAGGATTTTCCGAACCAGGGGACTGTGGTGGCATC
TTAAGGTGTGAACACGGTGTCATAGGCATCGTAACCATGGGAGGCGAAGGTGTTGTGGGT
TTTGCTGACGTGCGCGACCTCTTATGGTTAGAGGATGACGCTATGGAGCAGGGTGTGAAG
GACTACGTGGAGCAACTTGGAAATGCATTTGGTTCAGGCTTCACCAATCAGATCTGTGAG
CAAGTTAACCTTTTAAAAGAATCACTAGTGGGTCAAGACTCCATCTTAGAGAAATCTCTA
AAAGCCCTAGTCAAGATAATATCAGCCTTAGTGATCGTGGTGAGGAACCACGATGACCTA
ATTACAGTGACTGCCATACTAGCCCTCATCGGTTGCACCTCGTCTCCATGGCGGTGGCTT
AAACAGAAAGTGTCACAGTATTATGGGATACCCATGGCTGAACGCCAAAATGATAGCTGG
CTCAAGAAATTCACTGAAATGACAAATGCCTGCAAACGAATGGAGTGGATAGCCATCAAA
ATTCAGAAGTTTATAGAGTGGCTCAAAGTTAAAATTCTACCAGAGGTAAGGGAGAAGCAT
GAGTTCCTGAACAGACTTAAACAGCTTCCCCTATTAGAGAGTCAGATTGCCACCATCGAG
CAGAGTGCACCATCCCAAAGCGACCAAGAGCAATTGTTTTCCAATGTCCAGTACTTTGCA
CACTATTGCAGAAAGTATGCCCCCCTCTACGCAGCAGAGGCAAAGAGGGTGTTCTCCCTT
GAGAAAAAGATGAGCAATTACATACAGTTCAAGTCCAAATGCCGTATTGAGCCTGTATGT
TTGCTCCTACATGGGAGTCCAGGTGCCGGCAAGTCGGTGGCAACAAACCTAATTGGAAGG
TCACTCGCTGAGAAATTAAACAGTTCAGTGTACTCATTACCACCAGACCCAGATCACTTT
GATGGCTACAAACAACAGGCCGTAGTGATTATGGATGACCTATGCCAGAACCCTGATGGA
AAAGATGTCTCCTTGTTTTGCCAAATGGTCTCTAGTGTAGATTTTGTGCCGCCCATGGCT
GCCTTGGAAGAGAAGGGCATTTTGTTCACCTCTCCGTTCGTTCTGGCATCGACTAATGCA
GGATCCATAAATGCTCCAACTGTGTCAGACAGCAGGGCCTTAGCAAGGAGGTTTCACTTC
GATATGAACATTGAAGTTATCTCCATGTATAGTCAGAACGGCAAAATAAATATGCCGATG
TCAGTGAAGACGTGTGATGAAGAGTGCTGTCCAGTCAACTTTAAGAAGTGTTGCCCTCTA
GTATGTGGTAAAGCCATCCAGTTCATAGACAGAAGAACCCAAGTTAGATACTCCCTTGAC
ATGCTGGTAACTGAGATGTTTAGAGAGTATAACCATAGGCATAGTGTCGGGGCCACCCTT
GAGGCATTATTCCAGGGTCCACCGATATATAGAGAAATTAAGATCAGTGTTGCGCCAGAG
ACACCACCACCACCTGTCATCGCTGATCTACTCAAGTCGGTGGACAGTGAGGATGTGAGA
GAGTACTGCAAAGAAAAGGGATGGTTGATCCCTGAGGTAAACTCCACCCTCCAAATTGAA
AAATACGTCAGTCGGGCTTTCATTTGCTTGCAGGCAATAACCACATTCGTGTCAGTAGCT
GGGATCATCTACATAATATATAAGCTCTTTGCAGGCTTTCAGGGTGCATATACAGGAATA
CCCAATCAGAAACCTAAGGTACCTACCTTAAGACAAGCAAAAGTGCAGGGTCCCGCATTT
GAATTCGCCGTTGCAATGATGAAGAGAAACTCAAGCACGGTGAAGACTGAGTATGGCGAA
TTCACCATGCTGGGCATCTATGACAGGTGGGCCGTCTTACCACGCCACGCTAAGCCTGGA
CCAACCATCCTGATGAATGACCAGGAAGTGGGCGTGATGGATGCTAAGGAATTAGTGGAT
AAGGATGGCACAAACCTAGAACTGACATTGCTTAAATTAAACAGGAATGAGAAGTTCAGA
GACATCAGAGGCTTCTTAGCTAAGGAGGAGATGGAGGTCAACGAAGCCGTGCTAGCAATT
AATACCAGTAAATTTCCCAACATGTACATTCCAGTGGGACAAGTCACGGACTACGGCTTC
CTAAACCTGGGTGGTACACCCACTAAGAGAATGCTCATGTACAACTTCCCCACAAGAGCA
GGTCAGTGCGGCGGAGTGCTCATGTCCACTGGCAAAGTCTTGGGAATCCATGTTGGTGGA
AATGGTCATCAAGGTTTCTCAGCAGCACTTCTCAAGCACTACTTCAATGATGAACAAGGA
GAGATCGAGTTCATTGAGAGTTCAAAGGATGCAGGGTTCCCGATTATCAATACACCTAGT
AAGACCAAGCTGGAGCCAAGTGTCTTCCATCAAGTTTTTGAAGGTGTCAAAGAACCAGCG
GTCCTCAGGAATGGTGATCCACGCCTCAAAGCTAATTTTGAGGAAGCCATATTTTCCAAG
TACATCGGAAATGTTAACACGCACGTGGATGAATACATGCTGGAAGCTGTTGATCATTAT
GCCGGACAATTGGCCACCCTAGATATTAGCACTGAACCAATGAAGTTGGAGGATGCTGTA
TACGGTACTGAAGGTCTTGAGGCTCTTGACCTAACAACGAGTGCAGGTTACCCTTATGTT
GCTCTGGGCATCAAGAAGAGGGACATTCTCTCAAAGAAGACCAGGGACCTGACCAAGCTG
AAGGAGTGCATGGACAAGTATGGCCTAAACTTGCCAATGATAACCTATGTGAAAGATCAA
CTCAGATCTGCAGAGAAGGTGGCAAAGGGAAAGTCTAGGCTCATTGAGGCGTCCAGTTTG
AATGACTCCGTGGCAATGAGACAGACATTCGGCAACCTATACAAAACTTTTCACCTAAAC
CCAGGGATTGTGACTGGCAGTGCCGTCGGGTGTGACCCGGATCTCTTTTGGAGTAAAATA
CCAGTAATGTTAAACGGTCACCTCATAGCCTTTGATTACTCTGGATATGATGCTAGCTTG
AGTCCTGTATGGTTTGCTTGTCTAAAACTACTACTTGAGAAACTTGGTTACTCGCACAAG
GAGACCAATTACATTGATTACCTGTGCAACTCCCATCACCTGTACAGGGACAAGCATTAT
TTCGTGCGGGGTGGCATGCCATCAGGATGTTCTGGCACGAGCATCTTTAACTCAATGATA
AACAACATCATAATTAGGACACTCATGTTGAAGGTTTACAAAGGGATCGACTTGGATCAA
TTCAGGATGATTGCTTATGGTGACGATGTGATCGCATCATACCCGTGGCCCATAGATGCG
TCTTTGCTTGCTGAAGCTGGCAAGGACTATGGATTAATCATGACACCAGCAGACAAAGGG
GAGTGCTTCAATGAAGTTACTTGGACTAACGTCACATTCCTAAAGAGGTATTTTAGAGCA
GATGAACAATACCCCTTTTTAGTGCACCCTGTTATGCCTATGAAAGACATACACGAATCA
ATCAGATGGACCAAGGATCCAAAGAACACCCAAGACCACGTGCGCTCGCTATGCTTATTA
GCTTGGCACAACGGGGAGCACGAATATGAGGAGTTCATTCGCAAAATCAGGAGCGTCCCA
GTTGGACGTTGTTTGACCCTACCTGCGTTCTCAACCCTACGCAGGAAGTGGTTGGACTCT
TTCTAA

# Drug_Target_8_General_Function:
Involved in ATP binding

# Drug_Target_8_General_References:
10647183	Hendry E, Hatanaka H, Fry E, Smyth M, Tate J, Stanway G, Santti J, Maaronen M, Hyypia T, Stuart D: The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses. Structure. 1999 Dec 15;7(12):1527-38.
15194773	Williams CH, Kajander T, Hyypia T, Jackson T, Sheppard D, Stanway G: Integrin alpha v beta 6 is an RGD-dependent receptor for coxsackievirus A9. J Virol. 2004 Jul;78(13):6967-73.
2558158	Chang KH, Auvinen P, Hyypia T, Stanway G: The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classification. J Gen Virol. 1989 Dec;70 ( Pt 12):3269-80.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
6736

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
246533.1

# Drug_Target_8_Name:
Genome polyprotein

# Drug_Target_8_Number_of_Residues:
2201

# Drug_Target_8_PDB_ID:
Not Available

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF00073	Rhv
PF00548	Peptidase_C3
PF00680	RdRP_1
PF00910	RNA_helicase
PF00947	Pico_P2A
PF01552	Pico_P2B
PF02226	Pico_P1A
PF08727	P3A

# Drug_Target_8_Protein_Sequence:
>Genome polyprotein
MGAQVSTQKTGAHETSLSAAGNSIIHYTNINYYKDAASNSANRQDFTQDPSKFTEPVKDV
MIKSLPALNSPTVEECGYSDRVRSITLGNSTITTQECANVVVGYGRWPTYLRDDEATAED
QPTQPDVATCRFYTLDSIKWEKGSVGWWWKFPEALSDMGLFGQNMQYHYLGRAGYTIHLQ
CNASKFHQGCLLVVCVPEAEMGGAVVGQAFSATAMANGDKAYEFTSATQSDQTKVQTAIH
NAGMGVGVGNLTIYPHQWINLRTNNSATIVMPYINSVPMDNMFRHYNFTLMVIPFVKLDY
ADTASTYVPITVTVAPMCAEYNGLRLAQAQGLPTMNTPGSTQFLTSDDFQSPCALPQFDV
TPSMNIPGEVKNLMEIAEVDSVVPVNNVQDTTDQMEMFRIPVTINAPLQQQVFGLRLQPG
LDSVFKHTLLGEILNYYAHWSGSMKLTFVFCGSAMATGKFLIAYSPPGANPPKTRKDAML
GTHIIWDIGLQSSCVLCVPWISQTHYRLVQQDEYTSAGYVTCWYQTGMIVPPGTPNSSSI
MCFASACNDFSVRMLRDTPFISQDNKLQGDVEEAIERARCTVADTMRTGPSNSASVPALT
AVETGHTSQVTPSDTMQTRHVKNYHSRSESTVENFLGRSACVYMEEYKTTDKHVNKKFVA
WPINTKQMVQMRRKLEMFTYLRFDMEVTFVITSRQDPGTTLAQDMPVLTRQIMYVPPGGP
IPAKVDDYAWQTSTNPSIFWTEGNAPARMSIPFISIGNAYSNFYDGWSNFDQRGSYGYNT
LNNLGHIYVRHVSGSSPHPITSTIRVYFKPKHTRAWVPRPPRLCQYKKAFSVDFTPTPIT
DTRKDINTVTTVAQSRRRGDMSTLNTHGAFGQQSGAVYVGNYRVINRHLATHTDWQNCVW
EDYNRDLLVSTTTAHGCDVIARCQCTTGVYFCASKNKHYPVSFEGPGLVEVQESEYYPKR
YQSHVLLAAGFSEPGDCGGILRCEHGVIGIVTMGGEGVVGFADVRDLLWLEDDAMEQGVK
DYVEQLGNAFGSGFTNQICEQVNLLKESLVGQDSILEKSLKALVKIISALVIVVRNHDDL
ITVTAILALIGCTSSPWRWLKQKVSQYYGIPMAERQNDSWLKKFTEMTNACKRMEWIAIK
IQKFIEWLKVKILPEVREKHEFLNRLKQLPLLESQIATIEQSAPSQSDQEQLFSNVQYFA
HYCRKYAPLYAAEAKRVFSLEKKMSNYIQFKSKCRIEPVCLLLHGSPGAGKSVATNLIGR
SLAEKLNSSVYSLPPDPDHFDGYKQQAVVIMDDLCQNPDGKDVSLFCQMVSSVDFVPPMA
ALEEKGILFTSPFVLASTNAGSINAPTVSDSRALARRFHFDMNIEVISMYSQNGKINMPM
SVKTCDEECCPVNFKKCCPLVCGKAIQFIDRRTQVRYSLDMLVTEMFREYNHRHSVGATL
EALFQGPPIYREIKISVAPETPPPPVIADLLKSVDSEDVREYCKEKGWLIPEVNSTLQIE
KYVSRAFICLQAITTFVSVAGIIYIIYKLFAGFQGAYTGIPNQKPKVPTLRQAKVQGPAF
EFAVAMMKRNSSTVKTEYGEFTMLGIYDRWAVLPRHAKPGPTILMNDQEVGVMDAKELVD
KDGTNLELTLLKLNRNEKFRDIRGFLAKEEMEVNEAVLAINTSKFPNMYIPVGQVTDYGF
LNLGGTPTKRMLMYNFPTRAGQCGGVLMSTGKVLGIHVGGNGHQGFSAALLKHYFNDEQG
EIEFIESSKDAGFPIINTPSKTKLEPSVFHQVFEGVKEPAVLRNGDPRLKANFEEAIFSK
YIGNVNTHVDEYMLEAVDHYAGQLATLDISTEPMKLEDAVYGTEGLEALDLTTSAGYPYV
ALGIKKRDILSKKTRDLTKLKECMDKYGLNLPMITYVKDQLRSAEKVAKGKSRLIEASSL
NDSVAMRQTFGNLYKTFHLNPGIVTGSAVGCDPDLFWSKIPVMLNGHLIAFDYSGYDASL
SPVWFACLKLLLEKLGYSHKETNYIDYLCNSHHLYRDKHYFVRGGMPSGCSGTSIFNSMI
NNIIIRTLMLKVYKGIDLDQFRMIAYGDDVIASYPWPIDASLLAEAGKDYGLIMTPADKG
ECFNEVTWTNVTFLKRYFRADEQYPFLVHPVMPMKDIHESIRWTKDPKNTQDHVRSLCLL
AWHNGEHEYEEFIRKIRSVPVGRCLTLPAFSTLRRKWLDSF

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
RNA-directed RNA polymerase 3D-POL replicates genomic and antigenomic RNA by recognizing replications specific signals (By similarity)

# Drug_Target_8_SwissProt_ID:
P21404

# Drug_Target_8_SwissProt_Name:
POLG_CXA9

# Drug_Target_8_Synonyms:
P1A
P1B
P1C
P1D
P2A
P2B
P2C
P3A
P3B
P3C
P3D-POL
Picornain 2A
Picornain 3C
Protease 3C
Protein 2A
Protein 2B
Protein 2C
Protein 3A
Protein 3B
Protein VP0
Protein VP1
Protein VP2
Protein VP3
Protein VP4
RNA-directed RNA polymerase 3D-POL
VP4-VP2
VPg
Virion protein 1
Virion protein 2
Virion protein 3
Virion protein 4

# Drug_Target_8_Theoretical_pI:
7.09

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
RNA-directed RNA polymerase 3D-POL:Host cytoplasmic vesicle membrane

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_9_Essentiality:
Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
M12197

# Drug_Target_9_GenBank_ID_Protein:
332891

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
Not Available

# Drug_Target_9_Gene_Sequence:
>6624 bp
ATGGGCGCCCAAGTCTCATCACAGAAAGTTGGAGCCCATGAGAATTCAAACAGAGCTTAT
GGCGGATCCACCATTAATTACACTACTATTAATTATTACAGGGATTCTGCGAGCAATGCC
GCTAGTAAGCAGGACTTTGCACAAGACCCATCCAAGTTCACTGAACCTATTAAAGATGTT
CTCATTAAGACCGCTCCCACACTAAACTCTCCTAATATCGAGGCGTGTGGGTATAGCGAC
AGAGTGATGCAACTAACCCTAGGCAATTCCACCATTACCACACAGGAGGCGGCCAATTCT
GTCGTTGCATACGGCCGGTGGCCCGAGTACATCAAGGACTCAGAAGCAAATCCTGTGGAC
CAGCCAACTGAACCGGACGTTGCCGCGTGCAGGTTTTACACACTAGACACTGTTACTTGG
CGCAAGGAGTCCAGAGGGTGGTGGTGGAAACTGCCTGATGCACTAAAGGACATGGGATTA
TTCGGCCAGAACATGTTCTACCACTACCTCGGGAGGGCTGGCTATACTGTGCACGTACAG
TGTAATGCTTCAAAGTTTCACCAGGGCGCCCTCGGGGTATTCGCAGTTCCAGAAATGTGC
CTGGCAGGCGACAGCACAACCCACATGTTTACAAAATATGAGAATGCAAATCCGGGTGAG
AAAGGGGGTGAATTCAAAGGGAGTTTTACTCTGGATACTAACGCTACCAACCCTGCACGC
AACTTTTGTCCCGTTGATTATCTCTTCGGGAGCGGAGTACTGGCGGGAAATGCGTTTGTT
TACCCACATCAGATAATTAATCTGCGCACCAACAACTGTGCCACGTTGGTGCTGCCATAC
GTTAATTCACTTTCCATAGACAGCATGACAAAACACAACAATTGGGGAATTGCTATCCTT
CCGCTGGCACCACTTGACTTTGCCACCGAGTCCTCCACTGAGATACCCATTACTCTAACT
ATTGCCCCTATGTGTTGTGAATTCAATGGGTTGCGCAACATCACTGTACCCAGAACTCAA
GGGTTGCCAGTCTTAAACACTCCAGGAAGCAACCAGTACTTAACAGCAGACAACTATCAA
TCCCCATGTGCGATACCCGAGTTTGATGTAACACCACCCATAGACATCCCGGGGGAAGTG
CGCAACATGATGGAATTGGCAGAGATAGACACCATGATACCTCTCAATCTGACGAACCAG
CGCAAGAACACCATGGATATGTACAGAGTCGAACTGAATGATGCGGCTCACTCTGACACA
CCAATATTGTGTCTCTCACTGTCTCCAGCATCAGATCCTAGGCTAGCACACACTATGCTA
GGTGAAATACTGAACTACTACACACACTGGGCAGGGTCATTGAAGTTCACATTTCTCTTC
TGCGGCTCAATGATGGCCACTGGTAAATTGCTAGTGTCCTATGCACCTCCTGGTGCGGAA
GCCCCTAAAAGCCGCAAAGAAGCGATGCTCGGCACCCACGTGATCTGGGACATCGGATTA
CAGTCATCATGCACTATGGTGGTACCTTGGATTAGCAACACCACATACAGACAAACCATC
AACGATAGCTTCACAGAAGGAGGGTACATCAGTATGTTTTACCAAACTAGAGTTGTTGTG
CCATTGTCCACCCCTAGAAAGATGGACATATTGGGCTTTGTGTCAGCCTGCAATGACTTC
AGTGTGCGCCTGTTGCGTGACACGACGCACATAAGCCAAGAGGCTATGCCACAAGGATTG
GGTGATTTAATTGAAGGGGTTGTTGAGGGAGTCACGAGAAATGCCTTGACACCACTGACA
CCTGCCAACAACTTGCCTGATACACAATCTAGCGGCCCAGCCCACTCTAAGGAAACACCA
GCGCTAACAGCCGTAGAGACAGGGGCCACCAACCCATTGGTGCCTTCAGACACGGTACAA
ACTCGTCACGTCATCCAAAAGCGGACGCGGTCGGAGTCTACGGTTGAGTCTTTCTTCGCA
AGAGGAGCTTGTGTGGCCATTATTGAAGTGGATAATGATGCTCCAACAAAGCGTGCCAGT
AAATTATTTTCAGTCTGGAAGATAACTTACAAAGACACCGTTCAGTTAAGACGTAAGTTG
GAGTTCTTTACATATTCAAGGTTTGACATGGAGTTCACCTTTGTGGTTACATCCAATTAT
ACCGATGCAAACAATGGGCACGCACTAAATCAAGTTTACCAGATAATGTACATACCACCT
GGGGCACCGATCCCTGGCAAGTGGAATGATTACACATGGCAAACGTCATCTAACCCATCA
GTGTTTTACACTTACGGGGCACCTCCAGCTAGAATATCAGTGCCCTACGTGGGCATTGCC
AATGCATATTCTCATTTTTACGATGGGTTTGCCAAAGTACCACTAGCAGGCCAAGCCTCA
ACAGAGGGTGACTCGCTGTATGGAGCGGCTTCATTGAATGACTTCGGATCACTGGCTGTT
CGAGTGGTGAATGACCACAACCCTACGAAACTCACCTCAAAAATCAGAGTGTACATGAAA
CCAAAGCACGTCAGAGTGTGGTGTCCGCGACCCCCTCGAGCAGTCCCATACTACGGACCA
GGGGTTGACTACAAGGATGGACTAGCCCCACTGCCAGGGAAAGGCTTGACAACCTATGGT
TTTGGCCACCAAAATAAGGCAGTGTACACGGCAGGTTACAAAATTTGCAATTACCACCTC
GCCACCCAGGAAGACTTACAAAATGCGGTAAACATTATGTGGATTAGAGACCTTTTAGTA
GTGGAATCCAAAGCCCAAGGCATAGACTCAATTGCTAGATGTAACTGCCACACTGGAGTG
TACTACTGTGAATCCAGGAGGAAGTACTACCCGGTCTCTTTTACTGGCCCCACCTTTCAG
TACATGGAAGCAAATGAGTACTATCCAGCCCGATACCAATCCCACATGTTAATTGGCCAT
GGTTTTGCATCTCCAGGGGACTGTGGTGGGATTCTCAGGTGCCAACATGGAGTAATTGGA
ATCATTACAGCTGGAGGAGAAGGCCTAGTCGCTTTCTCGGACATCAGAGATCTGTACGCA
TACGAGGAGGAGGCTATGGAGCAGGGAGTCTCCAACTATATTGAGTCCCTTGGGGCTGCA
TTTGGGAGTGGATTCACCCAGCAAATAGGAAACAAAATTTCAGAACTCACTAGCATGGTC
ACCAGCACTATAACTGAGAAACTACTAAAGAATCTCATTAAAATAATTTCATCCCTTGTT
ATCATCACCAGAAACTATGAAGACACGACCACAGTGCTGGCTACCCTTGCTCTCCTCGGT
TGTGATGCGTCCCCATGGCAATGGCTAAAGAAGAAAGCCTGTGACATCTTGGAAATCCCC
TACATCATGCGACAGGGCGATAGCTGGTTGAAGAAGTTTACAGAGGCATGCAATGCAGCT
AAGGGATTGGAATGGGTGTCTAATAAAATATCCAAATTTATTGACTGGCTCAAAGAGAAG
ATCATTCCACAGGCTAGAGACAAGCTAGAGTTTGTTACCAAACTGAAGCAACTAGAAATG
TTGGAGAACCAAATTGCAACCATTCATCAATCGTGCCCAAGTCAGGAGCATCAAGAAATC
CTGTTCAATAACGTGAGATGGTTATCCATACAGTCAAAGAGATTTGCCCCGCTCTATGCG
GTTGAGGCTAAGAGAATACAAAAGTTAGAGCACACGATTAACAACTACGTACAGTTCAAG
AGCAAACACCGTATTGAACCAGTATGTTTGTTGGTGCACGGTAGCCCAGGCACGGGCAAG
TCAGTTGCCACCAATTTAATTGCCAGAGCAATAGCAGAGAAGGAGAACACCTCCACATAC
TCACTACCACCAGATCCCTCCCATTTCGATGGGTACAAGCAACAAGGTGTGGTGATCATG
GATGATTTGAATCAGAACCCAGACGGAGCAGACATGAAGCTGTTTTGTCAGATGGTCTCC
ACTGTAGAATTCATACCACCAATGGCTTCGCTAGAAGAAAAGGGTATTTTGTTCACATCT
AATTACGTTTTGGCCTCAACCAATTCCAGTCGCATCACCCCACCAACTGTTGCGCACAGC
GATGCCCTAGCCAGGCGCTTTGCATTTGACATGGACATACAAATCATGAGCGAGTATTCT
AGAGATGGAAAATTGAACATGGCGATGGCAACTGAAATGTGTAAGAACTGTCATCACCCA
GCAAACTTCAAGAGATGTTGCCCATTGGTGTGTGGCAAAGCCATCCAGCTGATGGACAAA
TCTTCCAGAGTCAGATATAGTATAGATCAGATTACTACCATGATTATTAATGAGAGGAAC
AGAAGATCAAGTATCGGTAATTGCATGGAGGCACTTTTCCAAGGTCCTCTTCAATACAAA
GACCTGAAAATAGACATTAAGACCACACCTCCTCCTGAGTGCATCAATGATTTGCTCCAA
GCAGTTGATTCTCAAGAGGTAAGAGACTACTGTGAGAAGAAGGGTTGGATAGTAGACATC
ACTAGTCAGGTGCAAACCGAAAGAAACATCAATAGAGCAATGACTATTCTTCAGGCGGTC
ACCACATTTGCCGCAGTTGCTGGAGTGGTGTATGTGATGTACAAACTCTTTGCAGGGCAT
CAAGGAGCGTATACAGGGCTTCCCAATAAGAGACCCAATGTCCCCACCATCAGGACTGCC
AAGGTTCAGGGCCCAGGATTTGACTACGCAGTGGCAATGGCCAAAAGAAACATTCTTACG
GCAACTACCATTAAGGGAGAGTTCACAATGCTCGGAGTGCATGATAATGTGGCCATTCTA
CCAACCCACGCATCACCGGGTGAAACAATAGTCATTGATGGCAAGGAAGTAGAGGTACTG
GATGCTAAAGCCCTGGAGGACCAGGCCGGGACCAACCTGGAAATCACCATTGTCACTCTT
AAGAGAAATGAGAAGTTCAGGGACATCAGACCACACATCCCCACTCAAATCACTGAGACA
AATGATGGAGTTTTAATTGTGAACACTAGTAAGTACCCCAACATGTATGTTCCTGTCGGT
GCTGTGACTGAACAGGGGTATCTCAATCTCAGTGGACGCCAAACTGCTCGTACTTTAATG
TACAACTTTCCAACGAGAGCAGGTCAATGTGGTGGAGTTATCACCTGCACTGGCAAGGTC
ATCGGGATGCATGTTGGTGGGAACGGTTCACATGGGTTCGCAGCAGCCCTGAAGCGATCC
TATTTCACTCAGAGTCAAGGTGAAATCCAGTGGATGAGACCATCAAAAGAAGTGGGCTAC
CCCGTTATTAATGCTCCATCTAAAACTAAACTGGAACCCAGTGCATTCCATTATGTGTTT
GAAGGTGTCAAGGAACCAGCTGTGCTCACCAAAAGTGACCCCAGATTGAAGACAGATTTT
GAAGAGGCTATCTTTTCCAAGTATGTGGGAAATAAGATTACTGAAGTGGATGAGTACATG
AAAGAAGCTGTCGATCATTACGCAGGCCAGCTCATGTCACTAGACATCAACACAGAACAA
ATGTGCCTTGAGGATGCAATGTATGGCACTGACGGTCTCGAAGCTCTAGACCTCAGTACC
AGTGCTGGGTATCCCTATGTGGCAATGGGGAAAAAGAAAAGAGACATTTTGAATAAGCAA
ACCAGAGACACAAAGGAAATGCAAAGGCTTCTGGACACCTATGGTATTAATTTACCTTTA
GTCACCTATGTGAAAGATGAGCTTAGATCCAAGACCAAAGTGGAACAGGGCAAGTCCAGG
CTAATTGAGGCCTCAAGTCTCAATGACTCTGTCGCCATGAGGATGGCTTTTGGCAACTTG
TACGCAGCATTCCACAAGAACCCAGGTGTAGTGACAGGATCGGCTGTTGGCTGTGACCCA
GATTTGTTTTGGAGTAAAATACCAGTCCTCATGGAGGAAAAACTCTTTGCATTTGATTAC
ACGGGTTATGATGCTTCACTAAGCCCCGCCTGGTTTGAGGCTCTCAAGATGGTTCTAGAG
AAAATTGGGTTTGGTGACAGAGTGGATTACATTGATTATCTGAATCACTCGCACCATCTA
TATAAAAATAAGACATATTGTGTTAAGGGCGGCATGCCATCTGGCTGCTCTGGCACCTCA
ATTTTTAATTCAATGATTAATAATCTAATAATCAGGACTCTCTTACTGAAAACCTACAAG
GGCATAGATTTAGACCACCTGAAGATGATAGCCTATGGTGATGATGTAATTGCTTCCTAC
CCCCATGAGGTTGATGCTAGTCTCCTAGCCCAATCAGGAAAAGACTATGGACTAACCATG
ACACCAGCTGACAAATCAGCCACCTTTGAAACAGTCACATGGGAGAATGTAACATTCTTG
AAAAGATTCTTTAGAGCAGATGAAAAGTATCCCTTTCTGGTACATCCAGTGATGCCAATG
AAAGAAATTCACGAATCAATTAGATGGACTAAAGATCCCAGAAACACTCAGGATCATGTT
CGCTCACTGTGCTTATTGGCTTGGCACAATGGCGAGGAAGAGTACAATAAATTTTTAGCT
AAGATTAGAAGTGTGCCAATCGGAAGAGCATTACTGCTCCCTGAGTACTCCACATTGTAC
CGCCGTTGGCTCGACTCATTTTAG

# Drug_Target_9_General_Function:
Involved in ATP binding

# Drug_Target_9_General_References:
3003384	La Monica N, Meriam C, Racaniello VR: Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing. J Virol. 1986 Feb;57(2):515-25.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
6737

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
245828.6

# Drug_Target_9_Name:
Genome polyprotein

# Drug_Target_9_Number_of_Residues:
2207

# Drug_Target_9_PDB_ID:
1RDR

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF00073	Rhv
PF00548	Peptidase_C3
PF00680	RdRP_1
PF00910	RNA_helicase
PF00947	Pico_P2A
PF01552	Pico_P2B
PF02226	Pico_P1A
PF08727	P3A

# Drug_Target_9_Protein_Sequence:
>Genome polyprotein
MGAQVSSQKVGAHENSNRAYGGSTINYTTINYYRDSASNAASKQDFAQDPSKFTEPIKDV
LIKTAPTLNSPNIEACGYSDRVMQLTLGNSTITTQEAANSVVAYGRWPEYIKDSEANPVD
QPTEPDVAACRFYTLDTVTWRKESRGWWWKLPDALKDMGLFGQNMFYHYLGRAGYTVHVQ
CNASKFHQGALGVFAVPEMCLAGDSTTHMFTKYENANPGEKGGEFKGSFTLDTNATNPAR
NFCPVDYLFGSGVLAGNAFVYPHQIINLRTNNCATLVLPYVNSLSIDSMTKHNNWGIAIL
PLAPLDFATESSTEIPITLTIAPMCCEFNGLRNITVPRTQGLPVLNTPGSNQYLTADNYQ
SPCAIPEFDVTPPIDIPGEVRNMMELAEIDTMIPLNLTNQRKNTMDMYRVELNDAAHSDT
PILCLSLSPASDPRLAHTMLGEILNYYTHWAGSLKFTFLFCGSMMATGKLLVSYAPPGAE
APKSRKEAMLGTHVIWDIGLQSSCTMVVPWISNTTYRQTINDSFTEGGYISMFYQTRVVV
PLSTPRKMDILGFVSACNDFSVRLLRDTTHISQEAMPQGLGDLIEGVVEGVTRNALTPLT
PANNLPDTQSSGPAHSKETPALTAVETGATNPLVPSDTVQTRHVIQKRTRSESTVESFFA
RGACVAIIEVDNDAPTKRASKLFSVWKITYKDTVQLRRKLEFFTYSRFDMEFTFVVTSNY
TDANNGHALNQVYQIMYIPPGAPIPGKWNDYTWQTSSNPSVFYTYGAPPARISVPYVGIA
NAYSHFYDGFAKVPLAGQASTEGDSLYGAASLNDFGSLAVRVVNDHNPTKLTSKIRVYMK
PKHVRVWCPRPPRAVPYYGPGVDYKDGLAPLPGKGLTTYGFGHQNKAVYTAGYKICNYHL
ATQEDLQNAVNIMWIRDLLVVESKAQGIDSIARCNCHTGVYYCESRRKYYPVSFTGPTFQ
YMEANEYYPARYQSHMLIGHGFASPGDCGGILRCQHGVIGIITAGGEGLVAFSDIRDLYA
YEEEAMEQGVSNYIESLGAAFGSGFTQQIGNKISELTSMVTSTITEKLLKNLIKIISSLV
IITRNYEDTTTVLATLALLGCDASPWQWLKKKACDILEIPYIMRQGDSWLKKFTEACNAA
KGLEWVSNKISKFIDWLKEKIIPQARDKLEFVTKLKQLEMLENQIATIHQSCPSQEHQEI
LFNNVRWLSIQSKRFAPLYAVEAKRIQKLEHTINNYVQFKSKHRIEPVCLLVHGSPGTGK
SVATNLIARAIAEKENTSTYSLPPDPSHFDGYKQQGVVIMDDLNQNPDGADMKLFCQMVS
TVEFIPPMASLEEKGILFTSNYVLASTNSSRITPPTVAHSDALARRFAFDMDIQIMSEYS
RDGKLNMAMATEMCKNCHHPANFKRCCPLVCGKAIQLMDKSSRVRYSIDQITTMIINERN
RRSSIGNCMEALFQGPLQYKDLKIDIKTTPPPECINDLLQAVDSQEVRDYCEKKGWIVDI
TSQVQTERNINRAMTILQAVTTFAAVAGVVYVMYKLFAGHQGAYTGLPNKRPNVPTIRTA
KVQGPGFDYAVAMAKRNILTATTIKGEFTMLGVHDNVAILPTHASPGETIVIDGKEVEVL
DAKALEDQAGTNLEITIVTLKRNEKFRDIRPHIPTQITETNDGVLIVNTSKYPNMYVPVG
AVTEQGYLNLSGRQTARTLMYNFPTRAGQCGGVITCTGKVIGMHVGGNGSHGFAAALKRS
YFTQSQGEIQWMRPSKEVGYPVINAPSKTKLEPSAFHYVFEGVKEPAVLTKSDPRLKTDF
EEAIFSKYVGNKITEVDEYMKEAVDHYAGQLMSLDINTEQMCLEDAMYGTDGLEALDLST
SAGYPYVAMGKKKRDILNKQTRDTKEMQRLLDTYGINLPLVTYVKDELRSKTKVEQGKSR
LIEASSLNDSVAMRMAFGNLYAAFHKNPGVVTGSAVGCDPDLFWSKIPVLMEEKLFAFDY
TGYDASLSPAWFEALKMVLEKIGFGDRVDYIDYLNHSHHLYKNKTYCVKGGMPSGCSGTS
IFNSMINNLIIRTLLLKTYKGIDLDHLKMIAYGDDVIASYPHEVDASLLAQSGKDYGLTM
TPADKSATFETVTWENVTFLKRFFRADEKYPFLVHPVMPMKEIHESIRWTKDPRNTQDHV
RSLCLLAWHNGEEEYNKFLAKIRSVPIGRALLLPEYSTLYRRWLDSF

# Drug_Target_9_Reaction:
Not Available

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
RNA-directed RNA polymerase 3D-POL replicates genomic and antigenomic RNA by recognizing replications specific signals (By similarity)

# Drug_Target_9_SwissProt_ID:
P06210

# Drug_Target_9_SwissProt_Name:
POLG_POL2L

# Drug_Target_9_Synonyms:
P1A
P1B
P1C
P1D
P2A
P2B
P2C
P3A
P3B
P3C
P3D-POL
Picornain 2A
Picornain 3C
Protease 3C
Protein 2A
Protein 2B
Protein 2C
Protein 3A
Protein 3B
Protein VP0
Protein VP1
Protein VP2
Protein VP3
Protein VP4
RNA-directed RNA polymerase 3D-POL
VP4-VP2
VPg
Virion protein 1
Virion protein 2
Virion protein 3
Virion protein 4

# Drug_Target_9_Theoretical_pI:
7.17

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB08231
